
<html lang="en"     class="pb-page"  data-request-id="5546dd74-148a-4879-b1ea-550ccf5e76f8"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2015.58.issue-8;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm501740a;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents" /></meta><meta name="dc.Creator" content="Yong  Liu" /></meta><meta name="dc.Creator" content="Yunhui  Lang" /></meta><meta name="dc.Creator" content="Narendra Kumar  Patel" /></meta><meta name="dc.Creator" content="Grace  Ng" /></meta><meta name="dc.Creator" content="Radoslaw  Laufer" /></meta><meta name="dc.Creator" content="Sze-Wan  Li" /></meta><meta name="dc.Creator" content="Louise  Edwards" /></meta><meta name="dc.Creator" content="Bryan  Forrest" /></meta><meta name="dc.Creator" content="Peter B.  Sampson" /></meta><meta name="dc.Creator" content="Miklos  Feher" /></meta><meta name="dc.Creator" content="Fuqiang  Ban" /></meta><meta name="dc.Creator" content="Donald E.  Awrey" /></meta><meta name="dc.Creator" content="Irina  Beletskaya" /></meta><meta name="dc.Creator" content="Guodong  Mao" /></meta><meta name="dc.Creator" content="Richard  Hodgson" /></meta><meta name="dc.Creator" content="Olga  Plotnikova" /></meta><meta name="dc.Creator" content="Wei  Qiu" /></meta><meta name="dc.Creator" content="Nickolay Y.  Chirgadze" /></meta><meta name="dc.Creator" content="Jacqueline M.  Mason" /></meta><meta name="dc.Creator" content="Xin  Wei" /></meta><meta name="dc.Creator" content="Dan Chi-Chia  Lin" /></meta><meta name="dc.Creator" content="Yi  Che" /></meta><meta name="dc.Creator" content="Reza  Kiarash" /></meta><meta name="dc.Creator" content="Brian  Madeira" /></meta><meta name="dc.Creator" content="Graham C.  Fletcher" /></meta><meta name="dc.Creator" content="Tak W.  Mak" /></meta><meta name="dc.Creator" content="Mark R.  Bray" /></meta><meta name="dc.Creator" content="Henry W.  Pauls" /></meta><meta name="dc.Description" content="The acetamido and carboxamido substituted 3-(1H-indazol-3-yl)benzenesulfonamides are potent TTK inhibitors. However, they display modest ability to attenuate cancer cell growth; their physicochemic..." /></meta><meta name="Description" content="The acetamido and carboxamido substituted 3-(1H-indazol-3-yl)benzenesulfonamides are potent TTK inhibitors. However, they display modest ability to attenuate cancer cell growth; their physicochemic..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 3, 2015" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm501740a" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2015 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm501740a" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm501740a" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm501740a" /></link>
        
    
    

<title>The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm501740a" /></meta><meta property="og:title" content="The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0024.jpeg" /></meta><meta property="og:description" content="The acetamido and carboxamido substituted 3-(1H-indazol-3-yl)benzenesulfonamides are potent TTK inhibitors. However, they display modest ability to attenuate cancer cell growth; their physicochemical properties, and attendant pharmacokinetic parameters, are not drug-like. By eliminating the polar 3-sulfonamide group and grafting a heterocycle at the 4 position of the phenyl ring, potent inhibitors with oral exposure were obtained. An X-ray cocrystal structure and a refined binding model allowed for a structure guided approach. Systematic optimization resulted in novel TTK inhibitors, namely 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides. Compounds incorporating the 3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl bicyclic system were potent (TTK IC50 &lt; 10 nM, HCT116 GI50 &lt; 0.1 μM), displayed low off-target activity (&gt;500×), and microsomal stability (T1/2 &gt; 30 min). A subset was tested in rodent PK and mouse xenograft models of human cancer. Compound 75 (CFI-401870) recapitulated the phenotype of TTK RNAi, demonstrated in vivo tumor growth inhibition upon oral dosing, and was selected for preclinical evaluation." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm501740a"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm501740a">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm501740a&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm501740a&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm501740a&amp;href=/doi/10.1021/jm501740a" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2015</span><span class="cit-fg-volume">, 58</span><span class="cit-fg-issue">, 8</span><span class="cit-fg-pageRange">, 3366-3392</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/58/8" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm501655t" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm501759m" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamides as Anticancer Agents</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yong++Liu">Yong Liu</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yunhui++Lang">Yunhui Lang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Narendra+Kumar++Patel">Narendra Kumar Patel</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Grace++Ng">Grace Ng</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Radoslaw++Laufer">Radoslaw Laufer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sze-Wan++Li">Sze-Wan Li</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Louise++Edwards">Louise Edwards</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bryan++Forrest">Bryan Forrest</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+B.++Sampson">Peter B. Sampson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Miklos++Feher">Miklos Feher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Fuqiang++Ban">Fuqiang Ban</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+E.++Awrey">Donald E. Awrey</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Irina++Beletskaya">Irina Beletskaya</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Guodong++Mao">Guodong Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Hodgson">Richard Hodgson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Olga++Plotnikova">Olga Plotnikova</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Qiu">Wei Qiu</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nickolay+Y.++Chirgadze">Nickolay Y. Chirgadze</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jacqueline+M.++Mason">Jacqueline M. Mason</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xin++Wei">Xin Wei</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dan+Chi-Chia++Lin">Dan Chi-Chia Lin</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yi++Che">Yi Che</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Reza++Kiarash">Reza Kiarash</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Brian++Madeira">Brian Madeira</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Graham+C.++Fletcher">Graham C. Fletcher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tak+W.++Mak">Tak W. Mak</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+R.++Bray">Mark R. Bray</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Henry+W.++Pauls">Henry W. Pauls</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Campbell Family Cancer Research Institute, University Health Network, Princess Margaret Cancer Centre, 610 University Avenue, Toronto, Ontario M5G 2C4, Canada</span></div><div class="corresp-info"><strong>*</strong>For H.W.P.: phone, 416-581-7620; E-mail, <a href="/cdn-cgi/l/email-protection#84ecf4e5f1e8f7c4f1eceaf6e1f7e1e5f6e7ecaae7e5"><span class="__cf_email__" data-cfemail="7e160e1f0b120d3e0b16100c1b0d1b1f0c1d16501d1f">[email protected]</span></a></div><div class="corresp-info"><strong>*</strong>For Y.L.: phone, 416-581-8550 (8450); E-mail, <a href="/cdn-cgi/l/email-protection#50293f3e373c1025383e22352335312233387e3331"><span class="__cf_email__" data-cfemail="e69f8988818aa6938e88948395838794858ec88587">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm501740a&amp;href=/doi/10.1021%2Fjm501740a" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2015</span></span><span class="cit-volume">, 58</span><span class="cit-issue">, 8</span><span class="cit-pageRange">, 3366–3392</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">March 12, 2015</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>10 November 2014</li><li><span class="item_label"><b>Published</b> online</span>3 April 2015</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 April 2015</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm501740a" title="DOI URL">https://doi.org/10.1021/jm501740a</a></div><div class="article_header-article-copyright"><strong>Copyright © 2015 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D3366%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DYong%2BLiu%252C%2BYunhui%2BLang%252C%2BNarendra%2BKumar%2BPatel%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D58%26issueNum%3D8%26contentID%3Djm501740a%26title%3DThe%2BDiscovery%2Bof%2BOrally%2BBioavailable%2BTyrosine%2BThreonine%2BKinase%2B%2528TTK%2529%2BInhibitors%253A%2B3-%25284-%2528heterocyclyl%2529phenyl%2529-1H-indazole-5-carboxamides%2Bas%2BAnticancer%2BAgents%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D3392%26publicationDate%3DApril%2B2015">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm501740a"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3075</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">32</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm501740a" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;The Discovery of Orally Bioavailable Tyrosine Threonine Kinase (TTK) Inhibitors: 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides as Anticancer Agents&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Yong&quot;,&quot;last_name&quot;:&quot;Liu&quot;},{&quot;first_name&quot;:&quot;Yunhui&quot;,&quot;last_name&quot;:&quot;Lang&quot;},{&quot;first_name&quot;:&quot;Narendra&quot;,&quot;last_name&quot;:&quot;Kumar Patel&quot;},{&quot;first_name&quot;:&quot;Grace&quot;,&quot;last_name&quot;:&quot;Ng&quot;},{&quot;first_name&quot;:&quot;Radoslaw&quot;,&quot;last_name&quot;:&quot;Laufer&quot;},{&quot;first_name&quot;:&quot;Sze-Wan&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Louise&quot;,&quot;last_name&quot;:&quot;Edwards&quot;},{&quot;first_name&quot;:&quot;Bryan&quot;,&quot;last_name&quot;:&quot;Forrest&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;B. Sampson&quot;},{&quot;first_name&quot;:&quot;Miklos&quot;,&quot;last_name&quot;:&quot;Feher&quot;},{&quot;first_name&quot;:&quot;Fuqiang&quot;,&quot;last_name&quot;:&quot;Ban&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;E. Awrey&quot;},{&quot;first_name&quot;:&quot;Irina&quot;,&quot;last_name&quot;:&quot;Beletskaya&quot;},{&quot;first_name&quot;:&quot;Guodong&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Hodgson&quot;},{&quot;first_name&quot;:&quot;Olga&quot;,&quot;last_name&quot;:&quot;Plotnikova&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Qiu&quot;},{&quot;first_name&quot;:&quot;Nickolay&quot;,&quot;last_name&quot;:&quot;Y. Chirgadze&quot;},{&quot;first_name&quot;:&quot;Jacqueline&quot;,&quot;last_name&quot;:&quot;M. Mason&quot;},{&quot;first_name&quot;:&quot;Xin&quot;,&quot;last_name&quot;:&quot;Wei&quot;},{&quot;first_name&quot;:&quot;Dan&quot;,&quot;last_name&quot;:&quot;Chi-Chia Lin&quot;},{&quot;first_name&quot;:&quot;Yi&quot;,&quot;last_name&quot;:&quot;Che&quot;},{&quot;first_name&quot;:&quot;Reza&quot;,&quot;last_name&quot;:&quot;Kiarash&quot;},{&quot;first_name&quot;:&quot;Brian&quot;,&quot;last_name&quot;:&quot;Madeira&quot;},{&quot;first_name&quot;:&quot;Graham&quot;,&quot;last_name&quot;:&quot;C. Fletcher&quot;},{&quot;first_name&quot;:&quot;Tak&quot;,&quot;last_name&quot;:&quot;W. Mak&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;R. Bray&quot;},{&quot;first_name&quot;:&quot;Henry&quot;,&quot;last_name&quot;:&quot;W. Pauls&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2015&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;03&quot;,&quot;issue&quot;:&quot;8&quot;,&quot;volume&quot;:&quot;58&quot;,&quot;pages&quot;:&quot;3366-3392&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm501740a&quot;},&quot;abstract&quot;:&quot;The acetamido and carboxamido substituted 3-(1H-indazol-3-yl)benzenesulfonamides are potent TTK inhibitors. However, they display modest ability to attenuate cancer cell growth; their physicochemical properties, and attendant pharmacokinetic parameters, are not drug-like. By eliminating the polar 3-sulfonamide group and grafting a heterocycle at the 4 position of the phenyl ring, potent inhibitors with oral exposure were obtained. An X-ray cocrystal structure and a refined binding model allowed for a structure guided approach. Systematic optimization resulted in novel TTK inhibitors, namely 3-(4-(heterocyclyl)phenyl)-1H-indazole-5-carboxamides. Compounds incorporating the 3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl bicyclic system were potent (TTK IC50 &lt; 10 nM, HCT116 GI50 &lt; 0.1 μM), displayed low off-target activity (&gt;500×), and microsomal stability (T1/2 &gt; 30 min). A subset was tested in rodent PK and mouse xenograft models of human cancer. Compound 75 (CFI-401870) recapitulated the phenotype of TTK RNAi, demon&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501740a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501740a" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501740a&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501740a" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm501740a&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501740a" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm501740a&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm501740a&amp;href=/doi/10.1021/jm501740a" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm501740a" /></input><a href="/doi/pdf/10.1021/jm501740a" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm501740a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm501740a%26sid%3Dliteratum%253Aachs%26pmid%3D25763473%26genre%3Darticle%26aulast%3DLiu%26date%3D2015%26atitle%3DThe%2BDiscovery%2Bof%2BOrally%2BBioavailable%2BTyrosine%2BThreonine%2BKinase%2B%2528TTK%2529%2BInhibitors%253A%2B3-%25284-%2528heterocyclyl%2529phenyl%2529-1H-indazole-5-carboxamides%2Bas%2BAnticancer%2BAgents%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D58%26issue%3D8%26spage%3D3366%26epage%3D3392%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/58/8" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jmcmar.2015.58.issue-8/20150423/jmcmar.2015.58.issue-8.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The acetamido and carboxamido substituted 3-(1<i>H</i>-indazol-3-yl)benzenesulfonamides are potent TTK inhibitors. However, they display modest ability to attenuate cancer cell growth; their physicochemical properties, and attendant pharmacokinetic parameters, are not drug-like. By eliminating the polar 3-sulfonamide group and grafting a heterocycle at the 4 position of the phenyl ring, potent inhibitors with oral exposure were obtained. An X-ray cocrystal structure and a refined binding model allowed for a structure guided approach. Systematic optimization resulted in novel TTK inhibitors, namely 3-(4-(heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamides. Compounds incorporating the 3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl bicyclic system were potent (TTK IC<sub>50</sub> < 10 nM, HCT116 GI<sub>50</sub> < 0.1 μM), displayed low off-target activity (>500×), and microsomal stability (<i>T</i><sub>1/2</sub> > 30 min). A subset was tested in rodent PK and mouse xenograft models of human cancer. Compound <b>75</b> (CFI-401870) recapitulated the phenotype of TTK RNAi, demonstrated in vivo tumor growth inhibition upon oral dosing, and was selected for preclinical evaluation.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A number of cell cycle and checkpoint kinases have been targeted as potential strategies for the treatment of cancer.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The spindle assembly checkpoint (SAC) is an important and highly orchestrated control mechanism during mitosis; it assures the proper attachment of chromosomes to the mitotic spindle prior to anaphase.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Most cancer cells are aneuploid<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and thus take longer than normal diploid cells to align and attach their chromosomes to the mitotic spindle.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> It has been demonstrated that chromosomal instability (CIN) causes aneuploidy, a hallmark of cancer,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> therefore the selective suppression of aneuploid cells should be beneficial.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The conserved dual-specificity kinase TTK (threonine tyrosine kinase, also known as Mps1) is essential for alignment of chromosomes to the metaphase plate<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and genomic integrity during cell division through establishment and maintenance of the SAC.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> TTK is overexpressed in a variety of solid cancers,<a onclick="showRef(event, 'ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12 ref13">(9-13)</a> and elevated levels of TTK correlate with high histological grade in tumors<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and poor patient outcome.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> High levels of TTK in cancer cells may contribute to their tolerance of the aneuploidy state.<a onclick="showRef(event, 'ref11 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref11 ref14 ref15">(11, 14, 15)</a> Inhibition of TTK impairs the SAC and allows cancer cells to progress through mitosis in the presence of misaligned chromosomes, resulting in an intolerably high degree of aneuploidy and eventual cell death.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">TTK has been identified as one of the top 25 genes overexpressed in tumors with chromosomal instability<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15, 16)</a> and aneuploidy.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17, 18)</a> PTEN-deficient breast tumor cells are particularly dependent upon TTK for their survival such that RNAi-mediated knockdown leads to cell death. TTK inhibitors have been shown to target PTEN-deficient cells more acutely, presumably exploiting their underlying aneuploidy and genomic instability.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Besides its role in mitosis, TTK has been implicated in the Hedgehog,<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> EGFR,<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> and DNA damage signaling pathways.<a onclick="showRef(event, 'ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23">(21-23)</a> TTK controls DNA damage responses and genome stability by phosphorylating the Bloom syndrome helicase (BLM),<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> CHK2 in the G2/M checkpoint,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> and c-ABL after oxidative stress.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a></div><div class="NLM_p">TTK first came to our attention as a hit in a genome wide siRNA screen in which the growth of 7 out of 12 breast cancer cell lines tested was attenuated.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Subsequently we were able to show that siRNA knockdown abrogated cancer cell growth and caused gross chromosome segregation errors, resulting in aneuploidy and cell death. In vivo, interfering RNA mediated depletion suppressed the growth of tumor xenografts in mice.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Taken together, these observations encouraged us to pursue TTK as a viable target for cancer therapy.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">TTK has received considerable attention from laboratories interested in the development of small molecule inhibitors of this potential cancer target. Representative structures are given in Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>. The structural feature most commonly incorporated in these inhibitors is the 2-(phenylamino)pyrimidine motif found in AZ3146,<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> reversine,<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Mps1-IN-2, and its analogue <b>1</b> (methoxy-Mps1-IN-2, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>),<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a><b>2</b> (NMS-P715),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> and the Genentech inhibitor.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> The Shionogi-1 compound<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> and CCT251455<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> incorporate variations on this theme. These compounds have been used to further understanding of the cellular functions of TTK. A patent from Oncotherapy<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> describes (alkylamino)imidazo[1,2-<i>b</i>]pyridazines as a novel series of TTK inhibitors. The related (alkylamino)imidazo[1,2-<i>a</i>]pyrazines (Mps-BAY2a and Mps-BAY2b) are potent TTK inhibitors, and the latter has demonstrated complete inhibition of xenograft tumor growth in combination with paclitaxel.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Recently, a clinical study with a TTK inhibitor from Bayer, dosed in combination with paclitaxel, has been initiated.</div><figure id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0026.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Representative TTK Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0001.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of TTK inhibitors. The figure was obtained by aligning compound <b>1</b>/TTK X-ray structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3H9F">3H9F</a>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> with compound <b>3</b> docked into a previously described<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> 3-(1<i>H</i>-indazol-3-yl)benzenesulfonamide/TTK X-ray structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JT3">4JT3</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our approach built upon hits obtained from a focused screening exercise which eventually led to the identification of acetamido and carboxamido substituted 3-(1<i>H</i>-indazol-3-yl)benzenesulfonamides.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Independently, Shionogi has developed a series of 3-(1<i>H</i>-indazol-3-yl)benzenesulfonamides with very different substitution patterns on the indazole core (Shionogi-2, Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> We found that the 5-substituted acetamido and carboxamido 3-(1<i>H</i>-indazol-3-yl)benzenesulfonamides such as <b>3</b> and <b>4</b>, respectively (Chart <a class="ref internalNav" href="#cht2" aria-label="2">2</a>), were potent inhibitors of TTK with modest ability to attenuate the growth of cancer cells. However, during the course of our in vivo evaluation of these compounds, it became apparent that their physicochemical properties, and attendant pharmacokinetic parameters (Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), were not sufficiently drug-like to move these compounds forward. We postulated that the polar nature of the sulfonamide group (e.g., compound <b>3</b>, PSA = 130) was detrimental to the permeability of these molecules. We embarked upon a structure guided modification of phenyl ring substituents while simultaneously exploring the 5 position of the indazole core. In moving the series forward, we were cognizant of the desirability of optimizing PK, while maintaining selectivity and potency, in order to further explore the unique role of TTK in tumor growth. This article describes the successful realization of these objectives and the identification of selective, orally bioavailable inhibitors of TTK.</div><figure id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0027.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. 3-(1<i>H</i>-Indazol-3-yl)benzenesulfonamide TTK Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Racemic <i>N</i>-(3-(4-(Heterocyclyl and sulfonyl)phenyl)-1<i>H</i>-indazol-5-yl)acetamides</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0012.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0013.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">All entries are racemic mixtures.</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Compounds <b>3</b> and <b>12</b> are single determinations with standard errors, the rest are two or more replicates with standard deviation. <LOD: below limit of detection. ND: not determined.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. 3-(4-(Heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamide TTK Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0014.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">Compound <b>51</b> is enantiomerically enriched; the rest of the entries are achiral or racemic mixtures.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Compounds <b>4</b>, <b>37</b>, <b>38</b>, and <b>51</b> are single determinations with standard errors, the rest are two or more replicates with standard deviation. ND: not determined.</p></div></div><div></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63272" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63272" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Inhibitor Design</h3><div class="NLM_p last">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> illustrates the design of our new inhibitors; the model shows an overlay of 3-sulfonamide <b>3</b> with the Dana-Farber inhibitor <b>1</b>.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> We sought to reduce the polar surface area of the molecules by morphing the sulfonamide (PSA = 130) to a sulfone (PSA = 104) moiety as found in compound <b>12</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Subsequently, we explored the addition of heterocycles to the 4-position of the phenyl ring. Our modeling suggested that substitution at position 4 of the phenyl ring is tolerated and allows for the projection of polar moieties toward the enzyme/solvent interface. These heterocyclic motifs were drawn from those found most frequently in known TTK inhibitors (Chart <a class="ref internalNav" href="#cht1" aria-label="1">1</a>). We also contemplated the removal of the substituent at the 3-position of the phenyl ring because our computational analysis supported the hypothesis that 4-mono substituted compounds would be potent TTK inhibitors.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemical Synthesis</h3><div class="NLM_p">The retrosynthesis of the <i>N</i>-(3-(4-heterocyclyl and/or 3-(methylsulfonyl)phenyl)-1<i>H</i>-indazol-5-yl)acetamides of Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> yields the requisite Boc-protected 3-iodo-1<i>H</i>-indazol-5-amine <b>9b</b> or <i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)acetamides <b>10</b> and boronates <b>7</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). When R<sup>1</sup> was methyl (<b>5c</b>), direct borylation yielded the desired boronate <b>7c</b>, however, when R<sup>1</sup> was a proton (<b>5a</b>,<b>b</b>), derivatization of the piperidine nitrogen as an amide preceded the borylation step. Aryl boronates <b>7</b> were generally prepared from aryl halides, such as <b>6a</b>,<b>b</b> and <b>8d</b>,<b>e</b>, using either pinacol borane<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> or bis(pinocolato)diborane,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> whereas, for the hydroxypiperidine R″, piperidinone <b>8f</b> was borylated and reduced in situ. The acetamidoindazole iodide coupling partner <b>10a</b> was assembled most readily by an amide bond formation from 3-iodo-1-(tetrahydro-2<i>H</i>-pyran-2-yl)-1<i>H</i>-indol-5-amine <b>9a</b>. The requisite carboxylic acids (R‴CO<sub>2</sub>H) were commercially available as racemic mixtures or prepared by Petasis reaction<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> or α-alkylation of arylacetate (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). Compound <b>10b</b> was prepared similarly, as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> Subsequent Suzuki–Miyaura coupling of boronates <b>7</b> (herein described) or commercially available boronic acids with <b>10b</b> yielded TTK inhibitors <b>12</b>–<b>18</b>. A THP deprotection step of <b>10a</b>, prior to Suzuki–Miyaura coupling, furnished compound <b>21</b>. For compounds <b>19</b> and <b>20</b>, the Suzuki–Miyaura coupling with <b>9b</b>, followed by Boc deprotection, gave <b>11</b>; a final amide bond formation step gave the desired products.</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (3-(4-Heterocyclyl and/or 3-sulfonyl)phenyl)-1<i>H</i>-indazol-5-yl)acetamides <b>12</b>–<b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) HCO<sub>2</sub>H or Me<sub>2</sub>NCH<sub>2</sub>CO<sub>2</sub>H, TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, 91–95%; (ii) Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, (Bpin)<sub>2</sub>, KOAc, DMF, 80 °C, or Pd(dba)<sub>2</sub>, (C<sub>6</sub>H<sub>11</sub>)<sub>3</sub>P·HBF<sub>4</sub>, (Bpin)<sub>2</sub>, KOAc, dioxane, 80 °C or Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, <i>S</i>-Phos, PinBH, dioxane, 100 °C, 29–91%; (iii) R‴CO<sub>2</sub>H, TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, 23–54%; (iv) TsOH·H<sub>2</sub>O, MeOH, 125 °C, microwave, 69%; (v) ArB(OH)<sub>2</sub> or <b>7</b>, aq Na<sub>2</sub>CO<sub>3</sub>, (Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, PhMe/EtOH, reflux) or (Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, dioxane, reflux), 10–58%; (vi) TFA, DCM, 38–55% (2 steps).</p></p></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Comparison of Acetamide and Carboxamide Linked TTK Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0016.gif" alt="" id="fx5" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="±" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="char" char="/" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center" char="±">kinase IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char="/"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">GI<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">linker</th><th class="colsep0 rowsep0" align="center" char="±">TTK<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">AURKB/INCENP</th><th class="colsep0 rowsep0" align="center">AURKA</th><th class="colsep0 rowsep0" align="center">KDR</th><th class="colsep0 rowsep0" align="center" char="/">microsomal <i>T</i><sub>1/2</sub> (min) mouse/rat</th><th class="colsep0 rowsep0" align="center" char=".">HCT116</th><th class="colsep0 rowsep0" align="center" char=".">MDA-MB- 468</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">acetamide</td><td class="colsep0 rowsep0" align="char" char="±">0.012 ± 0.001</td><td class="colsep0 rowsep0" align="center">ND<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">2.1 ± 0.4</td><td class="colsep0 rowsep0" align="center">1.2 ± 0.1</td><td class="colsep0 rowsep0" align="char" char="/">5.8/10</td><td class="colsep0 rowsep0" align="char" char=".">0.094</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>39</b></td><td class="colsep0 rowsep0" align="left">carboxamide</td><td class="colsep0 rowsep0" align="char" char="±">0.0077 ± 0.005</td><td class="colsep0 rowsep0" align="center">0.75 ± 0.05</td><td class="colsep0 rowsep0" align="center">2.3 ± 0.2</td><td class="colsep0 rowsep0" align="center">3.8 ± 0.3</td><td class="colsep0 rowsep0" align="char" char="/">1.7/1.5</td><td class="colsep0 rowsep0" align="char" char=".">0.039</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">acetamide</td><td class="colsep0 rowsep0" align="char" char="±">0.008 ± 0.0001</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">2.3 ± 0.3</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="char" char="/">29/15</td><td class="colsep0 rowsep0" align="char" char=".">0.059</td><td class="colsep0 rowsep0" align="char" char=".">0.19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>40</b></td><td class="colsep0 rowsep0" align="left">carboxamide</td><td class="colsep0 rowsep0" align="char" char="±">0.0027 ± 0.0009</td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">2.0 ± 0.3</td><td class="colsep0 rowsep0" align="center">2.9 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="/">21/24</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">acetamide</td><td class="colsep0 rowsep0" align="char" char="±">0.010 ± 0.002</td><td class="colsep0 rowsep0" align="center">0.071 ± 0.007</td><td class="colsep0 rowsep0" align="center">2.0 ± 0.2</td><td class="colsep0 rowsep0" align="center">1.5 ± 0.2</td><td class="colsep0 rowsep0" align="char" char="/">>60/16</td><td class="colsep0 rowsep0" align="char" char=".">0.057</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>41</b></td><td class="colsep0 rowsep0" align="left">carboxamide</td><td class="colsep0 rowsep0" align="char" char="±">0.004 ± 0.0008</td><td class="colsep0 rowsep0" align="center">0.18 ± 0.01</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">6.1 ± 0.8</td><td class="colsep0 rowsep0" align="char" char="/">51/38</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Compounds <b>19</b> and <b>39</b> are achiral, the rest of the entries are racemic mixtures.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">Compounds <b>19</b>, <b>21</b>, and <b>41</b> are single determinations with standard errors, the rest are two or more replicates with standard deviation.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">ND: not determined.</p></div></div></div><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a> describes the synthesis of racemic and achiral 3-(4-(heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamide TTK inhibitors of Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Aromatic nucleophilic substitution of 1-fluoro-4-iodobenzene with alcohols <b>22a</b>–<b>c</b> provided ethers <b>23a</b>–<b>c</b>.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> When R<sup>1</sup> was Boc, <b>23a</b>, TFA deprotection followed by amide coupling gave <b>24</b>, which was converted to its corresponding boronate <b>25a</b>. As for the tropine and pseudotropine derivatives <b>23b</b> and <b>23c</b>, direct borylation<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> gave the desired boronates <b>25b</b> and <b>25c</b>, respectively. Compound <b>28</b>, obtained by amide coupling of <b>26</b> and <b>27</b>, was the precursor to the achiral carboxamides of Tables <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. When racemic amines <b>31</b> were not commercially available, they were prepared by reductive amination of ketones <b>29</b><a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> or via a one-pot synthesis (Grignard addition and imine reduction)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> from 2-cyanopyridine <b>30</b>. Suzuki–Miyaura cross-coupling of <b>28</b> or <b>32</b> with the requisite aryl boronates furnished the desired achiral compounds (<b>33</b>, <b>38</b>, and <b>39</b>) and racemates (<b>34</b>–<b>37</b> and <b>40</b>–<b>48</b>), respectively.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0010.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Achiral (<b>33</b>, <b>38</b>, <b>39</b>) and Racemic (<b>34</b>–<b>37</b>, <b>40</b>–<b>48</b>) 3-(4-(Heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) 1-Fluoro-4-iodobenzene, NaH, DMF, 85 °C, 40–55%; (ii) TFA, DCM; (iii) HCO<sub>2</sub>H, TBTU, DIPEA, DMF, 36% (2 steps); (iv) Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, <i>S</i>-Phos, PinBH, dioxane, 110 °C or Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, (Bpin)<sub>2</sub>, KOAc, DMF, 85–100 °C, 37–75%; (v) TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, 81%; (vi) NH<sub>4</sub>OAc, NaBH<sub>3</sub>CN, MeOH, 60 °C, 93–100%; (vii) <i>c</i>-PrMgBr, THF, NaBH<sub>4</sub>, MeOH, 79%; (viii) ArB(OH)<sub>2</sub>, <b>7</b> or <b>25</b>, aq Na<sub>2</sub>CO<sub>3</sub>, (Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, PhMe/EtOH, reflux) or (Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, dioxane, reflux), 7–83%.</p></p></figure><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. 3-(4-(Piperidin-4-yloxy)phenyl)-1<i>H</i>-indazole-5-carboxamide TTK Inhibitors</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0018.gif" alt="" id="fx6" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0019.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">All entries are racemic mixtures.</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Compounds <b>43</b> and <b>45</b> are two or more replicates with standard deviation, the rest are single determinations with standard errors. ND: not determined.</p></div></div><div></div></div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. 3-(4-(Heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamides Incorporating Bridged Systems</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0020.gif" alt="" id="fx8" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0021.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0022.gif" alt="" id="GRAPHIC-d3845e1519-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0023.gif" alt="" id="GRAPHIC-d3845e1520-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>Table a</sup><p class="last">Compounds <b>49</b> and <b>50</b> are achiral, the rest of the entries are chiral.</p></div><div class="footnote" id="t5fn2"><sup>Table b</sup><p class="last">Compounds <b>69</b>, <b>71</b>, <b>72</b>, <b>74</b>, <b>75</b>, <b>76</b>, <b>78</b>, <b>83</b>, <b>84</b>, and <b>86</b> are two or more replicates with standard deviation, the rest are single determinations with standard errors.</p></div></div><div></div></div><div class="NLM_p">Achiral compounds <b>49</b> and <b>50</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>) were prepared by Suzuki–Miyaura cross-coupling of <b>28</b> with 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-oxa-3-azabicyclo[3.2.1]octane (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) and boronate <b>60a</b>, respectively (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Compound <b>51</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) was prepared using methods similar to those described in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> from the enantiomerically enriched 1-(2-chlorophenyl)propan-1-amine (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div><figure id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0011.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Chiral 3-(4-(Heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamide TTK Inhibitors <b>64</b>–<b>88</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) (Arene or cyclopentane)carbaldehyde, CuSO<sub>4</sub> or CuSO<sub>4</sub>/MgSO<sub>4</sub>, DCM, 61–89%; (ii) RMgBr, Me<sub>2</sub>Zn, THF, 62–100%; (iii) 2 M HCl in Et<sub>2</sub>O, MeOH, 64–87%; (iv) 2-bromopyridine, <sup><i>i</i></sup>PrMgCl·LiCl, THF, 33%; (v) TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, 3-iodo-1<i>H</i>-indazole-5-carboxylic acid, DMF, 75–98%; (vi) CuI, 1,4-diiodobenzene, K<sub>3</sub>PO<sub>4</sub>, BINOL, rt to 50 °C, 8–44%; (vii) Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, (Bpin)<sub>2</sub>, KOAc, DMF, 80 °C or Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, <i>S</i>-Phos, PinBH, dioxane, 100 °C, 44–100% for <b>60a</b>–<b>d</b> (1 step) and 10–29% for <b>60e</b>,<b>f</b> (2 steps); (viii) 3-oxopentanedioic acid, HCl, EtOH, 2-(2,2-diethoxyethoxy)-1,1-diethoxyethane or glutaraldehyde, 15–31%; (ix) NaBH<sub>4</sub>, MeOH; (x) aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, PhMe/EtOH, reflux; 12–59%.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> outlines the routes used to prepare the chiral <i>N</i>-(alkyl(aryl)methyl)-3-(4-(heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamides of Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. The asymmetric center in these TTK inhibitors resides in the 5-substituent of the indazole and is derived from chiral amine precursors. For the preparation of chiral amines <b>55</b>-<i>S</i> and <b>55</b>-<i>R</i>, we employed both chiral resolution and enantioselective synthesis. For example, racemic <b>55</b> (Ar = pyridin-2-yl, R = isobutyl) was resolved with (<span class="smallcaps smallerCapital">d</span>)- or (<span class="smallcaps smallerCapital">l</span>)-DBTA to provide both <i>R</i> and <i>S</i> enantiomers in good enantiomeric excess (ee) but poor yield. A more general and efficient synthesis made use of Ellman’s auxiliary following well established methods.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> Grignard reagent was added to sulfinamide <b>53</b>-<i>S</i> in the presence of Me<sub>2</sub>Zn to give <b>54</b>-<i>S</i>, which was subsequently hydrolyzed to afford <b>55</b>-<i>S</i> in high ee and moderate yield. Alternatively, for the preparation of (<i>S</i>)-cyclopentyl(pyridin-2-yl)methanamine, the (<i>R</i>)-2-methylpropane-2-sulfinamide <b>52</b>-<i>R</i> was converted to the requisite sufinamide <b>56</b>-<i>R</i>. Following a similar series of steps, using a pyridine-2-yl based Grignard reagent, the desired <i>S</i> enantiomer was obtained. The corresponding (<i>R</i>)-alkyl(aryl)methanamines (R = cyclopropyl, cyclopentyl, isobutyl) were similarly prepared.</div><div class="NLM_p">Subsequent amide coupling of the chiral amines so prepared, with 3-iodo-1<i>H</i>-indazole-5-carboxylic acid <b>27</b>, afforded the penultimate intermediates <b>32</b>-<i>S</i> and <b>32</b>-<i>R</i>. In some instances, racemic <b>32</b> was subjected to chiral HPLC separation to yield the desired enantiomeric iodoindazole intermediates <b>32</b>-<i>S</i> and <b>32</b>-<i>R</i>.</div><div class="NLM_p last">For the bridged heterocycles, the precursor azabicycloalkanes <b>58a</b>–<b>d</b> were arylated with 1,4-diiodobenzene in the presence of CuI catalyst<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> to give iodides <b>59a</b>–<b>d</b> which were converted to pinacol boronic esters as described above. The homologue <b>60e</b> and the tropine–morpholine hybrid <b>60f</b> were prepared from ketones <b>62e</b> and <b>62f</b>, respectively. Compounds <b>62e</b> and <b>62f</b> were obtained by a one pot Robinson synthesis<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> from <b>61</b> using glutaraldehyde and 2-(2,2-diethoxyethoxy)-1,1-diethoxyethane, respectively. Reduction of the ketones with NaBH<sub>4</sub> gave alcohols <b>63e</b> and <b>63f</b>, which were subsequently borylated to provide <b>60e</b> and <b>60f</b>. Standard Suzuki–Miyaura coupling between <b>32</b>-<i>S</i> or <b>32</b>-<i>R</i> and boronates <b>60</b> completed the synthesis of the chiral 3-(4-(heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamides <b>64</b>–<b>88</b>.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Lead Optimization</h3><div class="NLM_p">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> summarizes our initial findings; the sulfonamide <b>3</b> to sulfone <b>12</b> modification was tolerated in that potent TTK inhibitory activity was maintained. As anticipated, the reduced polar surface area of sulfone <b>12</b> was reflected in a concomitant increase in exposure upon oral dosing as compared to the analogous sulfonamide <b>3</b>. Unfortunately, this modification resulted in a 4-fold decreased potency in the cell viability assay, a result also seen in sulfone <b>14</b>. This tendency was observed for several additional sulfones (data not shown) with the lone exception being compound <b>13</b> wherein a basic dimethylaminopropyl group was grafted onto the 4-position of the phenyl ring. However, this modification served to abrogate oral exposure, therefore, we turned our attention to the 4-monosubstituted analogues <b>15</b>–<b>18</b>.</div><div class="NLM_p">The TTK IC<sub>50</sub> values for compounds <b>14</b> and <b>15</b> supported the reasoning, presented in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a> and predicted by molecular modeling, that substituents would be tolerated at position 4 of the phenyl ring. Furthermore, sulfonamides or sulfones, at position 3 of the phenyl ring, are not necessary for TTK inhibition. Subsequently, three additional compounds <b>16</b>–<b>18</b>, lacking the 3-substituent, were made to further explore this hypothesis. All four compounds <b>15</b>–<b>18</b> potently inhibited TTK, had much reduced polar surface area (ranging from 68 to 84), and were effective in the cell viability assays (HCT116 GI<sub>50</sub> ≤ 0.057 μM). In addition, these inhibitors achieved markedly higher exposures than the analogous sulfonamide <b>3</b> upon oral dosing in the mouse. Compounds <b>16</b> and <b>18</b> were of particular note, with <i>C</i><sub>max</sub> of 3.5 and 2.8 μg/mL and AUC of 7.9 and 6.8 μg·h/mL, respectively.</div><div class="NLM_p">Previously, we reported<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> that the isomeric amide linker, i.e., carboxamido, was effective when incorporated into prototypical sulfonamides such as <b>4</b>. Accordingly, we prepared representative carboxamides with the new heterocyclic moieties. The results, summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, indicate that carboxamides <b>33</b>, <b>34</b>, and <b>36</b>–<b>38</b>, were also potent inhibitors of TTK, with IC<sub>50</sub> values ranging from single- to double-digit nanomolar. As was also seen for the acetamides, the (1-methylpiperidin-4-yl)oxy group yielded the most potent inhibitors, compounds <b>36</b> and <b>51</b>. In contrast, and mirroring the acetamide result, the best exposure was achieved with compound <b>34</b>, which incorporates the morpholino R″ group. Its regioisomer, compound <b>35</b>, is 20-fold less active, indicating the preference for 4 versus 3 substitution on the phenyl ring. Plasma levels for a representative sulfonamide <b>4</b> were exceedingly low, over 2 orders of magnitude less than the morpholino analogue <b>34</b>. A priori, any one of the R″ heterocyclic moieties could be considered as viable starting points for subsequent lead optimization studies. Our initial effort focused on two: the (1-methylpiperidin-4-yl)oxy group for its potency and the morpholino group for its superior oral exposure.</div><div class="NLM_p">An additional consideration was the stereochemistry of the 5-indazole moiety. The acetamido and carboxamido substituted 3-(1<i>H</i>-indazol-3-yl)benzenesulfonamides both incorporate an asymmetric center which is recapitulated with the new heterocyclic R″ groups. This raises the possibility of racemization, alpha to the acetamide carbonyl, especially if the substituent is attached by a nitrogen atom. One way to reduce this liability might be to substitute a carbon atom for nitrogen, as in the matched pair, compounds <b>17</b> and <b>20</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). However, the direct comparison illustrates the beneficial effect of the nitrogen on in vitro performance; the former is about 2.5-fold more potent against TTK, which is reflected in its superior activity in the cell viability assays. In the carboxamides, racemization of the chiral center, which is alpha to the nitrogen, is less of a concern. In addition, for the assembly of the asymmetric carboxamides, there are a number of routes available for the preparation of the precursor chiral amines.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41, 42)</a> This is in contrast to the paucity of suitable methods for the preparation of the chiral α-amino acids required for asymmetric acetamide synthesis. Finally, Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> summarizes the head to head comparison of three matched pairs of inhibitors: <b>19</b>/<b>39</b>, <b>20</b>/<b>40</b>, and <b>21</b>/<b>41</b>. There is little difference in overall properties excepting a small but consistent advantage in potency for the carboxamides. Given these considerations, we decided to pursue the carboxamide linked inhibitors in our subsequent lead optimization efforts.</div><div class="NLM_p">Some published TTK inhibitors have a propensity to inhibit other mitotic kinases such as Aurora kinase B (AURKB/INCENP), and strategies to mitigate this activity have been reported.<a onclick="showRef(event, 'ref44'); return false;" href="javascript:void(0);" class="ref ref44">(44)</a> Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> captures the off-target kinase activity of the indazole based compounds against Aurora kinase A (AURKA), AURKB/INCENP, and a receptor tyrosine kinase KDR (kinase insert domain receptor). Good selectivity against AURKA and KDR were observed, however, we continued to monitor the off-target activity against AURKB/INCENP as the in vitro potency and eADME properties of the series were optimized. Our initial efforts on improving the properties of the 4-piperidin-4-yloxy class of TTK inhibitors are captured in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. With the starting assumption that the basicity of the piperidine ring (calculated p<i>K</i><sub>a</sub> 8.7) was contributing to low oral exposure, compounds were prepared that modulated this property. Formamides <b>42</b> and <b>43</b> (calculated p<i>K</i><sub>a</sub> ≤ 4.3) and amide <b>44</b> retained TTK potency and the latter two were of special interest given their effectiveness in the HCT116 cell viability assay. Unfortunately, compound <b>43</b> proved to be an inhibitor of AURKB/INCENP whereas the oral exposure of <b>44</b> was lower than its parent <b>36</b>.</div><div class="NLM_p">During the course of our work, we obtained a TTK co-complex X-ray structure with a 3-(4-((1-piperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide, namely compound <b>51</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). Inspection of this structure (vide infra) suggested that further modifications to the piperidine ring were possible. Accordingly, we prepared a pair of 8-azabicyclo[3.2.1]octane systems bridged in the endo <b>45</b> and exo <b>46</b> sense; modeling indicated that either of these modifications would be tolerated in the enzyme active site. We anticipated that these larger systems could make better contact with the enzyme surface, thereby increasing TTK potency while decreasing off-target activity through steric clashes. The exo version <b>46</b> was less active in vitro and, although TTK potency was retained for the endo compound <b>45</b>, selectivity enhancements were not realized. The good activity for the endo system was carried over to the formylated versions <b>47</b> and <b>48</b>. Compound <b>47</b> had poor oral exposure, whereas compound <b>48</b> achieved respectable plasma levels but suffered from significant off-target activity (AURKB/INCENP and CYP 3A4). In fact, we were not able to achieve the desired potency and oral exposure while minimizing off-target effects, using this strategy.</div><figure id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0002.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Active site view of co-complex X-ray structure of compound <b>51</b> with TTK (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O6L">4O6L</a>) indicating binding of the <i>R</i> enantiomer to chain A. H-bonds from indazole to the hinge region (Glu603 and Gly605) and from the amide carbonyl to Lys553 are shown by dotted lines. The ethyl group nestles in a side pocket, while the phenyl ring makes hydrophobic contact with the protein surface; the protonated piperdine ring extends toward the solvent interface and makes an interaction with the phosphorylated side chain of Thr675 (Tpo675). The position of the gatekeeper residue (Met602) is indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Consequently, we turned our attention to the morpholinophenyl containing compounds and, based on the reasoning above, prepared two bridged analogues, compounds <b>49</b> and <b>50</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The former (i.e., the 8-oxa-3-azabicyclo[3.2.1]octan-3-yl system) was less active than its parent <b>39</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), however, the latter (i.e., the 3-oxa-8-azabicyclo[3.2.1]octan-8-yl system) was not only more potent but about an order of magnitude more selective against AURKB/INCENP. A number of additional variations incorporating the latter R″ group were examined, compounds <b>64</b>–<b>70</b>. Potency against TTK was generally in the low nanomolar range; in addition to AURKB/INCENP selectivity, cell activity, microsomal stability, and cytochrome P450 activity was routinely monitored and employed as filters to move compounds forward. In general, the <i>S</i> enantiomer was marginally more potent against TTK however, the differences were subtle and AURKB/INCENP selectivity sometimes favored the <i>R</i> enantiomer. TTK inhibitors with desirable potency (TTK IC<sub>50</sub> < 10 nM), selectivity against AURKB/INCENP and CYP 3A4 (IC<sub>50</sub> > 500 nM), rodent microsomal stability (<i>T</i><sub>1/2</sub> > 30 min), and cell activity (HCT116 GI<sub>50</sub> < 0.1 μM) were selected for in vivo study.</div><div class="NLM_p">In common with other compounds incorporating the (1-morpholinocyclohexyl)methyl R‴ group, TTK inhibitor <b>50</b> had a low <i>T</i><sub>1/2</sub> in microsomal stability assays. This liability was generally mitigated by incorporating alkyl(aryl)methyl R‴ moieties as in compounds <b>64</b>–<b>66</b>. However, due to their off-target activities, none of these compounds were further evaluated. In addition, concerns about their low calculated solubilities (ACD/Stucture Designer)<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> prompted the investigation of compounds incorporating alkyl(pyridinyl)methyl R‴ groups. These mild bases (<b>67</b>–<b>70</b>) were effective inhibitors of TTK. Note that the meta and para pyridinyl analogues were not pursued because previous work with the phenyl sulfonamide series<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> had indicated a loss in activity for these congeners. The analogue in which the R″ group had been expanded to the 3-oxa-9-azabicyclo[3.3.1]nonan-9-yl ring system, compound <b>71</b>, was less potent and offered no other advantages over its closest analogue <b>69</b>. Compounds <b>68</b> and <b>69</b>, deemed to incorporate the best features from this subclass, were moved into rodent PK studies.</div><div class="NLM_p">Concurrently, a similar approach to the hydroxyl-piperidine R″ yielded a series of bridged bicyclics, compounds <b>72</b>–<b>88</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). As a group, these compounds had good in vitro potency and were generally selective against AURKB/INCENP (>100-fold). The first two entries in the series, compounds <b>72</b> and <b>73</b>, were moved quickly into mouse PK studies to gauge the impact of this new R″ group on oral exposure. The results (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) were sufficiently encouraging to warrant further investigation of this chemotype. Given their solubility advantage (vide supra), subsequent analoguing efforts concentrated on R‴ groups with nitrogen containing aromatics. Compounds <b>74</b> and <b>75</b>, isolated as salts, demonstrated good in vitro potency, were stable to microsomes (Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>), and otherwise met the criteria for in vivo study. A related set of compounds, the enantiomeric pair <b>76</b> and <b>77</b>, incorporate the larger cyclopentyl ring, resulting in enhanced selectivity against AURKB/INCENP. The <i>S</i>-enantiomer <b>76</b> had the most favorable combination of properties. Further variations on this theme yielded pyrimidines <b>78</b> and <b>79</b>, which showed comparable in vitro activity. They suffered somewhat from a lower selectivity; again, the more potent <i>S</i>-isomer was moved into a mouse PK study. Alternatively, the bulk of the alkyl side chain could be increased by incorporating a pendent isobutyl group alpha to the aromatic ring. Selectivity was maintained, however, enantiomers <b>80</b> and <b>81</b> demonstrated undesirable CYP 3A4 activity. This was mitigated by morphing the isobutyl group into a cyclopropylmethyl moiety, e.g., compound <b>82</b>, which was selected for in vivo study.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Rodent Pharmacokinetic Data for Selected TTK Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PK parameters</th><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center"><b>68</b></th><th class="colsep0 rowsep0" align="center"><b>69</b></th><th class="colsep0 rowsep0" align="center"><b>72</b></th><th class="colsep0 rowsep0" align="center"><b>73</b></th><th class="colsep0 rowsep0" align="center"><b>74</b></th><th class="colsep0 rowsep0" align="center"><b>75</b></th><th class="colsep0 rowsep0" align="center"><b>76</b></th><th class="colsep0 rowsep0" align="center"><b>78</b></th><th class="colsep0 rowsep0" align="center"><b>82</b></th><th class="colsep0 rowsep0" align="center"><b>86</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">mouse PO (10 mg/kg)</td><td class="colsep0 rowsep0" align="left"><i>C</i><sub>max</sub> (μg/mL)</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">0.33</td><td class="colsep0 rowsep0" align="left">0.48</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">2.0</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.75</td><td class="colsep0 rowsep0" align="left">1.2</td><td class="colsep0 rowsep0" align="left">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>INF</sub> (h·μg/mL)</td><td class="colsep0 rowsep0" align="left">2.1</td><td class="colsep0 rowsep0" align="left">2.8</td><td class="colsep0 rowsep0" align="left">0.62</td><td class="colsep0 rowsep0" align="left">0.67</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left">2.6</td><td class="colsep0 rowsep0" align="left">0.97</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="12" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat IV (1 mg/kg)</td><td class="colsep0 rowsep0" align="left">Cl (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">66</td><td class="colsep0 rowsep0" align="left">91</td><td class="colsep0 rowsep0" align="left">125</td><td class="colsep0 rowsep0" align="left">57</td><td class="colsep0 rowsep0" align="left">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><i>t</i><sub>1/2</sub> (h)</td><td class="colsep0 rowsep0" align="left">0.4</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">0.78</td><td class="colsep0 rowsep0" align="left">0.73</td><td class="colsep0 rowsep0" align="left">0.38</td><td class="colsep0 rowsep0" align="left">0.90</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">AUC<sub>INF</sub> (h·μg/mL)</td><td class="colsep0 rowsep0" align="left">0.24</td><td class="colsep0 rowsep0" align="left">0.22</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.25</td><td class="colsep0 rowsep0" align="left">0.19</td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">0.29</td><td class="colsep0 rowsep0" align="left">0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="12" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">rat PO (5 mg/kg)</td><td class="colsep0 rowsep0" align="left">AUC<sub>INF</sub> (h·μg/mL)</td><td class="colsep0 rowsep0" align="left">0.89</td><td class="colsep0 rowsep0" align="left">0.43</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">0.55</td><td class="colsep0 rowsep0" align="left">0.13</td><td class="colsep0 rowsep0" align="left">0.14</td><td class="colsep0 rowsep0" align="left">0.27</td><td class="colsep0 rowsep0" align="left">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">oral BA (%)</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">44</td><td class="colsep0 rowsep0" align="left">13</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">24</td></tr></tbody></table></div></div><div class="NLM_p last">Further variations to the R″ were also examined; ring expansion to a 9-azabicyclo[3.3.1]nonan-3-ol bicyclic system, compound <b>83</b>, resulted in a loss in potency which could be recovered by replacing the additional carbon with oxygen as in <b>84</b>. Nonetheless, the potent 3-oxa-9-azabicyclo[3.3.1]nonan-7-ols <b>84</b> (poor selectivity) and <b>85</b> (off-target CYP450 activity) did not meet the criteria for in vivo study. The stereochemistry of the substituent hydroxyl was probed by synthesis of the exo analogues <b>86</b>–<b>88</b>. Potency was maintained at least for the <i>S</i>-isomers, and the compound with the best balance of in vitro properties, namely <b>86</b>, was selected for rodent PK studies. Compound <b>88</b> was less stable upon incubation with rodent microsomes and inhibited CYP 2C9 with an IC<sub>50</sub> of 120 nM.</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> X-ray Structure</h3><div class="NLM_p last">The co-complex X-ray structure of compound <b>51</b> with the kinase domain of TTK was obtained at a resolution of 2.38 Å (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O6L">4O6L</a>, Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>). The present structure is the first reported for TTK in the C2 space group; it has two molecules in the asymmetric unit related by 2-fold noncrystallographic symmetry axis. Each protomer active site is located near the axis without blocking the other’s accessibility, and in both molecules, the activation loop is positioned away from any crystallographic contacts. In one of the protomer molecules (chain A), the activation loop is partially resolved (similar to our previous structure).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The electron density is well-defined up to residue Ser677 and indicates three phosphorylated residues (Thr675, Thr676, and Ser677). The other protomer (chain B) is also partially resolved but is unphosphorylated and away from the ligand in a conformation reminiscent of inactive kinases. The ligand density is consistent with binding of the <i>R</i> enantiomer although the crystallization well contained a 68:32 mixture of <i>R</i> and <i>S</i> enantiomers (i.e., 36% ee, see the omit map in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Figure S2">Supporting Information, Figure S2</a>). Key features of this structure (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) include H-bonds from the indazole nitrogens to the hinge region residues Glu603 and Gly605 and from the amide carbonyl to Lys553. For chain A, the chlorophenyl and ethyl groups occupy hydrophobic subpockets, while the phenyl ring makes contact with the protein surface. The protonated piperdine ring extends toward the solvent interface and makes an interaction with the phosphorylated side chain of Thr675.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Computational Chemistry</h3><div class="NLM_p">In the early phases of this work, the protein structure, cocrystallized with a molecule from the sulfonamide series,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> was utilized for predictions (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JT3">4JT3</a>). However, with the availability of the 4O6L structure (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>), a new predictive model was developed. We found that the raw GlideXP docking model using literature-standard docking protocols was unsatisfactory in that 10 of 86 molecules failed to dock. Achiral compounds such as <b>19</b> and <b>39</b> were particularly troublesome; in fact, inhibitors with the (1-morpholinocyclohexyl)methyl moiety at the 5 position of the indazole could not be scored. This result is not surprising when single copy docking is employed,<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> however, the model could be greatly improved by multiple copy docking.<a onclick="showRef(event, 'ref46 ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref46 ref47 ref48">(46-48)</a> All inhibitor molecules dock when multiple copies of each input structure are generated via a conformational search,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> followed by a post docking minimization step and by selecting the top scoring solution for each ligand.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The quality of predictions (<i>R</i><sup>2</sup>, 0.37; rmse, 0.86; <i>n</i>, 86, see <a class="ref internalNav" href="#notes-1" aria-label="Figure S3 in the Supporting Information">Figure S3 in the Supporting Information</a>) was further improved (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> left panel: <i>R</i><sup>2</sup>, 0.62; rmse, 0.68; <i>n</i>, 81) by removing the achiral outliers from the analysis. However, this outlier removal had little effect on ranking (Spearman’s rho values of 0.79 and 0.71, respectively). Moving forward, this chemotype was not pursued, thereby increasing our confidence in the working model which was used as an aid to prioritize target molecules for synthesis. This approach does not involve any training, hence it was found to be predictive across the entire range of TTK ligands in the project. In fact, the quality of predictions (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> right panel: <i>R</i><sup>2</sup>, 0.57; rmse, 0.69; <i>n</i>, 817) was sufficient for evaluating virtual libraries and to remove less promising target molecules from further consideration; the corresponding Spearman’s rho value for rank correlation was 0.62. We also noted that the experimental pIC<sub>50</sub>s are better described by nonlinear models or by omitting points with very low Glide scores (e.g., > −7.5), however, in absence of an underlying explanation, only linear models with all available data were used.</div><figure id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0003.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Predictive models using the 4O6L X-ray structure: pIC<sub>50</sub> (TTK) vs GlideXP docking scores wherein the best GlideXP score (from docking multiple conformers) is selected as the docked structure. (left panel) Using compounds from this work (minus achiral outliers) and our previous publication on indazole based TTK inhibitors<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<i>R</i><sup>2</sup> = 0.62, rmse = 0.68, <i>n</i> = 81). (right panel) Using all project compounds (<i>R</i><sup>2</sup> = 0.57, rmse = 0.69, <i>n</i> = 817).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Rodent PK</h3><div class="NLM_p last">The first two entries in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> are from the 3-oxa-8-azabicyclo[3.2.1]octane subclass of TTK inhibitors. Both demonstrated good oral exposure in the mouse and were selected for rat PK studies. The next eight entries are from the 3-hydroxy-8-azabicyclo[3.2.1]octane subclass, the first two of which showed significantly lower exposure than the rest. Compounds <b>72</b> and <b>73</b> were more hydrophobic than the latter entries which incorporated nitrogen in the R‴ aromatic moiety. Of these, two represent an enantiomeric pair <b>74</b> and <b>75</b>; the latter isomer, with the best exposure, was subsequently tested in rat. The remaining compounds showed good mouse plasma levels and were also tested in rat. In the rat, compounds <b>68</b> and <b>82</b> had short half-lives, whereas compounds <b>76</b>, <b>78</b>, and <b>82</b> had the lowest oral exposure. Thus, a short list of three TTK inhibitors (<b>69</b>, <b>75</b>, and <b>86</b>) was identified for subsequent study in mouse HCT116 xenografts. A pharmacokinetic study of compound <b>75</b> was also performed in the dog with key PK parameters as follows: intravenous <i>t</i><sub>1/2</sub> = 1.2 h; oral BA 43%.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> In Vivo Efficacy</h3><div class="NLM_p">The colon HCT116 cell line was chosen for in vivo screening of the short listed TTK inhibitors because the corresponding xenograft model was well characterized in our laboratory. The maximum tolerated dose (MTD) upon oral daily dosing (QD) was determined for each compound (<b>69</b>, <b>75</b>, and <b>86</b>) in athymic CD-1 nude mice. Compounds were dosed QD at their MTD and 2/3 MTD for 21 days. The results (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>) indicate that the best response, 77% and 55% tumor growth inhibition (TGI), was observed for compound <b>75</b> at 35 and 23 mg/kg, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Mice were lost at the highest dose for all three compounds; one death was observed for compound <b>75</b> at its putative MTD. On the basis of this result compound <b>75</b> (designated CFI-401870) was tested in two additional xenograft models (breast cancer cell line MDA-MB-468 and colon cancer cell line SW48), however, the highest dose was reduced to 30 mg/kg. TGIs of 98% and 66%, respectively, were observed for these xenografts (Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>), with minimal weight loss as compared to vehicle (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S5">Supporting Information, Table S5</a>) and no signs of overt toxicity. This level of response is comparable to or better than those previously described for TTK inhibitors. For example, the Nerviano compound <b>2</b>, given orally (90 mg/kg QD for 7 consecutive days), achieved a 53% tumor growth inhibition at the end of study (day 10) in an A2780 ovary carcinoma xenograft model.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> The Myriad/Myrexis compound (MPI-0479605 at 30 mg/kg QD for 21 days) had a TGI of 49% at day 22 in an HCT-116 xenograft model with one animal lost at day 15.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> It is possible that intermittent dosing strategies<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> and/or combination studies<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> will need to be explored to fully exploit the potential of TKK inhibitors in vivo.</div><figure id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0004.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Athymic CD-1 NUDE mice (<i>n</i> = 8) bearing HCT116 xenograft tumors treated daily for 21 days with compound <b>75</b> at 23 and 35 mg/kg (PO QD). Plot depicts tumor volume vs day of treatment. One mouse, receiving the high dose of compound <b>75</b>, was found dead at day 14; no adverse effects in the remaining animals were observed (body weight loss <20%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Mouse Xenograft Results for TTK Inhibitors <b>69</b>, <b>75</b>, and <b>86</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="4" align="center">percent tumor growth inhibition</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">entry</th><th class="colsep0 rowsep0" colspan="2" align="center">HCT116 cell line</th><th class="colsep0 rowsep0" align="center">MDA-MB-468 cell line</th><th class="colsep0 rowsep0" align="center">SW48 cell line</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>69</b></td><td class="colsep0 rowsep0" align="left">17 @ 25 mg/kg</td><td class="colsep0 rowsep0" align="left">56 @ 35 mg/kg<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>75</b></td><td class="colsep0 rowsep0" align="left">55 @ 23 mg/kg</td><td class="colsep0 rowsep0" align="left">77 @ 35 mg/kg<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">98 @ 30 mg/kg</td><td class="colsep0 rowsep0" align="center">66 @ 30 mg/kg</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>86</b></td><td class="colsep0 rowsep0" align="left">5 @ 100 mg/kg</td><td class="colsep0 rowsep0" align="left">53 @ 150 mg/kg<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">ND</td><td class="colsep0 rowsep0" align="center">ND</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">2/8 and </p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">1/8 animals in this arm were lost during the study.</p></div></div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> In Vitro Characterization</h3><div class="NLM_p">A kinetic analysis of TTK inhibitor <b>75</b> (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>) confirmed the potency (<i>K</i><sub>i</sub> = 0.7 ± 0.5 nM) and ATP competitive nature of the binding (i.e., Km<sub>App</sub> increases with dose). However, the variation in <i>V</i><sub>max</sub> over the concentration range indicates mixed kinetics for this inhibitor. Compound <b>75</b> was tested against an extensive panel of human kinases, and the results are shown as a heat map in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>. The compound was substantially more selective than sunitinib and comparable to imatinib, as measured by the number of off-target kinases hit. Half-maximal inhibitory concentrations were determined for those kinases most potently inhibited (Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). Although mutant forms of cKit and Ret were inhibited, the compound was ineffective against the wild-type enzymes. Of the remaining, JNK3, MAPK2, and PLK4 were most significantly inhibited, but there was a ≥1.3 log unit separation in activity and these kinases have been touted as anticancer targets in their own right. We were particularly interested in the activity of TTK inhibitor <b>75</b> against the mitotic kinases Aurora A and B. The fold separation was high, and compound <b>75</b> did not inhibit the intracellular activity of these mitotic kinases up to 6 μM concentration.</div><figure id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0005.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Heat map showing % inhibition of 278 kinases at 1.0 μM of compound <b>75</b> and two clinically used kinase inhibitors imatinib and sunitinib. Millipore radiometric assay data for each compound was individually sorted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Biochemical (IC<sub>50</sub>) and Cellular (EC<sub>50</sub>) Inhibition Constants for Compound <b>75</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cKit (V560G)</td><td class="colsep0 rowsep0" align="char" char=".">490</td><td class="colsep0 rowsep0" align="left">JNK3</td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="left">TTK</td><td class="colsep0 rowsep0" align="char" char=".">3.1</td><td class="colsep0 rowsep0" align="center">14</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cKit</td><td class="colsep0 rowsep0" align="char" char=".">>30000</td><td class="colsep0 rowsep0" align="left">MAPK1</td><td class="colsep0 rowsep0" align="char" char=".">320</td><td class="colsep0 rowsep0" align="left">PLK4</td><td class="colsep0 rowsep0" align="char" char=".">130</td><td class="colsep0 rowsep0" align="center">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ret (V804L)</td><td class="colsep0 rowsep0" align="char" char=".">250</td><td class="colsep0 rowsep0" align="left">MAPK2</td><td class="colsep0 rowsep0" align="char" char=".">57</td><td class="colsep0 rowsep0" align="left">AURKA</td><td class="colsep0 rowsep0" align="char" char=".">1300</td><td class="colsep0 rowsep0" align="center">>6000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ret (V804M)</td><td class="colsep0 rowsep0" align="char" char=".">280</td><td class="colsep0 rowsep0" align="left">MELK</td><td class="colsep0 rowsep0" align="char" char=".">160</td><td class="colsep0 rowsep0" align="left">AURKB/INCENP</td><td class="colsep0 rowsep0" align="char" char=".">1300</td><td class="colsep0 rowsep0" align="center">>6000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Ret</td><td class="colsep0 rowsep0" align="char" char=".">2800</td><td class="colsep0 rowsep0" align="left">MuSK</td><td class="colsep0 rowsep0" align="char" char=".">690</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="center"> </td></tr></tbody></table></div></div><div class="NLM_p">These results were reflected in the cell cycle progression of HCT116 colon cancer cells incubated with <b>75</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>); the profile recapitulated the phenotype of TTK silencing by RNAi. Compound <b>75</b> caused massive aneuploidy and cell death, as indicated by sub-G1 cells, at about 100–200 nM. Consistent with potent TTK inhibition and lack of intracellular Aurora B activity, <b>75</b> causes aneuploidy at low concentrations with no significant polyploidy at the highest concentration tested. Inhibition of cell growth by compound <b>75</b> was evaluated in an expanded panel of breast, colon, ovarian, prostate, melanoma, and lung human cancer derived cell lines (Table <a class="ref showTableEvent internalNav" data-ID="tbl9" href="#tbl9">9</a>). Excepting human mammary epithelial cells (HMEC GI<sub>50</sub> > 30 μM), the compound inhibited cell growth across the cell line panel; GI<sub>50</sub> values ranged between 0.008 and 0.21 μM, with typical GI<sub>50</sub> values in the double-digit nanomolar range.</div><figure id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0006.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell cycle analysis of HCT116 colon cancer cells treated with compound <b>75</b> at given concentrations. Percentage of 8N and 16N cells, at 48 h, normalized to DMSO control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Growth Inhibition Data for TTK Inhibitor <b>75</b> against HMECs and a Panel of Cancer Cell Lines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="5" align="center" char=".">breast GI<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">ovarian GI<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">HMEC GI<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">MDA-MB-231</th><th class="colsep0 rowsep0" align="center" char=".">BT-474</th><th class="colsep0 rowsep0" align="center" char=".">SKBr-3</th><th class="colsep0 rowsep0" align="center" char=".">MCF-7</th><th class="colsep0 rowsep0" align="center" char=".">T-47D</th><th class="colsep0 rowsep0" align="center" char=".">A2780</th><th class="colsep0 rowsep0" align="center" char=".">OV-90</th><th class="colsep0 rowsep0" align="center" char=".">SKOV-3</th><th class="colsep0 rowsep0" align="center" char=".">TOV-21G</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">>30</td><td class="colsep0 rowsep0" align="char" char=".">0.070</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">0.015</td><td class="colsep0 rowsep0" align="char" char=".">0.020</td><td class="colsep0 rowsep0" align="char" char=".">0.020</td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">0.016</td></tr></tbody></table><table class="table" border="0"><colgroup><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="rowsep1 colsep0" colspan="4" align="center" char=".">colon GI<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">prostate GI<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">melanoma GI<sub>50</sub> (μM)</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">lung GI<sub>50</sub> (μM)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center" char=".">COLO-205</th><th class="colsep0 rowsep0" align="center" char=".">HT29</th><th class="colsep0 rowsep0" align="center" char=".">SW48</th><th class="colsep0 rowsep0" align="center" char=".">SW620</th><th class="colsep0 rowsep0" align="center" char=".">PC-3</th><th class="colsep0 rowsep0" align="center" char=".">DU145</th><th class="colsep0 rowsep0" align="center" char=".">SK-MEL-5</th><th class="colsep0 rowsep0" align="center" char=".">SK-MEL-28</th><th class="colsep0 rowsep0" align="center" char=".">A549</th><th class="colsep0 rowsep0" align="center" char=".">H23</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="char" char=".">0.060</td><td class="colsep0 rowsep0" align="char" char=".">0.018</td><td class="colsep0 rowsep0" align="char" char=".">0.019</td><td class="colsep0 rowsep0" align="char" char=".">0.030</td><td class="colsep0 rowsep0" align="char" char=".">0.060</td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="char" char=".">0.020</td><td class="colsep0 rowsep0" align="char" char=".">0.21</td><td class="colsep0 rowsep0" align="char" char=".">0.024</td><td class="colsep0 rowsep0" align="char" char=".">0.036</td></tr></tbody></table></div></div><div class="NLM_p">The effect of compound <b>75</b> on chromosome segregation in colon cancer cells was examined by imaging HCT116 cells during mitosis (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Cells treated with TTK inhibitor <b>75</b> for 2 h prior to entry into mitosis exhibited severe defects in their ability to segregate chromosomes (>60% and >90% of cells at 100 and 500 nM of compound <b>75</b>, respectively). Despite defects in chromosome segregation, the majority of TTK inhibitor <b>75</b> treated cells complete cytokinesis with a gain or loss in chromosomes (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). A decrease in cell viability was observed as early as 24 h after treatment with compound <b>75</b>, and at the same time, increases are induced in cleaved PARP (apoptosis marker), phospho-H2AX (DNA damage marker), and p53 (data not shown).</div><figure id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0007.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (upper panels) Mitotic figures of HCT116 cells treated with compound <b>75</b> or DMSO 6 h post double thymidine block. Centromeres are stained in green, α-tubulin in red, and DAPI in blue. (lower panel) Graph of the percentage of anaphase and telophase cells with and without lagging chromosomes. Mean % ± SD lagging chromosomes for DMSO, 19 ± 2%; 100 nM <b>75</b>, 61 ± 2%; 500 nM <b>75</b>, 94 ± 1%. Data are representative of three independent experiments with a variation <10%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0008.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (left panel) Plot of the chromosome counts on metaphase spreads from HCT116 cells treated with 500 nM <b>75</b> or DMSO for 28 h. Data are representative of three independent experiments. (right panels) Representative images of metaphase spreads from <b>75</b> (500 nM) and DMSO treated HCT116 cells. Chromosomes were stained with DAPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Compound <b>75</b> was tested in several early ADME assays including CYP450 and hERG inhibition; separation in activity between these off-target effects and TTK inhibition approximated 3 orders of magnitude (<a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S4">Supporting Information, Table S4</a>). In addition, compound <b>75</b> demonstrated good stability (<i>T</i><sub>1/2</sub> >60 min) in mouse, rat, dog, and human microsomes. Plasma protein binding was observed to be 95.8, 93.1, 88.6, and 97.8% in mouse, rat, dog, and human plasma, respectively.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62070" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62070" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The transformation of the 3-substituted sulfonamido phenyls to 4-substituted heterocyclic phenyl systems on the 1<i>H</i>-indazole 5-(carboxamide and acetamide) cores maintained TTK potency and greatly improved the PK properties of the molecules. This breakthrough set the stage for systematic lead optimization of this series; subsequent efforts focused on enantiomerically enriched carboxamides because they were more synthetically accessible and potent in vitro. A molecular model based on the TTK/compound <b>51</b> co-complex X-ray structure (pdb: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O6L">4O6L</a>) was used to prioritize target compounds for synthesis. The SAR indicated that R″ moieties based on morpholino and hydroxypiperidinyl groups were of particular interest. Ten compounds with desirable potency (TTK IC<sub>50</sub> < 10 nM), selectivity against AURBK/INCENP and CYP 3A4 (IC<sub>50</sub> >500 nM), microsomal stability (<i>T</i><sub>1/2</sub> > 30 min), and cell activity (HCT116 GI<sub>50</sub> < 0.1 μM) were identified for in vivo study. Compounds incorporating the 8-oxa-3-azabicyclo[3.2.1]octan-3-yl and 3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl bicyclic systems demonstrated high exposure upon oral dosing in mice and were further evaluated in rat PK studies.</div><div class="NLM_p last">Compounds <b>69</b>, <b>75</b>, and <b>86</b> are single-digit nanomolar TTK inhibitors, with acceptable off-target activity and good oral exposure in rodents. The short listed compounds attenuate the growth of MDA-MB-468 and HCT-116 cancer cells and are somewhat less effective against OVCAR-3. Compound <b>75</b> was the most efficacious of the shortlisted compounds in an HCT116 tumor xenograft model (77% TGI at 35 mg/kg PO). This compound inhibited off-target kinases (panel of 278 human kinases) with a frequency comparable to clinically used inhibitors deemed to be selective (e.g., imatinib). Compound <b>75</b> inhibited the growth of a broad panel of human cancer cell lines including breast, ovarian, colon, prostate, lung, and melanoma and recapitulated the phenotype of TTK interfering RNA in HCT116 cells. It demonstrated a reasonable separation of effects between TTK potency and human CYP and hERG activity (≥1000-fold). On the strength of the data presented herein, compound <b>75</b> was selected for preclinical development studies.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_36332" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_36332" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Computational Methods</h3><div class="NLM_p last">Ligands were prepared, and docking results were analyzed in the MOE software.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Appropriate protonation states were generated using the Wash process, and all reasonable stereoisomers were produced using Corina.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Low energy conformations were generated using the Conformer Import option (max 30 conformers within a 3 kcal/mol window) and minimized using the MMFF94x force field within MOE. The protein structure was prepared using standard settings with the help of the Protein Preparation Wizard in the Schrodinger suite<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> with all water molecules deleted. For each molecule, the pregenerated conformations were docked using the GlideXP program<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> and the solutions with the highest docking score (gscore) were selected. In these docking runs, hydrogen bonding to one of the two key hinge residues (Glu603 and Gly605) was used as a constraint and no state penalties for protomers/tautomers were added to the docking score, otherwise default settings were employed including postdocking minimization.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General Synthetic Methods</h3><div class="NLM_p">Commercially available starting materials, reagents, and solvents were used as received. In general, anhydrous reactions were performed under nitrogen or argon. Microwave reactions were performed using a Biotage Initiator microwave reactor. Reaction progress was generally monitored by LCMS (Bruker Esquire 4000). Flash column chromatographic purification of intermediates or final products was performed on a Biotage Isolera One purification system using SNAP KP-sil cartridges or SNAP C-18 reverse-phase (RP) columns. Crude reactions were partially purified using Waters PoraPak Rxn CX cartridges. Preparative reverse-phase HPLC purification was performed on a Varian PrepStar model SD-1 HPLC system with a Varian Monochrom 10 μm C-18 reverse-phase column. Elution was performed using a gradient of 10% MeOH/water to 90% MeOH/water (0.05% TFA) over a 46 min period at a flow rate of 40 mL/min. Fractions containing the desired material were concentrated and/or lyophilized to obtain the final products. All reported yields are unoptimized.</div><div class="NLM_p">Proton nuclear magnetic resonance (<sup>1</sup>H NMR) spectra were recorded on a Bruker AV 400 MHz spectrometer. Chemical shifts are reported in parts per million (ppm) from tetramethylsilane. Proton coupling patterns are described as singlet (s), doublet (d), triplet (t), quartet (q), multiplet (m), and broad (br).</div><div class="NLM_p">Low resolution mass spectra (MS ESI) were obtained using a Bruker Esquire 4000 spectrometer under electron spray ionization conditions. High resolution mass spectra (HRMS) were obtained by a Waters Acquity UPLC coupled with a Waters Synapt G2 time-of-flight mass spectrometer, using an ESI source. Compounds in DMSO solutions (5 mg/mL) were diluted to 0.01 mg/mL; 5 μL was injected on to a Waters BEH C-18 1.7 μm 2.1 mm × 100 mm column equilibrated at 10% acetonitrile in water, spiked with 0.1% formic acid at a flow rate of 0.5 mL/min. Bound analytes were eluted by a linear gradient of 10–95% acetonitrile in water between 1 and 8 min. The mass spectrum was calibrated using formate clusters; leucine enkephalin was used as a “lock mass” for additional, real-time, accurate-mass correction.</div><div class="NLM_p last">The purity of compounds described within was determined by HPLC (UV detection at λ = 214 and 254 nm) was performed on a Varian Prostar HPLC, using a 100 mm × 4.6 mm Phenomenex Luna 3 μm C-18 column with a gradient of 10–90% acetonitrile in water (with 0.1% TFA in each mobile phases). The purity of all final compounds was shown by HPLC to be ≥95%.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Suzuki–Miyaura Cross-Coupling of Iodoindazoles: General Procedure A</h3><div class="NLM_p last">A mixture of 3-iodo-1<i>H</i>-indazole (1.0 equiv), aryl boronic acid, or boronate ester (1–2 equiv), base (2–3 equiv, 1 M aq Na<sub>2</sub>CO<sub>3</sub>), and palladium catalyst (0.05–0.2 equiv PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub> or Pd(PPh<sub>3</sub>)<sub>4</sub>) in appropriate solvents (1:1 to 2:1 EtOH/PhMe or dioxane) was degassed with argon, sealed, and heated in a Biotage microwave reactor or oil bath at 100–130 °C for 2–48 h. The reaction was monitored by LCMS. After aqueous workup, the product was purified by Biotage silica gel column or by RP prep-HPLC to provide the desired compound. Ion-exchange PoraPak Rxn columns were used to assist the purification as necessary. Salts (HCl) were prepared by dissolution of the free base in MeOH and treatment with 1–2 equiv of 1 M HCl in Et<sub>2</sub>O. After evaporation of solvents, the process was repeated several times to obtain the desired mono- or di-HCl salt. In some instances, trifluoroacetic acid salts were prepared.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Synthesis of Indazole Acetamides: General Procedure B</h3><div class="NLM_p last">A solution of 3-iodo-1<i>H</i>-indazol-5-amine 2,2,2-trifluoroacetate (1.0 equiv), DIPEA (3 equiv), and RCO<sub>2</sub>H (1.05 equiv) at 0 °C in DMF was treated with TBTU (1.05 equiv), added in one portion. The reaction was stirred and slowly warmed to rt. After several hours or overnight, stirring the crude reaction was diluted with H<sub>2</sub>O. Generally, filtration of the precipitate followed by washing with water provided the desired material in high purity. Alternatively, the material was purified directly by prep-HPLC and/or flash chromatography.</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> <i>N</i>-(3-(3-(Methylsulfonyl)phenyl)-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (<b>12</b>)</h3><div class="NLM_p last">Prepared according to general procedure A using <i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide trifluoroacetate<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (290 mg, 0.51 mmol), (3-(methylsulfonyl)phenyl)boronic acid (120 mg, 0.6 mmol), PhCH<sub>3</sub>/EtOH (3 mL/9 mL), 1 M aq Na<sub>2</sub>CO<sub>3</sub> (1.5 mL, 1.5 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (11.6 mg, 0.01 mmol, 2 mol %), 1 h at 125 °C, <b>12</b> was obtained as a light-brown solid (TFA salt, 176 mg, 58%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.44 (s, 1H), 8.38 (s, 1H), 8.17 (d, <i>J</i> = 7.6 Hz, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.87 (s, 1H), 7.68 (t, <i>J</i> = 7.8 Hz, 1H), 7.62–7.57 (m, 1H), 7.51 (s, 2H), 7.39 (d, <i>J</i> = 5.2 Hz, 1H), 5.34 (s, 1H), 3.92–3.88 (m, 1H), 3.36–3.00 (m, 6H), 2.25–1.90 (m, 4H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>24</sub>H<sub>24</sub>N<sub>4</sub>O<sub>3</sub>S<sub>2</sub> + H]<sup>+</sup>, 481.1368; found, 481.1360.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(3-(4-(3-(Dimethylamino)propyl)-3-(methylsulfonyl)phenyl)-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (<b>13</b>)</h3><div class="NLM_p last">Prepared according to general procedure A using <i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (60 mg, 0.13 mmol), <i>N</i>,<i>N</i>-dimethyl-3-(2-(methylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)propan-1-amine (54 mg, 0.15 mmol), PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub> (5.4 mg, 0.007 mmol), Cs<sub>2</sub>CO<sub>3</sub> (130 mg, 0.4 mmol) in DMF (2.5 mL), and H<sub>2</sub>O (0.6 mL), 2 h at 130 °C, <b>13</b> was obtained as an off-white powder (11 mg, 15%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.56 (d, <i>J</i> = 2.0 Hz, 1H), 8.36 (s, 1H), 8.20 (dd, <i>J</i> = 8.0, 2.0 Hz, 1H), 7.65 (d, <i>J</i> = 8.0 Hz, 1H), 7.57–7.55 (m, 2H), 7.52 (dd, <i>J</i> = 3.0, 1.2 Hz, 1H), 7.43 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H), 7.35 (dd, <i>J</i> = 5.1, 1.1 Hz, 1H), 4.14 (s, 1H), 3.25 (s, 3H), 3.14–3.07 (m, 2H), 2.74–2.65 (m, 2H), 2.62–2.56 (m, 2H), 2.56–2.48 (m, 2H), 2.37 (s, 6H), 2.03–1.93 (m, 2H), 1.86 (m, 4H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>35</sub>N<sub>5</sub>O<sub>3</sub>S<sub>2</sub> + H]<sup>+</sup>, 566.2; found, 566.1.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(3-(4-(4-Methylpiperazin-1-yl)-3-(methylsulfonyl)phenyl)-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (<b>14</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophene-3-yl)acetamide (75 mg, 0.165 mmol), 1-methyl-4-(2-(methylsulfonyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) phenyl) piperazine (76 mg, 0.199 mmol), 1 M aq Na<sub>2</sub>CO<sub>3</sub> (0.33 mL, 0.33 mmol), PhMe (2.2 mL), EtOH (1.1 mL), and Pd(PPh<sub>3</sub>)<sub>4</sub> (10 mg, 0.008 mmol) and purified using a silica flash column (0–35% MeOH in DCM) followed by reverse phase C-18 flash chromatography (10–20% MeOH in 0.1% aqueous TFA) to give <b>14</b> as a white solid (TFA salt, 52 mg, 49%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.63 (d, <i>J</i> = 2.0 Hz, 1H), 8.43 (d, <i>J</i> = 0.8 Hz, 1H), 8.32 (dd, <i>J</i> = 8.3, 2.3 Hz, 1H), 7.89–7.88 (m, 1H), 7.73 (d, <i>J</i> = 8.4 Hz, 1H), 7.66–7.64 (m, 1H), 7.60–7.53 (m, 2H), 7.39 (d, <i>J</i> = 1.2, 1H), 5.27 (s, 1H), 3.91–3.88 (m, 1H), 3.68 (d, <i>J</i> = 12.0 Hz, 2H), 3.63 (d, <i>J</i> = 11.6 Hz, 2H), 3.55–3.41 (m, 5H), 3.35–3.31 (3H coincident with solvent peak), 3.28–3.13 (m, 2H), 3.01 (s, 3H), 2.18–2.13 (m, 3H), 2.01 (br s, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>34</sub>N<sub>6</sub>O<sub>3</sub>S<sub>2</sub> + H]<sup>+</sup>, 579.2212; found, 579.2214.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-(3-(4-(4-Methylpiperazin-1-yl)phenyl)-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (<b>15</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (50 mg, 0.11 mmol), 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine (40 mg, 0.13 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (6.35 mg, 0.005 mmol), and 1 M aq Na<sub>2</sub>CO<sub>3</sub> (0.22 mL) in PhMe/EtOH (2.25 mL, 2:1 mixture), <b>15</b> was obtained as a pale-yellow solid (TFA salt, 21 mg, 26%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.35 (s, 1H), 7.85–7.83 (m, 3H), 7.64 (br s, 1H), 7.54–7.49 (m, 2H), 7.38 (dd, <i>J</i> = 4.4 Hz, 1H), 7.19 (d, <i>J</i> = 8.4 Hz, 2H), 5.26 (s, 1H), 3.98–3.86 (m, 3H), 3.67–3.60 (m, 2H), 3.41–3.25 (3H coincident with solvent peak), 3.17–3.11 (m, 4H), 3.00 (s, 3H), 2.26–2.14 (m, 3H), 2.02–2.01 (br s, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>28</sub>H<sub>32</sub>N<sub>6</sub>OS + H]<sup>+</sup>, 501.2437; found, 501.2426.</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-(3-(4-Morpholinophenyl)-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (<b>16</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (300 mg, 0.66 mmol) and (4-morpholinophenyl)boronic acid (191 mg, 0.93 mmol), <b>16</b> was obtained as a yellow powder (TFA salt, 265 mg, 56%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.38 (d, <i>J</i> = 1.2 Hz, 1H), 7.87 (dd, <i>J</i> = 3.0, 1.2 Hz, 1H), 7.80 (d, <i>J</i> = 8.8 Hz, 2H), 7.67 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H), 7.53 (d, <i>J</i> = 9.0 Hz, 1H), 7.48 (dd, <i>J</i> = 9.0, 1.7 Hz, 1H), 7.38 (dd, <i>J</i> = 5.0, 1.2 Hz, 1H), 7.20 (d, <i>J</i> = 8.8 Hz, 2H), 5.20 (s, 1H), 3.90–3.84 (m, 5H), 3.30–3.25 (m, 4H), 3.24–3.13 (m, 1H), 3.10 (br s, 1H), 2.27–2.13 (m, 3H), 1.99 (br s, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>27</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub>S + H]<sup>+</sup>, 488.2120; found, 488.2116.</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(3-(4-((1-Methylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (<b>17</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (400 mg, 0.88 mmol) and 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)piperidine (368 mg, 1.05 mmol), <b>17</b> was obtained as an off-white solid (TFA salt, 545 mg, 28%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.36 (s, 1H), 7.91–7.82 (m, 3H), 7.64 (dd, <i>J</i> = 5.0, 3.0 Hz, 1H), 7.57–7.49 (m, 2H), 7.38 (dd, <i>J</i> = 5.1, 1.1 Hz, 1H), 7.22–7.11 (m, 2H), 5.29 (s, 1H), 4.73–4.62 (m, 0.33H), 3.87 (br s, 1H), 3.60–3.69 (m, 0.67H), 3.49–3.34 (m, 3.33H), 3.27–3.02 (m, 3H), 2.93 (s, 3H), 2.43 (d, <i>J</i> = 14.3 Hz, 0.67H), 2.34–1.86 (m, 8H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>33</sub>N<sub>5</sub>O<sub>2</sub>S + H]<sup>+</sup>, 516.2433; found, 516.2437.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-(3-(4-(4-Hydroxypiperidin-1-yl)phenyl)-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-(thiophen-3-yl)acetamide (<b>18</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)-2-(pyrrolidin-1-yl)-2-thiophen-3-yl) acetamide (250 mg, 0.55 mmol), 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidin-4-ol (168 mg, 0.55 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (48 mg, 0.041 mmol), and 1 M aq Na<sub>2</sub>CO<sub>3</sub> (1.11 mL) in toluene/EtOH (7.5 mL, 1:0.5 mixture), 3.5 h at 130 °C, <b>18</b> was obtained as a light-brown solid (TFA salt, 40 mg, 10%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.42 (m, 1H), 8.13 (dd, <i>J</i> = 6.8, 2.0 Hz, 2H), 7.89 (dd, <i>J</i> = 2.8, 1.2 Hz, 1H), 7.79 (s, 1H), 7.77 (s, 1H), 7.64–7.62 (m, 1H), 7.59–7.53 (m, 2H), 7.39 (dd, <i>J</i> = 4.8, 1.2 Hz, 1H), 5.36 (s, 1H), 4.12–4.10 (m, 1H), 3.90–3.85 (m, 3H), 3.66–3.61(m, 2H), 3.30–3.05 (m, 2H), 2.29–2.01(m, 8H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>28</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> S + H]<sup>+</sup>, 502.2277; found, 502.2270.</div></div><div id="sec4_4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 2-(1-Morpholinocyclohexyl)-<i>N</i>-(3-(4-morpholinophenyl)-1<i>H</i>-indazol-5-yl)acetamide (<b>19</b>)</h3><div class="NLM_p last">Prepared according to general procedure B, using 2-(1-morpholinocyclohexyl)acetic acid hydrochloride (100 mg, 0.34 mmol), 3-(4-morpholinophenyl)-1<i>H</i>-indazol-5-amine (106 mg, 0.34 mmol), TBTU (109 mg, 0.34 mmol), DIPEA (0.3 mL, 1.70 mmol), and DMF (3 mL), <b>19</b> was obtained as a yellow solid (di-TFA salt, 87 mg, 35%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 10.62 (s, 1 H), 8.41 (s, 1H), 7.91 (d, <i>J</i> = 8.8 Hz, 2H), 7.58–7.52 (m, 2H), 7.30 (d, <i>J</i> = 8.8 Hz, 2H), 4.18 (d, <i>J</i> = 11.6 Hz, 2H), 3.93–3.81 (m, 6H), 3.64 (d, <i>J</i> = 12.0 Hz, 2H), 3.37–3.24 (m, 5H), 3.20 (s, 2H), 1.94–1.80 (m, 7H), 1.68–1.62 (m, 2H), 1.36–1.25 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>37</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 504.3; found, 504.3.</div></div><div id="sec4_4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 2-Cyclopentyl-<i>N</i>-(3-(4-((1-methylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazol-5-yl)-2-(thiophen-3-yl)acetamide (<b>20</b>)</h3><div class="NLM_p last">Prepared according to general procedure B, using 2-cyclopentyl-2-(thiophen-3-yl)acetic acid (19.0 mg, 0.09 mmol), 3-(4-((1-methylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazol-5-amine trifluoroacetate (50 mg, 0.09 mmol), TBTU (29.1 mg, 0.09 mmol), DIPEA (0.08 mL, 0.45 mmol), and DMF (1.5 mL), <b>20</b> was obtained as an off-white solid (TFA salt, 31 mg, 54%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 10.11–10.02 (m, 1H), 8.43 (d, <i>J</i> = 1.0 Hz, 1H), 7.91–7.82 (m, 2H), 7.51 (d, <i>J</i> = 9.0 Hz, 1H), 7.42–7.35 (m, 2H), 7.31 (dd, <i>J</i> = 2.9, 1.1 Hz, 1H), 7.24–7.11 (m, 3H), 4.88–4.83 (m, 2H), 4.71–4.61 (m, 1H), 3.65–3.54 (m, 2H), 3.44–3.24 (m, 2H), 2.94 (s, 3H), 2.45–2.28 (m, 2H), 2.15–2.07 (m, 3H), 1.75–1.61 (m, 5H), 1.40–1.35 (m, 1H), 1.18–1.13 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>34</sub>N<sub>4</sub>O<sub>2</sub>S + H]<sup>+</sup> 515.2; found, 515.5.</div></div><div id="sec4_4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Cyclopentyl-<i>N</i>-(3-(4-((1-methylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazol-5-yl)-2-(pyridin-2-yl)acetamide (<b>21</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using 2-cyclopentyl-<i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)-2-(pyridin-2-yl)acetamide and 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-piperidine, <b>21</b> was obtained as a white solid (18 mg, 32%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.53–8.47 (m, 1H), 8.37 (d, <i>J</i> = 1.0 Hz, 1H), 7.85–7.75 (m, 3H), 7.64 (d, <i>J</i> = 8.0 Hz, 1H), 7.52–7.43 (m, 2H), 7.31 (ddd, <i>J</i> = 7.2, 5.0, 1.0 Hz, 1H), 7.05 (d, <i>J</i> = 8.8 Hz, 2H), 4.46 (br s, 1H), 3.61 (d, <i>J</i> = 11.0 Hz, 1H), 2.87–2.64 (m, 3H), 2.39 (br s, 2H), 2.33–2.27 (m, 3H), 2.09–1.90 (m, 3H), 1.89–1.40 (m, 8H), 1.16–1.05 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 510.3; found, 510.2.</div></div><div id="sec4_4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 3-(4-(4-Methylpiperazin-1-yl)phenyl)-<i>N</i>-((1-morpholinocyclohexyl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>33</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using 3-iodo-<i>N</i>-((1-morpholinocyclohexyl)methyl)-1<i>H</i>-indazole-5-carboxamide trifluoroacetate (95 mg, 0.16 mmol) and 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperazine (65 mg, 0.21 mmol), <b>33</b> was obtained as a white solid (TFA salt, 84 mg, 83%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.70 (s, 1H), 8.01 (dd, <i>J</i> = 8.9, 1.6 Hz, 1H), 7.96 (d, <i>J</i> = 8.8 Hz, 2H), 7.66 (d, <i>J</i> = 8.8 Hz, 1H), 7.23 (d, <i>J</i> = 8.8 Hz, 2H), 4.21–4.12 (m, 2H), 4.04–3.96 (m, 2H), 3.94 (s, 2H), 3.94–3.83 (m, 2H), 3.71–3.64 (m, 4H), 3.28–3.38 (m, 4H), 3.22–3.08 (m, 2H), 3.01 (s, 3H), 2.05–1.55 (m, 9H), 1.40–1.22 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> [C<sub>30</sub>H<sub>40</sub>N<sub>6</sub>O<sub>2</sub> + H]<sup>+</sup>, 517.3291; found, 517.3287.</div></div><div id="sec4_4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-(Cyclopropyl(phenyl)methyl)-3-(4-morpholinophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>34</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclopropyl(phenyl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (50 mg, 0.12 mmol) and 4-morpholinophenylboronic acid pinacol ester (40 mg, 0.14 mmol), <b>34</b> was obtained as a beige solid (TFA salt, 11 mg, 16%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.60 (s, 1H), 7.98–7.87 (m, 3H), 7.58 (d, <i>J</i> = 8.8 Hz, 1H), 7.47 (d, <i>J</i> = 7.0 Hz, 2H), 7.31 (t, <i>J</i> = 7.2 Hz, 2H), 7.22 (t, <i>J</i> = 6.8 Hz, 1H), 7.15 (d, <i>J</i> = 7.8 Hz, 2H), 4.48 (d, <i>J</i> = 9.5 Hz, 1H), 3.86 (br s, 4H), 3.25 (br s, 4H), 1.44–1.34 (m, 1H), 0.71–0.59 (m, 2H), 0.55–0.40 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 453.2291; found, 453.2282.</div></div><div id="sec4_4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-(Cyclopropyl(phenyl)methyl)-3-(3-morpholinophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>35</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclopropyl(phenyl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.24 mmol) and 4-(3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine (69 mg, 0.24 mmol), <b>35</b> was obtained as a beige solid (39 mg, 36%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.58 (s, 1H), 7.94 (dd, <i>J</i> = 8.8, 1.4 Hz, 1H), 7.62 (d, <i>J</i> = 8.8 Hz, 1H), 7.55–7.44 (m, 5H), 7.34 (t, <i>J</i> = 7.6 Hz, 2H), 7.24 (t, <i>J</i> = 7.3 Hz, 1H), 7.10–7.05 (m, 1H), 4.48 (d, <i>J</i> = 8.5 Hz, 1H), 3.89–3.84 (m, 4H), 3.27–3.22 (m, 4H), 1.44–1.33 (m, 1H), 0.69–0.62 (m, 2H), 0.54–0.41 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>28</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 453.2; found, 453.2.</div></div><div id="sec4_4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-(Cyclopropyl(phenyl)methyl)-3-(4-((1-methylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>36</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclopropyl(phenyl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (200 mg, 0.48 mmol) and (4-((1-methylpiperidin-4-yl)oxy)phenyl)boronic acid pinacol ester (152 mg, 0.48 mmol), <b>36</b> was obtained as a white solid (80 mg, 35%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.60 (s, 1H), 7.95 (d, <i>J</i> = 9.0 Hz, 1H), 7.90 (d, <i>J</i> = 8.8 Hz, 2H), 7.59 (d, <i>J</i> = 8.8 Hz, 1H), 7.47 (d, <i>J</i> = 7.5 Hz, 2H), 7.31 (t, <i>J</i> = 7.5 Hz, 2H), 7.22 (t, <i>J</i> = 7.5 Hz, 1H), 7.08 (d, <i>J</i> = 8.8 Hz, 2H), 4.55 (br s, 1H), 4.47 (d, <i>J</i> = 9.3 Hz, 1H), 3.03–2.91 (m, 2H), 2.76–2.63 (m, 2H), 2.50 (s, 3H), 2.14–2.02 (m, 2H), 1.98–1.85 (m, 2H), 1.44–1.34 (m, 1H), 0.64 (d, <i>J</i> = 8.3 Hz, 2H), 0.45 (dd, <i>J</i> = 9.5, 4.5 Hz, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 481.3; found, 481.4.</div></div><div id="sec4_4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>R</i>)-<i>N</i>-(1-(2-Chlorophenyl)propyl)-3-(4-((1-methylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>51</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-<i>N</i>-(1-(2-chlorophenyl)propyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (58 mg, 0.13 mmol, 36% ee) and 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)piperidine (55 mg, 0.17 mmol), <b>51</b> was obtained as an orange solid (TFA salt, 39 mg, 59%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.57 (s, 1H), 7.95–7.91 (m, 3H), 7.61 (d, <i>J</i> = 8.8 Hz, 1H), 7.55 (d, <i>J</i> = 7.0 Hz, 1H), 7.39 (d, <i>J</i> = 8.0 Hz, 1H), 7.30–7.14 (m, 4H), 5.47–5.43 (m, 1H), 4.87 (br s, 1H), 3.65–3.17 (m, 4H), 2.93–2.92 (m, 3H), 2.44–2.27 (m, 2H), 2.15–1.86 (m, 4H), 1.07 (t, <i>J</i> = 7.2 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>31</sub>ClN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 503.2214; found, 503.2214.</div></div><div id="sec4_4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>N</i>-(Cyclopropyl(thiophen-3-yl)methyl)-3-(4-(4-hydroxypiperidin-1-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>37</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclopropyl(thiophen-3-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (50 mg, 0.12 mmol) and 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidin-4-ol (54 mg, 80% pure, 0.14 mmol), <b>37</b> was obtained as a pale-pink solid (TFA salt, 27 mg, 39%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.63 (s, 1H), 8.24 (d, <i>J</i> = 8.8 Hz, 2H), 7.99 (dd, <i>J</i> = 8.9, 1.4 Hz, 1H), 7.78 (d, <i>J</i> = 8.8 Hz, 2H), 7.67 (d, <i>J</i> = 8.8 Hz, 1H), 7.40–7.36 (m, 2H), 7.21 (t, <i>J</i> = 3.3 Hz, 1H), 5.49 (s, 1H), 4.64 (d, <i>J</i> = 9.3 Hz, 1H), 4.11 (tt, <i>J</i> = 7.0, 3.3 Hz, 1H), 3.91 (ddd, <i>J</i> = 12.0, 8.4, 3.4 Hz, 2H), 3.65 (ddd, <i>J</i> = 11.9, 7.7, 3.5 Hz, 2H), 2.31–2.21 (m, 2H), 2.04 (dtd, <i>J</i> = 14.2, 7.2, 3.5 Hz, 2H), 1.51–1.41 (m, 1H), 0.74 (td, <i>J</i> = 8.3, 3.8 Hz, 1H), 0.65 (td, <i>J</i> = 8.3, 4.8 Hz, 1H), 0.56–0.45 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>27</sub>H<sub>28</sub>N<sub>4</sub>O<sub>2</sub>S + H]<sup>+</sup>, 473.2011; found, 473.2017.</div></div><div id="sec4_4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 3-(4-(4-Hydroxypiperidin-1-yl)phenyl)-<i>N</i>-((1-morpholinocyclohexyl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>38</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using 3-iodo-<i>N</i>-((1-morpholinocyclohexyl)methyl)-1<i>H</i>-indazole-5-carboxamide trifluoroacetate (80 mg, 0.136 mmol), 1-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)piperidin-4-ol (70 mg, 0.18 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (19 mg, 0.016 mmol), <b>38</b> was obtained as a pale-yellow solid (TFA salt, 31 mg, 30%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.73 (s, 1H), 8.25 (d, <i>J</i> = 8.8 Hz, 2H), 8.04 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 8.83 (d, <i>J</i> = 8.8 Hz, 2H), 7.71 (d, <i>J</i> = 8.8 Hz, 1H), 4.11–4.95 (m, 3H), 3.98–3.86 (m, 6H), 3.70–3.64 (m, 4H), 3.36–3.21 (1H coincident with solvent peak), 2.66 (s, 2H), 2.31–2.25 (m, 2H), 2.09–1.98 (m, 4H), 1.91–1.81(m, 2H), 1.81–1.75 (m, 5H), 1.42–1.21 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>39</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 518.3; found, 518.2.</div></div><div id="sec4_4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>N</i>-((1-Morpholinocyclohexyl)methyl)-3-(4-morpholinophenyl)-1<i>H</i>-indazole-5-carboxamide (<b>39</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using 3-iodo-<i>N</i>-((1-morpholinocyclohexyl)methyl)-1<i>H</i>-indazole-5-carboxamide trifluoroacetate (70 mg, 0.12 mmol) and (4-morpholinophenyl)boronic acid (35 mg, 0.17 mmol), <b>39</b> was obtained as pale-yellow solid (TFA salt, 46 mg, 74%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.54 (s, 1H), 7.89 (d, <i>J</i> = 9.0 Hz, 3H), 7.63 (d, <i>J</i> = 8.8 Hz, 1H), 7.13 (d, <i>J</i> = 9.0 Hz, 2H), 3.90–3.79 (m, 4H), 3.71–3.45 (m, 2H), 3.28–3.17 (m, 4H), 2.97–2.56 (m, 2H), 1.84–1.25 (m, 16H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>37</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 504.3; found, 504.3.</div></div><div id="sec4_4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>N</i>-(Cyclopentyl(thiophen-3-yl)methyl)-3-(4-((1-methylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>40</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclopentyl(thiophen-3-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (150 mg, 0.332 mmol) and 1-methyl-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)piperidine (106 mg, 0.334 mmol), <b>40</b> was obtained as an off-white solid (TFA salt, 60 mg, 28%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.52 (s, 1H), 7.94–7.88 (m, 3H), 7.60 (d, <i>J</i> = 8.8 Hz, 1H), 7.36–7.32 (m, 2H), 7.20–7.13 (m, 3H), 5.08 (d, <i>J</i> = 6.0 Hz, 1H),4.85 (s, 1H), 3.66 (t, <i>J</i> = 13.6 Hz, 1H), 3.44–3.32 (m, 5H), 3.23 (br s, 1H), 2.59–2.53 (m, 1H), 2.45–2.27 (m, 2H), 2.16–1.87 (m, 3H), 1.74–1.44 (m, 6H), 1.28–1.25 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>34</sub>N<sub>4</sub>O<sub>2</sub>S + H]<sup>+</sup>, 515.2; found, 515.4.</div></div><div id="sec4_4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>N</i>-(Cyclopentyl(pyridin-2-yl)methyl)-3-(4-((1-methylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>41</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclopentyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.22 mmol), and (4-((1-methylpiperidin-4-yl)oxy)phenyl)boronic acid pinacol ester (70 mg, 0.22 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (13 mg, 0.011 mmol), <b>41</b> was obtained as a white solid (43 mg, 38%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.57 (s, 1H), 8.51 (d, <i>J</i> = 4.3 Hz, 1H), 7.94–7.86 (m, 3H), 7.79 (t, <i>J</i> = 7.6 Hz, 1H), 7.59 (d, <i>J</i> = 8.8 Hz, 1H), 7.49 (d, <i>J</i> = 7.8 Hz, 1H), 7.29 (dd, <i>J</i> = 7.0, 5.0 Hz, 1H), 7.10 (d, <i>J</i> = 8.5 Hz, 2H), 5.01 (d, <i>J</i> = 10.3 Hz, 1H), 4.52 (br s, 1H), 2.82 (br s, 2H), 2.58–2.46 (m, 3H), 2.39 (s, 3H), 2.12–1.81 (m, 5H), 1.76–1.45 (m, 5H), 1.41–1.20 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 510.3; found, 510.2.</div></div><div id="sec4_4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>N</i>-(Cyclopropyl(phenyl)methyl)-3-(4-((1-formylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>42</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclopropyl(phenyl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (43 mg, 0.10 mmol) and 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)piperidine-1-carbaldehyde (41 mg, 0.12 mmol), <b>42</b> was obtained as a yellow solid (14 mg, 27%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.61 (s, 1H), 8.03 (s, 1H), 7.98–7.89 (m, 3H), 7.59 (d, <i>J</i> = 8.8 Hz, 1H), 7.48 (d, <i>J</i> = 7.3 Hz, 2H), 7.32 (t, <i>J</i> = 7.5 Hz, 2H), 7.23 (m, <i>J</i> = 7.5 Hz, 1H), 7.12 (d, <i>J</i> = 8.8 Hz, 2H), 4.77–4.69 (m, 1H), 4.51–4.45 (m, 1H), 3.79–3.62 (m, 2H), 3.58–3.49 (m, 1H), 3.46–3.37 (m, 1H), 2.08–1.91 (m, 2H), 1.91–1.72 (m, 2H), 1.46–1.34 (m, 1H), 0.65 (d, <i>J</i> = 8.3 Hz, 2H), 0.53–0.41 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>30</sub>N<sub>4</sub>O<sub>3</sub> + H]<sup>+</sup>, 495.2; found, 495.3.</div></div><div id="sec4_4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> <i>N</i>-(Cyclopropyl(pyridin-2-yl)methyl)-3-(4-((1-formylpiperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>43</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclopropyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (84 mg, 0.2 mmol) and 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)piperidine-1-carbaldehyde (74 mg, 0.22 mmol), <b>43</b> was obtained as a white solid (36 mg, 29%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.77 (dd, <i>J</i> = 5.7, 0.7 Hz, 1H), 8.70 (s, 1H), 8.56 (t, <i>J</i> = 7.1 Hz, 1H), 8.20 (d, <i>J</i> = 8.0 Hz, 1H), 8.05 (s, 1H), 8.01–7.90 (m, 4H), 7.63 (d, <i>J</i> = 8.8 Hz, 1H), 7.15 (d, <i>J</i> = 8.8 Hz, 2H), 4.80–4.72 (m, 1H), 4.49 (d, <i>J</i> = 10.0 Hz, 1H), 3.82–3.64 (m, 2H), 3.58–3.39 (m, 2H), 2.10–1.92 (m, 2H), 1.90–1.71 (m, 2H), 1.58–1.45 (m, 1H), 0.95–0.84 (m, 1H), 0.81–0.58 (m, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>29</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 496.2349; found, 496.2355.</div></div><div id="sec4_4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> <i>N</i>-(Cyclopropyl(phenyl)methyl)-3-(4-((1-(2-(dimethylamino)acetyl)piperidin-4-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>44</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-cyclopropyl(phenyl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (89 mg, 0.21 mmol) and 2-(dimethylamino)-1-(4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)piperidin-1-yl)ethanone (91 mg, 0.24 mmol), <b>44</b> was obtained as a pale-yellow solid (66 mg, 56%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.60 (s, 1H), 7.95 (m, <i>J</i> = 8.5 Hz, 3H), 7.61 (d, <i>J</i> = 8.8 Hz, 1H), 7.50 (d, <i>J</i> = 7.0 Hz, 2H), 7.35 (t, <i>J</i> = 7.6 Hz, 2H), 7.25 (m, <i>J</i> = 7.3 Hz, 1H), 7.16 (d, <i>J</i> = 8.8 Hz, 2H), 4.80–4.73 (m, 1H), 4.49 (d, <i>J</i> = 9.5 Hz, 1H), 3.92–3.74 (m, 2H), 3.67 (s, 3H), 3.55–3.47 (m, 1H), 2.58 (s, 6H), 2.14–1.96 (m, 2H), 1.93–1.76 (m, 2H), 1.47–1.37 (m, 1H), 0.70–0.64 (m, 2H), 0.53–0.44 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>33</sub>H<sub>37</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 552.3; found, 552.5.</div></div><div id="sec4_4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> <i>N</i>-(Cyclopropyl(phenyl)methyl)-3-(4-((<i>endo</i>)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>45</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using 2-cyclopropyl-<i>N</i>-(3-iodo-1<i>H</i>-indazol-5-yl)-2-phenylacetamide (90 mg, 0.22 mmol) and (<i>endo</i>)-8-methyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octane (0.14 g, 0.31 mmol), <b>45</b> was obtained as a white powder (7.5 mg, 7%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.61 (s, 1 H), 8.00–7.89 (m, 3H), 7.61 (d, <i>J</i> = 8.8 Hz, 1H), 7.49 (d, <i>J</i> = 7.2 Hz, 2H), 7.33 (t, <i>J</i> = 7.5 Hz, 2H), 7.24 (t, <i>J</i> = 7.3 Hz, 1H), 7.04 (d, <i>J</i> = 8.8 Hz, 2H), 4.69 (t, <i>J</i> = 4.7 Hz, 1H), 4.48 (d, <i>J</i> = 9.2 Hz, 1H), 3.44 (br s, 2H), 2.50 (s, 3H), 2.37–2.02 (m, 8H), 1.48–1.37 (m, 1H), 0.70–0.62 (m, 2H), 0.52–0.42 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>34</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 507.2760; found, 507.2758.</div></div><div id="sec4_4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>N</i>-(Cyclopropyl(phenyl)methyl)-3-(4-((<i>exo</i>)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>46</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclopropyl(phenyl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (208 mg, 0.5 mmol) and (<i>exo</i>)-8-methyl-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octane (137 mg, 0.4 mmol), <b>46</b> was obtained as a white solid (29 mg, 14%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.62 (s, 1H), 7.96 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 7.89 (d, <i>J</i> = 8.4 Hz, 2H), 7.59 (d, <i>J</i> = 8.8 Hz, 1H), 7.47 (d, <i>J</i> = 7.2 Hz, 2H), 7.32 (t, <i>J</i> = 7.6 Hz, 2H), 7.22 (t, <i>J</i> = 7.2 Hz, 1H), 7.05 (d, <i>J</i> = 8.8 Hz, 2H), 4.70–4.60 (m, 1H), 4.48 (d, <i>J</i> = 9.6 Hz, 1H), 3.30–3.23 (m, 2H), 2.33 (s, 3H), 2.17–2.04 (m, 4H), 1.85–1.74 (m, 4H), 1.45–1.35 (m, 1H), 0.68–0.60 (m, 2H), 0.52–0.40 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>34</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 507.2760; found, 507.2752.</div></div><div id="sec4_4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>N</i>-(Cyclobutyl(thiophen-3-yl)methyl)-3-(4-(((<i>endo</i>)-8-formyl-8-azabicyclo[3.2.1]octan-3-yl)oxy)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>47</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using <i>N</i>-(cyclobutyl(thiophen-3-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (56 mg, 0.13 mmol) and (<i>endo</i>)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octane-8-carbaldehyde (50 mg, 0.14 mmol), <b>47</b> was obtained as a white solid (17 mg, 25%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.56 (s, 1H), 8.10 (s, 1H), 7.95–7.85 (m, 3H), 7.58 (d, <i>J</i> = 8.8 Hz, 1H), 7.32 (dd, <i>J</i> = 4.8, 3.0 Hz, 1H), 7.26 (s, 1H), 7.12 (d, <i>J</i> = 5.0 Hz, 1H), 6.98 (d, <i>J</i> = 8.8 Hz, 2H), 5.27 (d, <i>J</i> = 10.5 Hz, 1H), 4.74 (br s, 1H), 4.57–4.45 (m, 1H), 4.15 (br s, 1H), 2.93 (d, <i>J</i> = 9.8 Hz, 1H), 2.34–1.74 (m, 14H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>32</sub>N<sub>4</sub>O<sub>3</sub>S + H]<sup>+</sup>, 541.2273; found, 541.2275.</div></div><div id="sec4_4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 3-((4-((<i>endo</i>)-8-Formyl-8-azabicyclo[3.2.1]octan-3-yl)oxy)phenyl)-<i>N</i>-(3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (<b>48</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using 3-iodo-<i>N</i>-(3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (55 mg, 0.13 mmol) and (<i>endo</i>)-3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)-8-azabicyclo[3.2.1]octane-8-carbaldehyde (50 mg, 0.14 mmol), <b>48</b> was obtained as a white solid (32 mg, 47%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.65 (s, 1H), 8.49 (d, <i>J</i> = 5.0 Hz, 1H), 8.08 (s, 1H), 7.97 (dd, <i>J</i> = 8.8, 1.5 Hz, 1H), 7.90–7.86 (m, 2H), 7.78–7.71 (m, 1H), 7.59 (d, <i>J</i> = 8.8 Hz, 1H), 7.47 (d, <i>J</i> = 7.8 Hz, 1H), 7.29–7.20 (m, 1H), 6.98–6.68 (m, 2H), 5.36 (dd, <i>J</i> = 9.8, 5.3 Hz, 1H), 4.68 (br s, 1H), 4.50 (br s, 1H), 4.11 (br s, 1H), 2.29–2.15 (m, 2H), 2.15–1.97 (m, 4H), 1.97–1.81 (m, 3H), 1.81–1.62 (m, 2H), 1.06–0.91 (m, 6H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>35</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 538.3; found, 538.4.</div></div><div id="sec4_4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 3-(4-(8-Oxa-3-azabicyclo[3.2.1]octan-3-yl)phenyl)-<i>N</i>-((1-morpholinocyclohexyl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>49</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using 3-iodo-<i>N</i>-((1-morpholinocyclohexyl)methyl)-1<i>H</i>-indazole-5-carboxamide (80 mg, 0.17 mmol), 3-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-oxa-3-azabicyclo[3.2.1]octane (54 mg, 0.17 mmol), and PdCl<sub>2</sub>dppf·CH<sub>2</sub>Cl<sub>2</sub> (14 mg, 0.017 mmol), <b>49</b> was obtained as a yellow solid (di-TFA salt, 36 mg, 31%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.68 (s, 1H), 8.00 (d, <i>J</i> = 9.3 Hz, 1H), 7.87 (d, <i>J</i> = 8.3 Hz, 2H), 7.64 (d, <i>J</i> = 8.8 Hz, 1H), 7.03 (d, <i>J</i> = 8.0 Hz, 2H), 4.51 (br s, 2H), 4.16 (d, <i>J</i> = 12.8 Hz, 2H), 3.98–3.82 (m, 4H), 3.66 (d, <i>J</i> = 12.3 Hz, 2H), 3.51 (d, <i>J</i> = 11.5 Hz, 2H), 2.98 (d, <i>J</i> = 11.5 Hz, 2H), 2.06–1.85 (m, 9H), 1.84–1.55 (m, 6H), 1.39–1.24 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>39</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 530.3131; found, 530.3125.</div></div><div id="sec4_4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 3-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((1-morpholinocyclohexyl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>50</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using 3-iodo-<i>N</i>-((1-morpholinocyclohexyl)methyl)-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.21 mmol) and 8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-8-azabicyclo[3.2.1]octane (67 mg, 0.21 mmol), <b>50</b> was obtained as a yellow solid (di-TFA salt, 70 mg, 44%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.67 (s, 1H), 7.99 (dd, <i>J</i> = 8.9, 1.6 Hz, 1H), 7.86 (d, <i>J</i> = 8.8 Hz, 2 H), 7.63 (dd, <i>J</i> = 8.9, 0.6 Hz, 1H), 7.03 (d, <i>J</i> = 8.5 Hz, 2H), 4.21 (br s, 2H), 4.15 (d, <i>J</i> = 12.5 Hz, 2H), 3.95–3.82 (m, 6H), 3.65 (d, <i>J</i> = 11.8 Hz, 2H), 3.54 (d, <i>J</i> = 10.8 Hz, 2H), 3.33–3.30 (m, 2H), 2.13–2.00 (m, 4H), 1.99–1.93 (m, 2H), 1.92–1.84 (m, 2H), 1.83–1.70 (m, 3H), 1.69–1.55 (m, 2H), 1.36–1.23 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>39</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 530.3131; found, 530.3124.</div></div><div id="sec4_4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 3-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((<i>S</i>)-cyclopropyl(2-fluorophenyl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>64</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopropyl(2-fluorophenyl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (75 mg, 0.17 mmol), 8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-8-azabicyclo[3.2.1]octane (55 mg, 0.17 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (15 mg, 0.012 mmol), <b>64</b> was obtained as a yellow solid (HCl salt, 54 mg, 59%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.62 (s, 1H), 8.27 (d, <i>J</i> = 8.4 Hz, 2H), 7.99 (d, <i>J</i> = 8.8 Hz, 1H), 7.81 (d, <i>J</i> = 8.4 Hz, 2H), 7.68 (d, <i>J</i> = 8.4 Hz, 1H), 7.58 (t, <i>J</i> = 6.4 Hz, 1H), 7.31–7.26 (m, 1H), 7.17 (t, <i>J</i> = 7.6 Hz, 1H), 7.11–7.06 (m, 1H), 4.77 (d, <i>J</i> = 9.6 Hz, 1H), 4.71 (br s, 2H), 4.25 (d, <i>J</i> = 12.4 Hz, 2H), 3.99 (d, <i>J</i> = 12.8 Hz, 2H), 2.37–2.35 (m, 2H), 2.22–2.19 (m, 2H), 1.48–1.46 (m, 1H), 0.73–0.70 (m, 1H), 0.69–0.59 (m, 1H), 0.54–0.45 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 497.2; found, 497.4.</div></div><div id="sec4_4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 3-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((<i>R</i>)-cyclopropyl(2-fluorophenyl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>65</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-<i>N</i>-(cyclopropyl(2-fluorophenyl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (80 mg, 0.18 mmol), 8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-8-azabicyclo[3.2.1]octane (65 mg, 0.2 mmol), and Pd(PPh<sub>3</sub>)<sub>4</sub> (10 mg, 0.009 mmol), <b>65</b> was obtained as a yellow solid (TFA salt, 13 mg, 12%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.61 (s, 1H), 7.97–7.84 (m, 3H), 7.63–7.50 (m, 2H), 7.31–7.22 (m, 1H), 7.16 (t, <i>J</i> = 7.2 Hz, 1H), 7.12–7.03 (m, 2H), 4.75 (d, <i>J</i> = 9.5 Hz, 1H), 4.24 (br s, 2H), 3.93 (d, <i>J</i> = 11.0 Hz, 2H), 3.57 (br s, 2H), 2.15–1.97 (m, 4H), 1.48–1.40 (m, 1H), 0.72–0.62 (m, 1H), 0.62–0.53 (m, 1H), 0.53–0.38 (m, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>29</sub>FN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 497.2; found, 497.4.</div></div><div id="sec4_4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 3-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((<i>S</i>)-1-(2-chlorophenyl)-2-methylpropyl)-1<i>H</i>-indazole-5-carboxamide (<b>66</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(1-(2-chlorophenyl)-2-methylpropyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.22 mmol) and 8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-8-azabicyclo[3.2.1]octane (69 mg, 0.22 mmol), <b>66</b> was obtained as a yellow solid (TFA salt, 51 mg, 37%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.54 (s, 1H), 7.93 (br s, 2H), 7.90–7.86 (m, 1H), 7.58 (d, <i>J</i> = 8.5 Hz, 1H), 7.54 (dd, <i>J</i> = 7.7, 1.6 Hz, 1H), 7.38 (dd, <i>J</i> = 7.9, 1.4 Hz, 1H), 7.32–7.27 (m, 1H), 7.25–7.13 (m, 3H), 5.37 (d, <i>J</i> = 9.8 Hz, 1H), 4.32 (br s, 2H), 4.00–3.95 (m, 2H), 3.64 (br s, 2H), 2.33–2.22 (m, 1H), 2.18–2.02 (m, 4H), 1.16 (d, <i>J</i> = 6.8 Hz, 3H), 0.86 (d, <i>J</i> = 6.5 Hz, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>31</sub>ClN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 515.2; found, 515.6.</div></div><div id="sec4_4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 3-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((<i>S</i>)-cyclopropyl(pyridin-2-yl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>67</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopropyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.24 mmol) and 8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-8-azabicyclo[3.2.1]octane (76 mg, 0.24 mmol), <b>67</b> was obtained as a yellow solid (di-TFA salt, 64 mg, 38%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.73–8.64 (m, 2H), 8.40 (td, <i>J</i> = 7.9, 1.8 Hz, 1H), 8.05 (d, <i>J</i> = 8.0 Hz, 1H), 7.96 (dd, <i>J</i> = 8.8, 1.5 Hz, 1H), 7.87 (d, <i>J</i> = 8.0 Hz, 2H), 7.83–7.77 (m, 1H), 7.60 (d, <i>J</i> = 8.8 Hz, 1H), 7.02 (br s, 2H), 4.48 (d, <i>J</i> = 10.0 Hz, 1H), 4.19 (br s, 2H), 3.90 (d, <i>J</i> = 10.8 Hz, 2H), 3.53 (br s, 2H), 2.12–1.96 (m, 4H), 1.54–1.42 (m, 1H), 0.89–0.80 (m, 1H), 0.75–0.56 (m, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 480.2; found, 480.2.</div></div><div id="sec4_4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> 3-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((<i>R</i>)-cyclopropyl(pyridin-2-yl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>68</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-<i>N</i>-(cyclopropyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.24 mmol) and 8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-8-azabicyclo[3.2.1]octane (76 mg, 0.24 mmol), <b>68</b> was obtained as a yellow solid (di-HCl salt, 68 mg, 51%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.83–8.78 (m, 2H), 8.66 (t, <i>J</i> = 8.4 Hz, 1H), 8.32 (d, <i>J</i> = 8.0 Hz, 1 H), 8.28 (d, <i>J</i> = 8.5 Hz, 2H), 8.05–8.00 (m, 2H), 7.75 (d, <i>J</i> = 8.5 Hz, 2H), 7.69 (d, <i>J</i> = 8.8 Hz, 1H), 4.68 (br s, 2H), 4.51 (d, <i>J</i> = 10.3 Hz, 1H), 4.21 (d, <i>J</i> = 12.5 Hz, 2H), 3.93 (d, <i>J</i> = 12.0 Hz, 2H), 2.38–2.30 (m, 2H), 2.24–2.16 (m, 2H), 1.65–1.56 (m, 1H), 0.98–0.89 (m, 1H), 0.82–0.62 (m, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>29</sub>H<sub>29</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 480.2400; found, 480.2399.</div></div><div id="sec4_4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 3-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((<i>S</i>)-cyclopentyl(pyridin-2-yl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>69</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopentyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.22 mmol) and 8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-8-azabicyclo[3.2.1]octane (69 mg, 0.22 mmol), <b>69</b> was obtained as a yellow solid (di-TFA salt, 32 mg, 20%, >99.9% ee). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.78 (d, <i>J</i> = 6.0 Hz, 1H), 8.61 (s, 1H), 8.55 (t, <i>J</i> = 7.9 Hz, 1H), 8.09 (d, <i>J</i> = 8.0 Hz, 1H), 7.98–7.81 (m, 4H), 7.60 (d, <i>J</i> = 8.3 Hz, 1H), 7.08 (br s, 2H), 5.01 (d, <i>J</i> = 10.8 Hz, 1H), 4.25 (br s, 2H), 3.94 (d, <i>J</i> = 11.0 Hz, 2H), 3.58 (br s, 2H), 2.68–2.55 (m, 1H), 2.26–2.15 (m, 1H), 2.14–2.00 (m, 4H), 1.84–1.67 (m, 3H), 1.67–1.53 (m, 2H), 1.49–1.39 (m, 1H), 1.29–1.18 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>33</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 508.2713; found, 508.2709. Optical rotation (<b>69</b>-2HCl): [α]<sup>23</sup><sub>D</sub> = +90.9° (<i>c</i> 0.473, MeOH). Chiral HPLC retention time (<b>69</b>-2HCl): 16.6 min; Daicel Chiralpak IA (150 mm × 4.6 mm); isocratic 40% <sup><i>i</i></sup>PrOH (0.5% Et<sub>2</sub>NH) in hexane; 1 mL/min, λ = 254 nm.</div></div><div id="sec4_4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 3-(4-(3-Oxa-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((<i>R</i>)-cyclopentyl(pyridin-2-yl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>70</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-<i>N</i>-(cyclopentyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.22 mmol) and 8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-8-azabicyclo[3.2.1]octane (69 mg, 0.22 mmol), <b>70</b> was obtained as a yellow solid (di-TFA salt, 93 mg, 58%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.76 (d, <i>J</i> = 6.0 Hz, 1H), 8.60 (s, 1H), 8.53–8.46 (m, 1H), 8.05 (d, <i>J</i> = 8.3 Hz, 1H), 7.93–7.83 (m, 4H), 7.60 (d, <i>J</i> = 8.8 Hz, 1H), 7.10–7.01 (m, 2H), 5.01 (d, <i>J</i> = 10.8 Hz, 1 H), 4.24 (br s, 2H), 3.93 (d, <i>J</i> = 11.3 Hz, 2H), 3.57 (d, <i>J</i> = 11.5 Hz, 2H), 2.66–2.55 (m, 1H), 2.23–2.13 (m, 1H), 2.10 (br s, 4H), 1.84–1.67 (m, 3H), 1.67–1.54 (m, 2H), 1.48–1.38 (m, 1H), 1.30–1.19 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>33</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 508.3; found, 508.3.</div></div><div id="sec4_4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> 3-(4-(3-Oxa-9-azabicyclo[3.3.1]nonan-9-yl)phenyl)-<i>N</i>-((<i>S</i>)-cyclopentyl(pyridin-2-yl)methyl)-1<i>H</i>-indazole-5-carboxamide (<b>71</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopentyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.22 mmol) and 9-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-9-azabicyclo[3.3.1]nonane (74 mg, 0.22 mmol), <b>71</b> was obtained as a yellow solid (di-TFA salt, 49 mg, 30%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.78 (d, <i>J</i> = 5.8 Hz, 1H), 8.61 (s, 1H), 8.56 (t, <i>J</i> = 7.3 Hz, 1H), 8.09 (d, <i>J</i> = 8.0 Hz, 1H), 7.95 (t, <i>J</i> = 6.8 Hz, 1H), 7.92–7.82 (m, 3H), 7.59 (d, <i>J</i> = 8.8 Hz, 1H), 7.04 (d, <i>J</i> = 8.5 Hz, 2H), 5.01 (d, <i>J</i> = 10.8 Hz, 1H), 4.05 (d, <i>J</i> = 11.0 Hz, 2H), 3.98 (d, <i>J</i> = 11.3 Hz, 2H), 3.92 (br s, 2H), 2.70–2.55 (m, 2H), 2.25–2.15 (m, 1H), 2.12–1.99 (m, 2H), 1.84–1.69 (m, 5H), 1.67–1.54 (m, 3H), 1.49–1.39 (m, 1H), 1.30–1.16 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 522.3; found, 522.4.</div></div><div id="sec4_4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>N</i>-((<i>S</i>)-1-(2-Chlorophenyl)-2-methylpropyl)-3-(4-((<i>endo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>72</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(1-(2-chlorophenyl)-2-methylpropyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (69 mg, 0.15 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (50 mg, 0.15 mmol), <b>72</b> was obtained as a yellow solid (15 mg, 19%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.55 (dd, <i>J</i> = 1.6, 0.9 Hz, 1H), 7.87 (dd, <i>J</i> = 8.8, 1.5 Hz, 1H), 7.78 (d, <i>J</i> = 8.8 Hz, 2H), 7.58–7.50 (m, 2H), 7.36 (dd, <i>J</i> = 8.0, 1.3 Hz, 1H), 7.30–7.23 (m, 1H), 7.20 (dd, <i>J</i> = 8.0, 1.8 Hz, 1H), 6.89 (d, <i>J</i> = 8.8 Hz, 2H), 5.38 (d, <i>J</i> = 9.8 Hz, 1H), 4.21 (br s, 2H), 3.91 (s, 1H), 2.35 (d, <i>J</i> = 7.0 Hz, 2H), 2.31–2.23 (m, 1H), 2.19 (d, <i>J</i> = 14.8 Hz, 2H), 2.06–1.98 (m, 2H), 1.61 (d, <i>J</i> = 14.6 Hz, 2H), 1.14 (d, <i>J</i> = 6.5 Hz, 3H), 0.85 (d, <i>J</i> = 6.8 Hz, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>33</sub>ClN<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 529.2370; found, 529.2366.</div></div><div id="sec4_4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>N</i>-((<i>S</i>)-Cyclopropyl(phenyl)methyl)-3-(4-((<i>endo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>73</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopropyl(phenyl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (115 mg, 0.28 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (100 mg, 0.3 mmol), <b>73</b> was obtained as a yellow solid (40 mg, 29%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.64 (d, <i>J</i> = 0.8 Hz, 1H), 7.95 (dd, <i>J</i> = 8.9, 1.4 Hz, 1H), 7.82 (d, <i>J</i> = 8.5 Hz, 2H), 7.56 (d, <i>J</i> = 8.8 Hz, 1H), 7.47 (d, <i>J</i> = 7.5 Hz, 2H), 7.30 (t, <i>J</i> = 7.5 Hz, 2H), 7.21 (m, <i>J</i> = 7.5 Hz, 1H), 6.90 (d, <i>J</i> = 8.8 Hz, 2H), 4.47 (d, <i>J</i> = 9.5 Hz, 1H), 4.20 (br s, 2 H), 3.92–3.87 (m, 1 H), 2.34 (m, <i>J</i> = 7.0 Hz, 2H), 2.23–2.13 (m, 2H), 2.06–1.97 (m, 2H), 1.60 (d, <i>J</i> = 14.3 Hz, 2H), 1.45–1.31 (m, 1H), 0.67–0.56 (m, 2H), 0.51–0.36 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>32</sub>N<sub>4</sub>O<sub>2</sub> + H]<sup>+</sup>, 493.2604; found, 493.2604.</div></div><div id="sec4_4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> <i>N</i>-((<i>S</i>)-Cyclopropyl(pyridin-2-yl)methyl)-3-(4-((<i>endo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>74</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopropyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (106 mg, 0.25 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (100 mg, 0.3 mmol), <b>74</b> was obtained as a yellow solid (13 mg, 10%, >99.9% ee). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.67 (d, <i>J</i> = 0.8 Hz, 1H), 8.51 (d, <i>J</i> = 4.0 Hz, 1H), 7.95 (dd, <i>J</i> = 8.8, 1.5 Hz, 1H), 7.88–7.76 (m, 3H), 7.57 (d, <i>J</i> = 8.5 Hz, 1H), 7.53 (d, <i>J</i> = 8.0 Hz, 1H), 7.33–7.25 (m, 1H), 6.94 (d, <i>J</i> = 8.8 Hz, 2H), 4.51 (d, <i>J</i> = 9.5 Hz, 1H), 4.25 (br s, 2H), 3.93 (s, 1H), 2.36 (d, <i>J</i> = 7.3 Hz, 2H), 2.22 (d, <i>J</i> = 14.3 Hz, 2H), 2.09–2.00 (m, 2H), 1.63 (d, <i>J</i> = 14.6 Hz, 2H), 1.49–1.34 (m, 1H), 0.72–0.63 (m, 1H), 0.61–0.45 (m, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 494.2556; found, 494.2565. [α]<sup>23</sup><sub>D</sub> = +80.4° (<i>c</i> 0.746, MeOH). Chiral HPLC retention time (<b>74</b>-2HCl): 10.6 min; Daicel Chiralpak IA (150 mm × 4.6 mm); isocratic 40% <i><sup>i</sup></i>PrOH (0.5% Et<sub>2</sub>NH) in hexane; 1 mL/min, λ = 254 nm.</div></div><div id="sec4_4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> <i>N</i>-((<i>R</i>)-Cyclopropyl(pyridin-2-yl)methyl)-3-(4-((<i>endo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>75</b>)</h3><div class="NLM_p last">A mixture of (<i>R</i>)-<i>N</i>-(cyclopropyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (4.95 g, 11.8 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (4.29 g, 13.04 mmol) was treated with EtOH/PhMe (100 mL/50 mL), 1 M aq Na<sub>2</sub>CO<sub>3</sub> (23.7 mL, 2.7 mmol, 2 equiv), followed by Pd(PPh<sub>3</sub>)<sub>4</sub> (685 mg, 0.593 mmol, 5 mol %). The resulting mixture was refluxed (oil bath temperature at 110 °C) under argon for 1.5 days; LCMS showed the reaction was incomplete. Additional portions of 1 M aq Na<sub>2</sub>CO<sub>3</sub> (14.2 mL, 1.2 equiv) and Pd(PPh<sub>3</sub>)<sub>4</sub> (685 mg, 0.59 mmol) were added, and the resulting mixture was refluxed (oil bath temperature at 110 °C) for 1 day. Water (100 mL) and brine (50 mL) were added, followed by EtOAc (300 mL). Upon separation, the aqueous layer was extracted with EtOAc (2 × 60 mL) and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The resulting dark-brown oil was purified by flash chromatography using two Biotage 100g SiO<sub>2</sub> columns (10–100% EtOAc in hexanes, followed by 0–10% MeOH in DCM). The impure fractions were combined and purified by flash chromatography for a second time. All clean fractions were combined and dried to give <b>75</b> (2.64 g, 45%, >99.9% ee) as a light-brown foam. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) 8.67 (s, 1H), 8.51 (d, <i>J</i> = 4.8 Hz, 1H), 7.95 (d, <i>J</i> = 8.4 Hz, 1H), 7.85 (d, <i>J</i> = 8.8 Hz, 2H), 7.80 (dt, <i>J</i> = 8.0, 1.6 Hz, 1H), 7.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.53 (d, <i>J</i> = 8.0 Hz, 1H), 7.30 (dd, <i>J</i> = 5.2, 2.0 Hz, 1H), 6.94 (d, <i>J</i> = 8.8 Hz, 2H), 4.50 (d, <i>J</i> = 9.2 Hz, 1H), 4.25 (br s, 2H), 3.93 (br t, <i>J</i> = 4.8 Hz, 1H), 2.39–2.36 (m, 2H), 2.26–2.18 (m, 2H), 2.07–2.02 (m, 2H), 1.63 (d, <i>J</i> = 14.8 Hz, 2H), 1.46–1.36 (m, 1H), 0.71–0.66 (m, 1H), 0.61–0.50 (m, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 494.2556; found, 494.2552. Optical rotation (<b>75</b>-2HCl): [α]<sup>23</sup><sub>D</sub> = −81.2° (<i>c</i> 1.13, MeOH). Chiral HPLC retention time (<b>75</b>-2HCl): 7.9 min; Daicel Chiralpak IA (150 mm × 4.6 mm); isocratic 40% <sup><i>i</i></sup>PrOH (0.5% Et<sub>2</sub>NH) in hexane; 1 mL/min, λ = 254 nm.</div></div><div id="sec4_4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>N</i>-((<i>S</i>)-Cyclopentyl(pyridin-2-yl)methyl)-3-(4-((<i>endo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>76</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopentyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (86 mg, 0.19 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (70 mg, 0.21 mmol), <b>76</b> was obtained as a white solid (33 mg, 33%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.61 (dd, <i>J</i> = 1.5, 0.8 Hz, 1H), 8.54–8.48 (m, 1H), 7.91 (dd, <i>J</i> = 8.8, 1.5 Hz, 1H), 7.84–7.73 (m, 3H), 7.56 (dd, <i>J</i> = 8.9, 0.6 Hz, 1H), 7.50–7.45 (m, 1H), 7.28 (ddd, <i>J</i> = 7.5, 5.0, 1.3 Hz, 1H), 6.90 (d, <i>J</i> = 8.8 Hz, 2H), 5.01 (d, <i>J</i> = 10.3 Hz, 1H), 4.22 (br s, 2H), 3.91 (t, <i>J</i> = 4.5 Hz, 1H), 2.58–2.46 (m, 1H), 2.40–2.29 (m, 2H), 2.19 (d, <i>J</i> = 11.0 Hz, 2H), 2.07–1.88 (m, 3H), 1.74–1.43 (m, 7H), 1.40–1.19 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 522.2869; found, 522.2844</div></div><div id="sec4_4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>N</i>-((<i>R</i>)-Cyclopentyl(pyridin-2-yl)methyl)-3-(4-((<i>endo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>77</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-<i>N</i>-(cyclopentyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (86 mg, 0.19 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (70 mg, 0.21 mmol), <b>77</b> was obtained as a yellow solid (34 mg, 24%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.61 (dd, <i>J</i> = 1.5, 0.8 Hz, 1H), 8.54–8.48 (m, 1H), 7.91 (dd, <i>J</i> = 8.8, 1.5 Hz, 1H), 7.84–7.73 (m, 3H), 7.56 (dd, <i>J</i> = 8.9, 0.6 Hz, 1H), 7.50–7.45 (m, 1H), 7.28 (ddd, <i>J</i> = 7.5, 5.0, 1.3 Hz, 1H), 6.90 (d, <i>J</i> = 8.8 Hz, 2H), 5.01 (d, <i>J</i> = 10.3 Hz, 1H), 4.22 (br s, 2H), 3.91 (t, <i>J</i> = 4.5 Hz, 1H), 2.58–2.46 (m, 1H), 2.40–2.29 (m, 2H), 2.19 (d, <i>J</i> = 11.0 Hz, 2H), 2.07–1.88 (m, 3H), 1.74–1.43 (m, 7H), 1.40–1.19 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 522.2869; found, 522.2844.</div></div><div id="sec4_4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>N</i>-((<i>S</i>)-Cyclopentyl(pyrimidin-2-yl)methyl)-3-(4-((<i>endo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>78</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopentyl(pyrimidin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (70 mg, 0.16 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (52 mg, 0.16 mmol), <b>78</b> was obtained as a yellow solid (19 mg, 23%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.76 (d, <i>J</i> = 5.0 Hz, 2H), 8.63 (d, <i>J</i> = 0.5 Hz, 1H), 7.92 (dd, <i>J</i> = 8.9, 1.6 Hz, 1H), 7.83 (d, <i>J</i> = 8.8 Hz, 2H), 7.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.35 (t, <i>J</i> = 4.9 Hz, 1H), 6.93 (d, <i>J</i> = 8.8 Hz, 2H), 5.18 (d, <i>J</i> = 9.5 Hz, 1H), 4.24 (br s, 2H), 3.92 (t, <i>J</i> = 4.4 Hz, 1H), 2.57 (m, <i>J</i> = 9.0 Hz, 1H), 2.40–2.31 (m, 2H), 2.21 (d, <i>J</i> = 15.1 Hz, 2H), 2.08–2.00 (m, 2H), 1.92 (d, <i>J</i> = 7.3 Hz, 1H), 1.75–1.47 (m, 7H), 1.45–1.36 (m, 2H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>34</sub>N<sub>6</sub>O<sub>2</sub> + H]<sup>+</sup>, 523.2821; found, 523.2801.</div></div><div id="sec4_4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-((<i>R</i>)-Cyclopentyl(pyrimidin-2-yl)methyl)-3-(4-((<i>endo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>79</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-<i>N</i>-(cyclopentyl(pyrimidin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (70 mg, 0.16 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (52 mg, 0.16 mmol), <b>79</b> was obtained as a yellow solid (30 mg, 37%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.80–8.72 (m, 2H), 8.65–8.60 (m, 1H), 7.92 (dd, <i>J</i> = 8.8, 1.5 Hz, 1H), 7.84 (d, <i>J</i> = 8.8 Hz, 2H), 7.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.36 (t, <i>J</i> = 4.9 Hz, 1H), 6.94 (d, <i>J</i> = 8.8 Hz, 2H), 5.18 (d, <i>J</i> = 9.8 Hz, 1H), 4.25 (br s, 2H), 3.93 (s, 1H), 2.66–2.48 (m, 1H), 2.36 (d, <i>J</i> = 7.3 Hz, 2H), 2.21 (d, <i>J</i> = 14.6 Hz, 2H), 2.08–2.00 (m, 2H), 1.98–1.88 (m, 1H), 1.75–1.47 (m, 7H), 1.46–1.33 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>34</sub>N<sub>6</sub>O<sub>2</sub> + H]<sup>+</sup>, 523.3; found, 523.4.</div></div><div id="sec4_4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> 3-(4-((<i>endo</i>)-3-Hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((<i>S</i>)-3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (<b>80</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-3-iodo-<i>N</i>-(3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (133 mg, 0.3 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (120 mg, 0.36 mmol), <b>80</b> was obtained as a yellow solid (di-HCl salt, 44 mg, 25%). <sup>1</sup>H NMR (free base, 400 MHz, CD<sub>3</sub>OD) δ 8.65 (d, <i>J</i> = 0.8 Hz, 1H), 8.52–8.49 (m, 1H), 7.95 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 7.81 (d, <i>J</i> = 8.8 Hz, 2H), 7.77 (dt, <i>J</i> = 7.6, 1.7 Hz, 1H), 7.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 1H), 7.30–7.26 (m, 1H), 6.92 (d, <i>J</i> = 8.8 Hz, 2H), 5.34 (dd, <i>J</i> = 10.0, 5.2 Hz, 1H), 4.25–4.18 (m, 2H), 3.92 (t, <i>J</i> = 4.6 Hz, 1H), 2.38–2.31 (m, 2H), 2.23–2.16 (m, 2H), 2.06–1.98 (m, 2H), 1.96–1.85 (m, 1H), 1.80–1.66 (m, 2H), 1.62 (d, <i>J</i> = 14.4 Hz, 2H), 1.03–0.97 (m, 6H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 510.3; found, 510.4.</div></div><div id="sec4_4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> 3-(4-((<i>endo</i>)-3-Hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-<i>N</i>-((<i>R</i>)-3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (<b>81</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-3-iodo-<i>N</i>-(3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (130 mg, 0.3 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (109 mg, 0.33 mmol), <b>81</b> was obtained as a yellow solid (di-HCl salt, 52 mg, 30%). <sup>1</sup>H NMR (free base, 400 MHz, CD<sub>3</sub>OD) δ 8.66 (d, <i>J</i> = 0.8 Hz, 1H), 8.52–8.49 (m, 1H), 7.95 (dd, <i>J</i> = 8.8, 1.6 Hz, 1H), 7.82 (d, <i>J</i> = 8.8 Hz, 2H), 7.77 (dt, <i>J</i> = 7.6, 1.7 Hz, 1H), 7.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.48 (d, <i>J</i> = 8.0 Hz, 1H), 7.29–7.25 (m, 1H), 6.91 (d, <i>J</i> = 8.8 Hz, 2H), 5.35 (dd, <i>J</i> = 10.0, 5.2 Hz, 1H), 4.25–4.18 (m, 2H), 3.91 (t, <i>J</i> = 4.6 Hz, 1H), 2.38–2.31 (m, 2H), 2.23–2.16 (m, 2H), 2.06–1.98 (m, 2H), 1.96–1.85 (m, 1H), 1.80–1.66 (m, 2H), 1.61 (d, <i>J</i> = 14.4 Hz, 2H), 1.02–0.97 (m, 6H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 510.3; found, 510.3.</div></div><div id="sec4_4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>N</i>-((<i>R</i>)-2-Cyclopropyl-1-(pyridin-2-yl)ethyl)-3-(4-((<i>endo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>82</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-<i>N</i>-(2-cyclopropyl-1-(pyridin-2-yl)ethyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (166 mg, 0.4 mmol) and (<i>endo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (132 mg, 0.4 mmol), <b>82</b> was obtained as a yellow solid (di-HCl salt, 67 mg, 29%). <sup>1</sup>H NMR (free base, 400 MHz, CD<sub>3</sub>OD) δ 8.68–8.61 (m, 1H), 8.53 (d, <i>J</i> = 5.0 Hz, 1H), 7.94 (d, <i>J</i> = 8.5 Hz, 1H), 7.86 (d, <i>J</i> = 8.5 Hz, 2H), 7.82 (td, <i>J</i> = 7.7, 1.88 Hz, 1H), 7.59 (d, <i>J</i> = 9.0 Hz, 1H), 7.52 (d, <i>J</i> = 7.8 Hz, 1H), 7.34–7.28 (m, 1H), 6.99 (d, <i>J</i> = 8.8 Hz, 2H), 5.34 (dd, <i>J</i> = 8.7, 6.40 Hz, 1H), 4.32–4.26 (m, 2H), 3.99–3.93 (m, 1H), 2.42–2.35 (m, 2H), 2.30–2.22 (m, 2H), 2.10–2.03 (m, 2H), 1.99–1.90 (m, 1H), 1.88–1.78 (m, 1H), 1.70–1.63 (m, 2H), 0.85–0.76 (m, 1H), 0.56–0.39 (m, 2H), 0.25–0.17 (m, 1H), 0.11–0.03 (m, 1H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>33</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 508.2713; found, 508.2712.</div></div><div id="sec4_4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> 3-(4-((<i>endo</i>)-3-Hydroxy-9-azabicyclo[3.3.1]nonan-9-yl)phenyl)-<i>N</i>-((S)-3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (<b>83</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-3-iodo-<i>N</i>-(3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (130 mg, 0.3 mmol) and (<i>endo</i>)-9-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-9-azabicyclo[3.3.1]nonan-3-ol (113 mg, 0.33 mmol), <b>83</b> was obtained as a yellow solid (di-HCl salt, 36 mg, 20%). <sup>1</sup>H NMR (free base, 400 MHz, CD<sub>3</sub>OD) δ 8.66 (d, <i>J</i> = 0.4 Hz, 1H), 8.52–8.48 (m, 1H), 7.95 (dd, <i>J</i> = 9.0, 1.4 Hz, 1H), 7.80 (d, <i>J</i> = 8.4 Hz, 2H), 7.76 (dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.58 (d, <i>J</i> = 8.8 Hz, 1H), 7.48 (d, <i>J</i> = 7.6 Hz, 1H), 7.29–7.25 (m, 1H), 7.98 (d, <i>J</i> = 8.8 Hz, 2H), 5.38–5.32 (m, 1H), 4.35–4.27 (m, 2H), 3.75–3.66 (m, 1H), 2.47–2.37 (m, 2H), 2.30–2.15 (m, 1H), 1.95–1.85 (m, 1H), 1.85–1.77 (m, 4H), 1.68–1.40 (m, 5H), 1.05–0.97 (m, 6H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>37</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 524.3; found, 524.3.</div></div><div id="sec4_4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> 3-(4-((<i>endo</i>)-7-Hydroxy-3-oxa-9-azabicyclo[3.3.1]nonan-9-yl)phenyl)-<i>N</i>-((<i>S</i>)-3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (<b>84</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-3-iodo-<i>N</i>-(3-methyl-1-(pyridin-2-yl)butyl)-1<i>H</i>-indazole-5-carboxamide (130 mg, 0.3 mmol) and (<i>endo</i>)-9-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-9-azabicyclo[3.3.1]nonan-7-ol (99 mg, 0.3 mmol), <b>84</b> was obtained as a yellow solid (di-HCl salt, 59 mg, 33%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.88 (s, 1H), 8.32 (d, <i>J</i> = 4.8 Hz, 1H), 8.70–8.62 (m, 1H), 8.28 (d, <i>J</i> = 6.4 Hz, 1H), 8.20 (d, <i>J</i> = 8.8 Hz, 1H), 8.08–7.98 (m, 3H), 7.76 (d, <i>J</i> = 8.8 Hz, 1H), 7.22 (d, <i>J</i> = 6.4 Hz, 2H), 5.53–5.45 (m, 1H), 4.19 (br s, 2H), 4.07–3.95 (m, 4H), 3.92–3.87 (m, 1H), 2.40–2.31 (m, 3H), 1.91–1.78 (m, 4H), 1.08 (d, <i>J</i> = 5.2 Hz, 3H), 1.06 (d, <i>J</i> = 5.2 Hz, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>31</sub>H<sub>35</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 526.3; found, 526.4.</div></div><div id="sec4_4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>N</i>-((<i>R</i>)-Cyclopentyl(pyridin-2-yl)methyl)-3-(4-((<i>endo</i>)-7-hydroxy-3-oxa-9-azabicyclo[3.3.1]nonan-9-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>85</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-<i>N</i>-(cyclopentyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (100 mg, 0.22 mmol) and (<i>endo</i>)-9-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-3-oxa-9-azabicyclo[3.3.1]nonan-7-ol (76 mg, 0.22 mmol), <b>85</b> was obtained as a yellow solid (di-TFA salt, 68 mg, 40%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.76 (d, <i>J</i> = 5.0 Hz, 1H), 8.60 (s, 1H), 8.48 (td, <i>J</i> = 7.9, 1.5 Hz, 1H), 8.04 (d, <i>J</i> = 8.0 Hz, 1H), 7.93–7.84 (m, 4H), 7.59 (d, <i>J</i> = 8.8 Hz, 1H), 7.05 (d, <i>J</i> = 8.5 Hz, 2H), 5.01 (d, <i>J</i> = 10.8 Hz, 1H), 4.09–4.03 (m, 2H), 4.02–3.91 (m, 4H), 3.88 (br s, 1H), 2.66–2.54 (m, 1H), 2.37–2.27 (m, 2H), 2.22–2.13 (m, 1H), 1.82–1.67 (m, 5H), 1.66–1.53 (m, 2H), 1.48–1.38 (m, 1H), 1.29–1.18 (m, 1H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>35</sub>N<sub>5</sub>O<sub>3</sub> + H]<sup>+</sup>, 538.3; found, 538.5.</div></div><div id="sec4_4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> <i>N</i>-((<i>S</i>)-Cyclopropyl(pyridin-2-yl)methyl)-3-(4-((<i>exo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>86</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopropyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (125 mg, 0.3 mmol) and (<i>exo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (99 mg, 0.3 mmol), <b>86</b> was obtained as a yellow solid (di-HCl salt, 65 mg, 38%, >99.9% ee). <sup>1</sup>H NMR (free base, 400 MHz, CD<sub>3</sub>OD) δ 8.67 (s, 1H), 8.51 (d, <i>J</i> = 4.8 Hz, 1H), 7.95 (dd, <i>J</i> = 8.8, 1.2 Hz, 1H), 7.86 (d, <i>J</i> = 8.8 Hz, 2H), 7.79 (dt, <i>J</i> = 8.0, 1.7 Hz, 1H), 7.57 (d, <i>J</i> = 7.2 Hz, 1H), 7.52 (d, <i>J</i> = 8.0 Hz, 1H), 7.29 (dd, <i>J</i> = 7.4, 5.0 Hz, 1H), 6.96 (d, <i>J</i> = 8.8 Hz, 2H), 4.51 (d, <i>J</i> = 8.8 Hz, 1H), 4.33 (s, 2H), 4.20–4.08 (m, 1H), 2.14–1.97 (m, 2H), 1.90–1.68 (m, 6H), 1.45–1.35 (m, 1H), 0.72–0.64 (m, 1H), 0.60–0.48 (m, 3H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 494.2556; found, 494.2563. Optical rotation (<b>86</b>-2HCl): [α]<sup>23</sup><sub>D</sub> = +82.0° (<i>c</i> 0.305, MeOH). Chiral HPLC retention time (<b>86</b>-2HCl): 13.7 min; Daicel Chiralpak IA (150 mm × 4.6 mm); isocratic 40% <sup><i>i</i></sup>PrOH (0.5% Et<sub>2</sub>NH) in hexane; 1 mL/min, λ = 254 nm.</div></div><div id="sec4_4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-((<i>R</i>)-Cyclopropyl(pyridin-2-yl)methyl)-3-(4-((<i>exo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>87</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>R</i>)-<i>N</i>-(cyclopropyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (92 mg, 0.22 mmol) and (<i>exo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (80 mg, 0.24 mmol), <b>87</b> was obtained as a yellow solid (58 mg, 53%, >99.9% ee). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.68 (d, <i>J</i> = 0.8 Hz, 1H), 8.53–8.45 (m, 1H), 7.95 (dd, <i>J</i> = 8.9, 1.4 Hz, 1H), 7.84 (d, <i>J</i> = 8.5 Hz, 2H), 7.76 (td, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.56 (d, <i>J</i> = 8.8 Hz, 1H), 7.50 (d, <i>J</i> = 7.8 Hz, 1H), 7.26 (ddd, <i>J</i> = 7.5, 5.0, 1.0 Hz, 1H), 6.92 (d, <i>J</i> = 8.8 Hz, 2H), 4.51 (d, <i>J</i> = 9.3 Hz, 1H), 4.29 (br s, 2H), 4.12 (tt, <i>J</i> = 11.0, 5.2 Hz, 1H), 2.07–1.97 (m, 2H), 1.84–1.65 (m, 6H), 1.48–1.28 (m, 1H), 0.70–0.62 (m, 1H), 0.59–0.46 (m, 3H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>30</sub>H<sub>31</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 494.3; found, 494.5. [α]<sup>23</sup><sub>D</sub> = −85.8° (<i>c</i> 0.746, MeOH). Chiral HPLC retention time (<b>87</b>-2HCl): 9.15 min; Daicel Chiralpak IA (150 mm × 4.6 mm); isocratic 40% <sup><i>i</i></sup>PrOH (0.5% Et<sub>2</sub>NH) in hexane; 1 mL/min, λ = 254 nm.</div></div><div id="sec4_4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>-((<i>S</i>)-Cyclopentyl(pyridin-2-yl)methyl)-3-(4-((<i>exo</i>)-3-hydroxy-8-azabicyclo[3.2.1]octan-8-yl)phenyl)-1<i>H</i>-indazole-5-carboxamide (<b>88</b>)</h3><div class="NLM_p last">Prepared according to general procedure A, using (<i>S</i>)-<i>N</i>-(cyclopentyl(pyridin-2-yl)methyl)-3-iodo-1<i>H</i>-indazole-5-carboxamide (99 mg, 0.22 mmol) and (<i>exo</i>)-8-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)-8-azabicyclo[3.2.1]octan-3-ol (80 mg, 0.24 mmol), <b>88</b> was obtained as a yellow solid (66 mg, 57%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 8.59 (s, 1 H), 8.53 (d, <i>J</i> = 4.0 Hz, 1H), 7.91 (d, <i>J</i> = 8.8 Hz, 1H), 7.86 (d, <i>J</i> = 8.8 Hz, 2H), 7.83–7.79 (m, 1H), 7.58 (d, <i>J</i> = 8.8 Hz, 1H), 7.51 (d, <i>J</i> = 7.8 Hz, 1H), 7.35–7.27 (m, 1H), 7.01 (d, <i>J</i> = 8.8 Hz, 2H), 5.02 (d, <i>J</i> = 10.3 Hz, 1H), 4.38 (br s, 1H), 4.23–4.10 (m, 1H), 2.64–2.47 (m, 1H), 2.09 (d, <i>J</i> = 5.5 Hz, 2H), 2.04–1.93 (m, 1H), 1.89–1.48 (m, 12H), 1.43–1.24 (m, 2H). LCMS (ESI) <i>m</i>/<i>z</i> calcd for [C<sub>32</sub>H<sub>35</sub>N<sub>5</sub>O<sub>2</sub> + H]<sup>+</sup>, 522.3; found, 522.5.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Purification of TTK-N Protein Substrate</h3><div class="NLM_p">An N-terminal fragment of human TTK (TTK-N; amino acids 1–275) was subcloned into the pET-SUMO vector (Life Technologies, Burlington, ON) for bacterial expression. The TTK- N protein was expressed in <i>Escherichia coli</i> BL21 (DE3) CodonPlus-RIPL (Life Technologies) cells in TB Broth media overnight at 15 °C with 1.0 mM IPTG.</div><div class="NLM_p last">The bacterial pellet was lysed in lysis buffer (30 mM Tris pH 7.5, 500 mM NaCl, 10% (v/v) glycerol, 1 mM TCEP), supplemented with 1 mM PMSF, Complete Protease Inhibitor Tablets EDTA-free (Roche Diagnostics, Mississagua, ON) (1 tablet per 50 mL), and 0.01 μL/mL benzonase nuclease (Sigma, Oakville, ON). The cell suspensions were stirred for 30 min on ice and kept at 4 °C for DNA cleavage and after that lysed by 3× passage using an EmulsiFlex C5 homogenizer (Avestin, Ottawa, ON). The lysed cells were centrifuged 40000<i>g</i>, 45 min, 4 °C. Cell lysate supernatants were treated with 1 g/50 mL Whatman DE52 resin (GE Life Sciences, Baie d’Urfe, QC), which had been preswollen and pre-equilibrated with lysis buffer. Lysate was allowed to contact the resin for 20 min on ice to bind and remove DNA. Lysate was vacuum-filtered to remove DE52 resin beads and loaded onto a 5 mL HisTrap column (GE Life Sciences) for FPLC purification of His-tagged proteins. The column was pre-equilibrated with lysis buffer after being charged with Ni<sup>2+</sup> using 0.1 M NiSO<sub>4</sub> as per manufacturer’s instructions. The column was washed with 10 column volumes of lysis buffer, followed by 10 column volumes of lysis buffer supplemented with 10 mM imidazole. His6-SUMO-TTK-N protein was eluted with lysis buffer supplemented with 500 mM imidazole. Fractions were collected and analyzed by NuPAGE (Life Technologies). Appropriate fractions were pooled for size-exclusion chromatography on a Superdex 200 26/60 column (GE Life Sciences) equilibrated with 30 mM Tris pH 7.5, 200 mM NaCl, and 0.5 mM TCEP.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> TTK Inhibition Assay</h3><div class="NLM_p">TTK activity was determined using the N-terminal portion (residues 1–275) as a polypeptide substrate.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> His<sub>6</sub>-SUMO-TTK-N (see above) was as effective as a substrate as the cleaved version and thus was used without cleavage of the His<sub>6</sub>-SUMO fusion tag. Active TTK was purchased as an amino terminal GST fusion of full length human TTK (Life Technologies, Burlington, ON). TTK activity was measured using an indirect ELISA detection system using 96-well microtiter plates, coated with 5 μg/well His<sub>6</sub>-SUMO-TTK-N, as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p">Compound inhibition was determined at either a fixed concentration (10 μM) or at a variable inhibitor concentration (typically 50 μM to 0.1 μM in a 10 point dose response titration). Compounds were preincubated in the presence of enzyme for 15 min prior to addition of ATP, and the activity remaining quantified using the above-described activity assay. The % inhibition of a compound was determined using the following formula: % inhibition = 100(1 – (experimental value–background value)/(high activity control–background value)). The IC<sub>50</sub> value was determined using a nonlinear 4 point logistic curve fit (XLfit4, IDBS) with the formula; (<i>A</i> + (<i>B</i>/(1 + ((<i>x</i>/<i>C</i>)<sup><i>D</i></sup>)))), where <i>A</i> = background value, <i>B</i> = range, <i>C</i> = inflection point, <i>D</i> = curve fit parameter.</div><div class="NLM_p last">The apparent <i>K</i><sub>i</sub> for compound <b>75</b> was estimated to be 0.7 ± 0.5 nM by varying the ATP concentration in a series of TTK inhibition experiments at 2.2, 6.6, and 11 nM of inhibitor and applying nonlinear regression analysis (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> Biochemical Assays</h3><div class="NLM_p">Active PLK4 was purified and used to measure PLK4 activity, using an indirect ELISA detection system, as previously described.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> KDR, AURKA, and AURKB/INCENP compound inhibition were determined using FRET based homogeneous assay kits from Invitrogen (Life Technologies, Burlington, Ontario). Recombinant Aurora A and KDR were purchased from Invitrogen; AURKB/INCENP was purchased from Millipore (Billerica, MA). The assays were performed according to the manufacturer’s specifications with ATP concentrations of 156, 20, and 128 μM, respectively for KDR, AURKA, and AURKB/INCENP.<a onclick="showRef(event, 'ref25 ref56'); return false;" href="javascript:void(0);" class="ref ref25 ref56">(25, 56)</a> Compound inhibition was determined at either a fixed concentration (10 μM) or at a variable inhibitor concentrations (as described above) to determine an IC<sub>50</sub>. The KDR, AURKA, and AURKB/INCENP IC<sub>50</sub> values given in the Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> are the result of single determinations wherein standard fitting errors are given.</div><div class="NLM_p">The selectivity of inhibitor <b>75</b> against 278 protein kinases was assessed by Millipore (Dundee, Scotland) using a radiometric assay. Inhibition was determined at 0.1 μM inhibitor concentration with ATP at <i>K</i><sub>m</sub>; % inhibition was determined (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). For compound <b>75</b>, the inhibition constants (IC<sub>50</sub>s) were determined by Millipore, as per the suppliers specifications, against selected kinases: cKit (V560G), cKit, Ret (V804L), Ret (V804M), Ret, JNK3, MAPK1, MAPK2, MELK, and MUSK.</div><div class="NLM_p last">Fluorogenic cytochrome P450 inhibition studies were conducted at 37 °C in 96-well plates, as previously described,<a onclick="showRef(event, 'ref25 ref56'); return false;" href="javascript:void(0);" class="ref ref25 ref56">(25, 56)</a> for CYP 1A2, CYP 2D6, CYP 2C9, CYP 2C19, and CYP 3A4 (BFC and DBF substrates).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> Purification and Crystallization of TTK Kinase Domain</h3><div class="NLM_p">The kinase domain fragment of human TTK (TTK KD) (amino acids 513–795) was subcloned into the pET-SUMO vector (Life Technologies Inc., Burlington, ON) for bacterial expression. The protein was expressed in <i>E. coli</i> BL21 AI (Life Technologies) cells in Terrific Broth (TB) media overnight at 15 °C with 0.2% (w/v) <span class="smallcaps smallerCapital">l</span>-arabinose and 1.0 mM IPTG. His<sub>6</sub>-SUMO-TTK-KD was purified as for His<sub>6</sub>-SUMO-TTK-N (see above), except the lysis buffer was 50 mM HEPES, pH 7.5, 500 mM NaCl, 5% (v/v) glycerol, and 1 mM TCEP. Clarified lysates were loaded onto a 5 mL HisTrap equilibrated with lysis buffer containing 50 mM imidazole, and the His<sub>6</sub>-SUMO-TTK-KD was eluted with 300 mM imidazole. Size exclusion chromatography was performed on a Superdex 200 26/60 column equilibrated with 50 mM HEPES, pH 7.5, 250 mM NaCl, and 1 mM TCEP. Elution was confirmed by SDS PAGE.</div><div class="NLM_p">SUMO protease (LifeSensors Inc., Malvern, PA) was added to fractions containing His<sub>6</sub>-SUMO-TTK KD to remove the His<sub>6</sub>-SUMO tag, and the cleavage reaction was allowed to proceed overnight at 4 °C. The cleaved TTK-KD was separated from uncleaved protein, His<sub>6</sub>-SUMO protein, and His<sub>6</sub>-SUMO protease by loading onto a 5 mL HisTrap column. Uncleaved protein, His<sub>6</sub>-SUMO protein, and His<sub>6</sub>-SUMO protease were retained on the column, whereas cleaved TTK KD was collected in the flow-through. The TTK KD was further purified to homogeneity by ion-exchange chromatography (IEX). Cleaved TTK KD fractions were diluted 20× volume with IEX buffer (50 mM Tris, pH 8.0, 1 mM TCEP) and loaded onto FPLC IEX Resource Q (GE Life Sciences), 6 mL column. Elution with a gradient 12.5–500 mM NaCl was monitored by NuPAGE and TTK KD peak, which eluted at approximately 250 mM NaCl, was pooled and concentrated.</div><div class="NLM_p last">Purified TTK KD was crystallized in the presence of compound <b>51</b> using the hanging drop vapor diffusion method at 22 °C by mixing equal volumes of the protein solution and the reservoir solution. The TTK KD–compound <b>51</b> binary complex (protein:compound at a molar ratio of 1:5) was crystallized in 17% (v/v) PEG 10000, 0.2 M ammonium sulfate, and 0.1 M Bis-Tris pH 5.5. The crystals were soaked in the mother liquor supplemented with 15% (v/v) glycerol as cryoprotectant before freezing in liquid nitrogen.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> X-ray Structure Determination</h3><div class="NLM_p last">The X-ray data set of the TTK–compound <b>51</b> complex was collected at a temperature of 100 K using beamline 17-ID at the Advanced Photon Source, Argonne National Laboratory. The diffraction data was reduced and scaled with XDS software;<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> the crystal of this TTK complex belongs to the <i>C</i>2 space group. The initial phases of the TTK–inhibitor complex was determined by molecular replacement using PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CEK">3CEK</a> set of coordinates as a search model and Phaser from the Phenix program suite.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Following the initial rigid body refinement, interactive cycles of model building and refinement were carried out using COOT,<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> phenix.refine,<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> and buster-TNT.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> The coordinates and topology of the ligand from this study were generated using phenix.elbow.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The ligand (compound <b>51</b>) was introduced in the later stages of refinement after most of the protein model had been built. Water molecules as well as other solvent ligands were added based on the 2m<i>F</i><sub>o</sub> – D<i>F</i><sub>c</sub> map in COOT and refined with phenix.refine or buster-TNT. The final structure was refined to 2.38 Å resolution with an <i>R</i><sub>cryst</sub> of 20.97% and an <i>R</i><sub>free</sub> of 24.99% and deposited in the PDB as <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O6L">4O6L</a>; additional crystallographic data and refinement statistics are presented in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Cell Lines</h3><div class="NLM_p last">All cell lines were obtained from American Type Culture Collection (ATCC, Manassas, VA), and maintained according to the supplier’s instructions. Short tandem repeat (STR) profiling was used to verify authenticity of the cell lines. Sixteen STR loci were simultaneously amplified in a multiplex PCR reaction (The Hospital for Sick Children, Toronto), and the ATCC database was used for comparison. Cell lines were routinely tested for mycoplasma and used at low passage numbers (<15).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Cell Viability Assay (GI<sub>50</sub>)</h3><div class="NLM_p last">Cancer cell lines were seeded into 96-well plates at 800–6000 cells per 80 μL, depending on the cell growth rate (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information, Table S3">Supporting Information, Table S3</a>), 24 h before compound overlay, cultured, then fixed in situ and processed for sulforhodamine B (SRB) (Sigma, Oakville, ON) assay as previously described.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> GI<sub>50</sub>s were calculated using GraphPad PRISM software (GraphPad Software, Inc., San Diego, CA).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Antibodies</h3><div class="NLM_p last">Antibodies targeting the following were used according to the manufacturers’ instructions: α-tubulin (mouse monoclonal T6199; Sigma, Oakville, ON), centromere (human polyclonal 15–234–0001; Antibodies Inc., Davis, CA), phospho-Aurora A (Thr288)/Aurora B (Thr232)/Aurora C (Thr198) (rabbit monoclonal 2914; Cell Signaling Technology Inc., Danvers, MA), TTK (mouse monoclonal 05–682; Millipore, Billerica, MA), and GAPDH (mouse monoclonal MAB374; Millipore, Billerica, MA). Phospho-TTK (Thr12/Ser15) rabbit polyclonal antibodies were produced and affinity purified by Agro-Bio (La Ferte Saint Aubin, France) by using the synthetic peptide CGREL<b>pT</b>ID<b>pS</b>IMNKVRDIK coupled to keyhole limpet hemocyanin as antigen.</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Cellular Kinase Inhibition Assay (EC<sub>50</sub>)</h3><div class="NLM_p last">HCT116 colon cancer cells transfected with wild-type TTK (Origene; Rockville, MD) were treated with nocodazole (200 ng/mL; Sigma, Oakville, ON) for 17 h. Cells were pretreated with MG132 (15 μM; Sigma, Oakville, ON) for 30 min before treatment with <b>75</b> or DMSO for 4 h. Protein lysates were prepared using ice-cold radioimmunoprecipitation assay (RIPA) lysis buffer. A total of 75 mg of cell lysate was loaded onto Bis-Tris gels (Invitrogen, Carlsbad, CA) with full-range molecular weight marker (Invitrogen, Carlsbad, CA) as a size reference and resolved by SDS-PAGE electrophoresis. Proteins were transferred to nitrocellulose membrane (Millipore, Billerica, MA), blocked, and probed with antibodies for phospho-TTK (Thr12/Ser15), phospho-Aurora A (Thr288)/Aurora B (Thr232)/Aurora C (Thr198), TTK, and GAPDH. Secondary antibodies were diluted 1 in 15000 and incubated for 1 h at room temperature. Protein bands were visualized and quantified using Odyssey near-infrared imager (LI-COR, Lincoln, NE). EC<sub>50</sub>s were calculated using GraphPad PRISM software (GraphPad Software Inc., San Diego, CA).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Cell Cycle Analysis</h3><div class="NLM_p last">HCT116 colon cancer cells in 6-well plates were treated with <b>75</b> or DMSO at the indicated concentrations and cultured at 37 °C and 5% CO<sub>2</sub>. After 2 days, the cells were harvested in trypsin/EDTA (0.25%/5 mM; Invitrogen, Carlsbad, CA), washed once in phosphate buffer saline containing 10 mM phosphate buffer, 2.7 mM potassium chloride, 137 mM sodium chloride, and 1.76 mM potassium phosphate and adjusted to pH 7.4 (1× PBS), centrifuged at 1000 rpm for 5 min, fixed in cold (−20 °C) 70% (v/v) ethanol in 1× PBS, and stored at 4 °C for at least 1 h. The cells were then centrifuged at 1500 rpm for 5 min, washed twice in 1× PBS, and stained with 50 μg/mL propidium iodide (Sigma, Oakville, ON) in 1× PBS containing RNaseA (100 μg/mL; Invitrogen, Carlsbad, CA) overnight at 4 °C. The DNA content was measured using a FACSCalibur flow cytometer (Becton, Dickinson and Company–Canada, Mississauga, ON) and data was analyzed using FloJo software (Tree Star, Inc., Ashland, OR).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Immunofluorescence Microscopy</h3><div class="NLM_p last">HCT116 colon cancer cells treated with <b>75</b> or DMSO in 4-well chamber slides (NalgeNunc International, Rochester, NY) were washed twice in 1× PBS, fixed in cold methanol (−20 °C) for 10 min and then washed four times in 1× PBS at 5 min intervals. Cells were incubated in blocking buffer (1% BSA (v/v), 0.5% (v/v/)Triton X-100 in 1× PBS) for 1 h at rt. Antibodies targeting centromeres and α-tubulin in blocking buffer were added to cells for 2 h at rt followed by three 1× PBS washes at 5 min intervals. Goat antirabbit and goat antimouse secondary antibodies conjugated to Alexa 488 and Alexa 555 were used to detect primary antibodies. DNA was detected with DAPI and cells were mounted in Permafluor (Invitrogen, Carlsbad, CA). Slides were analyzed using a Leica DM5000 B microscope equipped with fluorescence optics with a Leica X63 oil-immersion objective.</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Metaphase Chromosome Spread</h3><div class="NLM_p last">After 24 h of treatment with <b>75</b> or DMSO, HCT116 colon cancer cells were treated for 4 h with nocodazole (200 ng/mL) and MG132 (15 μM). Cells were then lysed in hypotonic solution (0.56% (v/v) KCl) for 10 min at 37 °C and fixed in methanol/glacial acetic acid (3:1) solution for 10 min at 4 °C. One drop of suspended cells was applied to glass slides. DNA was detected with DAPI, and cells were mounted in Permafluor (Invitrogen, Carlsbad, CA). Slides were analyzed using a Leica DM5000 B microscope equipped with fluorescence optics with a Leica X63 oil-immersion objective, and chromosomes were counted using ImageJ analysis software.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Mouse Plasma Levels</h3><div class="NLM_p last">Adult female athymic CD1 nude mice (Charles River) were used in the experiments; all animal experiments were approved by UHN Animal Care Committee. Dosing solutions were prepared by dissolving the compound in 10% NMP/40% PEG400/50% DI water (v/v) such that the dose volume was 10 mL/kg of animal body weight. In some instances, brief sonication or vortexing and/or gentle warming was required to ensure dissolution and/or dispersion. Nine mice were dosed with compounds at 10 mg/kg (free base equivalents) via oral gavage by standard methods. Saphenous vein blood was collected from 3 mice per time point over an 8 h period. The plasma samples were analyzed for drug and internal standard via LCMS/MS protocol using a Waters (Millford, MA, USA) UPLC coupled to either a Q-ToF Premier or a XevoTQ mass spectrometer. The pharmacokinetic parameters were calculated using Microsoft Excel with pharmacokinetic add-in functions from Usansky et al.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Parameters were calculated using plasma concentration time data for composite averages.</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> Xenograft Model</h3><div class="NLM_p">To determine the maximum tolerated dose (MTD) in athymic CD-1 nude female mice, for use in the efficacy studies, compounds were formulated in 10% NMP/40% PEG400/50% DI water (v/v) and dosed daily by oral gavage. A range of compound concentrations, plus vehicle control, were dosed at 10 mL/kg body weight. The MTD was defined as the highest daily dose for which test subjects (<i>n</i> = 3) do not demonstrate body weight loss in excess 20% and are not deemed moribund, as evaluated in accordance with UHN IACUC humane end point guidelines standard. MTDs for compounds <b>69</b>, <b>75</b>, and <b>86</b> were estimated to be 35, 35, and 150 mg/kg, respectively.</div><div class="NLM_p">HCT116 colon cancer cells were purchased from ATCC (American Type Culture Collections) and cultured in DMEM (GIBCO, Life Technologies Inc., Burlington, ON) supplemented with 10% (v/v) fetal calf serum. Five million cells were injected subcutaneously in the right flank of 6–8 week old female athymic CD-1 NUDE mice purchased from Charles River laboratories. When the mean tumor volume reached 80–120 mm<sup>3</sup> (95–100% take rate), mice were randomized into groups (<i>n</i> = 8). Compounds <b>69</b>, <b>75</b>, and <b>86</b> were weighed and dissolved in 10% NMP/40% PEG400/50% DI water and sonicated at rt for 30 min. The compound was dispensed in aliquots and stored at −20 °C for the duration of the study, and each aliquot was thawed at rt before each dose. The mice received oral daily doses of vehicle or compound for 21 days at the doses indicated (i.e., the MTD and ∼2/3 MTD).</div><div class="NLM_p">MDA-MB-468 breast cancer cells were purchased from ATCC and grown as detailed above; 10 million cells were injected subcutaneously in the right flank of 6–8 week old female CB-17 SCID mice supplied by UHN animal facility. When the mean tumor volume reached 80–120 mm<sup>3</sup> (85% take rate), mice were randomized into groups (<i>n</i> = 5) and treated with vehicle or compound <b>75</b> as described above.</div><div class="NLM_p">SW48 colon cancer cells were purchased from ATCC and grown as detailed above; 5 million cells were injected subcutaneously in the right flank of 6–8 week old female CD-1 Nude mice purchased from Charles River laboratories (Wilmington, MA). When the mean tumor volume reached 80–120 mm<sup>3</sup> (95% take rate), mice were randomized into groups (<i>n</i> = 7) and treated with vehicle or compound <b>75</b> as described above.</div><div class="NLM_p last">Tumor volume and body weight were measured three times weekly. Efficacy data were graphically represented as the mean tumor volume. Tumor volume was calculated by the following formula: <i>x</i><sup>2</sup><i>y</i>/2. Percent tumor growth inhibition after initiation of treatment with compound was calculated by TGI = 100 × 1 – (tumor volume<sub>final</sub> – tumor volume<sub>initial</sub> for compound treated group)/(tumor volume<sub>final</sub> – tumor volume<sub>initial</sub> for compound control group).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> Rat Pharmacokinetic Studies</h3><div class="NLM_p last">The pharmacokinetic studies were performed by Shanghai Chempartner (Pudong New Area, Shanghai, China). Compounds were dissolved in 10% NMP/40% PEG/50% DI water. Male SD rats (200–230 g, purchased from SLAC Laboratory Animal Co. LTD, Shanghai) were administered IV (foot dorsal vein) and PO (oral gavage); blood samples were collected via cannulated jugular veins and stored frozen. Diluted time point samples were analyzed by LCMSMS-02 (API 4000, triple quadrupole) using a standard curve. The PK parameters were determined by a noncompartmental model using WinNonlin Professional 5.2.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i100"><a href="/doi/suppl/10.1021/jm501740a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_87584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_87584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthesis of compound intermediates; double reciprocal plot of TTK inhibition by compound <b>75</b>; inhibition of 278 kinase panel by <b>75</b>; summary of crystallographic data and refinement statistics for TTK-compound <b>51</b> co-complex (PDB accession code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O6L">4O6L</a>); omit map for TTK–compound <b>51</b> co-complex; correlation of pIC<sub>50</sub>(TTK) vs GlideXP docking scores (<i>n</i> = 86); cell seeding data for cancer cell lines; early ADME data for compound <b>75</b>; mouse weights upon oral QD dosing of compounds <b>69</b>, <b>75</b>, and <b>86</b>.  This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501740a/suppl_file/jm501740a_si_001.pdf">jm501740a_si_001.pdf (1.44 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm501740a" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88034" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88034" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yong Liu</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b3cadcddd4dff3c6dbddc1d6c0d6d2c1d0db9dd0d2"><span class="__cf_email__" data-cfemail="9ee7f1f0f9f2deebf6f0ecfbedfbffecfdf6b0fdff">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Henry W. Pauls</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#442c342531283704312c2a362137212536272c6a2725"><span class="__cf_email__" data-cfemail="e98199889c859aa99c81879b8c9a8c889b8a81c78a88">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yunhui Lang</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Narendra Kumar Patel</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grace Ng</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Radoslaw Laufer</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sze-Wan Li</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Louise Edwards</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bryan Forrest</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter B. Sampson</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Miklos Feher</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Fuqiang Ban</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald E. Awrey</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Irina Beletskaya</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Guodong Mao</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Hodgson</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Olga Plotnikova</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Qiu</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Cancer Research Institute, University Health
Network, Princess Margaret
Cancer Centre, 610 University Avenue, Toronto, Ontario M5G 2C4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nickolay Y. Chirgadze</span> - <span class="hlFld-Affiliation affiliation">Campbell Family
Cancer Research Institute, University Health
Network, Princess Margaret
Cancer Centre, 610 University Avenue, Toronto, Ontario M5G 2C4, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacqueline M. Mason</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xin Wei</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dan Chi-Chia Lin</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yi Che</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Reza Kiarash</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Brian Madeira</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Graham C. Fletcher</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tak W. Mak</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark R. Bray</span> - <span class="hlFld-Affiliation affiliation">Campbell Family Institute for Breast Cancer Research, University Health Network, TMDT East Tower, MaRS Centre, 101 College Street, Toronto, Ontario M5G 1L7, Canada</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d3845e8482-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i101">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85477" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85477" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Richard Brokx for editorial comment during manuscript preparation and Dr. Homer Pearce for helpful advice and discussion during the course of the work. The Canadian Institutes of Health Research and the Princess Margaret Cancer Foundation are acknowledged for financial support. The use of the IMCA-CAT beamline 17-ID at the Advanced Photon Source was supported by the companies of the Industrial Macromolecular Crystallography Association through a contract with the Center for Advanced Radiation Sources at the University of Chicago. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. W-31-109-Eng-38.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i102" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i102"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i103" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i103"> Abbreviations Used</h2><tr><td class="NLM_term">A%</td><td class="NLM_def"><p class="first last">area percent</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism and excretion</p></td></tr><tr><td class="NLM_term">anh</td><td class="NLM_def"><p class="first last">anhydrous</p></td></tr><tr><td class="NLM_term">aq</td><td class="NLM_def"><p class="first last">aqueous</p></td></tr><tr><td class="NLM_term">Ar</td><td class="NLM_def"><p class="first last">aromatic</p></td></tr><tr><td class="NLM_term">ATCC</td><td class="NLM_def"><p class="first last">American Type Culture Collection</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine-5′-triphosphate</p></td></tr><tr><td class="NLM_term">AURKA</td><td class="NLM_def"><p class="first last">Aurora kinase A</p></td></tr><tr><td class="NLM_term">AURKB/INCENP</td><td class="NLM_def"><p class="first last">Aurora kinase B/inner centromere protein</p></td></tr><tr><td class="NLM_term">b</td><td class="NLM_def"><p class="first last">broad</p></td></tr><tr><td class="NLM_term">BA</td><td class="NLM_def"><p class="first last">bioavailability</p></td></tr><tr><td class="NLM_term">BFC</td><td class="NLM_def"><p class="first last">7-benzyloxy-4-trifluoromethylcoumarin</p></td></tr><tr><td class="NLM_term">BLM</td><td class="NLM_def"><p class="first last">Bloom syndrome helicase</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butoxycarbonyl</p></td></tr><tr><td class="NLM_term">BSA</td><td class="NLM_def"><p class="first last">bovine serum albumin</p></td></tr><tr><td class="NLM_term">calcd</td><td class="NLM_def"><p class="first last">calculated</p></td></tr><tr><td class="NLM_term">CHK2</td><td class="NLM_def"><p class="first last">checkpoint kinase 2</p></td></tr><tr><td class="NLM_term">CIN</td><td class="NLM_def"><p class="first last">chromosomal instability</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">d</td><td class="NLM_def"><p class="first last">doublet</p></td></tr><tr><td class="NLM_term">DAPI</td><td class="NLM_def"><p class="first last">4′,6-diamidino-2-phenylindole</p></td></tr><tr><td class="NLM_term">(<span class="smallcaps smallerCapital">d</span>)- or (<span class="smallcaps smallerCapital">l</span>)-DBTA</td><td class="NLM_def"><p class="first last">Dibenzoyl-<span class="smallcaps smallerCapital">d</span> or <span class="smallcaps smallerCapital">l</span>-tartaric acid</p></td></tr><tr><td class="NLM_term">DBF</td><td class="NLM_def"><p class="first last">dibenzylfluorescein</p></td></tr><tr><td class="NLM_term">DBU</td><td class="NLM_def"><p class="first last">1,8-diazabicycloundec-7-ene</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DI</td><td class="NLM_def"><p class="first last">deionized</p></td></tr><tr><td class="NLM_term">DIPEA</td><td class="NLM_def"><p class="first last">diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle’s Medium</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′- bis(diphenylphosphino) ferrocene</p></td></tr><tr><td class="NLM_term">eADME</td><td class="NLM_def"><p class="first last">early ADME</p></td></tr><tr><td class="NLM_term">ee</td><td class="NLM_def"><p class="first last">enantiomeric excess</p></td></tr><tr><td class="NLM_term">EGFR</td><td class="NLM_def"><p class="first last">epidermal growth factor receptor</p></td></tr><tr><td class="NLM_term">EGTA</td><td class="NLM_def"><p class="first last">ethylene glycol tetraacetic acid</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">FLT3</td><td class="NLM_def"><p class="first last">fms-related tyrosine kinase 3</p></td></tr><tr><td class="NLM_term">GI<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal cell growth inhibitory concentration</p></td></tr><tr><td class="NLM_term">GST</td><td class="NLM_def"><p class="first last">glutathione S-transferase</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hour</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go related gene</p></td></tr><tr><td class="NLM_term">HEPES</td><td class="NLM_def"><p class="first last">4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid</p></td></tr><tr><td class="NLM_term">HOBt</td><td class="NLM_def"><p class="first last">hydroxybenzotriazole</p></td></tr><tr><td class="NLM_term">HMBC</td><td class="NLM_def"><p class="first last">heteronuclear multiple-bond correlation spectroscopy</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HRMS</td><td class="NLM_def"><p class="first last">high-resolution mass spectrometry</p></td></tr><tr><td class="NLM_term">IEX</td><td class="NLM_def"><p class="first last">ion exchange</p></td></tr><tr><td class="NLM_term">IP</td><td class="NLM_def"><p class="first last">intraperitoneal</p></td></tr><tr><td class="NLM_term">IPTG</td><td class="NLM_def"><p class="first last">Isopropyl β-<span class="smallcaps smallerCapital">d</span>-thiogalactopyranoside</p></td></tr><tr><td class="NLM_term">JNK3</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase 3</p></td></tr><tr><td class="NLM_term">KD</td><td class="NLM_def"><p class="first last">kinase domain</p></td></tr><tr><td class="NLM_term">KDR</td><td class="NLM_def"><p class="first last">kinase insert domain receptor</p></td></tr><tr><td class="NLM_term">LB</td><td class="NLM_def"><p class="first last">lysis buffer</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography coupled to mass spectrometry</p></td></tr><tr><td class="NLM_term">MAPK2</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase 2</p></td></tr><tr><td class="NLM_term">MBP</td><td class="NLM_def"><p class="first last">myelin basic protein</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">multiplet</p></td></tr><tr><td class="NLM_term">Mps1</td><td class="NLM_def"><p class="first last">monopolar spindle 1</p></td></tr><tr><td class="NLM_term">MS ESI</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectrometry</p></td></tr><tr><td class="NLM_term">MTD</td><td class="NLM_def"><p class="first last">maximum tolerated dose</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methylpyrrolidone</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">NBS</td><td class="NLM_def"><p class="first last"><i>N</i>-bromosuccinimide</p></td></tr><tr><td class="NLM_term">PAMPA</td><td class="NLM_def"><p class="first last">parallel artificial membrane permeability assay</p></td></tr><tr><td class="NLM_term">PARP</td><td class="NLM_def"><p class="first last">poly ADP ribose polymerase</p></td></tr><tr><td class="NLM_term">PBS</td><td class="NLM_def"><p class="first last">phosphate buffered saline</p></td></tr><tr><td class="NLM_term">PCR</td><td class="NLM_def"><p class="first last">polymerase chain reaction</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PEG400</td><td class="NLM_def"><p class="first last">polyethylene glycol 400</p></td></tr><tr><td class="NLM_term">pin</td><td class="NLM_def"><p class="first last">pinacol</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PLK4</td><td class="NLM_def"><p class="first last">Polo-like kinase 4</p></td></tr><tr><td class="NLM_term">PMB</td><td class="NLM_def"><p class="first last"><i>p</i>-methoxybenzyl</p></td></tr><tr><td class="NLM_term">PMSF</td><td class="NLM_def"><p class="first last">phenylmethanesulfonyl-fluoride</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">prep</td><td class="NLM_def"><p class="first last">preparative</p></td></tr><tr><td class="NLM_term">PTEN</td><td class="NLM_def"><p class="first last">phosphatase and tensin homologue</p></td></tr><tr><td class="NLM_term">PSA</td><td class="NLM_def"><p class="first last">polar surface area</p></td></tr><tr><td class="NLM_term">QD</td><td class="NLM_def"><p class="first last">quaque die (once daily)</p></td></tr><tr><td class="NLM_term">QSAR</td><td class="NLM_def"><p class="first last">quantitative structure–activity relationship</p></td></tr><tr><td class="NLM_term">Ra–Ni</td><td class="NLM_def"><p class="first last">Raney nickel</p></td></tr><tr><td class="NLM_term">RBF</td><td class="NLM_def"><p class="first last">round bottomed flask</p></td></tr><tr><td class="NLM_term">RIPA</td><td class="NLM_def"><p class="first last">radio-immunoprecipitation assay</p></td></tr><tr><td class="NLM_term">rmse</td><td class="NLM_def"><p class="first last">root-mean-square error</p></td></tr><tr><td class="NLM_term">rt</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">RP</td><td class="NLM_def"><p class="first last">reverse phase</p></td></tr><tr><td class="NLM_term">s</td><td class="NLM_def"><p class="first last">singlet</p></td></tr><tr><td class="NLM_term">SAC</td><td class="NLM_def"><p class="first last">spindle assembly checkpoint</p></td></tr><tr><td class="NLM_term">satd</td><td class="NLM_def"><p class="first last">saturated</p></td></tr><tr><td class="NLM_term">SEM</td><td class="NLM_def"><p class="first last">2-(trimethylsilyl)ethoxy]methyl</p></td></tr><tr><td class="NLM_term">siRNA</td><td class="NLM_def"><p class="first last">small interfering RNA</p></td></tr><tr><td class="NLM_term">SMs</td><td class="NLM_def"><p class="first last">starting materials</p></td></tr><tr><td class="NLM_term">t</td><td class="NLM_def"><p class="first last">triplet</p></td></tr><tr><td class="NLM_term">SRB</td><td class="NLM_def"><p class="first last">sulforhodamine B</p></td></tr><tr><td class="NLM_term">STR</td><td class="NLM_def"><p class="first last">short tandem repeat</p></td></tr><tr><td class="NLM_term">SUMO</td><td class="NLM_def"><p class="first last">small ubiquitin-like modifier</p></td></tr><tr><td class="NLM_term">TB</td><td class="NLM_def"><p class="first last">terrific broth</p></td></tr><tr><td class="NLM_term">TBAB</td><td class="NLM_def"><p class="first last">tetra-<i>n</i>-butylammonium bromide</p></td></tr><tr><td class="NLM_term">TBAF</td><td class="NLM_def"><p class="first last">tetra-<i>n</i>-butylammonium fluoride</p></td></tr><tr><td class="NLM_term">TBTU</td><td class="NLM_def"><p class="first last"><i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate</p></td></tr><tr><td class="NLM_term">TCA</td><td class="NLM_def"><p class="first last">trichloroacetic acid</p></td></tr><tr><td class="NLM_term">TCEP</td><td class="NLM_def"><p class="first last">tris(2-carboxyethyl)phosphine</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">temp</td><td class="NLM_def"><p class="first last">temperature</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TGI</td><td class="NLM_def"><p class="first last">tumor growth inhibition</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">THP</td><td class="NLM_def"><p class="first last">tetrahydropyran</p></td></tr><tr><td class="NLM_term">TIE</td><td class="NLM_def"><p class="first last">tyrosine kinase with immunoglobulin-like and EGF-like domains</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin layer chromatography</p></td></tr><tr><td class="NLM_term">TMB</td><td class="NLM_def"><p class="first last">3,3′,5,5′-tetramethylbenzidine</p></td></tr><tr><td class="NLM_term">TRK</td><td class="NLM_def"><p class="first last">tropomyosin receptor kinase</p></td></tr><tr><td class="NLM_term">TTK</td><td class="NLM_def"><p class="first last">threonine tyrosine kinase</p></td></tr><tr><td class="NLM_term">TTK KD</td><td class="NLM_def"><p class="first last">TTK kinase domain</p></td></tr><tr><td class="NLM_term">q</td><td class="NLM_def"><p class="first last">quartet</p></td></tr><tr><td class="NLM_term">UPLC</td><td class="NLM_def"><p class="first last">ultra performance liquid chromatography</p></td></tr><tr><td class="NLM_term">UHN IACUC</td><td class="NLM_def"><p class="first last">University Health Network Institutional Animal Care and Use Committee</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum velocity</p></td></tr><tr><td class="NLM_term">XDS</td><td class="NLM_def"><p class="first last">X-ray detector software</p></td></tr><tr><td class="NLM_term">1× PBS</td><td class="NLM_def"><p class="first last">phosphate buffer saline containing 10 mM phosphate buffer, 2.7 mM potassium chloride, 137 mM sodium chloride, and 1.76 mM potassium phosphate and adjusted to pH 7.4</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i104">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33121" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33121" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 62 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Aarts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span> </span><span class="NLM_article-title">Tumour selective targeting of cell cycle kinases for cancer treatment</span> <span class="citation_source-journal">Curr. Opin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1016%2Fj.coph.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=23597425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtValsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=529-535&author=M.+Aartsauthor=S.+Linardopoulosauthor=N.+C.+Turner&title=Tumour+selective+targeting+of+cell+cycle+kinases+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour selective targeting of cell cycle kinases for cancer treatment</span></div><div class="casAuthors">Aarts, Marieke; Linardopoulos, Spiros; Turner, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">529-535</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The deregulation of the cell cycle and checkpoint machinery in cancer presents a highly attractive therapeutic strategy.  We review here the strategies used to exploit the dysregulated cell cycle, both through targeting kinases required for cell cycle progression, and checkpoint kinases to inappropriately force cells through the cell cycle.  Appropriate control of the cell cycle is crit. for proliferating normal cells, and we discuss the importance of defining tumor specific vulnerabilities that could be targeted with cell cycle kinase inhibitors.  Recent studies have shown that ER-pos. breast cancers rely on CDK4 to promote proliferation.  TP53 mutant cancer cell lines are sensitive to WEE1 and CHK1 inhibitors in combination with chemotherapy, while PTEN-deficient aneuploid cancer cell lines are sensitive to TTK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLoVeyM7O1HrVg90H21EOLACvtfcHk0lgKwqr-H-xa-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtValsbg%253D&md5=21d34a68d937abd09dad8bc15fd56bce</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DAarts%26aufirst%3DM.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26atitle%3DTumour%2520selective%2520targeting%2520of%2520cell%2520cycle%2520kinases%2520for%2520cancer%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Pharm.%26date%3D2013%26volume%3D13%26spage%3D529%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Foley, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, T. M.</span><span> </span><span class="NLM_article-title">Microtubule attachment and spindle assembly checkpoint signaling at the kinetochore</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fnrm3494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=23258294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=25-37&author=E.+A.+Foleyauthor=T.+M.+Kapoor&title=Microtubule+attachment+and+spindle+assembly+checkpoint+signaling+at+the+kinetochore"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore</span></div><div class="casAuthors">Foley, Emily A.; Kapoor, Tarun M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-37</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In eukaryotes, chromosome segregation during cell division is facilitated by the kinetochore, a multiprotein structure that is assembled on centromeric DNA.  The kinetochore attaches chromosomes to spindle microtubules, modulates the stability of these attachments and relays the microtubule-binding status to the spindle assembly checkpoint (SAC), a cell cycle surveillance pathway that delays chromosome segregation in response to unattached kinetochores.  Recent studies are shaping current thinking on how each of these kinetochore-centered processes is achieved, and how their integration ensures faithful chromosome segregation, focusing on the essential roles of kinase-phosphatase signaling and the microtubule-binding KMN protein network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0-fThmrgdaLVg90H21EOLACvtfcHk0lgiqnyFL3Kvmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgurjP&md5=d99b2423a2991a219f23f9ccfd81dd65</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm3494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3494%26sid%3Dliteratum%253Aachs%26aulast%3DFoley%26aufirst%3DE.%2BA.%26aulast%3DKapoor%26aufirst%3DT.%2BM.%26atitle%3DMicrotubule%2520attachment%2520and%2520spindle%2520assembly%2520checkpoint%2520signaling%2520at%2520the%2520kinetochore%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2013%26volume%3D14%26spage%3D25%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Rajagopalan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span> </span><span class="NLM_article-title">Progress Aneuploidy and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=338-341&author=H.+Rajagopalanauthor=C.+Lengauer&title=Progress+Aneuploidy+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopalan%26aufirst%3DH.%26aulast%3DLengauer%26aufirst%3DC.%26atitle%3DProgress%2520Aneuploidy%2520and%2520cancer%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D338%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loncarek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khodjakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieder, C. L.</span><span> </span><span class="NLM_article-title">Extra centrosomes and/or chromosomes prolong mitosis in human cells</span> <span class="citation_source-journal">Nature Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fncb1738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=18469805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFyktr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=748-751&author=Z.+Yangauthor=J.+Loncarekauthor=A.+Khodjakovauthor=C.+L.+Rieder&title=Extra+centrosomes+and%2For+chromosomes+prolong+mitosis+in+human+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Extra centrosomes and/or chromosomes prolong mitosis in human cells</span></div><div class="casAuthors">Yang, Zhenye; Loncarek, Jadranka; Khodjakov, Alexey; Rieder, Conly L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">748-751</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Using laser microsurgery and cell fusion we have explored how addnl. centrosomes and/or chromosomes influence the duration of mitosis in human cells.  We found that doubling the chromosome no. added approx. 10 min to a 20 min division, whereas doubling the no. of centrosomes added approx. 30 min more.  Extra centrosomes and/or chromosomes prolong mitosis by delaying satisfaction of the spindle assembly checkpoint.  Thus mitosis can be prolonged by non-genetic means and extra chromosomes and centrosomes probably contribute to the elevated mitotic index seen in many tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCq5DOSqG7krVg90H21EOLACvtfcHk0lgiqnyFL3Kvmg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFyktr4%253D&md5=7a8d5bb021025a3b3d0ab95b555f52c6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fncb1738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1738%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLoncarek%26aufirst%3DJ.%26aulast%3DKhodjakov%26aufirst%3DA.%26aulast%3DRieder%26aufirst%3DC.%2BL.%26atitle%3DExtra%2520centrosomes%2520and%252For%2520chromosomes%2520prolong%2520mitosis%2520in%2520human%2520cells%26jtitle%3DNature%2520Cell%2520Biol.%26date%3D2008%26volume%3D10%26spage%3D748%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Duesberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rausch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasnick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hehlmann, R.</span><span> </span><span class="NLM_article-title">Genetic instability of cancer cells is proportional to their degree of aneuploidy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">13692</span><span class="NLM_x">–</span> <span class="NLM_lpage">13695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=13692-13695&author=P.+Duesbergauthor=C.+Rauschauthor=D.+Rasnickauthor=R.+Hehlmann&title=Genetic+instability+of+cancer+cells+is+proportional+to+their+degree+of+aneuploidy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuesberg%26aufirst%3DP.%26aulast%3DRausch%26aufirst%3DC.%26aulast%3DRasnick%26aufirst%3DD.%26aulast%3DHehlmann%26aufirst%3DR.%26atitle%3DGenetic%2520instability%2520of%2520cancer%2520cells%2520is%2520proportional%2520to%2520their%2520degree%2520of%2520aneuploidy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D13692%26epage%3D13695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kops, G. J. P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span> </span><span class="NLM_article-title">Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">8699</span><span class="NLM_x">–</span> <span class="NLM_lpage">8704</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=8699-8704&author=G.+J.+P.+L.+Kopsauthor=D.+R.+Foltzauthor=D.+W.+Cleveland&title=Lethality+to+human+cancer+cells+through+massive+chromosome+loss+by+inhibition+of+the+mitotic+checkpoint"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DFoltz%26aufirst%3DD.%2BR.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26atitle%3DLethality%2520to%2520human%2520cancer%2520cells%2520through%2520massive%2520chromosome%2520loss%2520by%2520inhibition%2520of%2520the%2520mitotic%2520checkpoint%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D8699%26epage%3D8704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Abrieu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi-Jaulin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigneron, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorca, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labbe, J. C.</span><span> </span><span class="NLM_article-title">Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2001&pages=83-93&author=A.+Abrieuauthor=L.+Magnaghi-Jaulinauthor=J.+A.+Kahanaauthor=M.+Peterauthor=A.+Castroauthor=S.+Vigneronauthor=T.+Lorcaauthor=D.+W.+Clevelandauthor=J.+C.+Labbe&title=Mps1+is+a+kinetochore-associated+kinase+essential+for+the+vertebrate+mitotic+checkpoint"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbrieu%26aufirst%3DA.%26aulast%3DMagnaghi-Jaulin%26aufirst%3DL.%26aulast%3DKahana%26aufirst%3DJ.%2BA.%26aulast%3DPeter%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DVigneron%26aufirst%3DS.%26aulast%3DLorca%26aufirst%3DT.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26aulast%3DLabbe%26aufirst%3DJ.%2BC.%26atitle%3DMps1%2520is%2520a%2520kinetochore-associated%2520kinase%2520essential%2520for%2520the%2520vertebrate%2520mitotic%2520checkpoint%26jtitle%3DCell%26date%3D2001%26volume%3D106%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winey, M.</span><span> </span><span class="NLM_article-title">The Mps1 family of protein kinases</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1146%2Fannurev-biochem-061611-090435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=22482908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGls7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=561-585&author=X.+Liuauthor=M.+Winey&title=The+Mps1+family+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The MPS1 family of protein kinases</span></div><div class="casAuthors">Liu, Xuedong; Winey, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">561-585</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  MPS1 protein kinases are found widely, but not ubiquitously, in eukaryotes.  This family of potentially dual-specific protein kinases is among several that regulate a no. of steps of mitosis.  The most widely conserved MPS1 kinase functions involve activities at the kinetochore in both the chromosome attachment and the spindle checkpoint.  MPS1 kinases also function at centrosomes.  Beyond mitosis, MPS1 kinases have been implicated in development, cytokinesis, and several different signaling pathways.  Family members are identified by virtue of a conserved C-terminal kinase domain, though the N-terminal domain is quite divergent.  The kinase domain of the human enzyme has been crystd., revealing an unusual ATP-binding pocket.  The activity, level, and subcellular localization of Mps1 family members are tightly regulated during cell-cycle progression.  The mitotic functions of Mps1 kinases and their overexpression in some tumors have prompted the identification of Mps1 inhibitors and their active development as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraBW1z_I4wXbVg90H21EOLACvtfcHk0lg9bCNy_fj5Mw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGls7fE&md5=18dd99863b2bfac327a6b351ebd51bd3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-061611-090435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-061611-090435%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWiney%26aufirst%3DM.%26atitle%3DThe%2520Mps1%2520family%2520of%2520protein%2520kinases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2012%26volume%3D81%26spage%3D561%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amendola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodricks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, D.</span><span> </span><span class="NLM_article-title">Expression of TTK, a novel human protein kinase, is associated with cell proliferation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">16000</span><span class="NLM_x">–</span> <span class="NLM_lpage">16006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=16000-16006&author=G.+B.+Millsauthor=R.+Schmandtauthor=M.+McGillauthor=A.+Amendolaauthor=M.+Hillauthor=K.+Jacobsauthor=C.+Mayauthor=A.+M.+Rodricksauthor=S.+Campbellauthor=D.+Hogg&title=Expression+of+TTK%2C+a+novel+human+protein+kinase%2C+is+associated+with+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSchmandt%26aufirst%3DR.%26aulast%3DMcGill%26aufirst%3DM.%26aulast%3DAmendola%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DK.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DRodricks%26aufirst%3DA.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DD.%26atitle%3DExpression%2520of%2520TTK%252C%2520a%2520novel%2520human%2520protein%2520kinase%252C%2520is%2520associated%2520with%2520cell%2520proliferation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D16000%26epage%3D16006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Yuan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersto, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tully, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielson, E.</span><span> </span><span class="NLM_article-title">Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1158%2F1078-0432.CCR-05-0903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=16428479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=405-410&author=B.+Yuanauthor=Y.+Xuauthor=J.-H.+Wooauthor=Y.+Wangauthor=Y.+K.+Baeauthor=D.-S.+Yoonauthor=R.+P.+Werstoauthor=E.+Tullyauthor=K.+Wilsbachauthor=E.+Gabrielson&title=Increased+expression+of+mitotic+checkpoint+genes+in+breast+cancer+cells+with+chromosomal+instability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability</span></div><div class="casAuthors">Yuan, Bibo; Xu, Yi; Woo, Ju-Hyung; Wang, Yunyue; Bae, Young Kyung; Yoon, Dae-Sung; Wersto, Robert P.; Tully, Ellen; Wilsbach, Kathleen; Gabrielson, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-410</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Most breast cancers have chromosomal instability that seems related to defective mitotic spindle checkpoints.  Because the mol. basis of this defect is unknown, we evaluated breast cancer cell lines and tissues for possible defects involving the major mitotic checkpoint genes responsible for maintaining chromosomal stability.  Exptl. Design: We analyzed sequences and expression levels (RNA and protein) of eight major spindle checkpoint genes (MAD1L1, MAD2L1, MAD2L2, BUB1, BUB1B, BUB3, CDC20, and TTK) in a panel of 12 breast cancer cell lines, most with established genetic instability and defective spindle damage checkpoint response.  MRNA levels of these genes were also measured in primary tumor samples, and immunohistochem. staining was used to evaluate BUB1B protein levels in a panel of 270 addnl. cases of breast cancer.  Results: No functionally significant sequence variations were found for any of the eight genes in the breast cancer cell lines with chromosomal instability.  More surprisingly, the mRNA and protein levels for these checkpoint genes are significantly higher in the genetically unstable breast cancer cell lines and in high-grade primary breast cancer tissues than in the stable (and checkpoint proficient) MCF-10A and normal mammary epithelial cells, or in normal breast tissues.  In fact, overexpression of the BUB1B protein is a marker that recognizes nearly 80% of breast cancers in paraffin-embedded tissues.  Conclusions: Defective mitotic spindle checkpoints in breast cancer are most likely not caused by low expression or mutations of these eight checkpoint genes.  High levels of these particular transcripts could represent a cellular compensation for defects in other mol. components of the mitotic spindle damage checkpoint, and increased expression of these genes might be markers of breast cancers with chromosomal instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcNtMRC1xcrVg90H21EOLACvtfcHk0lgenzaoA3EMGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D&md5=06a8afcd6636218ae3a7bf38fe9939b4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0903%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBae%26aufirst%3DY.%2BK.%26aulast%3DYoon%26aufirst%3DD.-S.%26aulast%3DWersto%26aufirst%3DR.%2BP.%26aulast%3DTully%26aufirst%3DE.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DIncreased%2520expression%2520of%2520mitotic%2520checkpoint%2520genes%2520in%2520breast%2520cancer%2520cells%2520with%2520chromosomal%2520instability%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D405%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Daniel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielson, E.</span><span> </span><span class="NLM_article-title">High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">5384</span><span class="NLM_x">–</span> <span class="NLM_lpage">5389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5384-5389&author=J.+Danielauthor=J.+Coulterauthor=J.+H.+Wooauthor=K.+Wilsbachauthor=E.+Gabrielson&title=High+levels+of+the+Mps1+checkpoint+protein+are+protective+of+aneuploidy+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel%26aufirst%3DJ.%26aulast%3DCoulter%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DJ.%2BH.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DHigh%2520levels%2520of%2520the%2520Mps1%2520checkpoint%2520protein%2520are%2520protective%2520of%2520aneuploidy%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5384%26epage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Kilpinen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallioniemi, O.</span><span> </span><span class="NLM_article-title">Analysis of kinase gene expression patterns across 5681 human tissue samples reveals functional genomic taxonomy of the kinome</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e15068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e15068&author=S.+Kilpinenauthor=K.+Ojalaauthor=O.+Kallioniemi&title=Analysis+of+kinase+gene+expression+patterns+across+5681+human+tissue+samples+reveals+functional+genomic+taxonomy+of+the+kinome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKilpinen%26aufirst%3DS.%26aulast%3DOjala%26aufirst%3DK.%26aulast%3DKallioniemi%26aufirst%3DO.%26atitle%3DAnalysis%2520of%2520kinase%2520gene%2520expression%2520patterns%2520across%25205681%2520human%2520tissue%2520samples%2520reveals%2520functional%2520genomic%2520taxonomy%2520of%2520the%2520kinome%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De15068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Landi, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dracheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotunno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergen, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesatori, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Consonni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertazzi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacholder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caporaso, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jen, J.</span><span> </span><span class="NLM_article-title">Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e1651&author=M.+T.+Landiauthor=T.+Drachevaauthor=M.+Rotunnoauthor=J.+D.+Figueroaauthor=H.+Liuauthor=A.+Dasguptaauthor=F.+E.+Mannauthor=J.+Fukuokaauthor=M.+Hamesauthor=A.+W.+Bergenauthor=S.+E.+Murphyauthor=P.+Yangauthor=A.+C.+Pesatoriauthor=D.+Consonniauthor=P.+A.+Bertazziauthor=S.+Wacholderauthor=J.+H.+Shihauthor=N.+E.+Caporasoauthor=J.+Jen&title=Gene+expression+signature+of+cigarette+smoking+and+its+role+in+lung+adenocarcinoma+development+and+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandi%26aufirst%3DM.%2BT.%26aulast%3DDracheva%26aufirst%3DT.%26aulast%3DRotunno%26aufirst%3DM.%26aulast%3DFigueroa%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DDasgupta%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DF.%2BE.%26aulast%3DFukuoka%26aufirst%3DJ.%26aulast%3DHames%26aufirst%3DM.%26aulast%3DBergen%26aufirst%3DA.%2BW.%26aulast%3DMurphy%26aufirst%3DS.%2BE.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DPesatori%26aufirst%3DA.%2BC.%26aulast%3DConsonni%26aufirst%3DD.%26aulast%3DBertazzi%26aufirst%3DP.%2BA.%26aulast%3DWacholder%26aufirst%3DS.%26aulast%3DShih%26aufirst%3DJ.%2BH.%26aulast%3DCaporaso%26aufirst%3DN.%2BE.%26aulast%3DJen%26aufirst%3DJ.%26atitle%3DGene%2520expression%2520signature%2520of%2520cigarette%2520smoking%2520and%2520its%2520role%2520in%2520lung%2520adenocarcinoma%2520development%2520and%2520survival%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De1651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Fisk, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattison, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winey, M.</span><span> </span><span class="NLM_article-title">Human Mps1 protein kinase is required for centrosome duplication and normal mitotic progression</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">14875</span><span class="NLM_x">–</span> <span class="NLM_lpage">14880</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=14875-14880&author=H.+A.+Fiskauthor=C.+P.+Mattisonauthor=M.+Winey&title=Human+Mps1+protein+kinase+is+required+for+centrosome+duplication+and+normal+mitotic+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisk%26aufirst%3DH.%2BA.%26aulast%3DMattison%26aufirst%3DC.%2BP.%26aulast%3DWiney%26aufirst%3DM.%26atitle%3DHuman%2520Mps1%2520protein%2520kinase%2520is%2520required%2520for%2520centrosome%2520duplication%2520and%2520normal%2520mitotic%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D14875%26epage%3D14880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Carter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eklund, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohane, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szallasi, Z.</span><span> </span><span class="NLM_article-title">A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1043</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fng1861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=16921376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVWjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=1043-1048&author=S.+L.+Carterauthor=A.+C.+Eklundauthor=I.+S.+Kohaneauthor=L.+N.+Harrisauthor=Z.+Szallasi&title=A+signature+of+chromosomal+instability+inferred+from+gene+expression+profiles+predicts+clinical+outcome+in+multiple+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers</span></div><div class="casAuthors">Carter, Scott L.; Eklund, Aron C.; Kohane, Isaac S.; Harris, Lyndsay N.; Szallasi, Zoltan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1043-1048</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We developed a computational method to characterize aneuploidy in tumor samples based on coordinated aberrations in expression of genes localized to each chromosomal region.  We summarized the total level of chromosomal aberration in a given tumor in a univariate measure termed total functional aneuploidy.  We identified a signature of chromosomal instability from specific genes whose expression was consistently correlated with total functional aneuploidy in several cancer types.  Net overexpression of this signature was predictive of poor clin. outcome in 12 cancer data sets representing six cancer types.  Also, the signature of chromosomal instability was higher in metastasis samples than in primary tumors and was able to stratify grade 1 and grade 2 breast tumors according to clin. outcome.  These results provide a means to assess the potential role of chromosomal instability in detg. malignant potential over a broad range of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaDdEb7DAh87Vg90H21EOLACvtfcHk0lgenzaoA3EMGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVWjtr0%253D&md5=8d236ca65fd69447f0ed3bf0ac28eba8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fng1861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1861%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DS.%2BL.%26aulast%3DEklund%26aufirst%3DA.%2BC.%26aulast%3DKohane%26aufirst%3DI.%2BS.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DSzallasi%26aufirst%3DZ.%26atitle%3DA%2520signature%2520of%2520chromosomal%2520instability%2520inferred%2520from%2520gene%2520expression%2520profiles%2520predicts%2520clinical%2520outcome%2520in%2520multiple%2520human%2520cancers%26jtitle%3DNature%2520Genet.%26date%3D2006%26volume%3D38%26spage%3D1043%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Salvatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nappi, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miccoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirafici, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melillo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span> </span><span class="NLM_article-title">A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">10148</span><span class="NLM_x">–</span> <span class="NLM_lpage">10158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10148-10158&author=G.+Salvatoreauthor=T.+C.+Nappiauthor=P.+Salernoauthor=Y.+Jiangauthor=C.+Garbiauthor=C.+Ugoliniauthor=P.+Miccoliauthor=F.+Basoloauthor=M.+D.+Castelloneauthor=A.+M.+Ciraficiauthor=R.+M.+Melilloauthor=A.+Fuscoauthor=M.+L.+Bittnerauthor=M.+Santoro&title=A+cell+proliferation+and+chromosomal+instability+signature+in+anaplastic+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DG.%26aulast%3DNappi%26aufirst%3DT.%2BC.%26aulast%3DSalerno%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGarbi%26aufirst%3DC.%26aulast%3DUgolini%26aufirst%3DC.%26aulast%3DMiccoli%26aufirst%3DP.%26aulast%3DBasolo%26aufirst%3DF.%26aulast%3DCastellone%26aufirst%3DM.%2BD.%26aulast%3DCirafici%26aufirst%3DA.%2BM.%26aulast%3DMelillo%26aufirst%3DR.%2BM.%26aulast%3DFusco%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DM.%2BL.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DA%2520cell%2520proliferation%2520and%2520chromosomal%2520instability%2520signature%2520in%2520anaplastic%2520thyroid%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10148%26epage%3D10158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Brough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankum, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes-Pereira, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajrami, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Cabral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafiq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerone, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natrajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterskog, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawjee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Functional viability profiles of breast cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=260-273&author=R.+Broughauthor=J.+R.+Frankumauthor=D.+Simsauthor=A.+Mackayauthor=A.+M.+Mendes-Pereiraauthor=I.+Bajramiauthor=S.+Costa-Cabralauthor=R.+Rafiqauthor=A.+S.+Ahmadauthor=M.+A.+Ceroneauthor=R.+Natrajanauthor=R.+Sharpeauthor=K.+K.+Shiuauthor=D.+Wetterskogauthor=K.+J.+Dedesauthor=M.+B.+Lambrosauthor=T.+Rawjeeauthor=S.+Linardopoulosauthor=J.+S.+Reis-Filhoauthor=N.+C.+Turnerauthor=C.+J.+Lordauthor=A.+Ashworth&title=Functional+viability+profiles+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DFrankum%26aufirst%3DJ.%2BR.%26aulast%3DSims%26aufirst%3DD.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DMendes-Pereira%26aufirst%3DA.%2BM.%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DCosta-Cabral%26aufirst%3DS.%26aulast%3DRafiq%26aufirst%3DR.%26aulast%3DAhmad%26aufirst%3DA.%2BS.%26aulast%3DCerone%26aufirst%3DM.%2BA.%26aulast%3DNatrajan%26aufirst%3DR.%26aulast%3DSharpe%26aufirst%3DR.%26aulast%3DShiu%26aufirst%3DK.%2BK.%26aulast%3DWetterskog%26aufirst%3DD.%26aulast%3DDedes%26aufirst%3DK.%2BJ.%26aulast%3DLambros%26aufirst%3DM.%2BB.%26aulast%3DRawjee%26aufirst%3DT.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFunctional%2520viability%2520profiles%2520of%2520breast%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D260%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Gordon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span> </span><span class="NLM_article-title">Causes and consequences of aneuploidy in cancer</span> <span class="citation_source-journal">Nature Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fnrg3123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=22269907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=189-203&author=D.+J.+Gordonauthor=B.+Resioauthor=D.+Pellman&title=Causes+and+consequences+of+aneuploidy+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Causes and consequences of aneuploidy in cancer</span></div><div class="casAuthors">Gordon, David J.; Resio, Benjamin; Pellman, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-203</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic instability, which includes both numerical and structural chromosomal abnormalities, is a hallmark of cancer.  Whereas the structural chromosome rearrangements have received substantial attention, the role of whole-chromosome aneuploidy in cancer is much less well-understood.  Here we review recent progress in understanding the roles of whole-chromosome aneuploidy in cancer, including the mechanistic causes of aneuploidy, the cellular responses to chromosome gains or losses and how cells might adapt to tolerate these usually detrimental alterations.  We also explore the role of aneuploidy in cellular transformation and discuss the possibility of developing aneuploidy-specific therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4uwB4F0Xu7Vg90H21EOLACvtfcHk0ljspXwCAX8jMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D&md5=9c730e7390d7aafd54301777e2270721</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrg3123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3123%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BJ.%26aulast%3DResio%26aufirst%3DB.%26aulast%3DPellman%26aufirst%3DD.%26atitle%3DCauses%2520and%2520consequences%2520of%2520aneuploidy%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Genet.%26date%3D2012%26volume%3D13%26spage%3D189%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">de Sauvage, F.; Evangelista, M.</span><span> </span><span class="NLM_article-title">Hedgehog kinases and their use in modulating hedgehog signaling</span>. US Pat. Appl. US20070179091,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=F.+de+Sauvage&author=M.+Evangelista&title=Hedgehog+kinases+and+their+use+in+modulating+hedgehog+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BSauvage%26aufirst%3DF.%26atitle%3DHedgehog%2520kinases%2520and%2520their%2520use%2520in%2520modulating%2520hedgehog%2520signaling%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Nakamura, Y.; Daigo, Y.; Nakatsuru, S.</span><span> </span><span class="NLM_article-title">TTK as a tumor marker and therapeutic target for lung cancer</span>. PCT. Int. Appl. WO2008072777,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Y.+Nakamura&author=Y.+Daigo&author=S.+Nakatsuru&title=TTK+as+a+tumor+marker+and+therapeutic+target+for+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DTTK%2520as%2520a%2520tumor%2520marker%2520and%2520therapeutic%2520target%2520for%2520lung%2520cancer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Leng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">MPS1-dependent mitotic BLM phosphorylation is important for chromosome stability</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">11485</span><span class="NLM_x">–</span> <span class="NLM_lpage">11490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=11485-11490&author=M.+Lengauthor=D.+W.+Chanauthor=H.+Luoauthor=C.+Zhuauthor=J.+Qinauthor=Y.+Wang&title=MPS1-dependent+mitotic+BLM+phosphorylation+is+important+for+chromosome+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeng%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DD.%2BW.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DMPS1-dependent%2520mitotic%2520BLM%2520phosphorylation%2520is%2520important%2520for%2520chromosome%2520stability%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D11485%26epage%3D11490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Wei, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyan, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, S. Y.</span><span> </span><span class="NLM_article-title">TTK/Mps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">7748</span><span class="NLM_x">–</span> <span class="NLM_lpage">7757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=7748-7757&author=J.+H.+Weiauthor=Y.+F.+Chouauthor=Y.+H.+Ouauthor=Y.+H.+Yehauthor=S.+W.+Tyanauthor=T.+P.+Sunauthor=C.+Y.+Shenauthor=S.+Y.+Shieh&title=TTK%2FMps1+participates+in+the+regulation+of+DNA+damage+checkpoint+response+by+phosphorylating+CHK2+on+threonine+68"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DJ.%2BH.%26aulast%3DChou%26aufirst%3DY.%2BF.%26aulast%3DOu%26aufirst%3DY.%2BH.%26aulast%3DYeh%26aufirst%3DY.%2BH.%26aulast%3DTyan%26aufirst%3DS.%2BW.%26aulast%3DSun%26aufirst%3DT.%2BP.%26aulast%3DShen%26aufirst%3DC.%2BY.%26aulast%3DShieh%26aufirst%3DS.%2BY.%26atitle%3DTTK%252FMps1%2520participates%2520in%2520the%2520regulation%2520of%2520DNA%2520damage%2520checkpoint%2520response%2520by%2520phosphorylating%2520CHK2%2520on%2520threonine%252068%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D7748%26epage%3D7757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Nihira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span> </span><span class="NLM_article-title">TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">7285</span><span class="NLM_x">–</span> <span class="NLM_lpage">7295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=7285-7295&author=K.+Nihiraauthor=M.+Tairaauthor=Y.+Mikiauthor=K.+Yoshida&title=TTK%2FMps1+controls+nuclear+targeting+of+c-Abl+by+14-3-3-coupled+phosphorylation+in+response+to+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNihira%26aufirst%3DK.%26aulast%3DTaira%26aufirst%3DM.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DK.%26atitle%3DTTK%252FMps1%2520controls%2520nuclear%2520targeting%2520of%2520c-Abl%2520by%252014-3-3-coupled%2520phosphorylation%2520in%2520response%2520to%2520oxidative%2520stress%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D7285%26epage%3D7295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Targeting the Cell Cycle in Cancer: TTK (MPS1) and PLK4 as Novel Mitotic Targets</span>, <span class="NLM_conf-name">AACR 103rd Annual Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">April 1–5, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mak%2C+T.+W.+Targeting+the+Cell+Cycle+in+Cancer%3A+TTK+%28MPS1%29+and+PLK4+as+Novel+Mitotic+Targets%2C+AACR+103rd+Annual+Meeting%2C+Chicago%2C+IL%2C+April+1%E2%80%935%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520the%2520Cell%2520Cycle%2520in%2520Cancer%253A%2520TTK%2520%2528MPS1%2529%2520and%2520PLK4%2520as%2520Novel%2520Mitotic%2520Targets" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris-Brandts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirgadze, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">Discovery of inhibitors of the mitotic kinase TTK based on <i>N</i>-(3-(3-sulfamoylphenyl)-1<i>H</i>-indazol-5-yl)-acetamides and carboxamides</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4968-4997&author=R.+Lauferauthor=G.+Ngauthor=Y.+Liuauthor=N.+K.+Patelauthor=L.+Edwardsauthor=Y.+Langauthor=S.-W.+Liauthor=M.+Feherauthor=D.+Awreyauthor=G.+Leungauthor=I.+Beletskayaauthor=O.+Plotnikovaauthor=J.+Masonauthor=R.+Hodgsonauthor=X.+Weiauthor=G.+Maoauthor=X.+Luoauthor=P.+Huangauthor=E.+Greenauthor=R.+Kiarashauthor=D.+C.-C.+Linauthor=M.+Harris-Brandtsauthor=V.+Nadeemauthor=T.+W.+Makauthor=J.+G.+Panauthor=W.+Quiauthor=N.+Y.+Chirgadzeauthor=H.+W.+Pauls&title=Discovery+of+inhibitors+of+the+mitotic+kinase+TTK+based+on+N-%283-%283-sulfamoylphenyl%29-1H-indazol-5-yl%29-acetamides+and+carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DAwrey%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DHarris-Brandts%26aufirst%3DM.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DJ.%2BG.%26aulast%3DQui%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520TTK%2520based%2520on%2520N-%25283-%25283-sulfamoylphenyl%2529-1H-indazol-5-yl%2529-acetamides%2520and%2520carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4968%26epage%3D4997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Hewitt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santaguida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex</span> <span class="citation_source-journal">J. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1083%2Fjcb.201002133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=20624899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVOht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=25-34&author=L.+Hewittauthor=A.+Tigheauthor=S.+Santaguidaauthor=A.+M.+Whiteauthor=C.+D.+Jonesauthor=A.+Musacchioauthor=S.+Greenauthor=S.+S.+Taylor&title=Sustained+Mps1+activity+is+required+in+mitosis+to+recruit+O-Mad2+to+the+Mad1-C-Mad2+core+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex</span></div><div class="casAuthors">Hewitt, Laura; Tighe, Anthony; Santaguida, Stefano; White, Anne M.; Jones, Clifford D.; Musacchio, Andrea; Green, Stephen; Taylor, Stephen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Mps1 is an essential component of the spindle assembly checkpoint.  In this study, we describe a novel Mps1 inhibitor, AZ3146, and use it to probe the role of Mps1's catalytic activity during mitosis.  When Mps1 is inhibited before mitotic entry, subsequent recruitment of Mad1 and Mad2 to kinetochores is abolished.  However, if Mps1 is inhibited after mitotic entry, the Mad1-C-Mad2 core complex remains kinetochore bound, but O-Mad2 is not recruited to the core.  Although inhibiting Mps1 also interferes with chromosome alignment, we see no obvious effect on aurora B activity.  In contrast, kinetochore recruitment of centromere protein E (CENP-E), a kinesin-related motor protein, is severely impaired.  Strikingly, inhibition of Mps1 significantly increases its own abundance at kinetochores.  Furthermore, we show that Mps1 can dimerize and transphosphorylate in cells.  We propose a model whereby Mps1 transphosphorylation results in its release from kinetochores, thus facilitating recruitment of O-Mad2 and CENP-E and thereby simultaneously promoting checkpoint signaling and chromosome congression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr40BfrYS2Vu7Vg90H21EOLACvtfcHk0lg_0_glhjw3Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVOht7Y%253D&md5=2b95cfba4b228bada877bdb6dc95be1f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201002133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201002133%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DL.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DA.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DSustained%2520Mps1%2520activity%2520is%2520required%2520in%2520mitosis%2520to%2520recruit%2520O-Mad2%2520to%2520the%2520Mad1-C-Mad2%2520core%2520complex%26jtitle%3DJ.%2520Cell.%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Santaguida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alise, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span> </span><span class="NLM_article-title">Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=73-87&author=S.+Santaguidaauthor=A.+Tigheauthor=A.+M.+D%E2%80%99Aliseauthor=S.+S.+Taylorauthor=A.+Musacchio&title=Dissecting+the+role+of+MPS1+in+chromosome+biorientation+and+the+spindle+checkpoint+through+the+small+molecule+inhibitor+reversine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Alise%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DMusacchio%26aufirst%3DA.%26atitle%3DDissecting%2520the%2520role%2520of%2520MPS1%2520in%2520chromosome%2520biorientation%2520and%2520the%2520spindle%2520checkpoint%2520through%2520the%2520small%2520molecule%2520inhibitor%2520reversine%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D73%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelluma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manak, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deveraux, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kops, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fnchembio.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=20383151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=359-368&author=N.+Kwiatkowskiauthor=N.+Jellumaauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=M.+S.+Manakauthor=M.+Kwonauthor=H.+G.+Choiauthor=T.+Simauthor=Q.+L.+Deverauxauthor=S.+Rottmannauthor=D.+Pellmanauthor=J.+V.+Shahauthor=G.+J.+Kopsauthor=S.+Knappauthor=N.+S.+Gray&title=Small-molecule+kinase+inhibitors+provide+insight+into+Mps1+cell+cycle+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span></div><div class="casAuthors">Kwiatkowski, Nicholas; Jelluma, Nannette; Filippakopoulos, Panagis; Soundararajan, Meera; Manak, Michael S.; Kwon, Mijung; Choi, Hwan Geun; Sim, Taebo; Deveraux, Quinn L.; Rottmann, Sabine; Pellman, David; Shah, Jagesh V.; Kops, Geert J. P. L.; Knapp, Stefan; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mps1, a dual-specificity kinase, is required for the proper functioning of the spindle assembly checkpoint and for the maintenance of chromosomal stability.  As Mps1 function has been implicated in numerous phases of the cell cycle, the development of a potent, selective small-mol. inhibitor of Mps1 should facilitate dissection of Mps1-related biol.  We describe the cellular effects and Mps1 cocrystal structures of new, selective small-mol. inhibitors of Mps1.  Consistent with RNAi studies, chem. inhibition of Mps1 leads to defects in Mad1 and Mad2 establishment at unattached kinetochores, decreased Aurora B kinase activity, premature mitotic exit and gross aneuploidy, without any evidence of centrosome duplication defects.  However, in U2OS cells having extra centrosomes (an abnormality found in some cancers), Mps1 inhibition increases the frequency of multipolar mitoses.  Lastly, Mps1 inhibitor treatment resulted in a decrease in cancer cell viability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsnJhF04gwrVg90H21EOLACvtfcHk0lj9WvVRHn4rtA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D&md5=965e5e5e4f85e21c5ec27b0ea9417914</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.345%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DJelluma%26aufirst%3DN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DManak%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DRottmann%26aufirst%3DS.%26aulast%3DPellman%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DJ.%2BV.%26aulast%3DKops%26aufirst%3DG.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%2520provide%2520insight%2520into%2520Mps1%2520cell%2520cycle%2520function%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D359%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Caldarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disingrini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuvoloni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posteri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvagni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, R.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of new pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4507</span><span class="NLM_x">–</span> <span class="NLM_lpage">4511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4507-4511&author=M.+Caldarelliauthor=M.+Angioliniauthor=T.+Disingriniauthor=D.+Donatiauthor=M.+Guanciauthor=S.+Nuvoloniauthor=H.+Posteriauthor=F.+Quartieriauthor=M.+Silvagniauthor=R.+Colombo&title=Synthesis+and+SAR+of+new+pyrazolo%5B4%2C3-h%5Dquinazoline-3-carboxamide+derivatives+as+potent+and+selective+MPS1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DAngiolini%26aufirst%3DM.%26aulast%3DDisingrini%26aufirst%3DT.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGuanci%26aufirst%3DM.%26aulast%3DNuvoloni%26aufirst%3DS.%26aulast%3DPosteri%26aufirst%3DH.%26aulast%3DQuartieri%26aufirst%3DF.%26aulast%3DSilvagni%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520new%2520pyrazolo%255B4%252C3-h%255Dquinazoline-3-carboxamide%2520derivatives%2520as%2520potent%2520and%2520selective%2520MPS1%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4507%26epage%3D4511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9416</span><span class="NLM_x">–</span> <span class="NLM_lpage">9433</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective%2C+and+brain-penetrable+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrable%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Kusakabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Diaminopyridine-based potent and selective Mps1 kinase inhibitors binding to an unusual flipped-peptide conformation</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3000879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=560-564&author=K.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=K.+Higashinoauthor=Y.+Okanoauthor=G.+Tadanoauthor=Y.+Tachibanaauthor=Y.+Satoauthor=M.+Inoueauthor=T.+Wadaauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=S.+Tagashiraauthor=Y.+Kidoauthor=S.+Sakamotoauthor=K.+Yasuoauthor=M.+Maedaauthor=T.+Yamamotoauthor=M.+Higakiauthor=T.+Endohauthor=K.+Uedaauthor=T.+Shiotaauthor=H.+Muraiauthor=Y.+Nakamura&title=Diaminopyridine-based+potent+and+selective+Mps1+kinase+inhibitors+binding+to+an+unusual+flipped-peptide+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fml3000879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000879%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DEndoh%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DShiota%26aufirst%3DT.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiaminopyridine-based%2520potent%2520and%2520selective%2520Mps1%2520kinase%2520inhibitors%2520binding%2520to%2520an%2520unusual%2520flipped-peptide%2520conformation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D560%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Naud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faisal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrake, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavetsias, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAndrew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matijssen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span> </span><span class="NLM_article-title">Structure-based design of orally bioavailable 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine inhibitors of mitotic kinase monopolar spindle 1 (Mps1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">10045</span><span class="NLM_x">–</span> <span class="NLM_lpage">10065</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401395s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10045-10065&author=S.+Naudauthor=I.+M.+Westwoodauthor=A.+Faisalauthor=P.+Sheldrakeauthor=V.+Bavetsiasauthor=B.+Atrashauthor=K.-M.+J.+Cheungauthor=M.+Liuauthor=A.+Hayesauthor=J.+Schmittauthor=A.+Woodauthor=V.+Choiauthor=K.+Boxallauthor=G.+Makauthor=M.+Gurdenauthor=M.+Valentiauthor=A.+de+Haven+Brandonauthor=A.+Henleyauthor=R.+Bakerauthor=C.+McAndrewauthor=B.+Matijssenauthor=R.+Burkeauthor=S.+Hoelderauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=S.+Linardopoulosauthor=R.+L.+van+Montfortauthor=J.+Blagg&title=Structure-based+design+of+orally+bioavailable+1H-pyrrolo%5B3%2C2-c%5Dpyridine+inhibitors+of+mitotic+kinase+monopolar+spindle+1+%28Mps1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm401395s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401395s%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DV.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DGurden%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520orally%2520bioavailable%25201H-pyrrolo%255B3%252C2-c%255Dpyridine%2520inhibitors%2520of%2520mitotic%2520kinase%2520monopolar%2520spindle%25201%2520%2528Mps1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10045%26epage%3D10065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Kusakabe, K.-I.; Yoshida, H.; Nozu, K.; Hashizume, H.; Tadano, G.; Sato, J.; Tamura, Y.; Mitsuoka, Y.</span><span> </span><span class="NLM_article-title">Fused imidazole derivative having TTK inhibitory action</span>. PCT. Int. Appl. WO2011013729,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.-I.+Kusakabe&author=H.+Yoshida&author=K.+Nozu&author=H.+Hashizume&author=G.+Tadano&author=J.+Sato&author=Y.+Tamura&author=Y.+Mitsuoka&title=Fused+imidazole+derivative+having+TTK+inhibitory+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DFused%2520imidazole%2520derivative%2520having%2520TTK%2520inhibitory%2520action%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Jemaà, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senovilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boemer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prechtl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemeister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wengner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegelbauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrieu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castedo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Characterization of novel MPS1 inhibitors with preclinical anticancer activity</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fcdd.2013.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=23933817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2gurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1532-1545&author=M.+Jema%C3%A0author=L.+Galluzziauthor=O.+Keppauthor=L.+Senovillaauthor=M.+Brandsauthor=U.+Boemerauthor=M.+Koppitzauthor=P.+Lienauauthor=S.+Prechtlauthor=V.+Schulzeauthor=G.+Siemeisterauthor=A.+M.+Wengnerauthor=D.+Mumbergauthor=K.+Ziegelbauerauthor=A.+Abrieuauthor=M.+Castedoauthor=I.+Vitaleauthor=G.+Kroemer&title=Characterization+of+novel+MPS1+inhibitors+with+preclinical+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of novel MPS1 inhibitors with preclinical anticancer activity</span></div><div class="casAuthors">Jemaa, M.; Galluzzi, L.; Kepp, O.; Senovilla, L.; Brands, M.; Boemer, U.; Koppitz, M.; Lienau, P.; Prechtl, S.; Schulze, V.; Siemeister, G.; Wengner, A. M.; Mumberg, D.; Ziegelbauer, K.; Abrieu, A.; Castedo, M.; Vitale, I.; Kroemer, G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1532-1545</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (MPS1), a mitotic kinase that is overexpressed in several human cancers, contributes to the alignment of chromosomes to the metaphase plate as well as to the execution of the spindle assembly checkpoint (SAC).  Here, we report the identification and functional characterization of three novel inhibitors of MPS1 of two independent structural classes, N-(4-{2-[(2-cyanophenyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}phenyl)-2-phenylacetamide (Mps-BAY1) (a triazolopyridine), N-cyclopropyl-4-{8-[(2-methylpropyl)amino]-6-(quinolin-5-yl)imidazo[1,2-a]pyrazin-3-yl}benzamide (Mps-BAY2a) and N-cyclopropyl-4-{8-(isobutylamino)imidazo[1,2-a]pyrazin-3-yl}benzamide (Mps-BAY2b) (two imidazopyrazines).  By selectively inactivating MPS1, these small inhibitors can arrest the proliferation of cancer cells, causing their polyploidization and/or their demise.  Cancer cells treated with Mps-BAY1 or Mps-BAY2a manifested multiple signs of mitotic perturbation including inefficient chromosomal congression during metaphase, unscheduled SAC inactivation and severe anaphase defects.  Videomicroscopic cell fate profiling of histone 2B-green fluorescent protein-expressing cells revealed the capacity of MPS1 inhibitors to subvert the correct timing of mitosis as they induce a premature anaphase entry in the context of misaligned metaphase plates.  Hence, in the presence of MPS1 inhibitors, cells either divided in a bipolar (but often asym.) manner or entered one or more rounds of abortive mitoses, generating gross aneuploidy and polyploidy, resp.  In both cases, cells ultimately succumbed to the mitotic catastrophe-induced activation of the mitochondrial pathway of apoptosis.  Of note, low doses of MPS1 inhibitors and paclitaxel (a microtubular poison) synergized at increasing the frequency of chromosome misalignments and missegregations in the context of SAC inactivation.  This resulted in massive polyploidization followed by the activation of mitotic catastrophe.  A synergistic interaction between paclitaxel and MPS1 inhibitors could also be demonstrated in vivo, as the combination of these agents efficiently reduced the growth of tumor xenografts and exerted superior antineoplastic effects compared with either compd. employed alone.  Altogether, these results suggest that MPS1 inhibitors may exert robust anticancer activity, either as standalone therapeutic interventions or combined with microtubule-targeting chems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHoriIGxHO_rVg90H21EOLACvtfcHk0ljllGcjm_AZ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2gurjI&md5=867fb902b15b6df0f7049b069bd47a4c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2013.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2013.105%26sid%3Dliteratum%253Aachs%26aulast%3DJema%25C3%25A0%26aufirst%3DM.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DSenovilla%26aufirst%3DL.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DKoppitz%26aufirst%3DM.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DSchulze%26aufirst%3DV.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26aulast%3DAbrieu%26aufirst%3DA.%26aulast%3DCastedo%26aufirst%3DM.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520novel%2520MPS1%2520inhibitors%2520with%2520preclinical%2520anticancer%2520activity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26spage%3D1532%26epage%3D1545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Kusakabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4343</span><span class="NLM_x">–</span> <span class="NLM_lpage">4356</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4343-4356&author=K.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=Y.+Tachibanaauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=Y.+Hatoauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=K.+Yasuoauthor=M.+Maedaauthor=M.+Higakiauthor=K.+Uedaauthor=H.+Yoshizawaauthor=Y.+Babaauthor=T.+Shiotaauthor=H.+Muraiauthor=Y.+Nakamura&title=Indazole-based+potent+and+cell-active+Mps1+kinase+inhibitors%3A+rational+design+from+pan-kinase+inhibitor+anthrapyrazolone+%28SP600125%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm4000215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000215%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DHato%26aufirst%3DY.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DYoshizawa%26aufirst%3DH.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DT.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DIndazole-based%2520potent%2520and%2520cell-active%2520Mps1%2520kinase%2520inhibitors%253A%2520rational%2520design%2520from%2520pan-kinase%2520inhibitor%2520anthrapyrazolone%2520%2528SP600125%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4343%26epage%3D4356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Billingsley, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">An improved system for the palladium-catalyzed borylation of aryl halides with pinacol borane</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">5589</span><span class="NLM_x">–</span> <span class="NLM_lpage">5591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo800727s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsl2rsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=5589-5591&author=K.+L.+Billingsleyauthor=S.+L.+Buchwald&title=An+improved+system+for+the+palladium-catalyzed+borylation+of+aryl+halides+with+pinacol+borane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An Improved System for the Palladium-Catalyzed Borylation of Aryl Halides with Pinacol Borane</span></div><div class="casAuthors">Billingsley, Kelvin L.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5589-5591</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly efficient method for the Pd-catalyzed borylation of aryl halides with an inexpensive and atom-economical B source, pinacol borane, was developed.  This system allows for the conversion of aryl and heteroaryl iodides, bromides, and several chlorides, contg. a variety of functional groups, to the corresponding pinacol boronate esters.  In addn. to the increase in substrate scope, this is the 1st general method where relatively low quantities of catalyst and short reaction times can be employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd64LaMU77TbVg90H21EOLACvtfcHk0ljllGcjm_AZ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsl2rsr8%253D&md5=5a8e7398437b3f1b72b682b1317a62d8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo800727s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo800727s%26sid%3Dliteratum%253Aachs%26aulast%3DBillingsley%26aufirst%3DK.%2BL.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520improved%2520system%2520for%2520the%2520palladium-catalyzed%2520borylation%2520of%2520aryl%2520halides%2520with%2520pinacol%2520borane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D5589%26epage%3D5591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaura, N.</span><span> </span><span class="NLM_article-title">Palladium(0)-catalyzed cross-coupling reaction of alkoxydiboron with haloarenes: a direct procedure for arylboronic esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7508</span><span class="NLM_x">–</span> <span class="NLM_lpage">7510</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-catalyzed+cross-coupling+reaction+of+alkoxydiboron+with+haloarenes%3A+a+direct+procedure+for+arylboronic+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0ljllGcjm_AZ-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520cross-coupling%2520reaction%2520of%2520alkoxydiboron%2520with%2520haloarenes%253A%2520a%2520direct%2520procedure%2520for%2520arylboronic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span> </span><span class="NLM_article-title">CuBr/<i>rac</i>-BINOL-catalyzed <i>N</i>-arylations of aliphatic amines at room temperature</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo062060e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=672-674&author=D.+Jiangauthor=H.+Fuauthor=Y.+Jiangauthor=Y.+Zhao&title=CuBr%2Frac-BINOL-catalyzed+N-arylations+of+aliphatic+amines+at+room+temperature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo062060e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo062060e%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DCuBr%252Frac-BINOL-catalyzed%2520N-arylations%2520of%2520aliphatic%2520amines%2520at%2520room%2520temperature%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D672%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Sasse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Influence of bulky substituents on histamine H3 receptor agonist/antagonist properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020910m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4000-4010&author=A.+Sasseauthor=X.+Ligneauauthor=A.+Rouleauauthor=S.+Elzauthor=C.+R.+Ganellinauthor=J.-M.+Arrangauthor=J.-C.+Schwartzauthor=W.+Schunackauthor=H.+Stark&title=Influence+of+bulky+substituents+on+histamine+H3+receptor+agonist%2Fantagonist+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm020910m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020910m%26sid%3Dliteratum%253Aachs%26aulast%3DSasse%26aufirst%3DA.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DRouleau%26aufirst%3DA.%26aulast%3DElz%26aufirst%3DS.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DArrang%26aufirst%3DJ.-M.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DInfluence%2520of%2520bulky%2520substituents%2520on%2520histamine%2520H3%2520receptor%2520agonist%252Fantagonist%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4000%26epage%3D4010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Gregg, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golden, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wekesa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tymoshenko, D. O.</span><span> </span><span class="NLM_article-title">Rapid, one-pot synthesis of α,α-disubstituted primary amines by the addition of Grignard reagents to nitriles under microwave heating conditions</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3978</span><span class="NLM_x">–</span> <span class="NLM_lpage">3981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3978-3981&author=B.+T.+Greggauthor=K.+C.+Goldenauthor=J.+F.+Quinnauthor=H.-J.+Wangauthor=W.+Zhangauthor=R.+Wangauthor=F.+Wekesaauthor=D.+O.+Tymoshenko&title=Rapid%2C+one-pot+synthesis+of+%CE%B1%2C%CE%B1-disubstituted+primary+amines+by+the+addition+of+Grignard+reagents+to+nitriles+under+microwave+heating+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregg%26aufirst%3DB.%2BT.%26aulast%3DGolden%26aufirst%3DK.%2BC.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DH.-J.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWekesa%26aufirst%3DF.%26aulast%3DTymoshenko%26aufirst%3DD.%2BO.%26atitle%3DRapid%252C%2520one-pot%2520synthesis%2520of%2520%25CE%25B1%252C%25CE%25B1-disubstituted%2520primary%2520amines%2520by%2520the%2520addition%2520of%2520Grignard%2520reagents%2520to%2520nitriles%2520under%2520microwave%2520heating%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3978%26epage%3D3981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Catalytic asymmetric synthesis of <i>tert</i>-butanesulfinamide. Application to the asymmetric synthesis of amines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">9913</span><span class="NLM_x">–</span> <span class="NLM_lpage">9914</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja972012z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADyaK2sXms1Ohsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=9913-9914&author=G.+Liuauthor=D.+A.+Coganauthor=J.+A.+Ellman&title=Catalytic+asymmetric+synthesis+of+tert-butanesulfinamide.+Application+to+the+asymmetric+synthesis+of+amines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Asymmetric Synthesis of tert-Butanesulfinamide. Application to the Asymmetric Synthesis of Amines</span></div><div class="casAuthors">Liu, Guangcheng; Cogan, Derek A.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">9913-9914</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient two-step synthesis of optically pure tert-butanesulfinamide (R)-Me3CSONH2 in 75% overall yield from the inexpensive starting material tert-Bu disulfide, is reported.  The key step is asym. catalytic oxidn. of tert-Bu disulfide to provide tert-Bu tert-butanethiosulfinate using a vanadium catalyst, H2O2 as the stoichiometric oxidant, and a chiral ligand prepd. by condensation of 3,5-di-tert-butylsalicylaldehyde and (S)-tert-leucinol.  This reaction has been performed reproducibility on a half mol scale at 1.5 M concn. in CHCl3 with 1% catalyst to provide a 96-98% yield of pure product in 91% ee, after bulb to bulb distn.  The utility of the tert-butanesulfinamide for the asym. synthesis of amines is also reported.  Direct condensation of tert-butanesulfinamide with aldehydes provides the tert-butanesulfinimines in high yields (91-96%).  Nucleophilic addns. proceed in high yield (>90%) for a range of Grignard reagents and sulfinimine substrates.  The reaction diastereoselectivities are also high (89:11 to 98:2).  Removal of the sulfinyl group to provide the scalemic amine hydrochlorides is accomplished by treatment of sulfinamides with HCl in methanol followed by ether pptn. (88-97% yields).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpddQoHlNQunbVg90H21EOLACvtfcHk0ljQkst_oIRcTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXms1Ohsb0%253D&md5=0fe725557ccff775043a351295c65b91</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja972012z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja972012z%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DCogan%26aufirst%3DD.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DCatalytic%2520asymmetric%2520synthesis%2520of%2520tert-butanesulfinamide.%2520Application%2520to%2520the%2520asymmetric%2520synthesis%2520of%2520amines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D9913%26epage%3D9914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Almansa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yus, M.</span><span> </span><span class="NLM_article-title">Synthesis of highly enantiomerically enriched amines by the diastereoselective addition of triorganozincates to <i>N</i>-(<i>tert</i>-butanesulfinyl)imines</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2484</span><span class="NLM_x">–</span> <span class="NLM_lpage">2491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=2484-2491&author=R.+Almansaauthor=D.+Guijarroauthor=M.+Yus&title=Synthesis+of+highly+enantiomerically+enriched+amines+by+the+diastereoselective+addition+of+triorganozincates+to+N-%28tert-butanesulfinyl%29imines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlmansa%26aufirst%3DR.%26aulast%3DGuijarro%26aufirst%3DD.%26aulast%3DYus%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520highly%2520enantiomerically%2520enriched%2520amines%2520by%2520the%2520diastereoselective%2520addition%2520of%2520triorganozincates%2520to%2520N-%2528tert-butanesulfinyl%2529imines%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2008%26volume%3D19%26spage%3D2484%26epage%3D2491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Jung, D.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, J.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.-J.</span><span> </span><span class="NLM_article-title">Synthesis of di-(<i>N</i>-tropinonyl)alkanes and di-(<i>N</i>-tropinonyl)benzenes</span> <span class="citation_source-journal">Bull. Korean Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1932</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.5012%2Fbkcs.2004.25.12.1932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVChsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1932-1934&author=D.-I.+Jungauthor=J.-H.+Songauthor=Y.-H.+Kimauthor=D.-H.+Leeauthor=H.-A.+Songauthor=Y.-G.+Leeauthor=Y.-M.+Parkauthor=S.-K.+Choiauthor=J.-T.+Hahnauthor=S.-J.+Cho&title=Synthesis+of+di-%28N-tropinonyl%29alkanes+and+di-%28N-tropinonyl%29benzenes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of di-(N-tropinonyl)alkanes and di-(N-tropinonyl)benzenes</span></div><div class="casAuthors">Jung, Dai-Il; Song, Ju-Hyun; Kim, Yong-Hwan; Lee, Do-Hun; Song, Hyun-Ae; Lee, Yong-Gyun; Park, Yu-Mi; Choi, Soon-Kyu; Hahn, Jung-Tai; Cho, Seong-Jin</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1932-1934</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">A no. of di-(N-tropinonyl)alkanes and -benzenes were prepd. in medium to good yields by reaction of α,ω-diaminoalkanes (1,2-diaminoethane, 1,3-diaminopropane, and 1,8-diaminooctane) as well as m- or p-phenylenediamine (o-phenylenediamine did not react) with 2,5-dimethoxytetrahydrofuran and acetonedicarboxylic acid.  The structures of the products were elucidated by IR, NMR, and MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVYkB6VektZLVg90H21EOLACvtfcHk0lhY-TgoF5LU7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVChsL8%253D&md5=02727cc542622de2d0ea8e4a2f8ad7f0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2004.25.12.1932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2004.25.12.1932%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DD.-I.%26aulast%3DSong%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DY.-H.%26aulast%3DLee%26aufirst%3DD.-H.%26aulast%3DSong%26aufirst%3DH.-A.%26aulast%3DLee%26aufirst%3DY.-G.%26aulast%3DPark%26aufirst%3DY.-M.%26aulast%3DChoi%26aufirst%3DS.-K.%26aulast%3DHahn%26aufirst%3DJ.-T.%26aulast%3DCho%26aufirst%3DS.-J.%26atitle%3DSynthesis%2520of%2520di-%2528N-tropinonyl%2529alkanes%2520and%2520di-%2528N-tropinonyl%2529benzenes%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2004%26volume%3D25%26spage%3D1932%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">Kumar, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoarau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattum, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerrish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yager, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenderovich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimbora, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papac, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span> </span><span class="NLM_article-title">Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4377-4385&author=D.+V.+Kumarauthor=C.+Hoarauauthor=M.+Bursavichauthor=P.+Slattumauthor=D.+Gerrishauthor=K.+Yagerauthor=M.+Saundersauthor=M.+Shenderovichauthor=B.+L.+Rothauthor=R.+McKinnonauthor=A.+Chanauthor=D.+M.+Cimboraauthor=C.+Bradfordauthor=L.+Reevesauthor=S.+Pattonauthor=D.+I.+Papacauthor=B.+L.+Williamsauthor=R.+O.+Carlson&title=Lead+optimization+of+purine+based+orally+bioavailable+Mps1+%28TTK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DHoarau%26aufirst%3DC.%26aulast%3DBursavich%26aufirst%3DM.%26aulast%3DSlattum%26aufirst%3DP.%26aulast%3DGerrish%26aufirst%3DD.%26aulast%3DYager%26aufirst%3DK.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DShenderovich%26aufirst%3DM.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DBradford%26aufirst%3DC.%26aulast%3DReeves%26aufirst%3DL.%26aulast%3DPatton%26aufirst%3DS.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26atitle%3DLead%2520optimization%2520of%2520purine%2520based%2520orally%2520bioavailable%2520Mps1%2520%2528TTK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4377%26epage%3D4385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Warren, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaLonde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolven, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peishoff, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span> </span><span class="NLM_article-title">A critical assessment of docking programs and scoring functions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5931</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050362n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnslOrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5912-5931&author=G.+L.+Warrenauthor=C.+W.+Andrewsauthor=A.-M.+Capelliauthor=B.+Clarkeauthor=J.+LaLondeauthor=M.+H.+Lambertauthor=M.+Lindvallauthor=N.+Nevinsauthor=S.+F.+Semusauthor=S.+Sengerauthor=G.+Tedescoauthor=I.+D.+Wallauthor=J.+M.+Woolvenauthor=C.+E.+Peishoffauthor=M.+S.+Head&title=A+critical+assessment+of+docking+programs+and+scoring+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A Critical Assessment of Docking Programs and Scoring Functions</span></div><div class="casAuthors">Warren, Gregory L.; Andrews, C. Webster; Capelli, Anna-Maria; Clarke, Brian; LaLonde, Judith; Lambert, Millard H.; Lindvall, Mika; Nevins, Neysa; Semus, Simon F.; Senger, Stefan; Tedesco, Giovanna; Wall, Ian D.; Woolven, James M.; Peishoff, Catherine E.; Head, Martha S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5912-5931</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Docking is a computational technique that samples conformations of small mols. in protein binding sites; scoring functions are used to assess which of these conformations best complements the protein binding site.  An evaluation of 10 docking programs and 37 scoring functions was conducted against eight proteins of seven protein types for three tasks: binding mode prediction, virtual screening for lead identification, and rank-ordering by affinity for lead optimization.  All of the docking programs were able to generate ligand conformations similar to crystallog. detd. protein/ligand complex structures for at least one of the targets.  However, scoring functions were less successful at distinguishing the crystallog. conformation from the set of docked poses.  Docking programs identified active compds. from a pharmaceutically relevant pool of decoy compds.; however, no single program performed well for all of the targets.  For prediction of compd. affinity, none of the docking programs or scoring functions made a useful prediction of ligand binding affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfJn8_WHSjurVg90H21EOLACvtfcHk0lhY-TgoF5LU7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnslOrtrY%253D&md5=463ab40c3d23e67b62df408fc5e7f08d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm050362n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050362n%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DAndrews%26aufirst%3DC.%2BW.%26aulast%3DCapelli%26aufirst%3DA.-M.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DLaLonde%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DWall%26aufirst%3DI.%2BD.%26aulast%3DWoolven%26aufirst%3DJ.%2BM.%26aulast%3DPeishoff%26aufirst%3DC.%2BE.%26aulast%3DHead%26aufirst%3DM.%2BS.%26atitle%3DA%2520critical%2520assessment%2520of%2520docking%2520programs%2520and%2520scoring%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5912%26epage%3D5931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Effect of input differences on the results of docking calculations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1704</span><span class="NLM_x">–</span> <span class="NLM_lpage">1714</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci9000629" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1704-1714&author=M.+Feherauthor=C.+I.+Williams&title=Effect+of+input+differences+on+the+results+of+docking+calculations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Input Differences on the Results of Docking Calculations</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1704-1714</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sensitivity of docking calcns. to the geometry of the input ligand was studied.  It was found that even small changes in the ligand input conformation can lead to large differences in the geometries and scores of the resulting docked poses.  The accuracy of docked poses produced from different ligand input structures, the x-ray structure, the minimized Corina structure, and structures generated from conformational searches and mol. dynamics ensembles, were also assessed.  It was found that using the x-ray ligand conformation as docking input does not always produce the most accurate docked pose when compared with other sources of ligand input conformations.  Furthermore, no one method of conformer generation is guaranteed to always produce the most accurate docking pose.  The docking scores are also highly sensitive to the source of the input conformation, which might introduce some noise in compd. ranking and in binding affinity predictions.  It is concluded that for the purposes of reproducibility and optimal performance, the most prudent procedure is to use multiple input structures for docking.  The implications of these results on docking validation studies are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnfgWRxj66UbVg90H21EOLACvtfcHk0lhY-TgoF5LU7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmtro%253D&md5=fb35182895e0cc07cf4c4bb4de05e6d1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fci9000629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9000629%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DEffect%2520of%2520input%2520differences%2520on%2520the%2520results%2520of%2520docking%2520calculations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D1704%26epage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Reducing docking score variations arising from input differences</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100204x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVylsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1549-1560&author=M.+Feherauthor=C.+I.+Williams&title=Reducing+docking+score+variations+arising+from+input+differences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing Docking Score Variations Arising from Input Differences</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1549-1560</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The variability of docking results as a function of variations in ligand input conformations was studied for the GOLD, Glide, FlexX, and Surflex programs.  It is concluded that there are two major effects leading to such variability: the adequacy of conformational search during docking and random "chaotic" effects arising from sensitivity to small input perturbations.  It is shown that although the former is generally the stronger effect, the latter is also highly significant for almost all docking engines.  The strong target-to-target variation of the magnitude of these effects is emphasized.  The performance of different packages is compared using these measures.  Guidelines are provided for different programs to reduce variability and improve reproducibility, which involve using a small no. of input conformations as starting points for docking, followed by the selection of the top scoring docked pose from the results as the best docked soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrcPoOt5jOGbVg90H21EOLACvtfcHk0lgtX08k0Nnzfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVylsb4%253D&md5=dcbf21b1eaa7867a7c72acb23c244507</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fci100204x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100204x%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DReducing%2520docking%2520score%2520variations%2520arising%2520from%2520input%2520differences%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1549%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Numerical errors and chaotic behavior in docking simulations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200598m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=724-738&author=M.+Feherauthor=C.+I.+Williams&title=Numerical+errors+and+chaotic+behavior+in+docking+simulations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical Errors and Chaotic Behavior in Docking Simulations</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">724-738</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work examines the sensitivity of docking programs to tiny changes in ligand input files.  The results show that nearly identical ligand input structures can produce dramatically different top-scoring docked poses.  Even changing the atom order in a ligand input file can produce significantly different poses and scores.  In well-behaved cases the docking variations are small and follow a normal distribution around a central pose and score, but in many cases the variations are large and reflect wildly different top scores and binding modes.  The docking variations are characterized by statistical methods, and the sensitivity of high-throughput and more precise docking methods are compared.  The results demonstrate that part of docking variation is due to numerical sensitivity and potentially chaotic effects in current docking algorithms and not solely due to incomplete ligand conformation and pose searching.  These results have major implications for the way docking is currently used for pose prediction, ranking, and virtual screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nddk3ttKx7Vg90H21EOLACvtfcHk0lgtX08k0Nnzfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWhsrw%253D&md5=7aa7ef2005ad88f2b145c1a2975621c9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fci200598m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200598m%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DNumerical%2520errors%2520and%2520chaotic%2520behavior%2520in%2520docking%2520simulations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D724%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Colombo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennecozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Re Depaolini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cucchi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span> </span><span class="NLM_article-title">Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">10255</span><span class="NLM_x">–</span> <span class="NLM_lpage">10264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1158%2F0008-5472.CAN-10-2101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=21159646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10255-10264&author=R.+Colomboauthor=M.+Caldarelliauthor=M.+Mennecozziauthor=M.+L.+Giorginiauthor=F.+Solaauthor=P.+Cappellaauthor=C.+Perreraauthor=S.+Re+Depaoliniauthor=L.+Rusconiauthor=U.+Cucchiauthor=N.+Avanziauthor=J.+A.+Bertrandauthor=R.+T.+Bossiauthor=E.+Pesentiauthor=A.+Galvaniauthor=A.+Isacchiauthor=F.+Colottaauthor=D.+Donatiauthor=J.+Moll&title=Targeting+the+mitotic+checkpoint+for+cancer+therapy+with+NMS-P715%2C+an+inhibitor+of+MPS1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase</span></div><div class="casAuthors">Colombo, Riccardo; Caldarelli, Marina; Mennecozzi, Milena; Giorgini, Maria Laura; Sola, Francesco; Cappella, Paolo; Perrera, Claudia; Depaolini, Stefania Re; Rusconi, Luisa; Cucchi, Ulisse; Avanzi, Nilla; Bertrand, Jay Aaron; Bossi, Roberto Tiberio; Pesenti, Enrico; Galvani, Arturo; Isacchi, Antonella; Colotta, Francesco; Donati, Daniele; Moll, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10255-10264</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MPS1 kinase is a key regulator of the spindle assembly checkpoint (SAC), a mitotic mechanism specifically required for proper chromosomal alignment and segregation.  It has been found aberrantly overexpressed in a wide range of human tumors and is necessary for tumoral cell proliferation.  Here the authors report the identification and characterization of NMS-P715, a selective and orally bioavailable MPS1 small-mol. inhibitor, which selectively reduces cancer cell proliferation, leaving normal cells almost unaffected.  NMS-P715 accelerates mitosis and affects kinetochore components localization causing massive aneuploidy and cell death in a variety of tumoral cell lines and inhibits tumor growth in preclin. cancer models.  Inhibiting the SAC could represent a promising new approach to selectively target cancer cells.  Cancer Res; 70(24); 10255-64.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJeGyiQf0_uLVg90H21EOLACvtfcHk0lgtX08k0Nnzfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7bK&md5=6478b34886d1d2f2a364d142bbd388fe</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-2101%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DMennecozzi%26aufirst%3DM.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DPerrera%26aufirst%3DC.%26aulast%3DRe%2BDepaolini%26aufirst%3DS.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DCucchi%26aufirst%3DU.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DColotta%26aufirst%3DF.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DMoll%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520mitotic%2520checkpoint%2520for%2520cancer%2520therapy%2520with%2520NMS-P715%252C%2520an%2520inhibitor%2520of%2520MPS1%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10255%26epage%3D10264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Tardif, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassiano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimbora, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douce, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorweiler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papac, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlexander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B. L.</span><span> </span><span class="NLM_article-title">Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase (Mps1)</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1158%2F1535-7163.MCT-11-0453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=21980130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2267-2275&author=K.+D.+Tardifauthor=A.+Rogersauthor=J.+Cassianoauthor=B.+L.+Rothauthor=D.+M.+Cimboraauthor=R.+McKinnonauthor=A.+Petersonauthor=T.+B.+Douceauthor=R.+Robinsonauthor=I.+Dorweilerauthor=T.+Davisauthor=M.+A.+Hessauthor=K.+Ostaninauthor=D.+I.+Papacauthor=V.+Baichwalauthor=I.+McAlexanderauthor=J.+A.+Willardsenauthor=M.+Saundersauthor=H.+Christopheauthor=D.+V.+Kumarauthor=D.+A.+Wettsteinauthor=R.+O.+Carlsonauthor=B.+L.+Williams&title=Characterization+of+the+cellular+and+antitumor+effects+of+MPI-0479605%2C+a+small-molecule+inhibitor+of+the+mitotic+kinase+%28Mps1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span></div><div class="casAuthors">Tardif, Keith D.; Rogers, Aaron; Cassiano, Jared; Roth, Bruce L.; Cimbora, Daniel M.; McKinnon, Rena; Peterson, Ashley; Douce, Thomas B.; Robinson, Rosann; Dorweiler, Irene; Davis, Thaylon; Hess, Mark A.; Ostanin, Kirill; Papac, Damon I.; Baichwal, Vijay; McAlexander, Ian; Willardsen, J. Adam; Saunders, Michael; Christophe, Hoarau; Kumar, D. Vijay; Wettstein, Daniel A.; Carlson, Robert O.; Williams, Brandi L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2275</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mps1 is a dual specificity protein kinase that is essential for the bipolar attachment of chromosomes to the mitotic spindle and for maintaining the spindle assembly checkpoint until all chromosomes are properly attached.  Mps1 is expressed at high levels during mitosis and is abundantly expressed in cancer cells.  Disruption of Mps1 function induces aneuploidy and cell death.  We report the identification of MPI-0479605, a potent and selective ATP competitive inhibitor of Mps1.  Cells treated with MPI-0479605 undergo aberrant mitosis, resulting in aneuploidy and formation of micronuclei.  In cells with wild-type p53, this promotes the induction of a postmitotic checkpoint characterized by the ATM- and RAD3-related-dependent activation of the p53-p21 pathway.  In both wild-type and p53 mutant cells lines, there is a growth arrest and inhibition of DNA synthesis.  Subsequently, cells undergo mitotic catastrophe and/or an apoptotic response.  In xenograft models, MPI-0479605 inhibits tumor growth, suggesting that drugs targeting Mps1 may have utility as novel cancer therapeutics.  Mol Cancer Ther; 10(12); 2267-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMIODujnZWCLVg90H21EOLACvtfcHk0liKALBjw6gYiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO&md5=e243764443e9dfda40fc84a329d776c2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0453%26sid%3Dliteratum%253Aachs%26aulast%3DTardif%26aufirst%3DK.%2BD.%26aulast%3DRogers%26aufirst%3DA.%26aulast%3DCassiano%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DA.%26aulast%3DDouce%26aufirst%3DT.%2BB.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DDorweiler%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DM.%2BA.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMcAlexander%26aufirst%3DI.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DChristophe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DWettstein%26aufirst%3DD.%2BA.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520cellular%2520and%2520antitumor%2520effects%2520of%2520MPI-0479605%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520the%2520mitotic%2520kinase%2520%2528Mps1%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2267%26epage%3D2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span>MOE (Molecular Operating Environment), <span class="NLM_edition">version 2012.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. West, Suite 910, Montreal, Quebec, H3A 2R7, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28Molecular+Operating+Environment%29%2C+version+2012.10%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbrooke+St.+West%2C+Suite+910%2C+Montreal%2C+Quebec%2C+H3A+2R7%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%2520%2528Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span>Corina, <span class="NLM_edition">version 3.2</span>; <span class="NLM_publisher-name">Molecular Networks GmbH</span>: <span class="NLM_publisher-loc">Erlangen, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Corina%2C+version+3.2%3B+Molecular+Networks+GmbH%3A+Erlangen%2C+Germany%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCorina%26pub%3DMolecular%2520Networks%2520GmbH%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span>Schrödinger Suite 2012, <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2012%2C+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202012%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span>Glide, <span class="NLM_edition">version 5.6</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.6%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Structural and mechanistic insights into Mps1 kinase activation</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1111%2Fj.1582-4934.2008.00605.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=19120698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A280%3ADC%252BC3c7jt1KmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=1679-1694&author=W.+Wangauthor=Y.+Yangauthor=Y.+Gaoauthor=Q.+Xuauthor=F.+Wangauthor=S.+Zhuauthor=W.+Oldauthor=K.+Resingauthor=M.+Ahnauthor=M.+Leiauthor=X.+Liu&title=Structural+and+mechanistic+insights+into+Mps1+kinase+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and mechanistic insights into Mps1 kinase activation</span></div><div class="casAuthors">Wang Wei; Yang Yuting; Gao Yuefeng; Xu Quanbin; Wang Feng; Zhu Songcheng; Old William; Resing Katheryn; Ahn Natalie; Lei Ming; Liu Xuedong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8B</span>),
    <span class="NLM_cas:pages">1679-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mps1 is one of the several essential kinases whose activation is required for robust mitotic spindle checkpoint signalling.  The activity of Mps1 is tightly regulated and increases dramatically during mitosis or in response to spindle damage.  To understand the molecular mechanism underlying Mps1 regulation, we determined the crystal structure of the kinase domain of Mps1.  The 2.7-A-resolution crystal structure shows that the Mps1 kinase domain adopts a unique inactive conformation.  Intramolecular interactions between the key Glu residue in the C helix of the N-terminal lobe and the backbone amides in the catalytic loop lock the kinase in the inactive conformation.  Autophosphorylation appears to be a priming event for kinase activation.  We identified Mps1 autophosphorylation sites in the activation and the P+1 loops.  Whereas activation loop autophosphorylation enhances kinase activity, autophosphorylation at the P+1 loop (T686) is associated with the active kinase.  Mutation of T686 autophosphorylation site impairs both autophosphorylation and transphosphorylation.  Furthermore, we demonstrated that phosphorylation of T676 may be a priming event for phosphorylation at T686.  Finally, we identified two critical lysine residues in the loop between helices EF and F that are essential for substrate recruitment and maintaining high levels of kinase activity.  Our studies reveal critical biochemical mechanisms for Mps1 kinase regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ47lclfM-UTyCEBeYuoi7AfW6udTcc2eaRwflstHR5dLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7jt1KmsQ%253D%253D&md5=3122823a3c79099621c4836cc6e68c63</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00605.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00605.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DOld%26aufirst%3DW.%26aulast%3DResing%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DStructural%2520and%2520mechanistic%2520insights%2520into%2520Mps1%2520kinase%2520activation%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D1679%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The Discovery of PLK4 Inhibitors: (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones as novel anti-proliferative agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6069</span><span class="NLM_x">–</span> <span class="NLM_lpage">6087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400380m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6069-6087&author=R.+Lauferauthor=B.+Forrestauthor=S.-W.+Liauthor=Y.+Liuauthor=P.+Sampsonauthor=L.+Edwardsauthor=Y.+Langauthor=D.+E.+Awreyauthor=G.+Maoauthor=O.+Plotnikovaauthor=G.+Leungauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=J.+M.+Masonauthor=X.+Luoauthor=X.+Weiauthor=Y.+Yaoauthor=M.+Feherauthor=F.+Banauthor=R.+Kiarashauthor=E.+Greenauthor=T.+W.+Makauthor=G.+Panauthor=H.+W.+Pauls&title=The+Discovery+of+PLK4+Inhibitors%3A+%28E%29-3-%28%281H-indazol-6-yl%29methylene%29indolin-2-ones+as+novel+anti-proliferative+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm400380m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400380m%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSampson%26aufirst%3DP.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520Discovery%2520of%2520PLK4%2520Inhibitors%253A%2520%2528E%2529-3-%2528%25281H-indazol-6-yl%2529methylene%2529indolin-2-ones%2520as%2520novel%2520anti-proliferative%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6069%26epage%3D6087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgXbi6ZnuXgdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Adams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+Adamsauthor=P.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lgXbi6ZnuXgdA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%26aulast%3DAfonine%26aufirst%3DP.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D46%26spage%3D486%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>Buster 2.10.0; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=Buster+2.10.0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBuster%25202.10.0%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Usansky, J. I.; Desai, A.; Tang-Liu, D.</span>PK functions for Microsoft Excel; <a href="http://www.pharmpk.com/soft.html" class="extLink">http://www.pharmpk.com/soft.html</a> (accessed March, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Usansky%2C+J.+I.%3B+Desai%2C+A.%3B+Tang-Liu%2C+D.PK+functions+for+Microsoft+Excel%3B+http%3A%2F%2Fwww.pharmpk.com%2Fsoft.html+%28accessed+March%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DUsansky%26aufirst%3DJ.%2BI.%26jtitle%3DPK%2520functions%2520for%2520Microsoft%2520Excel" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span>ACD/Structure Designer, <span class="NLM_edition">version 12.01</span>; <span class="NLM_publisher-name">Advanced Chemistry Development, Inc.</span>: <span class="NLM_publisher-loc">Toronto, ON, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ACD%2FStructure+Designer%2C+version+12.01%3B+Advanced+Chemistry+Development%2C+Inc.%3A+Toronto%2C+ON%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DACD%252FStructure%2520Designer%26pub%3DAdvanced%2520Chemistry%2520Development%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 32 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jennifer R. Riggs, Jan Elsner, Dan Cashion, Dale Robinson, Lida Tehrani, Mark Nagy, Kimberly E. Fultz, Rama Krishna Narla, Xiaohui Peng, Tam Tran, Ashutosh Kulkarni, Sogole Bahmanyar, Kevin Condroski, Barbra Pagarigan, Gustavo Fenalti, Laurie LeBrun, Katerina Leftheris, Dan Zhu, <span class="NLM_string-name hlFld-ContribAuthor">John F. Boylan</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Optimization Leading to an Orally Active TTK Protein Kinase Inhibitor with Robust Single Agent Efficacy. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (9)
                                     , 4401-4410. <a href="https://doi.org/10.1021/acs.jmedchem.8b01869" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01869</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01869&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01869%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BOptimization%252BLeading%252Bto%252Ban%252BOrally%252BActive%252BTTK%252BProtein%252BKinase%252BInhibitor%252Bwith%252BRobust%252BSingle%252BAgent%252BEfficacy%26aulast%3DRiggs%26aufirst%3DJennifer%2BR.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D28112018%26date%3D30042019%26date%3D18042019%26volume%3D62%26issue%3D9%26spage%3D4401%26epage%3D4410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jennifer R.  Riggs</span>, <span class="hlFld-ContribAuthor ">Mark  Nagy</span>, <span class="hlFld-ContribAuthor ">Jan  Elsner</span>, <span class="hlFld-ContribAuthor ">Paul  Erdman</span>, <span class="hlFld-ContribAuthor ">Dan  Cashion</span>, <span class="hlFld-ContribAuthor ">Dale  Robinson</span>, <span class="hlFld-ContribAuthor ">Roy  Harris</span>, <span class="hlFld-ContribAuthor ">Dehua  Huang</span>, <span class="hlFld-ContribAuthor ">Lida  Tehrani</span>, <span class="hlFld-ContribAuthor ">Gordafaried  Deyanat-Yazdi</span>, <span class="hlFld-ContribAuthor ">Rama Krishna  Narla</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Peng</span>, <span class="hlFld-ContribAuthor ">Tam  Tran</span>, <span class="hlFld-ContribAuthor ">Leo  Barnes</span>, <span class="hlFld-ContribAuthor ">Terra  Miller</span>, <span class="hlFld-ContribAuthor ">Jason  Katz</span>, <span class="hlFld-ContribAuthor ">Yang  Tang</span>, <span class="hlFld-ContribAuthor ">Ming  Chen</span>, <span class="hlFld-ContribAuthor ">Mehran F.  Moghaddam</span>, <span class="hlFld-ContribAuthor ">Sogole  Bahmanyar</span>, <span class="hlFld-ContribAuthor ">Barbra  Pagarigan</span>, <span class="hlFld-ContribAuthor ">Silvia  Delker</span>, <span class="hlFld-ContribAuthor ">Laurie  LeBrun</span>, <span class="hlFld-ContribAuthor ">Philip P.  Chamberlain</span>, <span class="hlFld-ContribAuthor ">Andrew  Calabrese</span>, <span class="hlFld-ContribAuthor ">Stacie S.  Canan</span>, <span class="hlFld-ContribAuthor ">Katerina  Leftheris</span>, <span class="hlFld-ContribAuthor ">Dan  Zhu</span>, and <span class="hlFld-ContribAuthor ">John F.  Boylan</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of a Dual TTK Protein Kinase/CDC2-Like Kinase (CLK2) Inhibitor for the Treatment of Triple Negative Breast Cancer Initiated from a Phenotypic Screen. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (21)
                                     , 8989-9002. <a href="https://doi.org/10.1021/acs.jmedchem.7b01223" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01223</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01223&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01223%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252Ba%252BDual%252BTTK%252BProtein%252BKinase%25252FCDC2-Like%252BKinase%252B%252528CLK2%252529%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BTriple%252BNegative%252BBreast%252BCancer%252BInitiated%252Bfrom%252Ba%252BPhenotypic%252BScreen%26aulast%3DRiggs%26aufirst%3DJennifer%2BR.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D18082017%26date%3D27102017%26date%3D09112017%26date%3D09102017%26volume%3D60%26issue%3D21%26spage%3D8989%26epage%3D9002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong  Liu</span>, <span class="hlFld-ContribAuthor ">Radoslaw  Laufer</span>, <span class="hlFld-ContribAuthor ">Narendra Kumar  Patel</span>, <span class="hlFld-ContribAuthor ">Grace  Ng</span>, <span class="hlFld-ContribAuthor ">Peter B.  Sampson</span>, <span class="hlFld-ContribAuthor ">Sze-Wan  Li</span>, <span class="hlFld-ContribAuthor ">Yunhui  Lang</span>, <span class="hlFld-ContribAuthor ">Miklos  Feher</span>, <span class="hlFld-ContribAuthor ">Richard  Brokx</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Olga  Plotnikova</span>, <span class="hlFld-ContribAuthor ">Donald E.  Awrey</span>, <span class="hlFld-ContribAuthor ">Wei  Qiu</span>, <span class="hlFld-ContribAuthor ">Nickolay Y.  Chirgadze</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Dan Chi-Chia  Lin</span>, <span class="hlFld-ContribAuthor ">Yi  Che</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Graham C.  Fletcher</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Mark R.  Bray</span>, and <span class="hlFld-ContribAuthor ">Henry W.  Pauls</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Pyrazolo[1,5-a]pyrimidine TTK Inhibitors: CFI-402257 is a Potent, Selective, Bioavailable Anticancer Agent. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>7 </em>
                                    (7)
                                     , 671-675. <a href="https://doi.org/10.1021/acsmedchemlett.5b00485" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00485</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00485%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BPyrazolo%25255B1%25252C5-a%25255Dpyrimidine%252BTTK%252BInhibitors%25253A%252BCFI-402257%252Bis%252Ba%252BPotent%25252C%252BSelective%25252C%252BBioavailable%252BAnticancer%252BAgent%26aulast%3DLiu%26aufirst%3DYong%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D14122015%26date%3D26042016%26date%3D06052016%26date%3D14072016%26volume%3D7%26issue%3D7%26spage%3D671%26epage%3D675" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paolo  Innocenti</span>, <span class="hlFld-ContribAuthor ">Hannah L.  Woodward</span>, <span class="hlFld-ContribAuthor ">Savade  Solanki</span>, <span class="hlFld-ContribAuthor ">Sébastien  Naud</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Nora  Cronin</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Jennie  Roberts</span>, <span class="hlFld-ContribAuthor ">Alan T.  Henley</span>, <span class="hlFld-ContribAuthor ">Ross  Baker</span>, <span class="hlFld-ContribAuthor ">Amir  Faisal</span>, <span class="hlFld-ContribAuthor ">Grace Wing-Yan  Mak</span>, <span class="hlFld-ContribAuthor ">Gary  Box</span>, <span class="hlFld-ContribAuthor ">Melanie  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis  De Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Lisa  O’Fee</span>, <span class="hlFld-ContribAuthor ">Harry  Saville</span>, <span class="hlFld-ContribAuthor ">Jessica  Schmitt</span>, <span class="hlFld-ContribAuthor ">Berry  Matijssen</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Spiros  Linardopoulos</span>, <span class="hlFld-ContribAuthor ">Julian  Blagg</span>, and <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>  . </span><span class="cited-content_cbyCitation_article-title">Rapid Discovery of Pyrido[3,4-d]pyrimidine Inhibitors of Monopolar Spindle Kinase 1 (MPS1) Using a Structure-Based Hybridization Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (8)
                                     , 3671-3688. <a href="https://doi.org/10.1021/acs.jmedchem.5b01811" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01811</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01811&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01811%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRapid%252BDiscovery%252Bof%252BPyrido%25255B3%25252C4-d%25255Dpyrimidine%252BInhibitors%252Bof%252BMonopolar%252BSpindle%252BKinase%252B1%252B%252528MPS1%252529%252BUsing%252Ba%252BStructure-Based%252BHybridization%252BApproach%26aulast%3DInnocenti%26aufirst%3DPaolo%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D20112015%26date%3D07042016%26date%3D28042016%26volume%3D59%26issue%3D8%26spage%3D3671%26epage%3D3688" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nitin  Tandon</span>, <span class="hlFld-ContribAuthor ">Vijay  Luxami</span>, <span class="hlFld-ContribAuthor ">Divya  Kant</span>, <span class="hlFld-ContribAuthor ">Runjhun  Tandon</span>, <span class="hlFld-ContribAuthor ">Kamaldeep  Paul</span>. </span><span class="cited-content_cbyCitation_article-title">Current progress, challenges and future prospects of indazoles as protein kinase inhibitors for the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2021,</strong> <em>11 </em>
                                    (41)
                                     , 25228-25257. <a href="https://doi.org/10.1039/D1RA03979B" title="DOI URL">https://doi.org/10.1039/D1RA03979B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D1RA03979B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD1RA03979B%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DCurrent%252Bprogress%25252C%252Bchallenges%252Band%252Bfuture%252Bprospects%252Bof%252Bindazoles%252Bas%252Bprotein%252Bkinase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DTandon%26aufirst%3DNitin%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D41%26spage%3D25228%26epage%3D25257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Minhao  Huang</span>, <span class="hlFld-ContribAuthor ">Yongjun  Huang</span>, <span class="hlFld-ContribAuthor ">Jing  Guo</span>, <span class="hlFld-ContribAuthor ">Lei  Yu</span>, <span class="hlFld-ContribAuthor ">Yu  Chang</span>, <span class="hlFld-ContribAuthor ">Xiaolu  Wang</span>, <span class="hlFld-ContribAuthor ">Jinfeng  Luo</span>, <span class="hlFld-ContribAuthor ">Yanhui  Huang</span>, <span class="hlFld-ContribAuthor ">Zhengchao  Tu</span>, <span class="hlFld-ContribAuthor ">Xiaoyun  Lu</span>, <span class="hlFld-ContribAuthor ">Yong  Xu</span>, <span class="hlFld-ContribAuthor ">Zhimin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhang  Zhang</span>, <span class="hlFld-ContribAuthor ">Ke  Ding</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113023. <a href="https://doi.org/10.1016/j.ejmech.2020.113023" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113023%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPyrido%25255B2%25252C%252B3-d%25255Dpyrimidin-7%2525288H%252529-ones%252Bas%252Bnew%252Bselective%252Borally%252Bbioavailable%252BThreonine%252BTyrosine%252BKinase%252B%252528TTK%252529%252Binhibitors%26aulast%3DHuang%26aufirst%3DMinhao%26date%3D2021%26volume%3D211%26spage%3D113023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadia G.  Zaki</span>, <span class="hlFld-ContribAuthor ">Walaa H.  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>, <span class="hlFld-ContribAuthor ">Abanoub Mosaad  Abdallah</span>, <span class="hlFld-ContribAuthor ">Gehad G.  Mohamed</span>. </span><span class="cited-content_cbyCitation_article-title">Structural characterization, thermal, DFT, cytotoxicity, and antimetastatic properties of cocaine complexes with La(III), Er(III), and Yb(III). </span><span class="cited-content_cbyCitation_journal-name">Research on Chemical Intermediates</span><span> <strong>2020,</strong> <em>46 </em>
                                    (6)
                                     , 3193-3216. <a href="https://doi.org/10.1007/s11164-020-04146-3" title="DOI URL">https://doi.org/10.1007/s11164-020-04146-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11164-020-04146-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11164-020-04146-3%26sid%3Dliteratum%253Aachs%26jtitle%3DResearch%2520on%2520Chemical%2520Intermediates%26atitle%3DStructural%252Bcharacterization%25252C%252Bthermal%25252C%252BDFT%25252C%252Bcytotoxicity%25252C%252Band%252Bantimetastatic%252Bproperties%252Bof%252Bcocaine%252Bcomplexes%252Bwith%252BLa%252528III%252529%25252C%252BEr%252528III%252529%25252C%252Band%252BYb%252528III%252529%26aulast%3DZaki%26aufirst%3DNadia%2BG.%26date%3D2020%26date%3D2020%26volume%3D46%26issue%3D6%26spage%3D3193%26epage%3D3216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aysegul  Hanikoglu</span>, <span class="hlFld-ContribAuthor ">Hakan  Ozben</span>, <span class="hlFld-ContribAuthor ">Ferhat  Hanikoglu</span>, <span class="hlFld-ContribAuthor ">Tomris  Ozben</span>. </span><span class="cited-content_cbyCitation_article-title">Hybrid Compounds & Oxidative Stress Induced Apoptosis in Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Current Medicinal Chemistry</span><span> <strong>2020,</strong> <em>27 </em>
                                    (13)
                                     , 2118-2132. <a href="https://doi.org/10.2174/0929867325666180719145819" title="DOI URL">https://doi.org/10.2174/0929867325666180719145819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2174/0929867325666180719145819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2174%2F0929867325666180719145819%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Medicinal%2520Chemistry%26atitle%3DHybrid%252BCompounds%252B%252526%252BOxidative%252BStress%252BInduced%252BApoptosis%252Bin%252BCancer%252BTherapy%26aulast%3DHanikoglu%26aufirst%3DAysegul%26date%3D2020%26volume%3D27%26issue%3D13%26spage%3D2118%26epage%3D2132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadia G.  Zaki</span>, <span class="hlFld-ContribAuthor ">Walaa H.  Mahmoud</span>, <span class="hlFld-ContribAuthor ">Ahmed M.  El Kerdawy</span>, <span class="hlFld-ContribAuthor ">Abanoub Mosaad  Abdallah</span>, <span class="hlFld-ContribAuthor ">Gehad G.  Mohamed</span>. </span><span class="cited-content_cbyCitation_article-title">Heteroleptic complexes of cocaine/TMEDA with some f block metals: Synthesis, DFT studies, spectral, thermal, cytotoxicity and antimetastatic properties. </span><span class="cited-content_cbyCitation_journal-name">Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy</span><span> <strong>2020,</strong> <em>229 </em>, 117938. <a href="https://doi.org/10.1016/j.saa.2019.117938" title="DOI URL">https://doi.org/10.1016/j.saa.2019.117938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.saa.2019.117938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.saa.2019.117938%26sid%3Dliteratum%253Aachs%26jtitle%3DSpectrochimica%2520Acta%2520Part%2520A%253A%2520Molecular%2520and%2520Biomolecular%2520Spectroscopy%26atitle%3DHeteroleptic%252Bcomplexes%252Bof%252Bcocaine%25252FTMEDA%252Bwith%252Bsome%252Bf%252Bblock%252Bmetals%25253A%252BSynthesis%25252C%252BDFT%252Bstudies%25252C%252Bspectral%25252C%252Bthermal%25252C%252Bcytotoxicity%252Band%252Bantimetastatic%252Bproperties%26aulast%3DZaki%26aufirst%3DNadia%2BG.%26date%3D2020%26volume%3D229%26spage%3D117938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Zheng</span>, <span class="hlFld-ContribAuthor ">Zibo  Chen</span>, <span class="hlFld-ContribAuthor ">Masanori  Kawakami</span>, <span class="hlFld-ContribAuthor ">Yulong  Chen</span>, <span class="hlFld-ContribAuthor ">Jason  Roszik</span>, <span class="hlFld-ContribAuthor ">Lisa Maria  Mustachio</span>, <span class="hlFld-ContribAuthor ">Jonathan M.  Kurie</span>, <span class="hlFld-ContribAuthor ">Pamela  Villalobos</span>, <span class="hlFld-ContribAuthor ">Wei  Lu</span>, <span class="hlFld-ContribAuthor ">Carmen  Behrens</span>, <span class="hlFld-ContribAuthor ">Barbara  Mino</span>, <span class="hlFld-ContribAuthor ">Luisa M.  Solis</span>, <span class="hlFld-ContribAuthor ">Jennifer  Silvester</span>, <span class="hlFld-ContribAuthor ">Kelsie L.  Thu</span>, <span class="hlFld-ContribAuthor ">David W  Cescon</span>, <span class="hlFld-ContribAuthor ">Jaime  Rodriguez-Canales</span>, <span class="hlFld-ContribAuthor ">Ignacio I.  Wistuba</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>, <span class="hlFld-ContribAuthor ">Xi  Liu</span>, <span class="hlFld-ContribAuthor ">Ethan  Dmitrovsky</span>. </span><span class="cited-content_cbyCitation_article-title">Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (10)
                                     , 1775-1786. <a href="https://doi.org/10.1158/1535-7163.MCT-18-0864" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-0864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-0864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-0864%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DTyrosine%252BThreonine%252BKinase%252BInhibition%252BEliminates%252BLung%252BCancers%252Bby%252BAugmenting%252BApoptosis%252Band%252BPolyploidy%26aulast%3DZheng%26aufirst%3DLin%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D10%26spage%3D1775%26epage%3D1786" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon J.  Anderhub</span>, <span class="hlFld-ContribAuthor ">Grace Wing-Yan  Mak</span>, <span class="hlFld-ContribAuthor ">Mark D.  Gurden</span>, <span class="hlFld-ContribAuthor ">Amir  Faisal</span>, <span class="hlFld-ContribAuthor ">Konstantinos  Drosopoulos</span>, <span class="hlFld-ContribAuthor ">Katie  Walsh</span>, <span class="hlFld-ContribAuthor ">Hannah L.  Woodward</span>, <span class="hlFld-ContribAuthor ">Paolo  Innocenti</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Sébastien  Naud</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Efthymia  Theofani</span>, <span class="hlFld-ContribAuthor ">Simone  Filosto</span>, <span class="hlFld-ContribAuthor ">Harry  Saville</span>, <span class="hlFld-ContribAuthor ">Rosemary  Burke</span>, <span class="hlFld-ContribAuthor ">Rob L.M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Julian  Blagg</span>, <span class="hlFld-ContribAuthor ">Swen  Hoelder</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Spiros  Linardopoulos</span>. </span><span class="cited-content_cbyCitation_article-title">High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2019,</strong> <em>18 </em>
                                    (10)
                                     , 1696-1707. <a href="https://doi.org/10.1158/1535-7163.MCT-18-1203" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-18-1203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-18-1203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-18-1203%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DHigh%252BProliferation%252BRate%252Band%252Ba%252BCompromised%252BSpindle%252BAssembly%252BCheckpoint%252BConfers%252BSensitivity%252Bto%252Bthe%252BMPS1%252BInhibitor%252BBOS172722%252Bin%252BTriple-Negative%252BBreast%252BCancers%26aulast%3DAnderhub%26aufirst%3DSimon%2BJ.%26date%3D2019%26date%3D2019%26volume%3D18%26issue%3D10%26spage%3D1696%26epage%3D1707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shutao  Wang</span>, <span class="hlFld-ContribAuthor ">Muxin  Zhang</span>, <span class="hlFld-ContribAuthor ">Di  Liang</span>, <span class="hlFld-ContribAuthor ">Wei  Sun</span>, <span class="hlFld-ContribAuthor ">Chaozai  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengnan  Jiang</span>, <span class="hlFld-ContribAuthor ">Junli  Liu</span>, <span class="hlFld-ContribAuthor ">Jiaguo  Li</span>, <span class="hlFld-ContribAuthor ">Chenchen  Li</span>, <span class="hlFld-ContribAuthor ">Xiaohong  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaoping  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular design and anticancer activities of small-molecule monopolar spindle 1 inhibitors: A Medicinal chemistry perspective. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>175 </em>, 247-268. <a href="https://doi.org/10.1016/j.ejmech.2019.04.047" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.04.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.04.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.04.047%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252Bdesign%252Band%252Banticancer%252Bactivities%252Bof%252Bsmall-molecule%252Bmonopolar%252Bspindle%252B1%252Binhibitors%25253A%252BA%252BMedicinal%252Bchemistry%252Bperspective%26aulast%3DWang%26aufirst%3DShutao%26date%3D2019%26volume%3D175%26spage%3D247%26epage%3D268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Melissa A.  Herbage</span>, <span class="hlFld-ContribAuthor ">Jolaine  Savoie</span>, <span class="hlFld-ContribAuthor ">Joshua D.  Sieber</span>, <span class="hlFld-ContribAuthor ">Jean-Nicolas  Desrosiers</span>, <span class="hlFld-ContribAuthor ">Yongda  Zhang</span>, <span class="hlFld-ContribAuthor ">Maurice A.  Marsini</span>, <span class="hlFld-ContribAuthor ">Keith R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Daniel  Rivalti</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Addition of Non-Stabilized Carbon-Based Nucleophilic Reagents to Chiral
              N
              -Sulfinyl Imines. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 1-422. <a href="https://doi.org/10.1002/0471264180.or099.01" title="DOI URL">https://doi.org/10.1002/0471264180.or099.01</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471264180.or099.01&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471264180.or099.01%26sid%3Dliteratum%253Aachs%26atitle%3DAddition%252Bof%252BNon-Stabilized%252BCarbon-Based%252BNucleophilic%252BReagents%252Bto%252BChiral%252BN%252B-Sulfinyl%252BImines%26aulast%3DHerbage%26aufirst%3DMelissa%2BA.%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D422%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DOrganic%252BReactions%26date%3D2004%26date%3D2004%26volume%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bohong  Liao</span>, <span class="hlFld-ContribAuthor ">Lingrong  Peng</span>, <span class="hlFld-ContribAuthor ">Jin  Zhou</span>, <span class="hlFld-ContribAuthor ">Huiting  Mo</span>, <span class="hlFld-ContribAuthor ">Jialan  Zhao</span>, <span class="hlFld-ContribAuthor ">Zike  Yang</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Guo</span>, <span class="hlFld-ContribAuthor ">Peiquan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhibo  Zhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Activity Evaluation of Nasopharyngeal Carcinoma Inhibitors Based on 6‐(Pyrimidin‐4‐yl)‐1
              H
              ‐indazole. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (5)
                                     , e1800598. <a href="https://doi.org/10.1002/cbdv.201800598" title="DOI URL">https://doi.org/10.1002/cbdv.201800598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201800598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201800598%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BActivity%252BEvaluation%252Bof%252BNasopharyngeal%252BCarcinoma%252BInhibitors%252BBased%252Bon%252B6%2525E2%252580%252590%252528Pyrimidin%2525E2%252580%2525904%2525E2%252580%252590yl%252529%2525E2%252580%2525901%252BH%252B%2525E2%252580%252590indazole%26aulast%3DLiao%26aufirst%3DBohong%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D5%26spage%3De1800598" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fatima  Arshad</span>, <span class="hlFld-ContribAuthor ">Mohemmed Faraz  Khan</span>, <span class="hlFld-ContribAuthor ">Wasim  Akhtar</span>, <span class="hlFld-ContribAuthor ">Mohammad Mumtaz  Alam</span>, <span class="hlFld-ContribAuthor ">Lalit Mohan  Nainwal</span>, <span class="hlFld-ContribAuthor ">Sumit Kumar  Kaushik</span>, <span class="hlFld-ContribAuthor ">Mymoona  Akhter</span>, <span class="hlFld-ContribAuthor ">Suhel  Parvez</span>, <span class="hlFld-ContribAuthor ">Syed Misbahul  Hasan</span>, <span class="hlFld-ContribAuthor ">Mohammad  Shaquiquzzaman</span>. </span><span class="cited-content_cbyCitation_article-title">Revealing quinquennial anticancer journey of morpholine: A SAR based review. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>167 </em>, 324-356. <a href="https://doi.org/10.1016/j.ejmech.2019.02.015" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.02.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.02.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.02.015%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRevealing%252Bquinquennial%252Banticancer%252Bjourney%252Bof%252Bmorpholine%25253A%252BA%252BSAR%252Bbased%252Breview%26aulast%3DArshad%26aufirst%3DFatima%26date%3D2019%26volume%3D167%26spage%3D324%26epage%3D356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kai  Chen</span>, <span class="hlFld-ContribAuthor ">Wenxiu  Duan</span>, <span class="hlFld-ContribAuthor ">Qianqian  Han</span>, <span class="hlFld-ContribAuthor ">Xuan  Sun</span>, <span class="hlFld-ContribAuthor ">Wenqian  Li</span>, <span class="hlFld-ContribAuthor ">Shuangyun  Hu</span>, <span class="hlFld-ContribAuthor ">Jiajia  Wan</span>, <span class="hlFld-ContribAuthor ">Jiang  Wu</span>, <span class="hlFld-ContribAuthor ">Yushu  Ge</span>, <span class="hlFld-ContribAuthor ">Dan  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of the hot spot residues for pyridine derivative inhibitor CCT251455 and ATP substrate binding on monopolar spindle 1 (MPS1) kinase by molecular dynamic simulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2019,</strong> <em>37 </em>
                                    (3)
                                     , 611-622. <a href="https://doi.org/10.1080/07391102.2018.1433552" title="DOI URL">https://doi.org/10.1080/07391102.2018.1433552</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2018.1433552&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2018.1433552%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DIdentification%252Bof%252Bthe%252Bhot%252Bspot%252Bresidues%252Bfor%252Bpyridine%252Bderivative%252Binhibitor%252BCCT251455%252Band%252BATP%252Bsubstrate%252Bbinding%252Bon%252Bmonopolar%252Bspindle%252B1%252B%252528MPS1%252529%252Bkinase%252Bby%252Bmolecular%252Bdynamic%252Bsimulation%26aulast%3DChen%26aufirst%3DKai%26date%3D2019%26date%3D2018%26volume%3D37%26issue%3D3%26spage%3D611%26epage%3D622" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Samson  Afewerki</span>, <span class="hlFld-ContribAuthor ">Jia-Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Wei-Wei  Liao</span>, <span class="hlFld-ContribAuthor ">Armando  Córdova</span>. </span><span class="cited-content_cbyCitation_article-title">The Chemical Synthesis and Applications of Tropane Alkaloids. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 151-233. <a href="https://doi.org/10.1016/bs.alkal.2018.06.001" title="DOI URL">https://doi.org/10.1016/bs.alkal.2018.06.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.alkal.2018.06.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.alkal.2018.06.001%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BChemical%252BSynthesis%252Band%252BApplications%252Bof%252BTropane%252BAlkaloids%26aulast%3DAfewerki%26aufirst%3DSamson%26date%3D2019%26spage%3D151%26epage%3D233%26pub%3DElsevier%26date%3D2019%26volume%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana C.  Henriques</span>, <span class="hlFld-ContribAuthor ">Diana  Ribeiro</span>, <span class="hlFld-ContribAuthor ">Joel  Pedrosa</span>, <span class="hlFld-ContribAuthor ">Bruno  Sarmento</span>, <span class="hlFld-ContribAuthor ">Patrícia M.A.  Silva</span>, <span class="hlFld-ContribAuthor ">Hassan  Bousbaa</span>. </span><span class="cited-content_cbyCitation_article-title">Mitosis inhibitors in anticancer therapy: When blocking the exit becomes a solution. </span><span class="cited-content_cbyCitation_journal-name">Cancer Letters</span><span> <strong>2019,</strong> <em>440-441 </em>, 64-81. <a href="https://doi.org/10.1016/j.canlet.2018.10.005" title="DOI URL">https://doi.org/10.1016/j.canlet.2018.10.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.canlet.2018.10.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.canlet.2018.10.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Letters%26atitle%3DMitosis%252Binhibitors%252Bin%252Banticancer%252Btherapy%25253A%252BWhen%252Bblocking%252Bthe%252Bexit%252Bbecomes%252Ba%252Bsolution%26aulast%3DHenriques%26aufirst%3DAna%2BC.%26date%3D2019%26volume%3D440-441%26spage%3D64%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jith C.  Janardhanan</span>, <span class="hlFld-ContribAuthor ">Rakesh K.  Mishra</span>, <span class="hlFld-ContribAuthor ">Gourab  Das</span>, <span class="hlFld-ContribAuthor ">Suresh  Sini</span>, <span class="hlFld-ContribAuthor ">Purushothaman  Jayamurthy</span>, <span class="hlFld-ContribAuthor ">Cherumuttathu H.  Suresh</span>, <span class="hlFld-ContribAuthor ">Vakayil K.  Praveen</span>, <span class="hlFld-ContribAuthor ">Narayanapillai  Manoj</span>, <span class="hlFld-ContribAuthor ">Beneesh P.  Babu</span>. </span><span class="cited-content_cbyCitation_article-title">Functionalizable 1
              H
              -Indazoles by Palladium Catalyzed Aza-Nenitzescu Reaction: Pharmacophores to Donor-Acceptor Type Multi-Luminescent Fluorophores. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2018,</strong> <em>7 </em>
                                    (10)
                                     , 2094-2104. <a href="https://doi.org/10.1002/ajoc.201800413" title="DOI URL">https://doi.org/10.1002/ajoc.201800413</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201800413&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201800413%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFunctionalizable%252B1%252BH%252B-Indazoles%252Bby%252BPalladium%252BCatalyzed%252BAza-Nenitzescu%252BReaction%25253A%252BPharmacophores%252Bto%252BDonor-Acceptor%252BType%252BMulti-Luminescent%252BFluorophores%26aulast%3DJanardhanan%26aufirst%3DJith%2BC.%26date%3D2018%26date%3D2018%26volume%3D7%26issue%3D10%26spage%3D2094%26epage%3D2104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinyun  Dong</span>, <span class="hlFld-ContribAuthor ">Qijing  Zhang</span>, <span class="hlFld-ContribAuthor ">Zengtao  Wang</span>, <span class="hlFld-ContribAuthor ">Guang  Huang</span>, <span class="hlFld-ContribAuthor ">Shaoshun  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development of Indazole-based Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2018,</strong> <em>13 </em>
                                    (15)
                                     , 1490-1507. <a href="https://doi.org/10.1002/cmdc.201800253" title="DOI URL">https://doi.org/10.1002/cmdc.201800253</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201800253&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201800253%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Bof%252BIndazole-based%252BAnticancer%252BAgents%26aulast%3DDong%26aufirst%3DJinyun%26date%3D2018%26date%3D2018%26volume%3D13%26issue%3D15%26spage%3D1490%26epage%3D1507" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Zhu</span>, <span class="hlFld-ContribAuthor ">Shuichan  Xu</span>, <span class="hlFld-ContribAuthor ">Gordafaried  Deyanat-Yazdi</span>, <span class="hlFld-ContribAuthor ">Sophie X.  Peng</span>, <span class="hlFld-ContribAuthor ">Leo A.  Barnes</span>, <span class="hlFld-ContribAuthor ">Rama Krishna  Narla</span>, <span class="hlFld-ContribAuthor ">Tam  Tran</span>, <span class="hlFld-ContribAuthor ">David  Mikolon</span>, <span class="hlFld-ContribAuthor ">Yuhong  Ning</span>, <span class="hlFld-ContribAuthor ">Tao  Shi</span>, <span class="hlFld-ContribAuthor ">Ning  Jiang</span>, <span class="hlFld-ContribAuthor ">Heather K.  Raymon</span>, <span class="hlFld-ContribAuthor ">Jennifer R.  Riggs</span>, <span class="hlFld-ContribAuthor ">John F.  Boylan</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Lethal Strategy Identifies a Potent and Selective TTK and CLK1/2 Inhibitor for Treatment of Triple-Negative Breast Cancer with a Compromised G
              1
              –S Checkpoint. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2018,</strong> <em>17 </em>
                                    (8)
                                     , 1727-1738. <a href="https://doi.org/10.1158/1535-7163.MCT-17-1084" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-17-1084</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-17-1084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-17-1084%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSynthetic%252BLethal%252BStrategy%252BIdentifies%252Ba%252BPotent%252Band%252BSelective%252BTTK%252Band%252BCLK1%25252F2%252BInhibitor%252Bfor%252BTreatment%252Bof%252BTriple-Negative%252BBreast%252BCancer%252Bwith%252Ba%252BCompromised%252BG%252B1%252B%2525E2%252580%252593S%252BCheckpoint%26aulast%3DZhu%26aufirst%3DDan%26date%3D2018%26date%3D2018%26volume%3D17%26issue%3D8%26spage%3D1727%26epage%3D1738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana Rita R.  Maia</span>, <span class="hlFld-ContribAuthor ">Simon  Linder</span>, <span class="hlFld-ContribAuthor ">Ji-Ying  Song</span>, <span class="hlFld-ContribAuthor ">Chantal  Vaarting</span>, <span class="hlFld-ContribAuthor ">Ute  Boon</span>, <span class="hlFld-ContribAuthor ">Colin E. J.  Pritchard</span>, <span class="hlFld-ContribAuthor ">Arno  Velds</span>, <span class="hlFld-ContribAuthor ">Ivo J.  Huijbers</span>, <span class="hlFld-ContribAuthor ">Olaf  van Tellingen</span>, <span class="hlFld-ContribAuthor ">Jos  Jonkers</span>, <span class="hlFld-ContribAuthor ">René H.  Medema</span>. </span><span class="cited-content_cbyCitation_article-title">Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division. </span><span class="cited-content_cbyCitation_journal-name">British Journal of Cancer</span><span> <strong>2018,</strong> <em>118 </em>
                                    (12)
                                     , 1586-1595. <a href="https://doi.org/10.1038/s41416-018-0081-2" title="DOI URL">https://doi.org/10.1038/s41416-018-0081-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41416-018-0081-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41416-018-0081-2%26sid%3Dliteratum%253Aachs%26jtitle%3DBritish%2520Journal%2520of%2520Cancer%26atitle%3DMps1%252Binhibitors%252Bsynergise%252Bwith%252Blow%252Bdoses%252Bof%252Btaxanes%252Bin%252Bpromoting%252Btumour%252Bcell%252Bdeath%252Bby%252Benhancement%252Bof%252Berrors%252Bin%252Bcell%252Bdivision%26aulast%3DMaia%26aufirst%3DAna%2BRita%2BR.%26date%3D2018%26date%3D2018%26volume%3D118%26issue%3D12%26spage%3D1586%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagaraju  Kerru</span>, <span class="hlFld-ContribAuthor ">Parvesh  Singh</span>, <span class="hlFld-ContribAuthor ">Neil  Koorbanally</span>, <span class="hlFld-ContribAuthor ">Raghu  Raj</span>, <span class="hlFld-ContribAuthor ">Vipan  Kumar</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances (2015–2016) in anticancer hybrids. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>142 </em>, 179-212. <a href="https://doi.org/10.1016/j.ejmech.2017.07.033" title="DOI URL">https://doi.org/10.1016/j.ejmech.2017.07.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2017.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2017.07.033%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252B%2525282015%2525E2%252580%2525932016%252529%252Bin%252Banticancer%252Bhybrids%26aulast%3DKerru%26aufirst%3DNagaraju%26date%3D2017%26volume%3D142%26spage%3D179%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joost C.M.  Uitdehaag</span>, <span class="hlFld-ContribAuthor ">Jos  de Man</span>, <span class="hlFld-ContribAuthor ">Nicole  Willemsen-Seegers</span>, <span class="hlFld-ContribAuthor ">Martine B.W.  Prinsen</span>, <span class="hlFld-ContribAuthor ">Marion A.A.  Libouban</span>, <span class="hlFld-ContribAuthor ">Jan Gerard  Sterrenburg</span>, <span class="hlFld-ContribAuthor ">Joeri J.P.  de Wit</span>, <span class="hlFld-ContribAuthor ">Judith R.F.  de Vetter</span>, <span class="hlFld-ContribAuthor ">Jeroen A.D.M.  de Roos</span>, <span class="hlFld-ContribAuthor ">Rogier C.  Buijsman</span>, <span class="hlFld-ContribAuthor ">Guido J.R.  Zaman</span>. </span><span class="cited-content_cbyCitation_article-title">Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2017,</strong> <em>429 </em>
                                    (14)
                                     , 2211-2230. <a href="https://doi.org/10.1016/j.jmb.2017.05.014" title="DOI URL">https://doi.org/10.1016/j.jmb.2017.05.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2017.05.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2017.05.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DTarget%252BResidence%252BTime-Guided%252BOptimization%252Bon%252BTTK%252BKinase%252BResults%252Bin%252BInhibitors%252Bwith%252BPotent%252BAnti-Proliferative%252BActivity%26aulast%3DUitdehaag%26aufirst%3DJoost%2BC.M.%26date%3D2017%26volume%3D429%26issue%3D14%26spage%3D2211%26epage%3D2230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Xin  Wei</span>, <span class="hlFld-ContribAuthor ">Graham C.  Fletcher</span>, <span class="hlFld-ContribAuthor ">Reza  Kiarash</span>, <span class="hlFld-ContribAuthor ">Richard  Brokx</span>, <span class="hlFld-ContribAuthor ">Richard  Hodgson</span>, <span class="hlFld-ContribAuthor ">Irina  Beletskaya</span>, <span class="hlFld-ContribAuthor ">Mark R.  Bray</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>. </span><span class="cited-content_cbyCitation_article-title">Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2017,</strong> <em>114 </em>
                                    (12)
                                     , 3127-3132. <a href="https://doi.org/10.1073/pnas.1700234114" title="DOI URL">https://doi.org/10.1073/pnas.1700234114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1700234114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1700234114%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DFunctional%252Bcharacterization%252Bof%252BCFI-402257%25252C%252Ba%252Bpotent%252Band%252Bselective%252BMps1%25252FTTK%252Bkinase%252Binhibitor%25252C%252Bfor%252Bthe%252Btreatment%252Bof%252Bcancer%26aulast%3DMason%26aufirst%3DJacqueline%2BM.%26date%3D2017%26date%3D2017%26volume%3D114%26issue%3D12%26spage%3D3127%26epage%3D3132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lennart  Brewitz</span>, <span class="hlFld-ContribAuthor ">Naoya  Kumagai</span>, <span class="hlFld-ContribAuthor ">Masakatsu  Shibasaki</span>. </span><span class="cited-content_cbyCitation_article-title">Catalytic asymmetric synthesis of 2,3,3,3-tetrafluoro-2-methyl-1-arylpropan-1-amines as useful building blocks for SAR-studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Fluorine Chemistry</span><span> <strong>2017,</strong> <em>194 </em>, 1-7. <a href="https://doi.org/10.1016/j.jfluchem.2016.12.008" title="DOI URL">https://doi.org/10.1016/j.jfluchem.2016.12.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jfluchem.2016.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jfluchem.2016.12.008%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Fluorine%2520Chemistry%26atitle%3DCatalytic%252Basymmetric%252Bsynthesis%252Bof%252B2%25252C3%25252C3%25252C3-tetrafluoro-2-methyl-1-arylpropan-1-amines%252Bas%252Buseful%252Bbuilding%252Bblocks%252Bfor%252BSAR-studies%26aulast%3DBrewitz%26aufirst%3DLennart%26date%3D2017%26volume%3D194%26spage%3D1%26epage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jae-Hyun  Park</span>, <span class="hlFld-ContribAuthor ">Suyoun  Chung</span>, <span class="hlFld-ContribAuthor ">Yo  Matsuo</span>, <span class="hlFld-ContribAuthor ">Yusuke  Nakamura</span>. </span><span class="cited-content_cbyCitation_article-title">Development of small molecular compounds targeting cancer stem cells. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2017,</strong> <em>8 </em>
                                    (1)
                                     , 73-80. <a href="https://doi.org/10.1039/C6MD00385K" title="DOI URL">https://doi.org/10.1039/C6MD00385K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C6MD00385K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC6MD00385K%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDevelopment%252Bof%252Bsmall%252Bmolecular%252Bcompounds%252Btargeting%252Bcancer%252Bstem%252Bcells%26aulast%3DPark%26aufirst%3DJae-Hyun%26date%3D2017%26date%3D2017%26volume%3D8%26issue%3D1%26spage%3D73%26epage%3D80" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charles M.  Marson</span>. </span><span class="cited-content_cbyCitation_article-title">Saturated Heterocycles with Applications in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 13-33. <a href="https://doi.org/10.1016/bs.aihch.2016.03.004" title="DOI URL">https://doi.org/10.1016/bs.aihch.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.aihch.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.aihch.2016.03.004%26sid%3Dliteratum%253Aachs%26atitle%3DSaturated%252BHeterocycles%252Bwith%252BApplications%252Bin%252BMedicinal%252BChemistry%26aulast%3DMarson%26aufirst%3DCharles%2BM.%26date%3D2017%26spage%3D13%26epage%3D33%26pub%3DElsevier%26atitle%3DHeterocyclic%252BChemistry%252Bin%252Bthe%252B21st%252BCentury%252B-%252BA%252BTribute%252Bto%252BAlan%252BKatritzky%26date%3D2017%26volume%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qianqian  Xu</span>, <span class="hlFld-ContribAuthor ">Yali  Xu</span>, <span class="hlFld-ContribAuthor ">Bo  Pan</span>, <span class="hlFld-ContribAuthor ">Liangcai  Wu</span>, <span class="hlFld-ContribAuthor ">Xinyu  Ren</span>, <span class="hlFld-ContribAuthor ">Yidong  Zhou</span>, <span class="hlFld-ContribAuthor ">Feng  Mao</span>, <span class="hlFld-ContribAuthor ">Yan  Lin</span>, <span class="hlFld-ContribAuthor ">Jinghong  Guan</span>, <span class="hlFld-ContribAuthor ">Songjie  Shen</span>, <span class="hlFld-ContribAuthor ">Xiaohui  Zhang</span>, <span class="hlFld-ContribAuthor ">Changjun  Wang</span>, <span class="hlFld-ContribAuthor ">Ying  Zhong</span>, <span class="hlFld-ContribAuthor ">Liangrui  Zhou</span>, <span class="hlFld-ContribAuthor ">Zhiyong  Liang</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhao</span>, <span class="hlFld-ContribAuthor ">Qiang  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">TTK is a favorable prognostic biomarker for triple-negative breast cancer survival. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (49)
                                     , 81815-81829. <a href="https://doi.org/10.18632/oncotarget.13245" title="DOI URL">https://doi.org/10.18632/oncotarget.13245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.13245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.13245%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DTTK%252Bis%252Ba%252Bfavorable%252Bprognostic%252Bbiomarker%252Bfor%252Btriple-negative%252Bbreast%252Bcancer%252Bsurvival%26aulast%3DXu%26aufirst%3DQianqian%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D49%26spage%3D81815%26epage%3D81829" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ruoyu  Miao</span>, <span class="hlFld-ContribAuthor ">Yan  Wu</span>, <span class="hlFld-ContribAuthor ">Haohai  Zhang</span>, <span class="hlFld-ContribAuthor ">Huandi  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiaofeng  Sun</span>, <span class="hlFld-ContribAuthor ">Eva  Csizmadia</span>, <span class="hlFld-ContribAuthor ">Lian  He</span>, <span class="hlFld-ContribAuthor ">Yi  Zhao</span>, <span class="hlFld-ContribAuthor ">Chengyu  Jiang</span>, <span class="hlFld-ContribAuthor ">Rebecca A.  Miksad</span>, <span class="hlFld-ContribAuthor ">Tahereh  Ghaziani</span>, <span class="hlFld-ContribAuthor ">Simon C.  Robson</span>, <span class="hlFld-ContribAuthor ">Haitao  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Utility of the dual-specificity protein kinase TTK as a therapeutic target for intrahepatic spread of liver cancer. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep33121" title="DOI URL">https://doi.org/10.1038/srep33121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep33121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep33121%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DUtility%252Bof%252Bthe%252Bdual-specificity%252Bprotein%252Bkinase%252BTTK%252Bas%252Ba%252Btherapeutic%252Btarget%252Bfor%252Bintrahepatic%252Bspread%252Bof%252Bliver%252Bcancer%26aulast%3DMiao%26aufirst%3DRuoyu%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tarn C  Johnson</span>, <span class="hlFld-ContribAuthor ">Stephen P  Marsden</span>. </span><span class="cited-content_cbyCitation_article-title">A convergent, umpoled synthesis of 2-(1-amidoalkyl)pyridines. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>12 </em>, 1-4. <a href="https://doi.org/10.3762/bjoc.12.1" title="DOI URL">https://doi.org/10.3762/bjoc.12.1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.12.1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.12.1%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DA%252Bconvergent%25252C%252Bumpoled%252Bsynthesis%252Bof%252B2-%2525281-amidoalkyl%252529pyridines%26aulast%3DJohnson%26aufirst%3DTarn%2BC%26date%3D2016%26date%3D2016%26volume%3D12%26spage%3D1%26epage%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carmen  Dominguez-Brauer</span>, <span class="hlFld-ContribAuthor ">Kelsie L.  Thu</span>, <span class="hlFld-ContribAuthor ">Jacqueline M.  Mason</span>, <span class="hlFld-ContribAuthor ">Heiko  Blaser</span>, <span class="hlFld-ContribAuthor ">Mark R.  Bray</span>, <span class="hlFld-ContribAuthor ">Tak W.  Mak</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting Mitosis in Cancer: Emerging Strategies. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cell</span><span> <strong>2015,</strong> <em>60 </em>
                                    (4)
                                     , 524-536. <a href="https://doi.org/10.1016/j.molcel.2015.11.006" title="DOI URL">https://doi.org/10.1016/j.molcel.2015.11.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molcel.2015.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molcel.2015.11.006%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cell%26atitle%3DTargeting%252BMitosis%252Bin%252BCancer%25253A%252BEmerging%252BStrategies%26aulast%3DDominguez-Brauer%26aufirst%3DCarmen%26date%3D2015%26volume%3D60%26issue%3D4%26spage%3D524%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0024.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Chart 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0026.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 1. Representative TTK Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=cht1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0001.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Overlay of TTK inhibitors. The figure was obtained by aligning compound <b>1</b>/TTK X-ray structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3H9F">3H9F</a>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> with compound <b>3</b> docked into a previously described<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> 3-(1<i>H</i>-indazol-3-yl)benzenesulfonamide/TTK X-ray structure (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JT3">4JT3</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="cht2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Chart 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0027.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Chart 2. 3-(1<i>H</i>-Indazol-3-yl)benzenesulfonamide TTK Inhibitors</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=cht2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of (3-(4-Heterocyclyl and/or 3-sulfonyl)phenyl)-1<i>H</i>-indazol-5-yl)acetamides <b>12</b>–<b>21</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) HCO<sub>2</sub>H or Me<sub>2</sub>NCH<sub>2</sub>CO<sub>2</sub>H, TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, 91–95%; (ii) Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, (Bpin)<sub>2</sub>, KOAc, DMF, 80 °C, or Pd(dba)<sub>2</sub>, (C<sub>6</sub>H<sub>11</sub>)<sub>3</sub>P·HBF<sub>4</sub>, (Bpin)<sub>2</sub>, KOAc, dioxane, 80 °C or Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, <i>S</i>-Phos, PinBH, dioxane, 100 °C, 29–91%; (iii) R‴CO<sub>2</sub>H, TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, 23–54%; (iv) TsOH·H<sub>2</sub>O, MeOH, 125 °C, microwave, 69%; (v) ArB(OH)<sub>2</sub> or <b>7</b>, aq Na<sub>2</sub>CO<sub>3</sub>, (Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, PhMe/EtOH, reflux) or (Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, dioxane, reflux), 10–58%; (vi) TFA, DCM, 38–55% (2 steps).</p></p></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0010.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Achiral (<b>33</b>, <b>38</b>, <b>39</b>) and Racemic (<b>34</b>–<b>37</b>, <b>40</b>–<b>48</b>) 3-(4-(Heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamides<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) 1-Fluoro-4-iodobenzene, NaH, DMF, 85 °C, 40–55%; (ii) TFA, DCM; (iii) HCO<sub>2</sub>H, TBTU, DIPEA, DMF, 36% (2 steps); (iv) Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, <i>S</i>-Phos, PinBH, dioxane, 110 °C or Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, (Bpin)<sub>2</sub>, KOAc, DMF, 85–100 °C, 37–75%; (v) TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, DMF, 81%; (vi) NH<sub>4</sub>OAc, NaBH<sub>3</sub>CN, MeOH, 60 °C, 93–100%; (vii) <i>c</i>-PrMgBr, THF, NaBH<sub>4</sub>, MeOH, 79%; (viii) ArB(OH)<sub>2</sub>, <b>7</b> or <b>25</b>, aq Na<sub>2</sub>CO<sub>3</sub>, (Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, PhMe/EtOH, reflux) or (Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, dioxane, reflux), 7–83%.</p></p></figure><figure data-id="sch3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0011.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Chiral 3-(4-(Heterocyclyl)phenyl)-1<i>H</i>-indazole-5-carboxamide TTK Inhibitors <b>64</b>–<b>88</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(i) (Arene or cyclopentane)carbaldehyde, CuSO<sub>4</sub> or CuSO<sub>4</sub>/MgSO<sub>4</sub>, DCM, 61–89%; (ii) RMgBr, Me<sub>2</sub>Zn, THF, 62–100%; (iii) 2 M HCl in Et<sub>2</sub>O, MeOH, 64–87%; (iv) 2-bromopyridine, <sup><i>i</i></sup>PrMgCl·LiCl, THF, 33%; (v) TBTU, <sup><i>i</i></sup>Pr<sub>2</sub>NEt, 3-iodo-1<i>H</i>-indazole-5-carboxylic acid, DMF, 75–98%; (vi) CuI, 1,4-diiodobenzene, K<sub>3</sub>PO<sub>4</sub>, BINOL, rt to 50 °C, 8–44%; (vii) Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, (Bpin)<sub>2</sub>, KOAc, DMF, 80 °C or Pd(CH<sub>3</sub>CN)<sub>2</sub>Cl<sub>2</sub>, <i>S</i>-Phos, PinBH, dioxane, 100 °C, 44–100% for <b>60a</b>–<b>d</b> (1 step) and 10–29% for <b>60e</b>,<b>f</b> (2 steps); (viii) 3-oxopentanedioic acid, HCl, EtOH, 2-(2,2-diethoxyethoxy)-1,1-diethoxyethane or glutaraldehyde, 15–31%; (ix) NaBH<sub>4</sub>, MeOH; (x) aq Na<sub>2</sub>CO<sub>3</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub> or Pd(dppf)Cl<sub>2</sub>·CH<sub>2</sub>Cl<sub>2</sub>, PhMe/EtOH, reflux; 12–59%.</p></p></figure><figure data-id="fig2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0002.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Active site view of co-complex X-ray structure of compound <b>51</b> with TTK (PDB: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O6L">4O6L</a>) indicating binding of the <i>R</i> enantiomer to chain A. H-bonds from indazole to the hinge region (Glu603 and Gly605) and from the amide carbonyl to Lys553 are shown by dotted lines. The ethyl group nestles in a side pocket, while the phenyl ring makes hydrophobic contact with the protein surface; the protonated piperdine ring extends toward the solvent interface and makes an interaction with the phosphorylated side chain of Thr675 (Tpo675). The position of the gatekeeper residue (Met602) is indicated.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0003.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Predictive models using the 4O6L X-ray structure: pIC<sub>50</sub> (TTK) vs GlideXP docking scores wherein the best GlideXP score (from docking multiple conformers) is selected as the docked structure. (left panel) Using compounds from this work (minus achiral outliers) and our previous publication on indazole based TTK inhibitors<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> (<i>R</i><sup>2</sup> = 0.62, rmse = 0.68, <i>n</i> = 81). (right panel) Using all project compounds (<i>R</i><sup>2</sup> = 0.57, rmse = 0.69, <i>n</i> = 817).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0004.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Athymic CD-1 NUDE mice (<i>n</i> = 8) bearing HCT116 xenograft tumors treated daily for 21 days with compound <b>75</b> at 23 and 35 mg/kg (PO QD). Plot depicts tumor volume vs day of treatment. One mouse, receiving the high dose of compound <b>75</b>, was found dead at day 14; no adverse effects in the remaining animals were observed (body weight loss <20%).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0005.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Heat map showing % inhibition of 278 kinases at 1.0 μM of compound <b>75</b> and two clinically used kinase inhibitors imatinib and sunitinib. Millipore radiometric assay data for each compound was individually sorted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0006.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Cell cycle analysis of HCT116 colon cancer cells treated with compound <b>75</b> at given concentrations. Percentage of 8N and 16N cells, at 48 h, normalized to DMSO control.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0007.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (upper panels) Mitotic figures of HCT116 cells treated with compound <b>75</b> or DMSO 6 h post double thymidine block. Centromeres are stained in green, α-tubulin in red, and DAPI in blue. (lower panel) Graph of the percentage of anaphase and telophase cells with and without lagging chromosomes. Mean % ± SD lagging chromosomes for DMSO, 19 ± 2%; 100 nM <b>75</b>, 61 ± 2%; 500 nM <b>75</b>, 94 ± 1%. Data are representative of three independent experiments with a variation <10%.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/medium/jm-2014-01740a_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0008.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (left panel) Plot of the chromosome counts on metaphase spreads from HCT116 cells treated with 500 nM <b>75</b> or DMSO for 28 h. Data are representative of three independent experiments. (right panels) Representative images of metaphase spreads from <b>75</b> (500 nM) and DMSO treated HCT116 cells. Chromosomes were stained with DAPI.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2015/jmcmar.2015.58.issue-8/jm501740a/20150417/images/large/jm-2014-01740a_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm501740a&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i104">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00386" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00386" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 62 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Aarts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span> </span><span class="NLM_article-title">Tumour selective targeting of cell cycle kinases for cancer treatment</span> <span class="citation_source-journal">Curr. Opin. Pharm.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">529</span><span class="NLM_x">–</span> <span class="NLM_lpage">535</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1016%2Fj.coph.2013.03.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=23597425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmtValsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=529-535&author=M.+Aartsauthor=S.+Linardopoulosauthor=N.+C.+Turner&title=Tumour+selective+targeting+of+cell+cycle+kinases+for+cancer+treatment"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Tumour selective targeting of cell cycle kinases for cancer treatment</span></div><div class="casAuthors">Aarts, Marieke; Linardopoulos, Spiros; Turner, Nicholas C.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">529-535</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The deregulation of the cell cycle and checkpoint machinery in cancer presents a highly attractive therapeutic strategy.  We review here the strategies used to exploit the dysregulated cell cycle, both through targeting kinases required for cell cycle progression, and checkpoint kinases to inappropriately force cells through the cell cycle.  Appropriate control of the cell cycle is crit. for proliferating normal cells, and we discuss the importance of defining tumor specific vulnerabilities that could be targeted with cell cycle kinase inhibitors.  Recent studies have shown that ER-pos. breast cancers rely on CDK4 to promote proliferation.  TP53 mutant cancer cell lines are sensitive to WEE1 and CHK1 inhibitors in combination with chemotherapy, while PTEN-deficient aneuploid cancer cell lines are sensitive to TTK inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLoVeyM7O1HrVg90H21EOLACvtfcHk0lhiU34tCeESHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmtValsbg%253D&md5=21d34a68d937abd09dad8bc15fd56bce</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2013.03.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2013.03.012%26sid%3Dliteratum%253Aachs%26aulast%3DAarts%26aufirst%3DM.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26atitle%3DTumour%2520selective%2520targeting%2520of%2520cell%2520cycle%2520kinases%2520for%2520cancer%2520treatment%26jtitle%3DCurr.%2520Opin.%2520Pharm.%26date%3D2013%26volume%3D13%26spage%3D529%26epage%3D535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Foley, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapoor, T. M.</span><span> </span><span class="NLM_article-title">Microtubule attachment and spindle assembly checkpoint signaling at the kinetochore</span> <span class="citation_source-journal">Nature Rev. Mol. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">37</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fnrm3494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=23258294" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKgurjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=25-37&author=E.+A.+Foleyauthor=T.+M.+Kapoor&title=Microtubule+attachment+and+spindle+assembly+checkpoint+signaling+at+the+kinetochore"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore</span></div><div class="casAuthors">Foley, Emily A.; Kapoor, Tarun M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Molecular Cell Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-37</span>CODEN:
                <span class="NLM_cas:coden">NRMCBP</span>;
        ISSN:<span class="NLM_cas:issn">1471-0072</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In eukaryotes, chromosome segregation during cell division is facilitated by the kinetochore, a multiprotein structure that is assembled on centromeric DNA.  The kinetochore attaches chromosomes to spindle microtubules, modulates the stability of these attachments and relays the microtubule-binding status to the spindle assembly checkpoint (SAC), a cell cycle surveillance pathway that delays chromosome segregation in response to unattached kinetochores.  Recent studies are shaping current thinking on how each of these kinetochore-centered processes is achieved, and how their integration ensures faithful chromosome segregation, focusing on the essential roles of kinase-phosphatase signaling and the microtubule-binding KMN protein network.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0-fThmrgdaLVg90H21EOLACvtfcHk0ljjzlvICeC1og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKgurjP&md5=d99b2423a2991a219f23f9ccfd81dd65</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrm3494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrm3494%26sid%3Dliteratum%253Aachs%26aulast%3DFoley%26aufirst%3DE.%2BA.%26aulast%3DKapoor%26aufirst%3DT.%2BM.%26atitle%3DMicrotubule%2520attachment%2520and%2520spindle%2520assembly%2520checkpoint%2520signaling%2520at%2520the%2520kinetochore%26jtitle%3DNature%2520Rev.%2520Mol.%2520Cell%2520Biol.%26date%3D2013%26volume%3D14%26spage%3D25%26epage%3D37" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Rajagopalan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lengauer, C.</span><span> </span><span class="NLM_article-title">Progress Aneuploidy and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">338</span><span class="NLM_x">–</span> <span class="NLM_lpage">341</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=338-341&author=H.+Rajagopalanauthor=C.+Lengauer&title=Progress+Aneuploidy+and+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopalan%26aufirst%3DH.%26aulast%3DLengauer%26aufirst%3DC.%26atitle%3DProgress%2520Aneuploidy%2520and%2520cancer%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D338%26epage%3D341" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Yang, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loncarek, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khodjakov, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieder, C. L.</span><span> </span><span class="NLM_article-title">Extra centrosomes and/or chromosomes prolong mitosis in human cells</span> <span class="citation_source-journal">Nature Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">748</span><span class="NLM_x">–</span> <span class="NLM_lpage">751</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fncb1738" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=18469805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmsFyktr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2008&pages=748-751&author=Z.+Yangauthor=J.+Loncarekauthor=A.+Khodjakovauthor=C.+L.+Rieder&title=Extra+centrosomes+and%2For+chromosomes+prolong+mitosis+in+human+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Extra centrosomes and/or chromosomes prolong mitosis in human cells</span></div><div class="casAuthors">Yang, Zhenye; Loncarek, Jadranka; Khodjakov, Alexey; Rieder, Conly L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Cell Biology</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">748-751</span>CODEN:
                <span class="NLM_cas:coden">NCBIFN</span>;
        ISSN:<span class="NLM_cas:issn">1465-7392</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Using laser microsurgery and cell fusion we have explored how addnl. centrosomes and/or chromosomes influence the duration of mitosis in human cells.  We found that doubling the chromosome no. added approx. 10 min to a 20 min division, whereas doubling the no. of centrosomes added approx. 30 min more.  Extra centrosomes and/or chromosomes prolong mitosis by delaying satisfaction of the spindle assembly checkpoint.  Thus mitosis can be prolonged by non-genetic means and extra chromosomes and centrosomes probably contribute to the elevated mitotic index seen in many tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCq5DOSqG7krVg90H21EOLACvtfcHk0ljjzlvICeC1og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmsFyktr4%253D&md5=7a8d5bb021025a3b3d0ab95b555f52c6</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fncb1738&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncb1738%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DZ.%26aulast%3DLoncarek%26aufirst%3DJ.%26aulast%3DKhodjakov%26aufirst%3DA.%26aulast%3DRieder%26aufirst%3DC.%2BL.%26atitle%3DExtra%2520centrosomes%2520and%252For%2520chromosomes%2520prolong%2520mitosis%2520in%2520human%2520cells%26jtitle%3DNature%2520Cell%2520Biol.%26date%3D2008%26volume%3D10%26spage%3D748%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Duesberg, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rausch, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rasnick, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hehlmann, R.</span><span> </span><span class="NLM_article-title">Genetic instability of cancer cells is proportional to their degree of aneuploidy</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">95</span><span class="NLM_x">, </span> <span class="NLM_fpage">13692</span><span class="NLM_x">–</span> <span class="NLM_lpage">13695</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=1998&pages=13692-13695&author=P.+Duesbergauthor=C.+Rauschauthor=D.+Rasnickauthor=R.+Hehlmann&title=Genetic+instability+of+cancer+cells+is+proportional+to+their+degree+of+aneuploidy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDuesberg%26aufirst%3DP.%26aulast%3DRausch%26aufirst%3DC.%26aulast%3DRasnick%26aufirst%3DD.%26aulast%3DHehlmann%26aufirst%3DR.%26atitle%3DGenetic%2520instability%2520of%2520cancer%2520cells%2520is%2520proportional%2520to%2520their%2520degree%2520of%2520aneuploidy%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1998%26volume%3D95%26spage%3D13692%26epage%3D13695" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kops, G. J. P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Foltz, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span> </span><span class="NLM_article-title">Lethality to human cancer cells through massive chromosome loss by inhibition of the mitotic checkpoint</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">8699</span><span class="NLM_x">–</span> <span class="NLM_lpage">8704</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=8699-8704&author=G.+J.+P.+L.+Kopsauthor=D.+R.+Foltzauthor=D.+W.+Cleveland&title=Lethality+to+human+cancer+cells+through+massive+chromosome+loss+by+inhibition+of+the+mitotic+checkpoint"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKops%26aufirst%3DG.%2BJ.%2BP.%2BL.%26aulast%3DFoltz%26aufirst%3DD.%2BR.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26atitle%3DLethality%2520to%2520human%2520cancer%2520cells%2520through%2520massive%2520chromosome%2520loss%2520by%2520inhibition%2520of%2520the%2520mitotic%2520checkpoint%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D8699%26epage%3D8704" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Abrieu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnaghi-Jaulin, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kahana, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peter, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castro, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vigneron, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lorca, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cleveland, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labbe, J. C.</span><span> </span><span class="NLM_article-title">Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x">, </span> <span class="NLM_fpage">83</span><span class="NLM_x">–</span> <span class="NLM_lpage">93</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2001&pages=83-93&author=A.+Abrieuauthor=L.+Magnaghi-Jaulinauthor=J.+A.+Kahanaauthor=M.+Peterauthor=A.+Castroauthor=S.+Vigneronauthor=T.+Lorcaauthor=D.+W.+Clevelandauthor=J.+C.+Labbe&title=Mps1+is+a+kinetochore-associated+kinase+essential+for+the+vertebrate+mitotic+checkpoint"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbrieu%26aufirst%3DA.%26aulast%3DMagnaghi-Jaulin%26aufirst%3DL.%26aulast%3DKahana%26aufirst%3DJ.%2BA.%26aulast%3DPeter%26aufirst%3DM.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DVigneron%26aufirst%3DS.%26aulast%3DLorca%26aufirst%3DT.%26aulast%3DCleveland%26aufirst%3DD.%2BW.%26aulast%3DLabbe%26aufirst%3DJ.%2BC.%26atitle%3DMps1%2520is%2520a%2520kinetochore-associated%2520kinase%2520essential%2520for%2520the%2520vertebrate%2520mitotic%2520checkpoint%26jtitle%3DCell%26date%3D2001%26volume%3D106%26spage%3D83%26epage%3D93" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winey, M.</span><span> </span><span class="NLM_article-title">The Mps1 family of protein kinases</span> <span class="citation_source-journal">Annu. Rev. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">81</span><span class="NLM_x">, </span> <span class="NLM_fpage">561</span><span class="NLM_x">–</span> <span class="NLM_lpage">585</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1146%2Fannurev-biochem-061611-090435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=22482908" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVGls7fE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=561-585&author=X.+Liuauthor=M.+Winey&title=The+Mps1+family+of+protein+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The MPS1 family of protein kinases</span></div><div class="casAuthors">Liu, Xuedong; Winey, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Annual Review of Biochemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">561-585</span>CODEN:
                <span class="NLM_cas:coden">ARBOAW</span>;
        ISSN:<span class="NLM_cas:issn">0066-4154</span>.
    
            (<span class="NLM_cas:orgname">Annual Reviews Inc.</span>)
        </div><div class="casAbstract">A review.  MPS1 protein kinases are found widely, but not ubiquitously, in eukaryotes.  This family of potentially dual-specific protein kinases is among several that regulate a no. of steps of mitosis.  The most widely conserved MPS1 kinase functions involve activities at the kinetochore in both the chromosome attachment and the spindle checkpoint.  MPS1 kinases also function at centrosomes.  Beyond mitosis, MPS1 kinases have been implicated in development, cytokinesis, and several different signaling pathways.  Family members are identified by virtue of a conserved C-terminal kinase domain, though the N-terminal domain is quite divergent.  The kinase domain of the human enzyme has been crystd., revealing an unusual ATP-binding pocket.  The activity, level, and subcellular localization of Mps1 family members are tightly regulated during cell-cycle progression.  The mitotic functions of Mps1 kinases and their overexpression in some tumors have prompted the identification of Mps1 inhibitors and their active development as anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGraBW1z_I4wXbVg90H21EOLACvtfcHk0ljjzlvICeC1og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVGls7fE&md5=18dd99863b2bfac327a6b351ebd51bd3</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1146%2Fannurev-biochem-061611-090435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev-biochem-061611-090435%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DWiney%26aufirst%3DM.%26atitle%3DThe%2520Mps1%2520family%2520of%2520protein%2520kinases%26jtitle%3DAnnu.%2520Rev.%2520Biochem.%26date%3D2012%26volume%3D81%26spage%3D561%26epage%3D585" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Mills, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmandt, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amendola, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hill, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobs, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodricks, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Campbell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hogg, D.</span><span> </span><span class="NLM_article-title">Expression of TTK, a novel human protein kinase, is associated with cell proliferation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x">, </span> <span class="NLM_fpage">16000</span><span class="NLM_x">–</span> <span class="NLM_lpage">16006</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=16000-16006&author=G.+B.+Millsauthor=R.+Schmandtauthor=M.+McGillauthor=A.+Amendolaauthor=M.+Hillauthor=K.+Jacobsauthor=C.+Mayauthor=A.+M.+Rodricksauthor=S.+Campbellauthor=D.+Hogg&title=Expression+of+TTK%2C+a+novel+human+protein+kinase%2C+is+associated+with+cell+proliferation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMills%26aufirst%3DG.%2BB.%26aulast%3DSchmandt%26aufirst%3DR.%26aulast%3DMcGill%26aufirst%3DM.%26aulast%3DAmendola%26aufirst%3DA.%26aulast%3DHill%26aufirst%3DM.%26aulast%3DJacobs%26aufirst%3DK.%26aulast%3DMay%26aufirst%3DC.%26aulast%3DRodricks%26aufirst%3DA.%2BM.%26aulast%3DCampbell%26aufirst%3DS.%26aulast%3DHogg%26aufirst%3DD.%26atitle%3DExpression%2520of%2520TTK%252C%2520a%2520novel%2520human%2520protein%2520kinase%252C%2520is%2520associated%2520with%2520cell%2520proliferation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26spage%3D16000%26epage%3D16006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Yuan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bae, Y. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoon, D.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wersto, R. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tully, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielson, E.</span><span> </span><span class="NLM_article-title">Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">405</span><span class="NLM_x">–</span> <span class="NLM_lpage">410</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1158%2F1078-0432.CCR-05-0903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=16428479" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=405-410&author=B.+Yuanauthor=Y.+Xuauthor=J.-H.+Wooauthor=Y.+Wangauthor=Y.+K.+Baeauthor=D.-S.+Yoonauthor=R.+P.+Werstoauthor=E.+Tullyauthor=K.+Wilsbachauthor=E.+Gabrielson&title=Increased+expression+of+mitotic+checkpoint+genes+in+breast+cancer+cells+with+chromosomal+instability"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Increased Expression of Mitotic Checkpoint Genes in Breast Cancer Cells with Chromosomal Instability</span></div><div class="casAuthors">Yuan, Bibo; Xu, Yi; Woo, Ju-Hyung; Wang, Yunyue; Bae, Young Kyung; Yoon, Dae-Sung; Wersto, Robert P.; Tully, Ellen; Wilsbach, Kathleen; Gabrielson, Edward</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">405-410</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Most breast cancers have chromosomal instability that seems related to defective mitotic spindle checkpoints.  Because the mol. basis of this defect is unknown, we evaluated breast cancer cell lines and tissues for possible defects involving the major mitotic checkpoint genes responsible for maintaining chromosomal stability.  Exptl. Design: We analyzed sequences and expression levels (RNA and protein) of eight major spindle checkpoint genes (MAD1L1, MAD2L1, MAD2L2, BUB1, BUB1B, BUB3, CDC20, and TTK) in a panel of 12 breast cancer cell lines, most with established genetic instability and defective spindle damage checkpoint response.  MRNA levels of these genes were also measured in primary tumor samples, and immunohistochem. staining was used to evaluate BUB1B protein levels in a panel of 270 addnl. cases of breast cancer.  Results: No functionally significant sequence variations were found for any of the eight genes in the breast cancer cell lines with chromosomal instability.  More surprisingly, the mRNA and protein levels for these checkpoint genes are significantly higher in the genetically unstable breast cancer cell lines and in high-grade primary breast cancer tissues than in the stable (and checkpoint proficient) MCF-10A and normal mammary epithelial cells, or in normal breast tissues.  In fact, overexpression of the BUB1B protein is a marker that recognizes nearly 80% of breast cancers in paraffin-embedded tissues.  Conclusions: Defective mitotic spindle checkpoints in breast cancer are most likely not caused by low expression or mutations of these eight checkpoint genes.  High levels of these particular transcripts could represent a cellular compensation for defects in other mol. components of the mitotic spindle damage checkpoint, and increased expression of these genes might be markers of breast cancers with chromosomal instability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcNtMRC1xcrVg90H21EOLACvtfcHk0ljKo5X3s6WrDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtlKjtw%253D%253D&md5=06a8afcd6636218ae3a7bf38fe9939b4</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0903%26sid%3Dliteratum%253Aachs%26aulast%3DYuan%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DWoo%26aufirst%3DJ.-H.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DBae%26aufirst%3DY.%2BK.%26aulast%3DYoon%26aufirst%3DD.-S.%26aulast%3DWersto%26aufirst%3DR.%2BP.%26aulast%3DTully%26aufirst%3DE.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DIncreased%2520expression%2520of%2520mitotic%2520checkpoint%2520genes%2520in%2520breast%2520cancer%2520cells%2520with%2520chromosomal%2520instability%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2006%26volume%3D12%26spage%3D405%26epage%3D410" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Daniel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Coulter, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilsbach, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gabrielson, E.</span><span> </span><span class="NLM_article-title">High levels of the Mps1 checkpoint protein are protective of aneuploidy in breast cancer cells</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">108</span><span class="NLM_x">, </span> <span class="NLM_fpage">5384</span><span class="NLM_x">–</span> <span class="NLM_lpage">5389</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=108&publication_year=2011&pages=5384-5389&author=J.+Danielauthor=J.+Coulterauthor=J.+H.+Wooauthor=K.+Wilsbachauthor=E.+Gabrielson&title=High+levels+of+the+Mps1+checkpoint+protein+are+protective+of+aneuploidy+in+breast+cancer+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaniel%26aufirst%3DJ.%26aulast%3DCoulter%26aufirst%3DJ.%26aulast%3DWoo%26aufirst%3DJ.%2BH.%26aulast%3DWilsbach%26aufirst%3DK.%26aulast%3DGabrielson%26aufirst%3DE.%26atitle%3DHigh%2520levels%2520of%2520the%2520Mps1%2520checkpoint%2520protein%2520are%2520protective%2520of%2520aneuploidy%2520in%2520breast%2520cancer%2520cells%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2011%26volume%3D108%26spage%3D5384%26epage%3D5389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Kilpinen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ojala, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kallioniemi, O.</span><span> </span><span class="NLM_article-title">Analysis of kinase gene expression patterns across 5681 human tissue samples reveals functional genomic taxonomy of the kinome</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">e15068</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2010&pages=e15068&author=S.+Kilpinenauthor=K.+Ojalaauthor=O.+Kallioniemi&title=Analysis+of+kinase+gene+expression+patterns+across+5681+human+tissue+samples+reveals+functional+genomic+taxonomy+of+the+kinome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKilpinen%26aufirst%3DS.%26aulast%3DOjala%26aufirst%3DK.%26aulast%3DKallioniemi%26aufirst%3DO.%26atitle%3DAnalysis%2520of%2520kinase%2520gene%2520expression%2520patterns%2520across%25205681%2520human%2520tissue%2520samples%2520reveals%2520functional%2520genomic%2520taxonomy%2520of%2520the%2520kinome%26jtitle%3DPLoS%2520One%26date%3D2010%26volume%3D5%26spage%3De15068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Landi, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dracheva, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rotunno, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Figueroa, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dasgupta, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mann, F. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukuoka, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hames, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergen, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesatori, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Consonni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertazzi, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wacholder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shih, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caporaso, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jen, J.</span><span> </span><span class="NLM_article-title">Gene expression signature of cigarette smoking and its role in lung adenocarcinoma development and survival</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">e1651</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2008&pages=e1651&author=M.+T.+Landiauthor=T.+Drachevaauthor=M.+Rotunnoauthor=J.+D.+Figueroaauthor=H.+Liuauthor=A.+Dasguptaauthor=F.+E.+Mannauthor=J.+Fukuokaauthor=M.+Hamesauthor=A.+W.+Bergenauthor=S.+E.+Murphyauthor=P.+Yangauthor=A.+C.+Pesatoriauthor=D.+Consonniauthor=P.+A.+Bertazziauthor=S.+Wacholderauthor=J.+H.+Shihauthor=N.+E.+Caporasoauthor=J.+Jen&title=Gene+expression+signature+of+cigarette+smoking+and+its+role+in+lung+adenocarcinoma+development+and+survival"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLandi%26aufirst%3DM.%2BT.%26aulast%3DDracheva%26aufirst%3DT.%26aulast%3DRotunno%26aufirst%3DM.%26aulast%3DFigueroa%26aufirst%3DJ.%2BD.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DDasgupta%26aufirst%3DA.%26aulast%3DMann%26aufirst%3DF.%2BE.%26aulast%3DFukuoka%26aufirst%3DJ.%26aulast%3DHames%26aufirst%3DM.%26aulast%3DBergen%26aufirst%3DA.%2BW.%26aulast%3DMurphy%26aufirst%3DS.%2BE.%26aulast%3DYang%26aufirst%3DP.%26aulast%3DPesatori%26aufirst%3DA.%2BC.%26aulast%3DConsonni%26aufirst%3DD.%26aulast%3DBertazzi%26aufirst%3DP.%2BA.%26aulast%3DWacholder%26aufirst%3DS.%26aulast%3DShih%26aufirst%3DJ.%2BH.%26aulast%3DCaporaso%26aufirst%3DN.%2BE.%26aulast%3DJen%26aufirst%3DJ.%26atitle%3DGene%2520expression%2520signature%2520of%2520cigarette%2520smoking%2520and%2520its%2520role%2520in%2520lung%2520adenocarcinoma%2520development%2520and%2520survival%26jtitle%3DPLoS%2520One%26date%3D2008%26volume%3D3%26spage%3De1651" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Fisk, H. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mattison, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winey, M.</span><span> </span><span class="NLM_article-title">Human Mps1 protein kinase is required for centrosome duplication and normal mitotic progression</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">14875</span><span class="NLM_x">–</span> <span class="NLM_lpage">14880</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=14875-14880&author=H.+A.+Fiskauthor=C.+P.+Mattisonauthor=M.+Winey&title=Human+Mps1+protein+kinase+is+required+for+centrosome+duplication+and+normal+mitotic+progression"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisk%26aufirst%3DH.%2BA.%26aulast%3DMattison%26aufirst%3DC.%2BP.%26aulast%3DWiney%26aufirst%3DM.%26atitle%3DHuman%2520Mps1%2520protein%2520kinase%2520is%2520required%2520for%2520centrosome%2520duplication%2520and%2520normal%2520mitotic%2520progression%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D14875%26epage%3D14880" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Carter, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eklund, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohane, I. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, L. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szallasi, Z.</span><span> </span><span class="NLM_article-title">A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers</span> <span class="citation_source-journal">Nature Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">1043</span><span class="NLM_x">–</span> <span class="NLM_lpage">1048</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fng1861" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=16921376" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD28XovVWjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2006&pages=1043-1048&author=S.+L.+Carterauthor=A.+C.+Eklundauthor=I.+S.+Kohaneauthor=L.+N.+Harrisauthor=Z.+Szallasi&title=A+signature+of+chromosomal+instability+inferred+from+gene+expression+profiles+predicts+clinical+outcome+in+multiple+human+cancers"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers</span></div><div class="casAuthors">Carter, Scott L.; Eklund, Aron C.; Kohane, Isaac S.; Harris, Lyndsay N.; Szallasi, Zoltan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Genetics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1043-1048</span>CODEN:
                <span class="NLM_cas:coden">NGENEC</span>;
        ISSN:<span class="NLM_cas:issn">1061-4036</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">We developed a computational method to characterize aneuploidy in tumor samples based on coordinated aberrations in expression of genes localized to each chromosomal region.  We summarized the total level of chromosomal aberration in a given tumor in a univariate measure termed total functional aneuploidy.  We identified a signature of chromosomal instability from specific genes whose expression was consistently correlated with total functional aneuploidy in several cancer types.  Net overexpression of this signature was predictive of poor clin. outcome in 12 cancer data sets representing six cancer types.  Also, the signature of chromosomal instability was higher in metastasis samples than in primary tumors and was able to stratify grade 1 and grade 2 breast tumors according to clin. outcome.  These results provide a means to assess the potential role of chromosomal instability in detg. malignant potential over a broad range of tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqaDdEb7DAh87Vg90H21EOLACvtfcHk0li_Miw4BY5JZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XovVWjtr0%253D&md5=8d236ca65fd69447f0ed3bf0ac28eba8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fng1861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fng1861%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DS.%2BL.%26aulast%3DEklund%26aufirst%3DA.%2BC.%26aulast%3DKohane%26aufirst%3DI.%2BS.%26aulast%3DHarris%26aufirst%3DL.%2BN.%26aulast%3DSzallasi%26aufirst%3DZ.%26atitle%3DA%2520signature%2520of%2520chromosomal%2520instability%2520inferred%2520from%2520gene%2520expression%2520profiles%2520predicts%2520clinical%2520outcome%2520in%2520multiple%2520human%2520cancers%26jtitle%3DNature%2520Genet.%26date%3D2006%26volume%3D38%26spage%3D1043%26epage%3D1048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Salvatore, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nappi, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salerno, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ugolini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miccoli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Basolo, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castellone, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirafici, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Melillo, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fusco, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bittner, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santoro, M.</span><span> </span><span class="NLM_article-title">A cell proliferation and chromosomal instability signature in anaplastic thyroid carcinoma</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">67</span><span class="NLM_x">, </span> <span class="NLM_fpage">10148</span><span class="NLM_x">–</span> <span class="NLM_lpage">10158</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=10148-10158&author=G.+Salvatoreauthor=T.+C.+Nappiauthor=P.+Salernoauthor=Y.+Jiangauthor=C.+Garbiauthor=C.+Ugoliniauthor=P.+Miccoliauthor=F.+Basoloauthor=M.+D.+Castelloneauthor=A.+M.+Ciraficiauthor=R.+M.+Melilloauthor=A.+Fuscoauthor=M.+L.+Bittnerauthor=M.+Santoro&title=A+cell+proliferation+and+chromosomal+instability+signature+in+anaplastic+thyroid+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSalvatore%26aufirst%3DG.%26aulast%3DNappi%26aufirst%3DT.%2BC.%26aulast%3DSalerno%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DGarbi%26aufirst%3DC.%26aulast%3DUgolini%26aufirst%3DC.%26aulast%3DMiccoli%26aufirst%3DP.%26aulast%3DBasolo%26aufirst%3DF.%26aulast%3DCastellone%26aufirst%3DM.%2BD.%26aulast%3DCirafici%26aufirst%3DA.%2BM.%26aulast%3DMelillo%26aufirst%3DR.%2BM.%26aulast%3DFusco%26aufirst%3DA.%26aulast%3DBittner%26aufirst%3DM.%2BL.%26aulast%3DSantoro%26aufirst%3DM.%26atitle%3DA%2520cell%2520proliferation%2520and%2520chromosomal%2520instability%2520signature%2520in%2520anaplastic%2520thyroid%2520carcinoma%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D10148%26epage%3D10158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Brough, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frankum, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sims, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mackay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendes-Pereira, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bajrami, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costa-Cabral, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rafiq, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmad, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cerone, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Natrajan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharpe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiu, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wetterskog, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dedes, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambros, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rawjee, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reis-Filho, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turner, N. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lord, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashworth, A.</span><span> </span><span class="NLM_article-title">Functional viability profiles of breast cancer</span> <span class="citation_source-journal">Cancer Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">260</span><span class="NLM_x">–</span> <span class="NLM_lpage">273</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2011&pages=260-273&author=R.+Broughauthor=J.+R.+Frankumauthor=D.+Simsauthor=A.+Mackayauthor=A.+M.+Mendes-Pereiraauthor=I.+Bajramiauthor=S.+Costa-Cabralauthor=R.+Rafiqauthor=A.+S.+Ahmadauthor=M.+A.+Ceroneauthor=R.+Natrajanauthor=R.+Sharpeauthor=K.+K.+Shiuauthor=D.+Wetterskogauthor=K.+J.+Dedesauthor=M.+B.+Lambrosauthor=T.+Rawjeeauthor=S.+Linardopoulosauthor=J.+S.+Reis-Filhoauthor=N.+C.+Turnerauthor=C.+J.+Lordauthor=A.+Ashworth&title=Functional+viability+profiles+of+breast+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrough%26aufirst%3DR.%26aulast%3DFrankum%26aufirst%3DJ.%2BR.%26aulast%3DSims%26aufirst%3DD.%26aulast%3DMackay%26aufirst%3DA.%26aulast%3DMendes-Pereira%26aufirst%3DA.%2BM.%26aulast%3DBajrami%26aufirst%3DI.%26aulast%3DCosta-Cabral%26aufirst%3DS.%26aulast%3DRafiq%26aufirst%3DR.%26aulast%3DAhmad%26aufirst%3DA.%2BS.%26aulast%3DCerone%26aufirst%3DM.%2BA.%26aulast%3DNatrajan%26aufirst%3DR.%26aulast%3DSharpe%26aufirst%3DR.%26aulast%3DShiu%26aufirst%3DK.%2BK.%26aulast%3DWetterskog%26aufirst%3DD.%26aulast%3DDedes%26aufirst%3DK.%2BJ.%26aulast%3DLambros%26aufirst%3DM.%2BB.%26aulast%3DRawjee%26aufirst%3DT.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3DReis-Filho%26aufirst%3DJ.%2BS.%26aulast%3DTurner%26aufirst%3DN.%2BC.%26aulast%3DLord%26aufirst%3DC.%2BJ.%26aulast%3DAshworth%26aufirst%3DA.%26atitle%3DFunctional%2520viability%2520profiles%2520of%2520breast%2520cancer%26jtitle%3DCancer%2520Discovery%26date%3D2011%26volume%3D1%26spage%3D260%26epage%3D273" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Gordon, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resio, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span> </span><span class="NLM_article-title">Causes and consequences of aneuploidy in cancer</span> <span class="citation_source-journal">Nature Rev. Genet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">189</span><span class="NLM_x">–</span> <span class="NLM_lpage">203</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fnrg3123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=22269907" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=189-203&author=D.+J.+Gordonauthor=B.+Resioauthor=D.+Pellman&title=Causes+and+consequences+of+aneuploidy+in+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Causes and consequences of aneuploidy in cancer</span></div><div class="casAuthors">Gordon, David J.; Resio, Benjamin; Pellman, David</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Genetics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">189-203</span>CODEN:
                <span class="NLM_cas:coden">NRGAAM</span>;
        ISSN:<span class="NLM_cas:issn">1471-0056</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Genetic instability, which includes both numerical and structural chromosomal abnormalities, is a hallmark of cancer.  Whereas the structural chromosome rearrangements have received substantial attention, the role of whole-chromosome aneuploidy in cancer is much less well-understood.  Here we review recent progress in understanding the roles of whole-chromosome aneuploidy in cancer, including the mechanistic causes of aneuploidy, the cellular responses to chromosome gains or losses and how cells might adapt to tolerate these usually detrimental alterations.  We also explore the role of aneuploidy in cellular transformation and discuss the possibility of developing aneuploidy-specific therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqz4uwB4F0Xu7Vg90H21EOLACvtfcHk0li_Miw4BY5JZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFSnu7k%253D&md5=9c730e7390d7aafd54301777e2270721</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1038%2Fnrg3123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrg3123%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DD.%2BJ.%26aulast%3DResio%26aufirst%3DB.%26aulast%3DPellman%26aufirst%3DD.%26atitle%3DCauses%2520and%2520consequences%2520of%2520aneuploidy%2520in%2520cancer%26jtitle%3DNature%2520Rev.%2520Genet.%26date%3D2012%26volume%3D13%26spage%3D189%26epage%3D203" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">de Sauvage, F.; Evangelista, M.</span><span> </span><span class="NLM_article-title">Hedgehog kinases and their use in modulating hedgehog signaling</span>. US Pat. Appl. US20070179091,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=F.+de+Sauvage&author=M.+Evangelista&title=Hedgehog+kinases+and+their+use+in+modulating+hedgehog+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BSauvage%26aufirst%3DF.%26atitle%3DHedgehog%2520kinases%2520and%2520their%2520use%2520in%2520modulating%2520hedgehog%2520signaling%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Nakamura, Y.; Daigo, Y.; Nakatsuru, S.</span><span> </span><span class="NLM_article-title">TTK as a tumor marker and therapeutic target for lung cancer</span>. PCT. Int. Appl. WO2008072777,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=Y.+Nakamura&author=Y.+Daigo&author=S.+Nakatsuru&title=TTK+as+a+tumor+marker+and+therapeutic+target+for+lung+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DTTK%2520as%2520a%2520tumor%2520marker%2520and%2520therapeutic%2520target%2520for%2520lung%2520cancer%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Leng, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, Y.</span><span> </span><span class="NLM_article-title">MPS1-dependent mitotic BLM phosphorylation is important for chromosome stability</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">11485</span><span class="NLM_x">–</span> <span class="NLM_lpage">11490</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=11485-11490&author=M.+Lengauthor=D.+W.+Chanauthor=H.+Luoauthor=C.+Zhuauthor=J.+Qinauthor=Y.+Wang&title=MPS1-dependent+mitotic+BLM+phosphorylation+is+important+for+chromosome+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeng%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DD.%2BW.%26aulast%3DLuo%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DC.%26aulast%3DQin%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DY.%26atitle%3DMPS1-dependent%2520mitotic%2520BLM%2520phosphorylation%2520is%2520important%2520for%2520chromosome%2520stability%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2006%26volume%3D103%26spage%3D11485%26epage%3D11490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Wei, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chou, Y. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ou, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yeh, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tyan, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shen, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shieh, S. Y.</span><span> </span><span class="NLM_article-title">TTK/Mps1 participates in the regulation of DNA damage checkpoint response by phosphorylating CHK2 on threonine 68</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">280</span><span class="NLM_x">, </span> <span class="NLM_fpage">7748</span><span class="NLM_x">–</span> <span class="NLM_lpage">7757</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=280&publication_year=2005&pages=7748-7757&author=J.+H.+Weiauthor=Y.+F.+Chouauthor=Y.+H.+Ouauthor=Y.+H.+Yehauthor=S.+W.+Tyanauthor=T.+P.+Sunauthor=C.+Y.+Shenauthor=S.+Y.+Shieh&title=TTK%2FMps1+participates+in+the+regulation+of+DNA+damage+checkpoint+response+by+phosphorylating+CHK2+on+threonine+68"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWei%26aufirst%3DJ.%2BH.%26aulast%3DChou%26aufirst%3DY.%2BF.%26aulast%3DOu%26aufirst%3DY.%2BH.%26aulast%3DYeh%26aufirst%3DY.%2BH.%26aulast%3DTyan%26aufirst%3DS.%2BW.%26aulast%3DSun%26aufirst%3DT.%2BP.%26aulast%3DShen%26aufirst%3DC.%2BY.%26aulast%3DShieh%26aufirst%3DS.%2BY.%26atitle%3DTTK%252FMps1%2520participates%2520in%2520the%2520regulation%2520of%2520DNA%2520damage%2520checkpoint%2520response%2520by%2520phosphorylating%2520CHK2%2520on%2520threonine%252068%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2005%26volume%3D280%26spage%3D7748%26epage%3D7757" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Nihira, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taira, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshida, K.</span><span> </span><span class="NLM_article-title">TTK/Mps1 controls nuclear targeting of c-Abl by 14-3-3-coupled phosphorylation in response to oxidative stress</span> <span class="citation_source-journal">Oncogene</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">7285</span><span class="NLM_x">–</span> <span class="NLM_lpage">7295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2008&pages=7285-7295&author=K.+Nihiraauthor=M.+Tairaauthor=Y.+Mikiauthor=K.+Yoshida&title=TTK%2FMps1+controls+nuclear+targeting+of+c-Abl+by+14-3-3-coupled+phosphorylation+in+response+to+oxidative+stress"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNihira%26aufirst%3DK.%26aulast%3DTaira%26aufirst%3DM.%26aulast%3DMiki%26aufirst%3DY.%26aulast%3DYoshida%26aufirst%3DK.%26atitle%3DTTK%252FMps1%2520controls%2520nuclear%2520targeting%2520of%2520c-Abl%2520by%252014-3-3-coupled%2520phosphorylation%2520in%2520response%2520to%2520oxidative%2520stress%26jtitle%3DOncogene%26date%3D2008%26volume%3D27%26spage%3D7285%26epage%3D7295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Mak, T. W.</span><span> </span><span class="NLM_article-title">Targeting the Cell Cycle in Cancer: TTK (MPS1) and PLK4 as Novel Mitotic Targets</span>, <span class="NLM_conf-name">AACR 103rd Annual Meeting</span>, <span class="NLM_conf-loc">Chicago, IL</span>, <span class="NLM_conf-date">April 1–5, 2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Mak%2C+T.+W.+Targeting+the+Cell+Cycle+in+Cancer%3A+TTK+%28MPS1%29+and+PLK4+as+Novel+Mitotic+Targets%2C+AACR+103rd+Annual+Meeting%2C+Chicago%2C+IL%2C+April+1%E2%80%935%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DMak%26aufirst%3DT.%2BW.%26atitle%3DTargeting%2520the%2520Cell%2520Cycle%2520in%2520Cancer%253A%2520TTK%2520%2528MPS1%2529%2520and%2520PLK4%2520as%2520Novel%2520Mitotic%2520Targets" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ng, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, D. C.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris-Brandts, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nadeem, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chirgadze, N. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">Discovery of inhibitors of the mitotic kinase TTK based on <i>N</i>-(3-(3-sulfamoylphenyl)-1<i>H</i>-indazol-5-yl)-acetamides and carboxamides</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4968</span><span class="NLM_x">–</span> <span class="NLM_lpage">4997</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=4968-4997&author=R.+Lauferauthor=G.+Ngauthor=Y.+Liuauthor=N.+K.+Patelauthor=L.+Edwardsauthor=Y.+Langauthor=S.-W.+Liauthor=M.+Feherauthor=D.+Awreyauthor=G.+Leungauthor=I.+Beletskayaauthor=O.+Plotnikovaauthor=J.+Masonauthor=R.+Hodgsonauthor=X.+Weiauthor=G.+Maoauthor=X.+Luoauthor=P.+Huangauthor=E.+Greenauthor=R.+Kiarashauthor=D.+C.-C.+Linauthor=M.+Harris-Brandtsauthor=V.+Nadeemauthor=T.+W.+Makauthor=J.+G.+Panauthor=W.+Quiauthor=N.+Y.+Chirgadzeauthor=H.+W.+Pauls&title=Discovery+of+inhibitors+of+the+mitotic+kinase+TTK+based+on+N-%283-%283-sulfamoylphenyl%29-1H-indazol-5-yl%29-acetamides+and+carboxamides"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DNg%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DPatel%26aufirst%3DN.%2BK.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DAwrey%26aufirst%3DD.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DMason%26aufirst%3DJ.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DP.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DLin%26aufirst%3DD.%2BC.-C.%26aulast%3DHarris-Brandts%26aufirst%3DM.%26aulast%3DNadeem%26aufirst%3DV.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DJ.%2BG.%26aulast%3DQui%26aufirst%3DW.%26aulast%3DChirgadze%26aufirst%3DN.%2BY.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DDiscovery%2520of%2520inhibitors%2520of%2520the%2520mitotic%2520kinase%2520TTK%2520based%2520on%2520N-%25283-%25283-sulfamoylphenyl%2529-1H-indazol-5-yl%2529-acetamides%2520and%2520carboxamides%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D4968%26epage%3D4997" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Hewitt, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santaguida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span> </span><span class="NLM_article-title">Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex</span> <span class="citation_source-journal">J. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">25</span><span class="NLM_x">–</span> <span class="NLM_lpage">34</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1083%2Fjcb.201002133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=20624899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVOht7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=25-34&author=L.+Hewittauthor=A.+Tigheauthor=S.+Santaguidaauthor=A.+M.+Whiteauthor=C.+D.+Jonesauthor=A.+Musacchioauthor=S.+Greenauthor=S.+S.+Taylor&title=Sustained+Mps1+activity+is+required+in+mitosis+to+recruit+O-Mad2+to+the+Mad1-C-Mad2+core+complex"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Sustained Mps1 activity is required in mitosis to recruit O-Mad2 to the Mad1-C-Mad2 core complex</span></div><div class="casAuthors">Hewitt, Laura; Tighe, Anthony; Santaguida, Stefano; White, Anne M.; Jones, Clifford D.; Musacchio, Andrea; Green, Stephen; Taylor, Stephen S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cell Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">190</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">25-34</span>CODEN:
                <span class="NLM_cas:coden">JCLBA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9525</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Mps1 is an essential component of the spindle assembly checkpoint.  In this study, we describe a novel Mps1 inhibitor, AZ3146, and use it to probe the role of Mps1's catalytic activity during mitosis.  When Mps1 is inhibited before mitotic entry, subsequent recruitment of Mad1 and Mad2 to kinetochores is abolished.  However, if Mps1 is inhibited after mitotic entry, the Mad1-C-Mad2 core complex remains kinetochore bound, but O-Mad2 is not recruited to the core.  Although inhibiting Mps1 also interferes with chromosome alignment, we see no obvious effect on aurora B activity.  In contrast, kinetochore recruitment of centromere protein E (CENP-E), a kinesin-related motor protein, is severely impaired.  Strikingly, inhibition of Mps1 significantly increases its own abundance at kinetochores.  Furthermore, we show that Mps1 can dimerize and transphosphorylate in cells.  We propose a model whereby Mps1 transphosphorylation results in its release from kinetochores, thus facilitating recruitment of O-Mad2 and CENP-E and thereby simultaneously promoting checkpoint signaling and chromosome congression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr40BfrYS2Vu7Vg90H21EOLACvtfcHk0lgwQ6r6AgHlzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVOht7Y%253D&md5=2b95cfba4b228bada877bdb6dc95be1f</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1083%2Fjcb.201002133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1083%252Fjcb.201002133%26sid%3Dliteratum%253Aachs%26aulast%3DHewitt%26aufirst%3DL.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DWhite%26aufirst%3DA.%2BM.%26aulast%3DJones%26aufirst%3DC.%2BD.%26aulast%3DMusacchio%26aufirst%3DA.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26atitle%3DSustained%2520Mps1%2520activity%2520is%2520required%2520in%2520mitosis%2520to%2520recruit%2520O-Mad2%2520to%2520the%2520Mad1-C-Mad2%2520core%2520complex%26jtitle%3DJ.%2520Cell.%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D25%26epage%3D34" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Santaguida, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tighe, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">D’Alise, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Musacchio, A.</span><span> </span><span class="NLM_article-title">Dissecting the role of MPS1 in chromosome biorientation and the spindle checkpoint through the small molecule inhibitor reversine</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">190</span><span class="NLM_x">, </span> <span class="NLM_fpage">73</span><span class="NLM_x">–</span> <span class="NLM_lpage">87</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=190&publication_year=2010&pages=73-87&author=S.+Santaguidaauthor=A.+Tigheauthor=A.+M.+D%E2%80%99Aliseauthor=S.+S.+Taylorauthor=A.+Musacchio&title=Dissecting+the+role+of+MPS1+in+chromosome+biorientation+and+the+spindle+checkpoint+through+the+small+molecule+inhibitor+reversine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSantaguida%26aufirst%3DS.%26aulast%3DTighe%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Alise%26aufirst%3DA.%2BM.%26aulast%3DTaylor%26aufirst%3DS.%2BS.%26aulast%3DMusacchio%26aufirst%3DA.%26atitle%3DDissecting%2520the%2520role%2520of%2520MPS1%2520in%2520chromosome%2520biorientation%2520and%2520the%2520spindle%2520checkpoint%2520through%2520the%2520small%2520molecule%2520inhibitor%2520reversine%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2010%26volume%3D190%26spage%3D73%26epage%3D87" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Kwiatkowski, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jelluma, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Filippakopoulos, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soundararajan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manak, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwon, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, H. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sim, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deveraux, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rottmann, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellman, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shah, J. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kops, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span> <span class="citation_source-journal">Nature Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">368</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fnchembio.345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=20383151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=359-368&author=N.+Kwiatkowskiauthor=N.+Jellumaauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=M.+S.+Manakauthor=M.+Kwonauthor=H.+G.+Choiauthor=T.+Simauthor=Q.+L.+Deverauxauthor=S.+Rottmannauthor=D.+Pellmanauthor=J.+V.+Shahauthor=G.+J.+Kopsauthor=S.+Knappauthor=N.+S.+Gray&title=Small-molecule+kinase+inhibitors+provide+insight+into+Mps1+cell+cycle+function"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule kinase inhibitors provide insight into Mps1 cell cycle function</span></div><div class="casAuthors">Kwiatkowski, Nicholas; Jelluma, Nannette; Filippakopoulos, Panagis; Soundararajan, Meera; Manak, Michael S.; Kwon, Mijung; Choi, Hwan Geun; Sim, Taebo; Deveraux, Quinn L.; Rottmann, Sabine; Pellman, David; Shah, Jagesh V.; Kops, Geert J. P. L.; Knapp, Stefan; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">359-368</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Mps1, a dual-specificity kinase, is required for the proper functioning of the spindle assembly checkpoint and for the maintenance of chromosomal stability.  As Mps1 function has been implicated in numerous phases of the cell cycle, the development of a potent, selective small-mol. inhibitor of Mps1 should facilitate dissection of Mps1-related biol.  We describe the cellular effects and Mps1 cocrystal structures of new, selective small-mol. inhibitors of Mps1.  Consistent with RNAi studies, chem. inhibition of Mps1 leads to defects in Mad1 and Mad2 establishment at unattached kinetochores, decreased Aurora B kinase activity, premature mitotic exit and gross aneuploidy, without any evidence of centrosome duplication defects.  However, in U2OS cells having extra centrosomes (an abnormality found in some cancers), Mps1 inhibition increases the frequency of multipolar mitoses.  Lastly, Mps1 inhibitor treatment resulted in a decrease in cancer cell viability.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUsnJhF04gwrVg90H21EOLACvtfcHk0lgwQ6r6AgHlzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFaktb0%253D&md5=965e5e5e4f85e21c5ec27b0ea9417914</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.345%26sid%3Dliteratum%253Aachs%26aulast%3DKwiatkowski%26aufirst%3DN.%26aulast%3DJelluma%26aufirst%3DN.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DManak%26aufirst%3DM.%2BS.%26aulast%3DKwon%26aufirst%3DM.%26aulast%3DChoi%26aufirst%3DH.%2BG.%26aulast%3DSim%26aufirst%3DT.%26aulast%3DDeveraux%26aufirst%3DQ.%2BL.%26aulast%3DRottmann%26aufirst%3DS.%26aulast%3DPellman%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DJ.%2BV.%26aulast%3DKops%26aufirst%3DG.%2BJ.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSmall-molecule%2520kinase%2520inhibitors%2520provide%2520insight%2520into%2520Mps1%2520cell%2520cycle%2520function%26jtitle%3DNature%2520Chem.%2520Biol.%26date%3D2010%26volume%3D6%26spage%3D359%26epage%3D368" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Caldarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Disingrini, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanci, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuvoloni, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Posteri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quartieri, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvagni, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colombo, R.</span><span> </span><span class="NLM_article-title">Synthesis and SAR of new pyrazolo[4,3-<i>h</i>]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4507</span><span class="NLM_x">–</span> <span class="NLM_lpage">4511</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2011&pages=4507-4511&author=M.+Caldarelliauthor=M.+Angioliniauthor=T.+Disingriniauthor=D.+Donatiauthor=M.+Guanciauthor=S.+Nuvoloniauthor=H.+Posteriauthor=F.+Quartieriauthor=M.+Silvagniauthor=R.+Colombo&title=Synthesis+and+SAR+of+new+pyrazolo%5B4%2C3-h%5Dquinazoline-3-carboxamide+derivatives+as+potent+and+selective+MPS1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DAngiolini%26aufirst%3DM.%26aulast%3DDisingrini%26aufirst%3DT.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGuanci%26aufirst%3DM.%26aulast%3DNuvoloni%26aufirst%3DS.%26aulast%3DPosteri%26aufirst%3DH.%26aulast%3DQuartieri%26aufirst%3DF.%26aulast%3DSilvagni%26aufirst%3DM.%26aulast%3DColombo%26aufirst%3DR.%26atitle%3DSynthesis%2520and%2520SAR%2520of%2520new%2520pyrazolo%255B4%252C3-h%255Dquinazoline-3-carboxamide%2520derivatives%2520as%2520potent%2520and%2520selective%2520MPS1%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2011%26volume%3D21%26spage%3D4507%26epage%3D4511" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Estrada, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker-Glenn, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beresford, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burdick, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chambers, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ding, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiPasquale, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dominguez, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dotson, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drummond, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flagella, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flynn, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fuji, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gill, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunzner-Toste, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heffron, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleinheinz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Pichon, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyssikatos, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medhurst, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moffat, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mukund, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nash, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scearce-Levie, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheng, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shore, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trivedi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sweeney, Z. K.</span><span> </span><span class="NLM_article-title">Discovery of highly potent, selective, and brain-penetrable leucine-rich repeat kinase 2 (LRRK2) small molecule inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">9416</span><span class="NLM_x">–</span> <span class="NLM_lpage">9433</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm301020q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9416-9433&author=A.+A.+Estradaauthor=X.+Liuauthor=C.+Baker-Glennauthor=A.+Beresfordauthor=D.+J.+Burdickauthor=M.+Chambersauthor=B.+K.+Chanauthor=H.+Chenauthor=X.+Dingauthor=A.+G.+DiPasqualeauthor=S.+L.+Dominguezauthor=J.+Dotsonauthor=J.+Drummondauthor=M.+Flagellaauthor=S.+Flynnauthor=R.+Fujiauthor=A.+Gillauthor=J.+Gunzner-Tosteauthor=S.+F.+Harrisauthor=T.+P.+Heffronauthor=T.+Kleinheinzauthor=D.+W.+Leeauthor=C.+E.+Le+Pichonauthor=J.+P.+Lyssikatosauthor=A.+D.+Medhurstauthor=J.+G.+Moffatauthor=S.+Mukundauthor=K.+Nashauthor=K.+Scearce-Levieauthor=Z.+Shengauthor=D.+G.+Shoreauthor=T.+Tranauthor=N.+Trivediauthor=S.+Wangauthor=S.+Zhangauthor=X.+Zhangauthor=G.+Zhaoauthor=H.+Zhuauthor=Z.+K.+Sweeney&title=Discovery+of+highly+potent%2C+selective%2C+and+brain-penetrable+leucine-rich+repeat+kinase+2+%28LRRK2%29+small+molecule+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm301020q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301020q%26sid%3Dliteratum%253Aachs%26aulast%3DEstrada%26aufirst%3DA.%2BA.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DBaker-Glenn%26aufirst%3DC.%26aulast%3DBeresford%26aufirst%3DA.%26aulast%3DBurdick%26aufirst%3DD.%2BJ.%26aulast%3DChambers%26aufirst%3DM.%26aulast%3DChan%26aufirst%3DB.%2BK.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDing%26aufirst%3DX.%26aulast%3DDiPasquale%26aufirst%3DA.%2BG.%26aulast%3DDominguez%26aufirst%3DS.%2BL.%26aulast%3DDotson%26aufirst%3DJ.%26aulast%3DDrummond%26aufirst%3DJ.%26aulast%3DFlagella%26aufirst%3DM.%26aulast%3DFlynn%26aufirst%3DS.%26aulast%3DFuji%26aufirst%3DR.%26aulast%3DGill%26aufirst%3DA.%26aulast%3DGunzner-Toste%26aufirst%3DJ.%26aulast%3DHarris%26aufirst%3DS.%2BF.%26aulast%3DHeffron%26aufirst%3DT.%2BP.%26aulast%3DKleinheinz%26aufirst%3DT.%26aulast%3DLee%26aufirst%3DD.%2BW.%26aulast%3DLe%2BPichon%26aufirst%3DC.%2BE.%26aulast%3DLyssikatos%26aufirst%3DJ.%2BP.%26aulast%3DMedhurst%26aufirst%3DA.%2BD.%26aulast%3DMoffat%26aufirst%3DJ.%2BG.%26aulast%3DMukund%26aufirst%3DS.%26aulast%3DNash%26aufirst%3DK.%26aulast%3DScearce-Levie%26aufirst%3DK.%26aulast%3DSheng%26aufirst%3DZ.%26aulast%3DShore%26aufirst%3DD.%2BG.%26aulast%3DTran%26aufirst%3DT.%26aulast%3DTrivedi%26aufirst%3DN.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DG.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DSweeney%26aufirst%3DZ.%2BK.%26atitle%3DDiscovery%2520of%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrable%2520leucine-rich%2520repeat%2520kinase%25202%2520%2528LRRK2%2529%2520small%2520molecule%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9416%26epage%3D9433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Kusakabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wada, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tagashira, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Endoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Diaminopyridine-based potent and selective Mps1 kinase inhibitors binding to an unusual flipped-peptide conformation</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">560</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml3000879" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=560-564&author=K.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=T.+Itohauthor=K.+Higashinoauthor=Y.+Okanoauthor=G.+Tadanoauthor=Y.+Tachibanaauthor=Y.+Satoauthor=M.+Inoueauthor=T.+Wadaauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=S.+Tagashiraauthor=Y.+Kidoauthor=S.+Sakamotoauthor=K.+Yasuoauthor=M.+Maedaauthor=T.+Yamamotoauthor=M.+Higakiauthor=T.+Endohauthor=K.+Uedaauthor=T.+Shiotaauthor=H.+Muraiauthor=Y.+Nakamura&title=Diaminopyridine-based+potent+and+selective+Mps1+kinase+inhibitors+binding+to+an+unusual+flipped-peptide+conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fml3000879&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml3000879%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DTadano%26aufirst%3DG.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DWada%26aufirst%3DT.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DTagashira%26aufirst%3DS.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DEndoh%26aufirst%3DT.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DShiota%26aufirst%3DT.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DDiaminopyridine-based%2520potent%2520and%2520selective%2520Mps1%2520kinase%2520inhibitors%2520binding%2520to%2520an%2520unusual%2520flipped-peptide%2520conformation%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D560%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Naud, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faisal, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheldrake, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bavetsias, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Atrash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurden, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baker, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAndrew, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matijssen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burke, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Linardopoulos, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span> </span><span class="NLM_article-title">Structure-based design of orally bioavailable 1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine inhibitors of mitotic kinase monopolar spindle 1 (Mps1)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">10045</span><span class="NLM_x">–</span> <span class="NLM_lpage">10065</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm401395s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=10045-10065&author=S.+Naudauthor=I.+M.+Westwoodauthor=A.+Faisalauthor=P.+Sheldrakeauthor=V.+Bavetsiasauthor=B.+Atrashauthor=K.-M.+J.+Cheungauthor=M.+Liuauthor=A.+Hayesauthor=J.+Schmittauthor=A.+Woodauthor=V.+Choiauthor=K.+Boxallauthor=G.+Makauthor=M.+Gurdenauthor=M.+Valentiauthor=A.+de+Haven+Brandonauthor=A.+Henleyauthor=R.+Bakerauthor=C.+McAndrewauthor=B.+Matijssenauthor=R.+Burkeauthor=S.+Hoelderauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=S.+Linardopoulosauthor=R.+L.+van+Montfortauthor=J.+Blagg&title=Structure-based+design+of+orally+bioavailable+1H-pyrrolo%5B3%2C2-c%5Dpyridine+inhibitors+of+mitotic+kinase+monopolar+spindle+1+%28Mps1%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fjm401395s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm401395s%26sid%3Dliteratum%253Aachs%26aulast%3DNaud%26aufirst%3DS.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DFaisal%26aufirst%3DA.%26aulast%3DSheldrake%26aufirst%3DP.%26aulast%3DBavetsias%26aufirst%3DV.%26aulast%3DAtrash%26aufirst%3DB.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DSchmitt%26aufirst%3DJ.%26aulast%3DWood%26aufirst%3DA.%26aulast%3DChoi%26aufirst%3DV.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMak%26aufirst%3DG.%26aulast%3DGurden%26aufirst%3DM.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3DBaker%26aufirst%3DR.%26aulast%3DMcAndrew%26aufirst%3DC.%26aulast%3DMatijssen%26aufirst%3DB.%26aulast%3DBurke%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DLinardopoulos%26aufirst%3DS.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%26aulast%3DBlagg%26aufirst%3DJ.%26atitle%3DStructure-based%2520design%2520of%2520orally%2520bioavailable%25201H-pyrrolo%255B3%252C2-c%255Dpyridine%2520inhibitors%2520of%2520mitotic%2520kinase%2520monopolar%2520spindle%25201%2520%2528Mps1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D10045%26epage%3D10065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Kusakabe, K.-I.; Yoshida, H.; Nozu, K.; Hashizume, H.; Tadano, G.; Sato, J.; Tamura, Y.; Mitsuoka, Y.</span><span> </span><span class="NLM_article-title">Fused imidazole derivative having TTK inhibitory action</span>. PCT. Int. Appl. WO2011013729,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=K.-I.+Kusakabe&author=H.+Yoshida&author=K.+Nozu&author=H.+Hashizume&author=G.+Tadano&author=J.+Sato&author=Y.+Tamura&author=Y.+Mitsuoka&title=Fused+imidazole+derivative+having+TTK+inhibitory+action"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.-I.%26atitle%3DFused%2520imidazole%2520derivative%2520having%2520TTK%2520inhibitory%2520action%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Jemaà, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galluzzi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kepp, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senovilla, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boemer, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koppitz, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lienau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prechtl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schulze, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siemeister, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wengner, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mumberg, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ziegelbauer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrieu, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Castedo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vitale, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kroemer, G.</span><span> </span><span class="NLM_article-title">Characterization of novel MPS1 inhibitors with preclinical anticancer activity</span> <span class="citation_source-journal">Cell Death Differ.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">1532</span><span class="NLM_x">–</span> <span class="NLM_lpage">1545</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1038%2Fcdd.2013.105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=23933817" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsF2gurjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2013&pages=1532-1545&author=M.+Jema%C3%A0author=L.+Galluzziauthor=O.+Keppauthor=L.+Senovillaauthor=M.+Brandsauthor=U.+Boemerauthor=M.+Koppitzauthor=P.+Lienauauthor=S.+Prechtlauthor=V.+Schulzeauthor=G.+Siemeisterauthor=A.+M.+Wengnerauthor=D.+Mumbergauthor=K.+Ziegelbauerauthor=A.+Abrieuauthor=M.+Castedoauthor=I.+Vitaleauthor=G.+Kroemer&title=Characterization+of+novel+MPS1+inhibitors+with+preclinical+anticancer+activity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of novel MPS1 inhibitors with preclinical anticancer activity</span></div><div class="casAuthors">Jemaa, M.; Galluzzi, L.; Kepp, O.; Senovilla, L.; Brands, M.; Boemer, U.; Koppitz, M.; Lienau, P.; Prechtl, S.; Schulze, V.; Siemeister, G.; Wengner, A. M.; Mumberg, D.; Ziegelbauer, K.; Abrieu, A.; Castedo, M.; Vitale, I.; Kroemer, G.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Differentiation</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1532-1545</span>CODEN:
                <span class="NLM_cas:coden">CDDIEK</span>;
        ISSN:<span class="NLM_cas:issn">1350-9047</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Monopolar spindle 1 (MPS1), a mitotic kinase that is overexpressed in several human cancers, contributes to the alignment of chromosomes to the metaphase plate as well as to the execution of the spindle assembly checkpoint (SAC).  Here, we report the identification and functional characterization of three novel inhibitors of MPS1 of two independent structural classes, N-(4-{2-[(2-cyanophenyl)amino][1,2,4]triazolo[1,5-a]pyridin-6-yl}phenyl)-2-phenylacetamide (Mps-BAY1) (a triazolopyridine), N-cyclopropyl-4-{8-[(2-methylpropyl)amino]-6-(quinolin-5-yl)imidazo[1,2-a]pyrazin-3-yl}benzamide (Mps-BAY2a) and N-cyclopropyl-4-{8-(isobutylamino)imidazo[1,2-a]pyrazin-3-yl}benzamide (Mps-BAY2b) (two imidazopyrazines).  By selectively inactivating MPS1, these small inhibitors can arrest the proliferation of cancer cells, causing their polyploidization and/or their demise.  Cancer cells treated with Mps-BAY1 or Mps-BAY2a manifested multiple signs of mitotic perturbation including inefficient chromosomal congression during metaphase, unscheduled SAC inactivation and severe anaphase defects.  Videomicroscopic cell fate profiling of histone 2B-green fluorescent protein-expressing cells revealed the capacity of MPS1 inhibitors to subvert the correct timing of mitosis as they induce a premature anaphase entry in the context of misaligned metaphase plates.  Hence, in the presence of MPS1 inhibitors, cells either divided in a bipolar (but often asym.) manner or entered one or more rounds of abortive mitoses, generating gross aneuploidy and polyploidy, resp.  In both cases, cells ultimately succumbed to the mitotic catastrophe-induced activation of the mitochondrial pathway of apoptosis.  Of note, low doses of MPS1 inhibitors and paclitaxel (a microtubular poison) synergized at increasing the frequency of chromosome misalignments and missegregations in the context of SAC inactivation.  This resulted in massive polyploidization followed by the activation of mitotic catastrophe.  A synergistic interaction between paclitaxel and MPS1 inhibitors could also be demonstrated in vivo, as the combination of these agents efficiently reduced the growth of tumor xenografts and exerted superior antineoplastic effects compared with either compd. employed alone.  Altogether, these results suggest that MPS1 inhibitors may exert robust anticancer activity, either as standalone therapeutic interventions or combined with microtubule-targeting chems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrHoriIGxHO_rVg90H21EOLACvtfcHk0lh81RJXTQxZmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsF2gurjI&md5=867fb902b15b6df0f7049b069bd47a4c</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1038%2Fcdd.2013.105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcdd.2013.105%26sid%3Dliteratum%253Aachs%26aulast%3DJema%25C3%25A0%26aufirst%3DM.%26aulast%3DGalluzzi%26aufirst%3DL.%26aulast%3DKepp%26aufirst%3DO.%26aulast%3DSenovilla%26aufirst%3DL.%26aulast%3DBrands%26aufirst%3DM.%26aulast%3DBoemer%26aufirst%3DU.%26aulast%3DKoppitz%26aufirst%3DM.%26aulast%3DLienau%26aufirst%3DP.%26aulast%3DPrechtl%26aufirst%3DS.%26aulast%3DSchulze%26aufirst%3DV.%26aulast%3DSiemeister%26aufirst%3DG.%26aulast%3DWengner%26aufirst%3DA.%2BM.%26aulast%3DMumberg%26aufirst%3DD.%26aulast%3DZiegelbauer%26aufirst%3DK.%26aulast%3DAbrieu%26aufirst%3DA.%26aulast%3DCastedo%26aufirst%3DM.%26aulast%3DVitale%26aufirst%3DI.%26aulast%3DKroemer%26aufirst%3DG.%26atitle%3DCharacterization%2520of%2520novel%2520MPS1%2520inhibitors%2520with%2520preclinical%2520anticancer%2520activity%26jtitle%3DCell%2520Death%2520Differ.%26date%3D2013%26volume%3D20%26spage%3D1532%26epage%3D1545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Kusakabe, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ide, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Daigo, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tachibana, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Itoh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yamamoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hashizume, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higashino, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okano, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inoue, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Iguchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishioka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohi, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kido, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sakamoto, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuo, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maeda, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Higaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ueda, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yoshizawa, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakamura, Y.</span><span> </span><span class="NLM_article-title">Indazole-based potent and cell-active Mps1 kinase inhibitors: rational design from pan-kinase inhibitor anthrapyrazolone (SP600125)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">4343</span><span class="NLM_x">–</span> <span class="NLM_lpage">4356</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm4000215" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4343-4356&author=K.+Kusakabeauthor=N.+Ideauthor=Y.+Daigoauthor=Y.+Tachibanaauthor=T.+Itohauthor=T.+Yamamotoauthor=H.+Hashizumeauthor=Y.+Hatoauthor=K.+Higashinoauthor=Y.+Okanoauthor=Y.+Satoauthor=M.+Inoueauthor=M.+Iguchiauthor=T.+Kanazawaauthor=Y.+Ishiokaauthor=K.+Dohiauthor=Y.+Kidoauthor=S.+Sakamotoauthor=K.+Yasuoauthor=M.+Maedaauthor=M.+Higakiauthor=K.+Uedaauthor=H.+Yoshizawaauthor=Y.+Babaauthor=T.+Shiotaauthor=H.+Muraiauthor=Y.+Nakamura&title=Indazole-based+potent+and+cell-active+Mps1+kinase+inhibitors%3A+rational+design+from+pan-kinase+inhibitor+anthrapyrazolone+%28SP600125%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm4000215&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4000215%26sid%3Dliteratum%253Aachs%26aulast%3DKusakabe%26aufirst%3DK.%26aulast%3DIde%26aufirst%3DN.%26aulast%3DDaigo%26aufirst%3DY.%26aulast%3DTachibana%26aufirst%3DY.%26aulast%3DItoh%26aufirst%3DT.%26aulast%3DYamamoto%26aufirst%3DT.%26aulast%3DHashizume%26aufirst%3DH.%26aulast%3DHato%26aufirst%3DY.%26aulast%3DHigashino%26aufirst%3DK.%26aulast%3DOkano%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DM.%26aulast%3DIguchi%26aufirst%3DM.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DIshioka%26aufirst%3DY.%26aulast%3DDohi%26aufirst%3DK.%26aulast%3DKido%26aufirst%3DY.%26aulast%3DSakamoto%26aufirst%3DS.%26aulast%3DYasuo%26aufirst%3DK.%26aulast%3DMaeda%26aufirst%3DM.%26aulast%3DHigaki%26aufirst%3DM.%26aulast%3DUeda%26aufirst%3DK.%26aulast%3DYoshizawa%26aufirst%3DH.%26aulast%3DBaba%26aufirst%3DY.%26aulast%3DShiota%26aufirst%3DT.%26aulast%3DMurai%26aufirst%3DH.%26aulast%3DNakamura%26aufirst%3DY.%26atitle%3DIndazole-based%2520potent%2520and%2520cell-active%2520Mps1%2520kinase%2520inhibitors%253A%2520rational%2520design%2520from%2520pan-kinase%2520inhibitor%2520anthrapyrazolone%2520%2528SP600125%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4343%26epage%3D4356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Billingsley, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">An improved system for the palladium-catalyzed borylation of aryl halides with pinacol borane</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">73</span><span class="NLM_x">, </span> <span class="NLM_fpage">5589</span><span class="NLM_x">–</span> <span class="NLM_lpage">5591</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo800727s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsl2rsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2008&pages=5589-5591&author=K.+L.+Billingsleyauthor=S.+L.+Buchwald&title=An+improved+system+for+the+palladium-catalyzed+borylation+of+aryl+halides+with+pinacol+borane"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">An Improved System for the Palladium-Catalyzed Borylation of Aryl Halides with Pinacol Borane</span></div><div class="casAuthors">Billingsley, Kelvin L.; Buchwald, Stephen L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">73</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5589-5591</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A highly efficient method for the Pd-catalyzed borylation of aryl halides with an inexpensive and atom-economical B source, pinacol borane, was developed.  This system allows for the conversion of aryl and heteroaryl iodides, bromides, and several chlorides, contg. a variety of functional groups, to the corresponding pinacol boronate esters.  In addn. to the increase in substrate scope, this is the 1st general method where relatively low quantities of catalyst and short reaction times can be employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqd64LaMU77TbVg90H21EOLACvtfcHk0lh81RJXTQxZmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsl2rsr8%253D&md5=5a8e7398437b3f1b72b682b1317a62d8</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo800727s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo800727s%26sid%3Dliteratum%253Aachs%26aulast%3DBillingsley%26aufirst%3DK.%2BL.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DAn%2520improved%2520system%2520for%2520the%2520palladium-catalyzed%2520borylation%2520of%2520aryl%2520halides%2520with%2520pinacol%2520borane%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2008%26volume%3D73%26spage%3D5589%26epage%3D5591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Ishiyama, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murata, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyaura, N.</span><span> </span><span class="NLM_article-title">Palladium(0)-catalyzed cross-coupling reaction of alkoxydiboron with haloarenes: a direct procedure for arylboronic esters</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7508</span><span class="NLM_x">–</span> <span class="NLM_lpage">7510</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00128a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=1995&pages=7508-7510&author=T.+Ishiyamaauthor=M.+Murataauthor=N.+Miyaura&title=Palladium%280%29-catalyzed+cross-coupling+reaction+of+alkoxydiboron+with+haloarenes%3A+a+direct+procedure+for+arylboronic+esters"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Palladium(0)-Catalyzed Cross-Coupling Reaction of Alkoxydiboron with Haloarenes: A Direct Procedure for Arylboronic Esters</span></div><div class="casAuthors">Ishiyama, Tatsuo; Murata, Miki; Miyaura, Norio</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">7508-10</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The palladium-catalyzed cross-coupling reaction of the pinacol ester of diboronic acid I with haloarenes gave a direct procedure for arylboronic esters II (Ar = aryl) from aryl halides in a range of 60-98%.  The reaction was catalyzed by PdCl2(dppf) (3 mol %) at 80° in the presence of KOAc (3 equiv) in DMSO and available with various functional groups such as nitrile, cyanide, ester, and carbonyl groups.  The trans-ArPd(II)(OAc)(PPh3)2 intermediate was isolated and characterized to propose the catalytic cycle involving the transmetalation between the phenylpalladium(II) acetate complex and I.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobehJBGFjDH7Vg90H21EOLACvtfcHk0liKyRzrP5W-_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXovFSku7g%253D&md5=2666902270ec1efc5742480b133f1255</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Fjo00128a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00128a024%26sid%3Dliteratum%253Aachs%26aulast%3DIshiyama%26aufirst%3DT.%26aulast%3DMurata%26aufirst%3DM.%26aulast%3DMiyaura%26aufirst%3DN.%26atitle%3DPalladium%25280%2529-catalyzed%2520cross-coupling%2520reaction%2520of%2520alkoxydiboron%2520with%2520haloarenes%253A%2520a%2520direct%2520procedure%2520for%2520arylboronic%2520esters%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1995%26volume%3D60%26spage%3D7508%26epage%3D7510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Jiang, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fu, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, Y.</span><span> </span><span class="NLM_article-title">CuBr/<i>rac</i>-BINOL-catalyzed <i>N</i>-arylations of aliphatic amines at room temperature</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">72</span><span class="NLM_x">, </span> <span class="NLM_fpage">672</span><span class="NLM_x">–</span> <span class="NLM_lpage">674</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo062060e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2007&pages=672-674&author=D.+Jiangauthor=H.+Fuauthor=Y.+Jiangauthor=Y.+Zhao&title=CuBr%2Frac-BINOL-catalyzed+N-arylations+of+aliphatic+amines+at+room+temperature"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjo062060e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo062060e%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DD.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DZhao%26aufirst%3DY.%26atitle%3DCuBr%252Frac-BINOL-catalyzed%2520N-arylations%2520of%2520aliphatic%2520amines%2520at%2520room%2520temperature%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2007%26volume%3D72%26spage%3D672%26epage%3D674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Sasse, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ligneau, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rouleau, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elz, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganellin, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arrang, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schunack, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stark, H.</span><span> </span><span class="NLM_article-title">Influence of bulky substituents on histamine H3 receptor agonist/antagonist properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4000</span><span class="NLM_x">–</span> <span class="NLM_lpage">4010</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm020910m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2002&pages=4000-4010&author=A.+Sasseauthor=X.+Ligneauauthor=A.+Rouleauauthor=S.+Elzauthor=C.+R.+Ganellinauthor=J.-M.+Arrangauthor=J.-C.+Schwartzauthor=W.+Schunackauthor=H.+Stark&title=Influence+of+bulky+substituents+on+histamine+H3+receptor+agonist%2Fantagonist+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjm020910m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm020910m%26sid%3Dliteratum%253Aachs%26aulast%3DSasse%26aufirst%3DA.%26aulast%3DLigneau%26aufirst%3DX.%26aulast%3DRouleau%26aufirst%3DA.%26aulast%3DElz%26aufirst%3DS.%26aulast%3DGanellin%26aufirst%3DC.%2BR.%26aulast%3DArrang%26aufirst%3DJ.-M.%26aulast%3DSchwartz%26aufirst%3DJ.-C.%26aulast%3DSchunack%26aufirst%3DW.%26aulast%3DStark%26aufirst%3DH.%26atitle%3DInfluence%2520of%2520bulky%2520substituents%2520on%2520histamine%2520H3%2520receptor%2520agonist%252Fantagonist%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2002%26volume%3D45%26spage%3D4000%26epage%3D4010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Gregg, B. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Golden, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quinn, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wekesa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tymoshenko, D. O.</span><span> </span><span class="NLM_article-title">Rapid, one-pot synthesis of α,α-disubstituted primary amines by the addition of Grignard reagents to nitriles under microwave heating conditions</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">3978</span><span class="NLM_x">–</span> <span class="NLM_lpage">3981</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2009&pages=3978-3981&author=B.+T.+Greggauthor=K.+C.+Goldenauthor=J.+F.+Quinnauthor=H.-J.+Wangauthor=W.+Zhangauthor=R.+Wangauthor=F.+Wekesaauthor=D.+O.+Tymoshenko&title=Rapid%2C+one-pot+synthesis+of+%CE%B1%2C%CE%B1-disubstituted+primary+amines+by+the+addition+of+Grignard+reagents+to+nitriles+under+microwave+heating+conditions"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGregg%26aufirst%3DB.%2BT.%26aulast%3DGolden%26aufirst%3DK.%2BC.%26aulast%3DQuinn%26aufirst%3DJ.%2BF.%26aulast%3DWang%26aufirst%3DH.-J.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DWekesa%26aufirst%3DF.%26aulast%3DTymoshenko%26aufirst%3DD.%2BO.%26atitle%3DRapid%252C%2520one-pot%2520synthesis%2520of%2520%25CE%25B1%252C%25CE%25B1-disubstituted%2520primary%2520amines%2520by%2520the%2520addition%2520of%2520Grignard%2520reagents%2520to%2520nitriles%2520under%2520microwave%2520heating%2520conditions%26jtitle%3DTetrahedron%2520Lett.%26date%3D2009%26volume%3D50%26spage%3D3978%26epage%3D3981" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cogan, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellman, J. A.</span><span> </span><span class="NLM_article-title">Catalytic asymmetric synthesis of <i>tert</i>-butanesulfinamide. Application to the asymmetric synthesis of amines</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x">, </span> <span class="NLM_fpage">9913</span><span class="NLM_x">–</span> <span class="NLM_lpage">9914</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja972012z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADyaK2sXms1Ohsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=9913-9914&author=G.+Liuauthor=D.+A.+Coganauthor=J.+A.+Ellman&title=Catalytic+asymmetric+synthesis+of+tert-butanesulfinamide.+Application+to+the+asymmetric+synthesis+of+amines"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Catalytic Asymmetric Synthesis of tert-Butanesulfinamide. Application to the Asymmetric Synthesis of Amines</span></div><div class="casAuthors">Liu, Guangcheng; Cogan, Derek A.; Ellman, Jonathan A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">119</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">9913-9914</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An efficient two-step synthesis of optically pure tert-butanesulfinamide (R)-Me3CSONH2 in 75% overall yield from the inexpensive starting material tert-Bu disulfide, is reported.  The key step is asym. catalytic oxidn. of tert-Bu disulfide to provide tert-Bu tert-butanethiosulfinate using a vanadium catalyst, H2O2 as the stoichiometric oxidant, and a chiral ligand prepd. by condensation of 3,5-di-tert-butylsalicylaldehyde and (S)-tert-leucinol.  This reaction has been performed reproducibility on a half mol scale at 1.5 M concn. in CHCl3 with 1% catalyst to provide a 96-98% yield of pure product in 91% ee, after bulb to bulb distn.  The utility of the tert-butanesulfinamide for the asym. synthesis of amines is also reported.  Direct condensation of tert-butanesulfinamide with aldehydes provides the tert-butanesulfinimines in high yields (91-96%).  Nucleophilic addns. proceed in high yield (>90%) for a range of Grignard reagents and sulfinimine substrates.  The reaction diastereoselectivities are also high (89:11 to 98:2).  Removal of the sulfinyl group to provide the scalemic amine hydrochlorides is accomplished by treatment of sulfinamides with HCl in methanol followed by ether pptn. (88-97% yields).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpddQoHlNQunbVg90H21EOLACvtfcHk0liKyRzrP5W-_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXms1Ohsb0%253D&md5=0fe725557ccff775043a351295c65b91</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1021%2Fja972012z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja972012z%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DCogan%26aufirst%3DD.%2BA.%26aulast%3DEllman%26aufirst%3DJ.%2BA.%26atitle%3DCatalytic%2520asymmetric%2520synthesis%2520of%2520tert-butanesulfinamide.%2520Application%2520to%2520the%2520asymmetric%2520synthesis%2520of%2520amines%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26spage%3D9913%26epage%3D9914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Almansa, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guijarro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yus, M.</span><span> </span><span class="NLM_article-title">Synthesis of highly enantiomerically enriched amines by the diastereoselective addition of triorganozincates to <i>N</i>-(<i>tert</i>-butanesulfinyl)imines</span> <span class="citation_source-journal">Tetrahedron: Asymmetry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">2484</span><span class="NLM_x">–</span> <span class="NLM_lpage">2491</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2008&pages=2484-2491&author=R.+Almansaauthor=D.+Guijarroauthor=M.+Yus&title=Synthesis+of+highly+enantiomerically+enriched+amines+by+the+diastereoselective+addition+of+triorganozincates+to+N-%28tert-butanesulfinyl%29imines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAlmansa%26aufirst%3DR.%26aulast%3DGuijarro%26aufirst%3DD.%26aulast%3DYus%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520highly%2520enantiomerically%2520enriched%2520amines%2520by%2520the%2520diastereoselective%2520addition%2520of%2520triorganozincates%2520to%2520N-%2528tert-butanesulfinyl%2529imines%26jtitle%3DTetrahedron%253A%2520Asymmetry%26date%3D2008%26volume%3D19%26spage%3D2484%26epage%3D2491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Jung, D.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, J.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Song, H.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.-G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, Y.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Choi, S.-K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, J.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, S.-J.</span><span> </span><span class="NLM_article-title">Synthesis of di-(<i>N</i>-tropinonyl)alkanes and di-(<i>N</i>-tropinonyl)benzenes</span> <span class="citation_source-journal">Bull. Korean Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">1932</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.5012%2Fbkcs.2004.25.12.1932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhsVChsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1932-1934&author=D.-I.+Jungauthor=J.-H.+Songauthor=Y.-H.+Kimauthor=D.-H.+Leeauthor=H.-A.+Songauthor=Y.-G.+Leeauthor=Y.-M.+Parkauthor=S.-K.+Choiauthor=J.-T.+Hahnauthor=S.-J.+Cho&title=Synthesis+of+di-%28N-tropinonyl%29alkanes+and+di-%28N-tropinonyl%29benzenes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of di-(N-tropinonyl)alkanes and di-(N-tropinonyl)benzenes</span></div><div class="casAuthors">Jung, Dai-Il; Song, Ju-Hyun; Kim, Yong-Hwan; Lee, Do-Hun; Song, Hyun-Ae; Lee, Yong-Gyun; Park, Yu-Mi; Choi, Soon-Kyu; Hahn, Jung-Tai; Cho, Seong-Jin</div><div class="citationInfo"><span class="NLM_cas:title">Bulletin of the Korean Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1932-1934</span>CODEN:
                <span class="NLM_cas:coden">BKCSDE</span>;
        ISSN:<span class="NLM_cas:issn">0253-2964</span>.
    
            (<span class="NLM_cas:orgname">Korean Chemical Society</span>)
        </div><div class="casAbstract">A no. of di-(N-tropinonyl)alkanes and -benzenes were prepd. in medium to good yields by reaction of α,ω-diaminoalkanes (1,2-diaminoethane, 1,3-diaminopropane, and 1,8-diaminooctane) as well as m- or p-phenylenediamine (o-phenylenediamine did not react) with 2,5-dimethoxytetrahydrofuran and acetonedicarboxylic acid.  The structures of the products were elucidated by IR, NMR, and MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVYkB6VektZLVg90H21EOLACvtfcHk0lgJ7M8Bi4Xu2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhsVChsL8%253D&md5=02727cc542622de2d0ea8e4a2f8ad7f0</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.5012%2Fbkcs.2004.25.12.1932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5012%252Fbkcs.2004.25.12.1932%26sid%3Dliteratum%253Aachs%26aulast%3DJung%26aufirst%3DD.-I.%26aulast%3DSong%26aufirst%3DJ.-H.%26aulast%3DKim%26aufirst%3DY.-H.%26aulast%3DLee%26aufirst%3DD.-H.%26aulast%3DSong%26aufirst%3DH.-A.%26aulast%3DLee%26aufirst%3DY.-G.%26aulast%3DPark%26aufirst%3DY.-M.%26aulast%3DChoi%26aufirst%3DS.-K.%26aulast%3DHahn%26aufirst%3DJ.-T.%26aulast%3DCho%26aufirst%3DS.-J.%26atitle%3DSynthesis%2520of%2520di-%2528N-tropinonyl%2529alkanes%2520and%2520di-%2528N-tropinonyl%2529benzenes%26jtitle%3DBull.%2520Korean%2520Chem.%2520Soc.%26date%3D2004%26volume%3D25%26spage%3D1932%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">Kumar, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoarau, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bursavich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slattum, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gerrish, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yager, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shenderovich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimbora, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradford, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeves, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patton, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papac, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span> </span><span class="NLM_article-title">Lead optimization of purine based orally bioavailable Mps1 (TTK) inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">4377</span><span class="NLM_x">–</span> <span class="NLM_lpage">4385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=4377-4385&author=D.+V.+Kumarauthor=C.+Hoarauauthor=M.+Bursavichauthor=P.+Slattumauthor=D.+Gerrishauthor=K.+Yagerauthor=M.+Saundersauthor=M.+Shenderovichauthor=B.+L.+Rothauthor=R.+McKinnonauthor=A.+Chanauthor=D.+M.+Cimboraauthor=C.+Bradfordauthor=L.+Reevesauthor=S.+Pattonauthor=D.+I.+Papacauthor=B.+L.+Williamsauthor=R.+O.+Carlson&title=Lead+optimization+of+purine+based+orally+bioavailable+Mps1+%28TTK%29+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DHoarau%26aufirst%3DC.%26aulast%3DBursavich%26aufirst%3DM.%26aulast%3DSlattum%26aufirst%3DP.%26aulast%3DGerrish%26aufirst%3DD.%26aulast%3DYager%26aufirst%3DK.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DShenderovich%26aufirst%3DM.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DChan%26aufirst%3DA.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DBradford%26aufirst%3DC.%26aulast%3DReeves%26aufirst%3DL.%26aulast%3DPatton%26aufirst%3DS.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26atitle%3DLead%2520optimization%2520of%2520purine%2520based%2520orally%2520bioavailable%2520Mps1%2520%2528TTK%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D4377%26epage%3D4385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Warren, G. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, C. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Capelli, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaLonde, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lambert, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nevins, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Semus, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senger, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tedesco, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wall, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woolven, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peishoff, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Head, M. S.</span><span> </span><span class="NLM_article-title">A critical assessment of docking programs and scoring functions</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">5912</span><span class="NLM_x">–</span> <span class="NLM_lpage">5931</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm050362n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD2MXnslOrtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=5912-5931&author=G.+L.+Warrenauthor=C.+W.+Andrewsauthor=A.-M.+Capelliauthor=B.+Clarkeauthor=J.+LaLondeauthor=M.+H.+Lambertauthor=M.+Lindvallauthor=N.+Nevinsauthor=S.+F.+Semusauthor=S.+Sengerauthor=G.+Tedescoauthor=I.+D.+Wallauthor=J.+M.+Woolvenauthor=C.+E.+Peishoffauthor=M.+S.+Head&title=A+critical+assessment+of+docking+programs+and+scoring+functions"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">A Critical Assessment of Docking Programs and Scoring Functions</span></div><div class="casAuthors">Warren, Gregory L.; Andrews, C. Webster; Capelli, Anna-Maria; Clarke, Brian; LaLonde, Judith; Lambert, Millard H.; Lindvall, Mika; Nevins, Neysa; Semus, Simon F.; Senger, Stefan; Tedesco, Giovanna; Wall, Ian D.; Woolven, James M.; Peishoff, Catherine E.; Head, Martha S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">5912-5931</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Docking is a computational technique that samples conformations of small mols. in protein binding sites; scoring functions are used to assess which of these conformations best complements the protein binding site.  An evaluation of 10 docking programs and 37 scoring functions was conducted against eight proteins of seven protein types for three tasks: binding mode prediction, virtual screening for lead identification, and rank-ordering by affinity for lead optimization.  All of the docking programs were able to generate ligand conformations similar to crystallog. detd. protein/ligand complex structures for at least one of the targets.  However, scoring functions were less successful at distinguishing the crystallog. conformation from the set of docked poses.  Docking programs identified active compds. from a pharmaceutically relevant pool of decoy compds.; however, no single program performed well for all of the targets.  For prediction of compd. affinity, none of the docking programs or scoring functions made a useful prediction of ligand binding affinity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfJn8_WHSjurVg90H21EOLACvtfcHk0lgJ7M8Bi4Xu2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXnslOrtrY%253D&md5=463ab40c3d23e67b62df408fc5e7f08d</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm050362n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050362n%26sid%3Dliteratum%253Aachs%26aulast%3DWarren%26aufirst%3DG.%2BL.%26aulast%3DAndrews%26aufirst%3DC.%2BW.%26aulast%3DCapelli%26aufirst%3DA.-M.%26aulast%3DClarke%26aufirst%3DB.%26aulast%3DLaLonde%26aufirst%3DJ.%26aulast%3DLambert%26aufirst%3DM.%2BH.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DNevins%26aufirst%3DN.%26aulast%3DSemus%26aufirst%3DS.%2BF.%26aulast%3DSenger%26aufirst%3DS.%26aulast%3DTedesco%26aufirst%3DG.%26aulast%3DWall%26aufirst%3DI.%2BD.%26aulast%3DWoolven%26aufirst%3DJ.%2BM.%26aulast%3DPeishoff%26aufirst%3DC.%2BE.%26aulast%3DHead%26aufirst%3DM.%2BS.%26atitle%3DA%2520critical%2520assessment%2520of%2520docking%2520programs%2520and%2520scoring%2520functions%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D5912%26epage%3D5931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Effect of input differences on the results of docking calculations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1704</span><span class="NLM_x">–</span> <span class="NLM_lpage">1714</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci9000629" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1704-1714&author=M.+Feherauthor=C.+I.+Williams&title=Effect+of+input+differences+on+the+results+of+docking+calculations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Input Differences on the Results of Docking Calculations</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1704-1714</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The sensitivity of docking calcns. to the geometry of the input ligand was studied.  It was found that even small changes in the ligand input conformation can lead to large differences in the geometries and scores of the resulting docked poses.  The accuracy of docked poses produced from different ligand input structures, the x-ray structure, the minimized Corina structure, and structures generated from conformational searches and mol. dynamics ensembles, were also assessed.  It was found that using the x-ray ligand conformation as docking input does not always produce the most accurate docked pose when compared with other sources of ligand input conformations.  Furthermore, no one method of conformer generation is guaranteed to always produce the most accurate docking pose.  The docking scores are also highly sensitive to the source of the input conformation, which might introduce some noise in compd. ranking and in binding affinity predictions.  It is concluded that for the purposes of reproducibility and optimal performance, the most prudent procedure is to use multiple input structures for docking.  The implications of these results on docking validation studies are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnfgWRxj66UbVg90H21EOLACvtfcHk0lhaqZNUY2746w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnt1Cmtro%253D&md5=fb35182895e0cc07cf4c4bb4de05e6d1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1021%2Fci9000629&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci9000629%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DEffect%2520of%2520input%2520differences%2520on%2520the%2520results%2520of%2520docking%2520calculations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2009%26volume%3D49%26spage%3D1704%26epage%3D1714" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Reducing docking score variations arising from input differences</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1549</span><span class="NLM_x">–</span> <span class="NLM_lpage">1560</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100204x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvVylsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=1549-1560&author=M.+Feherauthor=C.+I.+Williams&title=Reducing+docking+score+variations+arising+from+input+differences"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Reducing Docking Score Variations Arising from Input Differences</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1549-1560</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The variability of docking results as a function of variations in ligand input conformations was studied for the GOLD, Glide, FlexX, and Surflex programs.  It is concluded that there are two major effects leading to such variability: the adequacy of conformational search during docking and random "chaotic" effects arising from sensitivity to small input perturbations.  It is shown that although the former is generally the stronger effect, the latter is also highly significant for almost all docking engines.  The strong target-to-target variation of the magnitude of these effects is emphasized.  The performance of different packages is compared using these measures.  Guidelines are provided for different programs to reduce variability and improve reproducibility, which involve using a small no. of input conformations as starting points for docking, followed by the selection of the top scoring docked pose from the results as the best docked soln.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrrcPoOt5jOGbVg90H21EOLACvtfcHk0lhaqZNUY2746w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvVylsb4%253D&md5=dcbf21b1eaa7867a7c72acb23c244507</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fci100204x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100204x%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DReducing%2520docking%2520score%2520variations%2520arising%2520from%2520input%2520differences%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D1549%26epage%3D1560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, C. I.</span><span> </span><span class="NLM_article-title">Numerical errors and chaotic behavior in docking simulations</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">724</span><span class="NLM_x">–</span> <span class="NLM_lpage">738</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci200598m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC38XjtFWhsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2012&pages=724-738&author=M.+Feherauthor=C.+I.+Williams&title=Numerical+errors+and+chaotic+behavior+in+docking+simulations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Numerical Errors and Chaotic Behavior in Docking Simulations</span></div><div class="casAuthors">Feher, Miklos; Williams, Christopher I.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">724-738</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work examines the sensitivity of docking programs to tiny changes in ligand input files.  The results show that nearly identical ligand input structures can produce dramatically different top-scoring docked poses.  Even changing the atom order in a ligand input file can produce significantly different poses and scores.  In well-behaved cases the docking variations are small and follow a normal distribution around a central pose and score, but in many cases the variations are large and reflect wildly different top scores and binding modes.  The docking variations are characterized by statistical methods, and the sensitivity of high-throughput and more precise docking methods are compared.  The results demonstrate that part of docking variation is due to numerical sensitivity and potentially chaotic effects in current docking algorithms and not solely due to incomplete ligand conformation and pose searching.  These results have major implications for the way docking is currently used for pose prediction, ranking, and virtual screening.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6nddk3ttKx7Vg90H21EOLACvtfcHk0lhaqZNUY2746w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjtFWhsrw%253D&md5=7aa7ef2005ad88f2b145c1a2975621c9</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fci200598m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200598m%26sid%3Dliteratum%253Aachs%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DC.%2BI.%26atitle%3DNumerical%2520errors%2520and%2520chaotic%2520behavior%2520in%2520docking%2520simulations%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2012%26volume%3D52%26spage%3D724%26epage%3D738" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Colombo, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldarelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mennecozzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Giorgini, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cappella, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perrera, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Re Depaolini, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusconi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cucchi, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avanzi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bertrand, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bossi, R. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesenti, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galvani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Isacchi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colotta, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donati, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moll, J.</span><span> </span><span class="NLM_article-title">Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">10255</span><span class="NLM_x">–</span> <span class="NLM_lpage">10264</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1158%2F0008-5472.CAN-10-2101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=21159646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7bK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=10255-10264&author=R.+Colomboauthor=M.+Caldarelliauthor=M.+Mennecozziauthor=M.+L.+Giorginiauthor=F.+Solaauthor=P.+Cappellaauthor=C.+Perreraauthor=S.+Re+Depaoliniauthor=L.+Rusconiauthor=U.+Cucchiauthor=N.+Avanziauthor=J.+A.+Bertrandauthor=R.+T.+Bossiauthor=E.+Pesentiauthor=A.+Galvaniauthor=A.+Isacchiauthor=F.+Colottaauthor=D.+Donatiauthor=J.+Moll&title=Targeting+the+mitotic+checkpoint+for+cancer+therapy+with+NMS-P715%2C+an+inhibitor+of+MPS1+kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Mitotic Checkpoint for Cancer Therapy with NMS-P715, an Inhibitor of MPS1 Kinase</span></div><div class="casAuthors">Colombo, Riccardo; Caldarelli, Marina; Mennecozzi, Milena; Giorgini, Maria Laura; Sola, Francesco; Cappella, Paolo; Perrera, Claudia; Depaolini, Stefania Re; Rusconi, Luisa; Cucchi, Ulisse; Avanzi, Nilla; Bertrand, Jay Aaron; Bossi, Roberto Tiberio; Pesenti, Enrico; Galvani, Arturo; Isacchi, Antonella; Colotta, Francesco; Donati, Daniele; Moll, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">10255-10264</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">MPS1 kinase is a key regulator of the spindle assembly checkpoint (SAC), a mitotic mechanism specifically required for proper chromosomal alignment and segregation.  It has been found aberrantly overexpressed in a wide range of human tumors and is necessary for tumoral cell proliferation.  Here the authors report the identification and characterization of NMS-P715, a selective and orally bioavailable MPS1 small-mol. inhibitor, which selectively reduces cancer cell proliferation, leaving normal cells almost unaffected.  NMS-P715 accelerates mitosis and affects kinetochore components localization causing massive aneuploidy and cell death in a variety of tumoral cell lines and inhibits tumor growth in preclin. cancer models.  Inhibiting the SAC could represent a promising new approach to selectively target cancer cells.  Cancer Res; 70(24); 10255-64.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJeGyiQf0_uLVg90H21EOLACvtfcHk0liB_xEjKhfs4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFGrt7bK&md5=6478b34886d1d2f2a364d142bbd388fe</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-2101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-2101%26sid%3Dliteratum%253Aachs%26aulast%3DColombo%26aufirst%3DR.%26aulast%3DCaldarelli%26aufirst%3DM.%26aulast%3DMennecozzi%26aufirst%3DM.%26aulast%3DGiorgini%26aufirst%3DM.%2BL.%26aulast%3DSola%26aufirst%3DF.%26aulast%3DCappella%26aufirst%3DP.%26aulast%3DPerrera%26aufirst%3DC.%26aulast%3DRe%2BDepaolini%26aufirst%3DS.%26aulast%3DRusconi%26aufirst%3DL.%26aulast%3DCucchi%26aufirst%3DU.%26aulast%3DAvanzi%26aufirst%3DN.%26aulast%3DBertrand%26aufirst%3DJ.%2BA.%26aulast%3DBossi%26aufirst%3DR.%2BT.%26aulast%3DPesenti%26aufirst%3DE.%26aulast%3DGalvani%26aufirst%3DA.%26aulast%3DIsacchi%26aufirst%3DA.%26aulast%3DColotta%26aufirst%3DF.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DMoll%26aufirst%3DJ.%26atitle%3DTargeting%2520the%2520mitotic%2520checkpoint%2520for%2520cancer%2520therapy%2520with%2520NMS-P715%252C%2520an%2520inhibitor%2520of%2520MPS1%2520kinase%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D10255%26epage%3D10264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Tardif, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rogers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cassiano, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cimbora, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKinnon, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Douce, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dorweiler, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hess, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ostanin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Papac, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baichwal, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McAlexander, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Willardsen, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saunders, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christophe, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, D. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wettstein, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carlson, R. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, B. L.</span><span> </span><span class="NLM_article-title">Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase (Mps1)</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">2267</span><span class="NLM_x">–</span> <span class="NLM_lpage">2275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1158%2F1535-7163.MCT-11-0453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=21980130" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=2267-2275&author=K.+D.+Tardifauthor=A.+Rogersauthor=J.+Cassianoauthor=B.+L.+Rothauthor=D.+M.+Cimboraauthor=R.+McKinnonauthor=A.+Petersonauthor=T.+B.+Douceauthor=R.+Robinsonauthor=I.+Dorweilerauthor=T.+Davisauthor=M.+A.+Hessauthor=K.+Ostaninauthor=D.+I.+Papacauthor=V.+Baichwalauthor=I.+McAlexanderauthor=J.+A.+Willardsenauthor=M.+Saundersauthor=H.+Christopheauthor=D.+V.+Kumarauthor=D.+A.+Wettsteinauthor=R.+O.+Carlsonauthor=B.+L.+Williams&title=Characterization+of+the+cellular+and+antitumor+effects+of+MPI-0479605%2C+a+small-molecule+inhibitor+of+the+mitotic+kinase+%28Mps1%29"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the Cellular and Antitumor Effects of MPI-0479605, a Small-Molecule Inhibitor of the Mitotic Kinase Mps1</span></div><div class="casAuthors">Tardif, Keith D.; Rogers, Aaron; Cassiano, Jared; Roth, Bruce L.; Cimbora, Daniel M.; McKinnon, Rena; Peterson, Ashley; Douce, Thomas B.; Robinson, Rosann; Dorweiler, Irene; Davis, Thaylon; Hess, Mark A.; Ostanin, Kirill; Papac, Damon I.; Baichwal, Vijay; McAlexander, Ian; Willardsen, J. Adam; Saunders, Michael; Christophe, Hoarau; Kumar, D. Vijay; Wettstein, Daniel A.; Carlson, Robert O.; Williams, Brandi L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2267-2275</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mps1 is a dual specificity protein kinase that is essential for the bipolar attachment of chromosomes to the mitotic spindle and for maintaining the spindle assembly checkpoint until all chromosomes are properly attached.  Mps1 is expressed at high levels during mitosis and is abundantly expressed in cancer cells.  Disruption of Mps1 function induces aneuploidy and cell death.  We report the identification of MPI-0479605, a potent and selective ATP competitive inhibitor of Mps1.  Cells treated with MPI-0479605 undergo aberrant mitosis, resulting in aneuploidy and formation of micronuclei.  In cells with wild-type p53, this promotes the induction of a postmitotic checkpoint characterized by the ATM- and RAD3-related-dependent activation of the p53-p21 pathway.  In both wild-type and p53 mutant cells lines, there is a growth arrest and inhibition of DNA synthesis.  Subsequently, cells undergo mitotic catastrophe and/or an apoptotic response.  In xenograft models, MPI-0479605 inhibits tumor growth, suggesting that drugs targeting Mps1 may have utility as novel cancer therapeutics.  Mol Cancer Ther; 10(12); 2267-75.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMIODujnZWCLVg90H21EOLACvtfcHk0liB_xEjKhfs4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsFylurnO&md5=e243764443e9dfda40fc84a329d776c2</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-11-0453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-11-0453%26sid%3Dliteratum%253Aachs%26aulast%3DTardif%26aufirst%3DK.%2BD.%26aulast%3DRogers%26aufirst%3DA.%26aulast%3DCassiano%26aufirst%3DJ.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DCimbora%26aufirst%3DD.%2BM.%26aulast%3DMcKinnon%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DA.%26aulast%3DDouce%26aufirst%3DT.%2BB.%26aulast%3DRobinson%26aufirst%3DR.%26aulast%3DDorweiler%26aufirst%3DI.%26aulast%3DDavis%26aufirst%3DT.%26aulast%3DHess%26aufirst%3DM.%2BA.%26aulast%3DOstanin%26aufirst%3DK.%26aulast%3DPapac%26aufirst%3DD.%2BI.%26aulast%3DBaichwal%26aufirst%3DV.%26aulast%3DMcAlexander%26aufirst%3DI.%26aulast%3DWillardsen%26aufirst%3DJ.%2BA.%26aulast%3DSaunders%26aufirst%3DM.%26aulast%3DChristophe%26aufirst%3DH.%26aulast%3DKumar%26aufirst%3DD.%2BV.%26aulast%3DWettstein%26aufirst%3DD.%2BA.%26aulast%3DCarlson%26aufirst%3DR.%2BO.%26aulast%3DWilliams%26aufirst%3DB.%2BL.%26atitle%3DCharacterization%2520of%2520the%2520cellular%2520and%2520antitumor%2520effects%2520of%2520MPI-0479605%252C%2520a%2520small-molecule%2520inhibitor%2520of%2520the%2520mitotic%2520kinase%2520%2528Mps1%2529%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D2267%26epage%3D2275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span>MOE (Molecular Operating Environment), <span class="NLM_edition">version 2012.10</span>; <span class="NLM_publisher-name">Chemical Computing Group Inc.</span>: <span class="NLM_publisher-loc">1010 Sherbrooke St. West, Suite 910, Montreal, Quebec, H3A 2R7, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=MOE+%28Molecular+Operating+Environment%29%2C+version+2012.10%3B+Chemical+Computing+Group+Inc.%3A+1010+Sherbrooke+St.+West%2C+Suite+910%2C+Montreal%2C+Quebec%2C+H3A+2R7%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DMOE%2520%2528Molecular%2520Operating%2520Environment%2529%26pub%3DChemical%2520Computing%2520Group%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span>Corina, <span class="NLM_edition">version 3.2</span>; <span class="NLM_publisher-name">Molecular Networks GmbH</span>: <span class="NLM_publisher-loc">Erlangen, Germany</span>,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Corina%2C+version+3.2%3B+Molecular+Networks+GmbH%3A+Erlangen%2C+Germany%2C+2006."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DCorina%26pub%3DMolecular%2520Networks%2520GmbH%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span>Schrödinger Suite 2012, <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Schr%C3%B6dinger+Suite+2012%2C+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DSchr%25C3%25B6dinger%2520Suite%25202012%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span>Glide, <span class="NLM_edition">version 5.6</span>; <span class="NLM_publisher-name">Schrödinger, LLC</span>: <span class="NLM_publisher-loc">New York</span>,<span class="NLM_x"> </span><span class="NLM_year">2010</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Glide%2C+version+5.6%3B+Schr%C3%B6dinger%2C+LLC%3A+New+York%2C+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%2520LLC%26date%3D2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Old, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Resing, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahn, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lei, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, X.</span><span> </span><span class="NLM_article-title">Structural and mechanistic insights into Mps1 kinase activation</span> <span class="citation_source-journal">J. Cell. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">1679</span><span class="NLM_x">–</span> <span class="NLM_lpage">1694</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1111%2Fj.1582-4934.2008.00605.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=19120698" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A280%3ADC%252BC3c7jt1KmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2009&pages=1679-1694&author=W.+Wangauthor=Y.+Yangauthor=Y.+Gaoauthor=Q.+Xuauthor=F.+Wangauthor=S.+Zhuauthor=W.+Oldauthor=K.+Resingauthor=M.+Ahnauthor=M.+Leiauthor=X.+Liu&title=Structural+and+mechanistic+insights+into+Mps1+kinase+activation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and mechanistic insights into Mps1 kinase activation</span></div><div class="casAuthors">Wang Wei; Yang Yuting; Gao Yuefeng; Xu Quanbin; Wang Feng; Zhu Songcheng; Old William; Resing Katheryn; Ahn Natalie; Lei Ming; Liu Xuedong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of cellular and molecular medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8B</span>),
    <span class="NLM_cas:pages">1679-94</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Mps1 is one of the several essential kinases whose activation is required for robust mitotic spindle checkpoint signalling.  The activity of Mps1 is tightly regulated and increases dramatically during mitosis or in response to spindle damage.  To understand the molecular mechanism underlying Mps1 regulation, we determined the crystal structure of the kinase domain of Mps1.  The 2.7-A-resolution crystal structure shows that the Mps1 kinase domain adopts a unique inactive conformation.  Intramolecular interactions between the key Glu residue in the C helix of the N-terminal lobe and the backbone amides in the catalytic loop lock the kinase in the inactive conformation.  Autophosphorylation appears to be a priming event for kinase activation.  We identified Mps1 autophosphorylation sites in the activation and the P+1 loops.  Whereas activation loop autophosphorylation enhances kinase activity, autophosphorylation at the P+1 loop (T686) is associated with the active kinase.  Mutation of T686 autophosphorylation site impairs both autophosphorylation and transphosphorylation.  Furthermore, we demonstrated that phosphorylation of T676 may be a priming event for phosphorylation at T686.  Finally, we identified two critical lysine residues in the loop between helices EF and F that are essential for substrate recruitment and maintaining high levels of kinase activity.  Our studies reveal critical biochemical mechanisms for Mps1 kinase regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ47lclfM-UTyCEBeYuoi7AfW6udTcc2eaiAXHsT678jbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3c7jt1KmsQ%253D%253D&md5=3122823a3c79099621c4836cc6e68c63</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1111%2Fj.1582-4934.2008.00605.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1582-4934.2008.00605.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DZhu%26aufirst%3DS.%26aulast%3DOld%26aufirst%3DW.%26aulast%3DResing%26aufirst%3DK.%26aulast%3DAhn%26aufirst%3DM.%26aulast%3DLei%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DX.%26atitle%3DStructural%2520and%2520mechanistic%2520insights%2520into%2520Mps1%2520kinase%2520activation%26jtitle%3DJ.%2520Cell.%2520Mol.%2520Med.%26date%3D2009%26volume%3D13%26spage%3D1679%26epage%3D1694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">Laufer, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forrest, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sampson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Awrey, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plotnikova, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hodgson, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beletskaya, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mason, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ban, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiarash, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, T. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pauls, H. W.</span><span> </span><span class="NLM_article-title">The Discovery of PLK4 Inhibitors: (<i>E</i>)-3-((1<i>H</i>-indazol-6-yl)methylene)indolin-2-ones as novel anti-proliferative agents</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">56</span><span class="NLM_x">, </span> <span class="NLM_fpage">6069</span><span class="NLM_x">–</span> <span class="NLM_lpage">6087</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400380m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=6069-6087&author=R.+Lauferauthor=B.+Forrestauthor=S.-W.+Liauthor=Y.+Liuauthor=P.+Sampsonauthor=L.+Edwardsauthor=Y.+Langauthor=D.+E.+Awreyauthor=G.+Maoauthor=O.+Plotnikovaauthor=G.+Leungauthor=R.+Hodgsonauthor=I.+Beletskayaauthor=J.+M.+Masonauthor=X.+Luoauthor=X.+Weiauthor=Y.+Yaoauthor=M.+Feherauthor=F.+Banauthor=R.+Kiarashauthor=E.+Greenauthor=T.+W.+Makauthor=G.+Panauthor=H.+W.+Pauls&title=The+Discovery+of+PLK4+Inhibitors%3A+%28E%29-3-%28%281H-indazol-6-yl%29methylene%29indolin-2-ones+as+novel+anti-proliferative+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm400380m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400380m%26sid%3Dliteratum%253Aachs%26aulast%3DLaufer%26aufirst%3DR.%26aulast%3DForrest%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DS.-W.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSampson%26aufirst%3DP.%26aulast%3DEdwards%26aufirst%3DL.%26aulast%3DLang%26aufirst%3DY.%26aulast%3DAwrey%26aufirst%3DD.%2BE.%26aulast%3DMao%26aufirst%3DG.%26aulast%3DPlotnikova%26aufirst%3DO.%26aulast%3DLeung%26aufirst%3DG.%26aulast%3DHodgson%26aufirst%3DR.%26aulast%3DBeletskaya%26aufirst%3DI.%26aulast%3DMason%26aufirst%3DJ.%2BM.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DYao%26aufirst%3DY.%26aulast%3DFeher%26aufirst%3DM.%26aulast%3DBan%26aufirst%3DF.%26aulast%3DKiarash%26aufirst%3DR.%26aulast%3DGreen%26aufirst%3DE.%26aulast%3DMak%26aufirst%3DT.%2BW.%26aulast%3DPan%26aufirst%3DG.%26aulast%3DPauls%26aufirst%3DH.%2BW.%26atitle%3DThe%2520Discovery%2520of%2520PLK4%2520Inhibitors%253A%2520%2528E%2529-3-%2528%25281H-indazol-6-yl%2529methylene%2529indolin-2-ones%2520as%2520novel%2520anti-proliferative%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D6069%26epage%3D6087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Kabsch, W.</span><span> </span><span class="NLM_article-title">XDS</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">125</span><span class="NLM_x">–</span> <span class="NLM_lpage">132</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=XDS"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lgm8QlpiH0qbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXDS%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Adams, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunkoczi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x">, </span> <span class="NLM_fpage">213</span><span class="NLM_x">–</span> <span class="NLM_lpage">221</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm501740a&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm501740a&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm501740a&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&author=P.+Adamsauthor=P.+Afonineauthor=G.+Bunkocziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+a+comprehensive+Python-based+system+for+macromolecular+structure+solution"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lgm8QlpiH0qbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%26aulast%3DAfonine%26aufirst%3DP.%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520a%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D213%26epage%3D221" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">486</span><span class="NLM_x">–</span> <span class="NLM_lpage">501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2010&pages=486-501&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D46%26spage%3D486%26epage%3D501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span>Buster 2.10.0; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, United Kingdom</span>,<span class="NLM_x"> </span><span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=Buster+2.10.0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26jtitle%3DBuster%25202.10.0%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Usansky, J. I.; Desai, A.; Tang-Liu, D.</span>PK functions for Microsoft Excel; <a href="http://www.pharmpk.com/soft.html" class="extLink">http://www.pharmpk.com/soft.html</a> (accessed March, 2015).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Usansky%2C+J.+I.%3B+Desai%2C+A.%3B+Tang-Liu%2C+D.PK+functions+for+Microsoft+Excel%3B+http%3A%2F%2Fwww.pharmpk.com%2Fsoft.html+%28accessed+March%2C+2015%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26aulast%3DUsansky%26aufirst%3DJ.%2BI.%26jtitle%3DPK%2520functions%2520for%2520Microsoft%2520Excel" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span>ACD/Structure Designer, <span class="NLM_edition">version 12.01</span>; <span class="NLM_publisher-name">Advanced Chemistry Development, Inc.</span>: <span class="NLM_publisher-loc">Toronto, ON, Canada</span>,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=ACD%2FStructure+Designer%2C+version+12.01%3B+Advanced+Chemistry+Development%2C+Inc.%3A+Toronto%2C+ON%2C+Canada%2C+2012."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DACD%252FStructure%2520Designer%26pub%3DAdvanced%2520Chemistry%2520Development%252C%2520Inc%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3H9F" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3H9F','PDB','3H9F'); return false;">PDB: 3H9F</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JT3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4JT3','PDB','4JT3'); return false;">PDB: 4JT3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O6L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O6L','PDB','4O6L'); return false;">PDB: 4O6L</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CEK" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3CEK','PDB','3CEK'); return false;">PDB: 3CEK</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i100"><a href="/doi/suppl/10.1021/jm501740a">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_20664"></div></div></div></div></div><hr /></hr><p class="last">Synthesis of compound intermediates; double reciprocal plot of TTK inhibition by compound <b>75</b>; inhibition of 278 kinase panel by <b>75</b>; summary of crystallographic data and refinement statistics for TTK-compound <b>51</b> co-complex (PDB accession code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4O6L">4O6L</a>); omit map for TTK–compound <b>51</b> co-complex; correlation of pIC<sub>50</sub>(TTK) vs GlideXP docking scores (<i>n</i> = 86); cell seeding data for cancer cell lines; early ADME data for compound <b>75</b>; mouse weights upon oral QD dosing of compounds <b>69</b>, <b>75</b>, and <b>86</b>.  This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm501740a/suppl_file/jm501740a_si_001.pdf">jm501740a_si_001.pdf (1.44 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm501740a&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2015.58.issue-8%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm501740a%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm501740a" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799666d2f263c10","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
